Secondary capillary rarefaction in pregnancy: can it ...



Effects of Candesartan versus Amlodipine on Capillary Rarefaction, pulse wave velocity, and central blood pressure in patients with Essential Hypertension1Rajendra P Raghuraman, MSc, 2Christine Carney, RGN, 2Helen Mullahy, RGN, 2Oluwabusola Ogunseitan, RGN, 3Duolao Wang, PhD, 1,2Tarek F Antonios, MD FESC FRCP 1 Vascular Biology Research Centre, Molecular & Clinical Sciences Research Institute, St. George’s, University of London, 2 Blood Pressure Unit, St George’s University Hospitals NHS Foundation Trust, London, and 3 Biostatistics Unit, Department of Clinical Sciences, Liverpool School of Tropical Medicine, United KingdomRunning Title: ARB Effects on microcirculation (CAMIRA study)Funding: Takeda UK Correspondence: Dr Tarek F AntoniosVascular Biology Research Centre, Molecular & Clinical Sciences Research Institute, St. George’s, University of London, London SW17 0RE, UKEmail: t.antonios@sgul.ac.uk Tel: +44 208 725 5627 Fax: +44 208 725 2722Trial registration: (EudraCT: 2008-005432-32, ISRCTN 62554526)?Abstract:BACKGROUND: A reduction in the density of capillaries (rarefaction) is known to occur in many tissues in patients with essential hypertension and play a role in increasing blood pressure (BP). The aim of this trial was to assess in a randomized, double blind, design the effects of treatment of hypertension with candesartan versus amlodipine on microvascular rarefaction and other indices of vascular function. Methods: We recruited twenty-two individuals with mild-to-moderate hypertension. After a 2-week placebo run-in period, patients who remained hypertensive (≥ 140/90 mmHg) were randomized to 8-weeks treatment with candesartan tablets 8mg daily (with forced titration to 16mg) or amlodipine tablets 5mg daily (with forced titration to 10mg). The capillary microcirculation was studied using CapiScope system CAM1. Pulse wave velocity, central BP and aortic Augmentation Index were also measured. Results: We observed significant reductions in brachial BP, and central BP after 4 and 8 weeks treatment with either candesartan or amlodipine but there was no significant effect on basal (functional) or maximal (structural) capillary densities, or pulse wave velocity. Conclusions: Eight weeks treatment of hypertension with either amlodipine or candesartan significantly reduced brachial and central BP but was not sufficient to induce a regression in functional or structural microvascular abnormalities. Keywords: Capillary density, capillary rarefaction, microcirculation, hypertension, candesartan, amlodipineTrial registration: (EudraCT: 2008-005432-32, ISRCTN 62554526)?List of AbbreviationsAI = Aortic Augmentation IndexARB = Angiotensin receptor blocker ACEi = Angiotensin converting enzyme inhibitorBCD = Basal capillary densityBP = Blood pressureCCB = Calcium channel blocker CI = Confidence intervalscSBP = Central Aortic PressureECG= ElectrocardiogramMCD = Maximal capillary densityPWV = Pulse Wave Velocity SHR = Spontaneously hypertensive ratsSE = Standard error Introduction:Increasing evidence suggests a crucial role for the microcirculation in the causation of hypertension and cardiovascular disease. ADDIN EN.CITE <EndNote><Cite><Author>Gavin</Author><Year>1998</Year><RecNum>15355</RecNum><DisplayText><style face="superscript">1</style></DisplayText><record><rec-number>15355</rec-number><foreign-keys><key app="EN" db-id="ztzasxe5cs00v4efwrpvftrwtafzwe22xezt" timestamp="1440515407">15355</key></foreign-keys><ref-type name="Journal Article">17</ref-type><contributors><authors><author>Gavin, J. B.</author><author>Maxwell, L.</author><author>Edgar, S. G.</author></authors></contributors><auth-address>Department of Pathology, University of Auckland, New Zealand.</auth-address><titles><title>Microvascular involvement in cardiac pathology</title><secondary-title>J Mol Cell Cardiol</secondary-title></titles><periodical><full-title>J Mol Cell Cardiol</full-title></periodical><pages>2531-40</pages><volume>30</volume><number>12</number><keywords><keyword>Cardiomyopathies/pathology</keyword><keyword>Heart Defects, Congenital/pathology</keyword><keyword>Heart Diseases/etiology/*pathology</keyword><keyword>Heart Failure/pathology</keyword><keyword>Humans</keyword><keyword>Hypertension, Renovascular/pathology</keyword><keyword>Hypertrophy/pathology</keyword><keyword>Microcirculation/*pathology</keyword><keyword>Myocardial Ischemia/pathology</keyword><keyword>Myocarditis/pathology</keyword></keywords><dates><year>1998</year><pub-dates><date>Dec</date></pub-dates></dates><isbn>0022-2828 (Print)&#xD;0022-2828 (Linking)</isbn><accession-num>9990524</accession-num><urls><related-urls><url> Impaired tissue perfusion secondary to microcirculatory abnormalities is also implicated in the pathogenesis of obesity, diabetes mellitus, and insulin resistance. ADDIN EN.CITE <EndNote><Cite><Author>Levy</Author><Year>2008</Year><RecNum>12053</RecNum><DisplayText><style face="superscript">2</style></DisplayText><record><rec-number>12053</rec-number><foreign-keys><key app="EN" db-id="ztzasxe5cs00v4efwrpvftrwtafzwe22xezt" timestamp="1382954401">12053</key></foreign-keys><ref-type name="Journal Article">17</ref-type><contributors><authors><author>Levy, B. I.</author><author>Schiffrin, E. L.</author><author>Mourad, J. J.</author><author>Agostini, D.</author><author>Vicaut, E.</author><author>Safar, M. E.</author><author>Struijker-Boudier, H. A.</author></authors></contributors><auth-address>Centre de Recherche Cardiovasculaire de Lariboisiere, INSERM U689, Service d&apos;Explorations Fonctionnelles, Hopital Lariboisiere, Paris, France. levy@larib.inserm.fr</auth-address><titles><title>Impaired tissue perfusion: a pathology common to hypertension, obesity, and diabetes mellitus</title><secondary-title>Circulation</secondary-title></titles><periodical><full-title>Circulation</full-title></periodical><pages>968-976</pages><volume>118</volume><number>9</number><keywords><keyword>Diabetic Angiopathies/epidemiology/*physiopathology/therapy</keyword><keyword>Humans</keyword><keyword>Hypertension/epidemiology/*physiopathology/therapy</keyword><keyword>Microcirculation/pathology/*physiology</keyword><keyword>Obesity/epidemiology/*physiopathology/therapy</keyword><keyword>Risk Factors</keyword><keyword>Vascular Resistance/physiology</keyword></keywords><dates><year>2008</year><pub-dates><date>Aug 26</date></pub-dates></dates><accession-num>18725503</accession-num><urls><related-urls><url> A reduction in the density (rarefaction) of capillaries and arterioles is a consistent finding among the many functional and structural microcirculatory abnormalities that occur in human hypertension. ADDIN EN.CITE <EndNote><Cite><Author>Struijker Boudier</Author><Year>1992</Year><RecNum>9078</RecNum><DisplayText><style face="superscript">3</style></DisplayText><record><rec-number>9078</rec-number><foreign-keys><key app="EN" db-id="ztzasxe5cs00v4efwrpvftrwtafzwe22xezt" timestamp="1382954400">9078</key></foreign-keys><ref-type name="Journal Article">17</ref-type><contributors><authors><author>Struijker Boudier, H. A.</author><author>le Noble, J. L.</author><author>Messing, M. W.</author><author>Huijberts, M. S.</author><author>le Noble, F. A.</author><author>van Essen, H.</author></authors></contributors><titles><title>The microcirculation and hypertension</title><secondary-title>J Hypertens Suppl</secondary-title></titles><periodical><full-title>J Hypertens Suppl</full-title></periodical><pages>S147-S156</pages><volume>10</volume><number>7</number><keywords><keyword>Animal</keyword><keyword>Arterioles/pathology/physiology</keyword><keyword>Human</keyword><keyword>Hypertension/*physiopathology</keyword><keyword>Hypertrophy</keyword><keyword>Microcirculation/*physiopathology</keyword><keyword>Vascular Resistance/physiology</keyword></keywords><dates><year>1992</year></dates><label>93180035</label><urls></urls></record></Cite></EndNote>3 We have previously shown that much of the capillary rarefaction in hypertension is due to the structural (i.e. anatomic) absence of capillaries. ADDIN EN.CITE <EndNote><Cite><Author>Antonios</Author><Year>1999</Year><RecNum>10278</RecNum><DisplayText><style face="superscript">4</style></DisplayText><record><rec-number>10278</rec-number><foreign-keys><key app="EN" db-id="ztzasxe5cs00v4efwrpvftrwtafzwe22xezt" timestamp="1382954400">10278</key></foreign-keys><ref-type name="Journal Article">17</ref-type><contributors><authors><author>Antonios, T. F. T.</author><author>Singer, D. R.</author><author>Markandu, N. D.</author><author>Mortimer, P. S.</author><author>MacGregor, G. A.</author></authors></contributors><titles><title>Structural skin capillary rarefaction in essential hypertension</title><secondary-title>Hypertension</secondary-title></titles><periodical><full-title>Hypertension</full-title></periodical><pages>998-1001</pages><volume>33</volume><number>4</number><keywords><keyword>Adult</keyword><keyword>Aged</keyword><keyword>Capillaries/pathology</keyword><keyword>Female</keyword><keyword>Human</keyword><keyword>Hypertension/etiology/*pathology/physiopathology</keyword><keyword>Male</keyword><keyword>Middle Age</keyword><keyword>Neovascularization, Physiologic</keyword><keyword>Skin/*blood supply</keyword><keyword>Vascular Resistance</keyword></keywords><dates><year>1999</year></dates><label>99221718</label><urls><related-urls><url> We have also shown significant capillary rarefaction in patients with borderline intermittent hypertension ADDIN EN.CITE <EndNote><Cite><Author>Antonios</Author><Year>1999</Year><RecNum>10863</RecNum><DisplayText><style face="superscript">5</style></DisplayText><record><rec-number>10863</rec-number><foreign-keys><key app="EN" db-id="ztzasxe5cs00v4efwrpvftrwtafzwe22xezt" timestamp="1382954400">10863</key></foreign-keys><ref-type name="Journal Article">17</ref-type><contributors><authors><author>Antonios, T. F. T.</author><author>Singer, D. R.</author><author>Markandu, N. D.</author><author>Mortimer, P. S.</author><author>MacGregor, G. A.</author></authors></contributors><titles><title>Rarefaction of skin capillaries in borderline essential hypertension suggests an early structural abnormality</title><secondary-title>Hypertension</secondary-title></titles><periodical><full-title>Hypertension</full-title></periodical><pages>655-658</pages><volume>34</volume><number>4 Pt 1</number><dates><year>1999</year></dates><label>99452826</label><urls><related-urls><url> as well as in normotensive offspring of hypertensive parents suggesting that capillary rarefaction may be a primary abnormality that precedes the onset of hypertension.PEVuZE5vdGU+PENpdGU+PEF1dGhvcj5BbnRvbmlvczwvQXV0aG9yPjxZZWFyPjIwMDM8L1llYXI+

PFJlY051bT4xMTQ4MjwvUmVjTnVtPjxEaXNwbGF5VGV4dD48c3R5bGUgZmFjZT0ic3VwZXJzY3Jp

cHQiPjYsIDc8L3N0eWxlPjwvRGlzcGxheVRleHQ+PHJlY29yZD48cmVjLW51bWJlcj4xMTQ4Mjwv

cmVjLW51bWJlcj48Zm9yZWlnbi1rZXlzPjxrZXkgYXBwPSJFTiIgZGItaWQ9Inp0emFzeGU1Y3Mw

MHY0ZWZ3cnB2ZnRyd3RhZnp3ZTIyeGV6dCIgdGltZXN0YW1wPSIxMzgyOTU0NDAxIj4xMTQ4Mjwv

a2V5PjwvZm9yZWlnbi1rZXlzPjxyZWYtdHlwZSBuYW1lPSJKb3VybmFsIEFydGljbGUiPjE3PC9y

ZWYtdHlwZT48Y29udHJpYnV0b3JzPjxhdXRob3JzPjxhdXRob3I+QW50b25pb3MsIFQuIEYuPC9h

dXRob3I+PGF1dGhvcj5SYXR0cmF5LCBGLiBNLjwvYXV0aG9yPjxhdXRob3I+U2luZ2VyLCBELiBS

LjwvYXV0aG9yPjxhdXRob3I+TWFya2FuZHUsIE4uIEQuPC9hdXRob3I+PGF1dGhvcj5Nb3J0aW1l

ciwgUC4gUy48L2F1dGhvcj48YXV0aG9yPk1hY0dyZWdvciwgRy4gQS48L2F1dGhvcj48L2F1dGhv

cnM+PC9jb250cmlidXRvcnM+PGF1dGgtYWRkcmVzcz5CbG9vZCBQcmVzc3VyZSBVbml0LCBTdCBH

ZW9yZ2UmYXBvcztzIEhvc3BpdGFsIE1lZGljYWwgU2Nob29sLCBMb25kb24sIFVLLiB0LmFudG9u

aW9zQHNnaG1zLmFjLnVrPC9hdXRoLWFkZHJlc3M+PHRpdGxlcz48dGl0bGU+UmFyZWZhY3Rpb24g

b2Ygc2tpbiBjYXBpbGxhcmllcyBpbiBub3Jtb3RlbnNpdmUgb2Zmc3ByaW5nIG9mIGluZGl2aWR1

YWxzIHdpdGggZXNzZW50aWFsIGh5cGVydGVuc2lvbjwvdGl0bGU+PHNlY29uZGFyeS10aXRsZT5I

ZWFydDwvc2Vjb25kYXJ5LXRpdGxlPjwvdGl0bGVzPjxwZXJpb2RpY2FsPjxmdWxsLXRpdGxlPkhl

YXJ0PC9mdWxsLXRpdGxlPjwvcGVyaW9kaWNhbD48cGFnZXM+MTc1LTE3ODwvcGFnZXM+PHZvbHVt

ZT44OTwvdm9sdW1lPjxudW1iZXI+MjwvbnVtYmVyPjxkYXRlcz48eWVhcj4yMDAzPC95ZWFyPjxw

dWItZGF0ZXM+PGRhdGU+RmViPC9kYXRlPjwvcHViLWRhdGVzPjwvZGF0ZXM+PGFjY2Vzc2lvbi1u

dW0+MTI1Mjc2NzE8L2FjY2Vzc2lvbi1udW0+PHVybHM+PHJlbGF0ZWQtdXJscz48dXJsPmh0dHA6

Ly93d3cubmNiaS5ubG0ubmloLmdvdi9lbnRyZXovcXVlcnkuZmNnaT9jbWQ9UmV0cmlldmUmYW1w

O2RiPVB1Yk1lZCZhbXA7ZG9wdD1DaXRhdGlvbiZhbXA7bGlzdF91aWRzPTEyNTI3NjcxPC91cmw+

PC9yZWxhdGVkLXVybHM+PC91cmxzPjwvcmVjb3JkPjwvQ2l0ZT48Q2l0ZT48QXV0aG9yPkFudG9u

aW9zPC9BdXRob3I+PFllYXI+MjAxMjwvWWVhcj48UmVjTnVtPjE0MjI4PC9SZWNOdW0+PHJlY29y

ZD48cmVjLW51bWJlcj4xNDIyODwvcmVjLW51bWJlcj48Zm9yZWlnbi1rZXlzPjxrZXkgYXBwPSJF

TiIgZGItaWQ9Inp0emFzeGU1Y3MwMHY0ZWZ3cnB2ZnRyd3RhZnp3ZTIyeGV6dCIgdGltZXN0YW1w

PSIxMzkwOTg4MzQzIj4xNDIyODwva2V5PjwvZm9yZWlnbi1rZXlzPjxyZWYtdHlwZSBuYW1lPSJK

b3VybmFsIEFydGljbGUiPjE3PC9yZWYtdHlwZT48Y29udHJpYnV0b3JzPjxhdXRob3JzPjxhdXRo

b3I+QW50b25pb3MsIFQuIEYuPC9hdXRob3I+PGF1dGhvcj5SYWdodXJhbWFuLCBSLiBQLjwvYXV0

aG9yPjxhdXRob3I+RCZhcG9zO1NvdXphLCBSLjwvYXV0aG9yPjxhdXRob3I+TmF0aGFuLCBQLjwv

YXV0aG9yPjxhdXRob3I+V2FuZywgRC48L2F1dGhvcj48YXV0aG9yPk1hbnlvbmRhLCBJLiBULjwv

YXV0aG9yPjwvYXV0aG9ycz48L2NvbnRyaWJ1dG9ycz48YXV0aC1hZGRyZXNzPkJsb29kIFByZXNz

dXJlIFVuaXQgJmFtcDsgRGVwYXJ0bWVudCBvZiBDbGluaWNhbCBTY2llbmNlcywgU3QuIEdlb3Jn

ZSZhcG9zO3MsIFVuaXZlcnNpdHkgb2YgTG9uZG9uLCBMb25kb24sIFVLLiB0LmFudG9uaW9zQHNn

dWwuYWMudWs8L2F1dGgtYWRkcmVzcz48dGl0bGVzPjx0aXRsZT5DYXBpbGxhcnkgcmVtb2RlbGlu

ZyBpbiBpbmZhbnRzIGJvcm4gdG8gaHlwZXJ0ZW5zaXZlIHByZWduYW5jeTogcGlsb3Qgc3R1ZHk8

L3RpdGxlPjxzZWNvbmRhcnktdGl0bGU+QW0gSiBIeXBlcnRlbnM8L3NlY29uZGFyeS10aXRsZT48

YWx0LXRpdGxlPkFtZXJpY2FuIGpvdXJuYWwgb2YgaHlwZXJ0ZW5zaW9uPC9hbHQtdGl0bGU+PC90

aXRsZXM+PHBlcmlvZGljYWw+PGZ1bGwtdGl0bGU+QW0gSiBIeXBlcnRlbnM8L2Z1bGwtdGl0bGU+

PC9wZXJpb2RpY2FsPjxhbHQtcGVyaW9kaWNhbD48ZnVsbC10aXRsZT5BbWVyaWNhbiBKb3VybmFs

IG9mIEh5cGVydGVuc2lvbjwvZnVsbC10aXRsZT48YWJici0xPkFtIEogSHlwZXJ0ZW5zPC9hYmJy

LTE+PC9hbHQtcGVyaW9kaWNhbD48cGFnZXM+ODQ4LTUzPC9wYWdlcz48dm9sdW1lPjI1PC92b2x1

bWU+PG51bWJlcj44PC9udW1iZXI+PGVkaXRpb24+MjAxMi8wNS8xMTwvZWRpdGlvbj48a2V5d29y

ZHM+PGtleXdvcmQ+QWR1bHQ8L2tleXdvcmQ+PGtleXdvcmQ+Q2FwaWxsYXJpZXMvYWJub3JtYWxp

dGllcy8qcGh5c2lvcGF0aG9sb2d5PC9rZXl3b3JkPjxrZXl3b3JkPkZlbWFsZTwva2V5d29yZD48

a2V5d29yZD5IdW1hbnM8L2tleXdvcmQ+PGtleXdvcmQ+SHlwZXJ0ZW5zaW9uLypwaHlzaW9wYXRo

b2xvZ3k8L2tleXdvcmQ+PGtleXdvcmQ+SW5mYW50LCBMb3cgQmlydGggV2VpZ2h0PC9rZXl3b3Jk

PjxrZXl3b3JkPkluZmFudCwgTmV3Ym9ybjwva2V5d29yZD48a2V5d29yZD5JbmZhbnQsIFByZW1h

dHVyZTwva2V5d29yZD48a2V5d29yZD5NaWNyb2NpcmN1bGF0aW9uLypwaHlzaW9sb2d5PC9rZXl3

b3JkPjxrZXl3b3JkPlBpbG90IFByb2plY3RzPC9rZXl3b3JkPjxrZXl3b3JkPlByZWduYW5jeTwv

a2V5d29yZD48a2V5d29yZD5QcmVnbmFuY3kgQ29tcGxpY2F0aW9ucywgQ2FyZGlvdmFzY3VsYXIv

KnBoeXNpb3BhdGhvbG9neTwva2V5d29yZD48a2V5d29yZD5Ta2luLypibG9vZCBzdXBwbHk8L2tl

eXdvcmQ+PGtleXdvcmQ+VG9lcy9ibG9vZCBzdXBwbHk8L2tleXdvcmQ+PC9rZXl3b3Jkcz48ZGF0

ZXM+PHllYXI+MjAxMjwveWVhcj48cHViLWRhdGVzPjxkYXRlPkF1ZzwvZGF0ZT48L3B1Yi1kYXRl

cz48L2RhdGVzPjxpc2JuPjE5NDEtNzIyNSAoRWxlY3Ryb25pYykmI3hEOzA4OTUtNzA2MSAoTGlu

a2luZyk8L2lzYm4+PGFjY2Vzc2lvbi1udW0+MjI1NzMwMTM8L2FjY2Vzc2lvbi1udW0+PHVybHM+

PHJlbGF0ZWQtdXJscz48dXJsPmh0dHA6Ly93d3cubmNiaS5ubG0ubmloLmdvdi9wdWJtZWQvMjI1

NzMwMTM8L3VybD48L3JlbGF0ZWQtdXJscz48L3VybHM+PGVsZWN0cm9uaWMtcmVzb3VyY2UtbnVt

PjEwLjEwMzgvYWpoLjIwMTIuNTE8L2VsZWN0cm9uaWMtcmVzb3VyY2UtbnVtPjwvcmVjb3JkPjwv

Q2l0ZT48L0VuZE5vdGU+

ADDIN EN.CITE PEVuZE5vdGU+PENpdGU+PEF1dGhvcj5BbnRvbmlvczwvQXV0aG9yPjxZZWFyPjIwMDM8L1llYXI+

PFJlY051bT4xMTQ4MjwvUmVjTnVtPjxEaXNwbGF5VGV4dD48c3R5bGUgZmFjZT0ic3VwZXJzY3Jp

cHQiPjYsIDc8L3N0eWxlPjwvRGlzcGxheVRleHQ+PHJlY29yZD48cmVjLW51bWJlcj4xMTQ4Mjwv

cmVjLW51bWJlcj48Zm9yZWlnbi1rZXlzPjxrZXkgYXBwPSJFTiIgZGItaWQ9Inp0emFzeGU1Y3Mw

MHY0ZWZ3cnB2ZnRyd3RhZnp3ZTIyeGV6dCIgdGltZXN0YW1wPSIxMzgyOTU0NDAxIj4xMTQ4Mjwv

a2V5PjwvZm9yZWlnbi1rZXlzPjxyZWYtdHlwZSBuYW1lPSJKb3VybmFsIEFydGljbGUiPjE3PC9y

ZWYtdHlwZT48Y29udHJpYnV0b3JzPjxhdXRob3JzPjxhdXRob3I+QW50b25pb3MsIFQuIEYuPC9h

dXRob3I+PGF1dGhvcj5SYXR0cmF5LCBGLiBNLjwvYXV0aG9yPjxhdXRob3I+U2luZ2VyLCBELiBS

LjwvYXV0aG9yPjxhdXRob3I+TWFya2FuZHUsIE4uIEQuPC9hdXRob3I+PGF1dGhvcj5Nb3J0aW1l

ciwgUC4gUy48L2F1dGhvcj48YXV0aG9yPk1hY0dyZWdvciwgRy4gQS48L2F1dGhvcj48L2F1dGhv

cnM+PC9jb250cmlidXRvcnM+PGF1dGgtYWRkcmVzcz5CbG9vZCBQcmVzc3VyZSBVbml0LCBTdCBH

ZW9yZ2UmYXBvcztzIEhvc3BpdGFsIE1lZGljYWwgU2Nob29sLCBMb25kb24sIFVLLiB0LmFudG9u

aW9zQHNnaG1zLmFjLnVrPC9hdXRoLWFkZHJlc3M+PHRpdGxlcz48dGl0bGU+UmFyZWZhY3Rpb24g

b2Ygc2tpbiBjYXBpbGxhcmllcyBpbiBub3Jtb3RlbnNpdmUgb2Zmc3ByaW5nIG9mIGluZGl2aWR1

YWxzIHdpdGggZXNzZW50aWFsIGh5cGVydGVuc2lvbjwvdGl0bGU+PHNlY29uZGFyeS10aXRsZT5I

ZWFydDwvc2Vjb25kYXJ5LXRpdGxlPjwvdGl0bGVzPjxwZXJpb2RpY2FsPjxmdWxsLXRpdGxlPkhl

YXJ0PC9mdWxsLXRpdGxlPjwvcGVyaW9kaWNhbD48cGFnZXM+MTc1LTE3ODwvcGFnZXM+PHZvbHVt

ZT44OTwvdm9sdW1lPjxudW1iZXI+MjwvbnVtYmVyPjxkYXRlcz48eWVhcj4yMDAzPC95ZWFyPjxw

dWItZGF0ZXM+PGRhdGU+RmViPC9kYXRlPjwvcHViLWRhdGVzPjwvZGF0ZXM+PGFjY2Vzc2lvbi1u

dW0+MTI1Mjc2NzE8L2FjY2Vzc2lvbi1udW0+PHVybHM+PHJlbGF0ZWQtdXJscz48dXJsPmh0dHA6

Ly93d3cubmNiaS5ubG0ubmloLmdvdi9lbnRyZXovcXVlcnkuZmNnaT9jbWQ9UmV0cmlldmUmYW1w

O2RiPVB1Yk1lZCZhbXA7ZG9wdD1DaXRhdGlvbiZhbXA7bGlzdF91aWRzPTEyNTI3NjcxPC91cmw+

PC9yZWxhdGVkLXVybHM+PC91cmxzPjwvcmVjb3JkPjwvQ2l0ZT48Q2l0ZT48QXV0aG9yPkFudG9u

aW9zPC9BdXRob3I+PFllYXI+MjAxMjwvWWVhcj48UmVjTnVtPjE0MjI4PC9SZWNOdW0+PHJlY29y

ZD48cmVjLW51bWJlcj4xNDIyODwvcmVjLW51bWJlcj48Zm9yZWlnbi1rZXlzPjxrZXkgYXBwPSJF

TiIgZGItaWQ9Inp0emFzeGU1Y3MwMHY0ZWZ3cnB2ZnRyd3RhZnp3ZTIyeGV6dCIgdGltZXN0YW1w

PSIxMzkwOTg4MzQzIj4xNDIyODwva2V5PjwvZm9yZWlnbi1rZXlzPjxyZWYtdHlwZSBuYW1lPSJK

b3VybmFsIEFydGljbGUiPjE3PC9yZWYtdHlwZT48Y29udHJpYnV0b3JzPjxhdXRob3JzPjxhdXRo

b3I+QW50b25pb3MsIFQuIEYuPC9hdXRob3I+PGF1dGhvcj5SYWdodXJhbWFuLCBSLiBQLjwvYXV0

aG9yPjxhdXRob3I+RCZhcG9zO1NvdXphLCBSLjwvYXV0aG9yPjxhdXRob3I+TmF0aGFuLCBQLjwv

YXV0aG9yPjxhdXRob3I+V2FuZywgRC48L2F1dGhvcj48YXV0aG9yPk1hbnlvbmRhLCBJLiBULjwv

YXV0aG9yPjwvYXV0aG9ycz48L2NvbnRyaWJ1dG9ycz48YXV0aC1hZGRyZXNzPkJsb29kIFByZXNz

dXJlIFVuaXQgJmFtcDsgRGVwYXJ0bWVudCBvZiBDbGluaWNhbCBTY2llbmNlcywgU3QuIEdlb3Jn

ZSZhcG9zO3MsIFVuaXZlcnNpdHkgb2YgTG9uZG9uLCBMb25kb24sIFVLLiB0LmFudG9uaW9zQHNn

dWwuYWMudWs8L2F1dGgtYWRkcmVzcz48dGl0bGVzPjx0aXRsZT5DYXBpbGxhcnkgcmVtb2RlbGlu

ZyBpbiBpbmZhbnRzIGJvcm4gdG8gaHlwZXJ0ZW5zaXZlIHByZWduYW5jeTogcGlsb3Qgc3R1ZHk8

L3RpdGxlPjxzZWNvbmRhcnktdGl0bGU+QW0gSiBIeXBlcnRlbnM8L3NlY29uZGFyeS10aXRsZT48

YWx0LXRpdGxlPkFtZXJpY2FuIGpvdXJuYWwgb2YgaHlwZXJ0ZW5zaW9uPC9hbHQtdGl0bGU+PC90

aXRsZXM+PHBlcmlvZGljYWw+PGZ1bGwtdGl0bGU+QW0gSiBIeXBlcnRlbnM8L2Z1bGwtdGl0bGU+

PC9wZXJpb2RpY2FsPjxhbHQtcGVyaW9kaWNhbD48ZnVsbC10aXRsZT5BbWVyaWNhbiBKb3VybmFs

IG9mIEh5cGVydGVuc2lvbjwvZnVsbC10aXRsZT48YWJici0xPkFtIEogSHlwZXJ0ZW5zPC9hYmJy

LTE+PC9hbHQtcGVyaW9kaWNhbD48cGFnZXM+ODQ4LTUzPC9wYWdlcz48dm9sdW1lPjI1PC92b2x1

bWU+PG51bWJlcj44PC9udW1iZXI+PGVkaXRpb24+MjAxMi8wNS8xMTwvZWRpdGlvbj48a2V5d29y

ZHM+PGtleXdvcmQ+QWR1bHQ8L2tleXdvcmQ+PGtleXdvcmQ+Q2FwaWxsYXJpZXMvYWJub3JtYWxp

dGllcy8qcGh5c2lvcGF0aG9sb2d5PC9rZXl3b3JkPjxrZXl3b3JkPkZlbWFsZTwva2V5d29yZD48

a2V5d29yZD5IdW1hbnM8L2tleXdvcmQ+PGtleXdvcmQ+SHlwZXJ0ZW5zaW9uLypwaHlzaW9wYXRo

b2xvZ3k8L2tleXdvcmQ+PGtleXdvcmQ+SW5mYW50LCBMb3cgQmlydGggV2VpZ2h0PC9rZXl3b3Jk

PjxrZXl3b3JkPkluZmFudCwgTmV3Ym9ybjwva2V5d29yZD48a2V5d29yZD5JbmZhbnQsIFByZW1h

dHVyZTwva2V5d29yZD48a2V5d29yZD5NaWNyb2NpcmN1bGF0aW9uLypwaHlzaW9sb2d5PC9rZXl3

b3JkPjxrZXl3b3JkPlBpbG90IFByb2plY3RzPC9rZXl3b3JkPjxrZXl3b3JkPlByZWduYW5jeTwv

a2V5d29yZD48a2V5d29yZD5QcmVnbmFuY3kgQ29tcGxpY2F0aW9ucywgQ2FyZGlvdmFzY3VsYXIv

KnBoeXNpb3BhdGhvbG9neTwva2V5d29yZD48a2V5d29yZD5Ta2luLypibG9vZCBzdXBwbHk8L2tl

eXdvcmQ+PGtleXdvcmQ+VG9lcy9ibG9vZCBzdXBwbHk8L2tleXdvcmQ+PC9rZXl3b3Jkcz48ZGF0

ZXM+PHllYXI+MjAxMjwveWVhcj48cHViLWRhdGVzPjxkYXRlPkF1ZzwvZGF0ZT48L3B1Yi1kYXRl

cz48L2RhdGVzPjxpc2JuPjE5NDEtNzIyNSAoRWxlY3Ryb25pYykmI3hEOzA4OTUtNzA2MSAoTGlu

a2luZyk8L2lzYm4+PGFjY2Vzc2lvbi1udW0+MjI1NzMwMTM8L2FjY2Vzc2lvbi1udW0+PHVybHM+

PHJlbGF0ZWQtdXJscz48dXJsPmh0dHA6Ly93d3cubmNiaS5ubG0ubmloLmdvdi9wdWJtZWQvMjI1

NzMwMTM8L3VybD48L3JlbGF0ZWQtdXJscz48L3VybHM+PGVsZWN0cm9uaWMtcmVzb3VyY2UtbnVt

PjEwLjEwMzgvYWpoLjIwMTIuNTE8L2VsZWN0cm9uaWMtcmVzb3VyY2UtbnVtPjwvcmVjb3JkPjwv

Q2l0ZT48L0VuZE5vdGU+

ADDIN EN.CITE.DATA 6, 7 Furthermore we have recently demonstrated that alterations in structural capillary density in early pregnancy can accurately and independently predict preeclampsia.PEVuZE5vdGU+PENpdGU+PEF1dGhvcj5BbnRvbmlvczwvQXV0aG9yPjxZZWFyPjIwMTM8L1llYXI+

PFJlY051bT4xMjU1MDwvUmVjTnVtPjxEaXNwbGF5VGV4dD48c3R5bGUgZmFjZT0ic3VwZXJzY3Jp

cHQiPjgsIDk8L3N0eWxlPjwvRGlzcGxheVRleHQ+PHJlY29yZD48cmVjLW51bWJlcj4xMjU1MDwv

cmVjLW51bWJlcj48Zm9yZWlnbi1rZXlzPjxrZXkgYXBwPSJFTiIgZGItaWQ9Inp0emFzeGU1Y3Mw

MHY0ZWZ3cnB2ZnRyd3RhZnp3ZTIyeGV6dCIgdGltZXN0YW1wPSIxMzgzMDQ3Mjk4Ij4xMjU1MDwv

a2V5PjwvZm9yZWlnbi1rZXlzPjxyZWYtdHlwZSBuYW1lPSJKb3VybmFsIEFydGljbGUiPjE3PC9y

ZWYtdHlwZT48Y29udHJpYnV0b3JzPjxhdXRob3JzPjxhdXRob3I+QW50b25pb3MsIFQuIEYuPC9h

dXRob3I+PGF1dGhvcj5OYW1hLCBWLjwvYXV0aG9yPjxhdXRob3I+V2FuZywgRC48L2F1dGhvcj48

YXV0aG9yPk1hbnlvbmRhLCBJLiBULjwvYXV0aG9yPjwvYXV0aG9ycz48L2NvbnRyaWJ1dG9ycz48

YXV0aC1hZGRyZXNzPkJsb29kIFByZXNzdXJlIFVuaXQgJmFtcDsgRGl2aXNpb24gb2YgQ2xpbmlj

YWwgU2NpZW5jZXMsIFN0IEdlb3JnZSZhcG9zO3MsIFVuaXZlcnNpdHkgb2YgTG9uZG9uLCBMb25k

b24sIFVLLjwvYXV0aC1hZGRyZXNzPjx0aXRsZXM+PHRpdGxlPk1pY3JvdmFzY3VsYXIgcmVtb2Rl

bGxpbmcgaW4gcHJlZWNsYW1wc2lhOiBxdWFudGlmeWluZyBjYXBpbGxhcnkgcmFyZWZhY3Rpb24g

YWNjdXJhdGVseSBhbmQgaW5kZXBlbmRlbnRseSBwcmVkaWN0cyBwcmVlY2xhbXBzaWE8L3RpdGxl

PjxzZWNvbmRhcnktdGl0bGU+QW0gSiBIeXBlcnRlbnM8L3NlY29uZGFyeS10aXRsZT48YWx0LXRp

dGxlPkFtZXJpY2FuIGpvdXJuYWwgb2YgaHlwZXJ0ZW5zaW9uPC9hbHQtdGl0bGU+PC90aXRsZXM+

PHBlcmlvZGljYWw+PGZ1bGwtdGl0bGU+QW0gSiBIeXBlcnRlbnM8L2Z1bGwtdGl0bGU+PC9wZXJp

b2RpY2FsPjxhbHQtcGVyaW9kaWNhbD48ZnVsbC10aXRsZT5BbWVyaWNhbiBKb3VybmFsIG9mIEh5

cGVydGVuc2lvbjwvZnVsbC10aXRsZT48YWJici0xPkFtIEogSHlwZXJ0ZW5zPC9hYmJyLTE+PC9h

bHQtcGVyaW9kaWNhbD48cGFnZXM+MTE2Mi05PC9wYWdlcz48dm9sdW1lPjI2PC92b2x1bWU+PG51

bWJlcj45PC9udW1iZXI+PGRhdGVzPjx5ZWFyPjIwMTM8L3llYXI+PHB1Yi1kYXRlcz48ZGF0ZT5T

ZXA8L2RhdGU+PC9wdWItZGF0ZXM+PC9kYXRlcz48aXNibj4xOTQxLTcyMjUgKEVsZWN0cm9uaWMp

JiN4RDswODk1LTcwNjEgKExpbmtpbmcpPC9pc2JuPjxhY2Nlc3Npb24tbnVtPjIzNzU3NDAxPC9h

Y2Nlc3Npb24tbnVtPjx1cmxzPjxyZWxhdGVkLXVybHM+PHVybD5odHRwOi8vd3d3Lm5jYmkubmxt

Lm5paC5nb3YvcHVibWVkLzIzNzU3NDAxPC91cmw+PC9yZWxhdGVkLXVybHM+PC91cmxzPjxlbGVj

dHJvbmljLXJlc291cmNlLW51bT4xMC4xMDkzL2FqaC9ocHQwODc8L2VsZWN0cm9uaWMtcmVzb3Vy

Y2UtbnVtPjwvcmVjb3JkPjwvQ2l0ZT48Q2l0ZT48QXV0aG9yPk5hbWE8L0F1dGhvcj48WWVhcj4y

MDEyPC9ZZWFyPjxSZWNOdW0+MTQ3MTU8L1JlY051bT48cmVjb3JkPjxyZWMtbnVtYmVyPjE0NzE1

PC9yZWMtbnVtYmVyPjxmb3JlaWduLWtleXM+PGtleSBhcHA9IkVOIiBkYi1pZD0ienR6YXN4ZTVj

czAwdjRlZndycHZmdHJ3dGFmendlMjJ4ZXp0IiB0aW1lc3RhbXA9IjE0MDkwNDUzNDAiPjE0NzE1

PC9rZXk+PC9mb3JlaWduLWtleXM+PHJlZi10eXBlIG5hbWU9IkpvdXJuYWwgQXJ0aWNsZSI+MTc8

L3JlZi10eXBlPjxjb250cmlidXRvcnM+PGF1dGhvcnM+PGF1dGhvcj5OYW1hLCBWLjwvYXV0aG9y

PjxhdXRob3I+TWFueW9uZGEsIEkuIFQuPC9hdXRob3I+PGF1dGhvcj5Pbnd1ZGUsIEouPC9hdXRo

b3I+PGF1dGhvcj5BbnRvbmlvcywgVC4gRi48L2F1dGhvcj48L2F1dGhvcnM+PC9jb250cmlidXRv

cnM+PGF1dGgtYWRkcmVzcz5CbG9vZCBQcmVzc3VyZSBVbml0LCBEZXBhcnRtZW50IG9mIENsaW5p

Y2FsIFNjaWVuY2VzLCBTdCBHZW9yZ2UmYXBvcztzLCBVbml2ZXJzaXR5IG9mIExvbmRvbiwgTG9u

ZG9uLCBVbml0ZWQgS2luZ2RvbS4gZHJ2bmFtYUBnbWFpbC5jb208L2F1dGgtYWRkcmVzcz48dGl0

bGVzPjx0aXRsZT5TdHJ1Y3R1cmFsIGNhcGlsbGFyeSByYXJlZmFjdGlvbiBhbmQgdGhlIG9uc2V0

IG9mIHByZWVjbGFtcHNpYTwvdGl0bGU+PHNlY29uZGFyeS10aXRsZT5PYnN0ZXQgR3luZWNvbDwv

c2Vjb25kYXJ5LXRpdGxlPjxhbHQtdGl0bGU+T2JzdGV0cmljcyBhbmQgZ3luZWNvbG9neTwvYWx0

LXRpdGxlPjwvdGl0bGVzPjxwZXJpb2RpY2FsPjxmdWxsLXRpdGxlPk9ic3RldCBHeW5lY29sPC9m

dWxsLXRpdGxlPjwvcGVyaW9kaWNhbD48cGFnZXM+OTY3LTc0PC9wYWdlcz48dm9sdW1lPjExOTwv

dm9sdW1lPjxudW1iZXI+NTwvbnVtYmVyPjxrZXl3b3Jkcz48a2V5d29yZD5BZHVsdDwva2V5d29y

ZD48a2V5d29yZD5BbnRpZ2VucywgQ0QvYmxvb2Q8L2tleXdvcmQ+PGtleXdvcmQ+QmlvbG9naWNh

bCBNYXJrZXJzL2Jsb29kPC9rZXl3b3JkPjxrZXl3b3JkPkNhcGlsbGFyaWVzLypwaHlzaW9wYXRo

b2xvZ3k8L2tleXdvcmQ+PGtleXdvcmQ+RmVtYWxlPC9rZXl3b3JkPjxrZXl3b3JkPkh1bWFuczwv

a2V5d29yZD48a2V5d29yZD5Mb25naXR1ZGluYWwgU3R1ZGllczwva2V5d29yZD48a2V5d29yZD5N

aWNyb2NpcmN1bGF0aW9uPC9rZXl3b3JkPjxrZXl3b3JkPk1pY3Jvc2NvcHksIFZpZGVvPC9rZXl3

b3JkPjxrZXl3b3JkPlByZS1FY2xhbXBzaWEvYmxvb2QvKnBoeXNpb3BhdGhvbG9neTwva2V5d29y

ZD48a2V5d29yZD5QcmVnbmFuY3k8L2tleXdvcmQ+PGtleXdvcmQ+UHJvc3BlY3RpdmUgU3R1ZGll

czwva2V5d29yZD48a2V5d29yZD5SZWNlcHRvcnMsIENlbGwgU3VyZmFjZS9ibG9vZDwva2V5d29y

ZD48a2V5d29yZD5Ta2luLypibG9vZCBzdXBwbHk8L2tleXdvcmQ+PC9rZXl3b3Jkcz48ZGF0ZXM+

PHllYXI+MjAxMjwveWVhcj48cHViLWRhdGVzPjxkYXRlPk1heTwvZGF0ZT48L3B1Yi1kYXRlcz48

L2RhdGVzPjxpc2JuPjE4NzMtMjMzWCAoRWxlY3Ryb25pYykmI3hEOzAwMjktNzg0NCAoTGlua2lu

Zyk8L2lzYm4+PGFjY2Vzc2lvbi1udW0+MjI1MjU5MDc8L2FjY2Vzc2lvbi1udW0+PHVybHM+PHJl

bGF0ZWQtdXJscz48dXJsPmh0dHA6Ly93d3cubmNiaS5ubG0ubmloLmdvdi9wdWJtZWQvMjI1MjU5

MDc8L3VybD48L3JlbGF0ZWQtdXJscz48L3VybHM+PGVsZWN0cm9uaWMtcmVzb3VyY2UtbnVtPjEw

LjEwOTcvQU9HLjBiMDEzZTMxODI0ZWEwOTI8L2VsZWN0cm9uaWMtcmVzb3VyY2UtbnVtPjwvcmVj

b3JkPjwvQ2l0ZT48L0VuZE5vdGU+AG==

ADDIN EN.CITE PEVuZE5vdGU+PENpdGU+PEF1dGhvcj5BbnRvbmlvczwvQXV0aG9yPjxZZWFyPjIwMTM8L1llYXI+

PFJlY051bT4xMjU1MDwvUmVjTnVtPjxEaXNwbGF5VGV4dD48c3R5bGUgZmFjZT0ic3VwZXJzY3Jp

cHQiPjgsIDk8L3N0eWxlPjwvRGlzcGxheVRleHQ+PHJlY29yZD48cmVjLW51bWJlcj4xMjU1MDwv

cmVjLW51bWJlcj48Zm9yZWlnbi1rZXlzPjxrZXkgYXBwPSJFTiIgZGItaWQ9Inp0emFzeGU1Y3Mw

MHY0ZWZ3cnB2ZnRyd3RhZnp3ZTIyeGV6dCIgdGltZXN0YW1wPSIxMzgzMDQ3Mjk4Ij4xMjU1MDwv

a2V5PjwvZm9yZWlnbi1rZXlzPjxyZWYtdHlwZSBuYW1lPSJKb3VybmFsIEFydGljbGUiPjE3PC9y

ZWYtdHlwZT48Y29udHJpYnV0b3JzPjxhdXRob3JzPjxhdXRob3I+QW50b25pb3MsIFQuIEYuPC9h

dXRob3I+PGF1dGhvcj5OYW1hLCBWLjwvYXV0aG9yPjxhdXRob3I+V2FuZywgRC48L2F1dGhvcj48

YXV0aG9yPk1hbnlvbmRhLCBJLiBULjwvYXV0aG9yPjwvYXV0aG9ycz48L2NvbnRyaWJ1dG9ycz48

YXV0aC1hZGRyZXNzPkJsb29kIFByZXNzdXJlIFVuaXQgJmFtcDsgRGl2aXNpb24gb2YgQ2xpbmlj

YWwgU2NpZW5jZXMsIFN0IEdlb3JnZSZhcG9zO3MsIFVuaXZlcnNpdHkgb2YgTG9uZG9uLCBMb25k

b24sIFVLLjwvYXV0aC1hZGRyZXNzPjx0aXRsZXM+PHRpdGxlPk1pY3JvdmFzY3VsYXIgcmVtb2Rl

bGxpbmcgaW4gcHJlZWNsYW1wc2lhOiBxdWFudGlmeWluZyBjYXBpbGxhcnkgcmFyZWZhY3Rpb24g

YWNjdXJhdGVseSBhbmQgaW5kZXBlbmRlbnRseSBwcmVkaWN0cyBwcmVlY2xhbXBzaWE8L3RpdGxl

PjxzZWNvbmRhcnktdGl0bGU+QW0gSiBIeXBlcnRlbnM8L3NlY29uZGFyeS10aXRsZT48YWx0LXRp

dGxlPkFtZXJpY2FuIGpvdXJuYWwgb2YgaHlwZXJ0ZW5zaW9uPC9hbHQtdGl0bGU+PC90aXRsZXM+

PHBlcmlvZGljYWw+PGZ1bGwtdGl0bGU+QW0gSiBIeXBlcnRlbnM8L2Z1bGwtdGl0bGU+PC9wZXJp

b2RpY2FsPjxhbHQtcGVyaW9kaWNhbD48ZnVsbC10aXRsZT5BbWVyaWNhbiBKb3VybmFsIG9mIEh5

cGVydGVuc2lvbjwvZnVsbC10aXRsZT48YWJici0xPkFtIEogSHlwZXJ0ZW5zPC9hYmJyLTE+PC9h

bHQtcGVyaW9kaWNhbD48cGFnZXM+MTE2Mi05PC9wYWdlcz48dm9sdW1lPjI2PC92b2x1bWU+PG51

bWJlcj45PC9udW1iZXI+PGRhdGVzPjx5ZWFyPjIwMTM8L3llYXI+PHB1Yi1kYXRlcz48ZGF0ZT5T

ZXA8L2RhdGU+PC9wdWItZGF0ZXM+PC9kYXRlcz48aXNibj4xOTQxLTcyMjUgKEVsZWN0cm9uaWMp

JiN4RDswODk1LTcwNjEgKExpbmtpbmcpPC9pc2JuPjxhY2Nlc3Npb24tbnVtPjIzNzU3NDAxPC9h

Y2Nlc3Npb24tbnVtPjx1cmxzPjxyZWxhdGVkLXVybHM+PHVybD5odHRwOi8vd3d3Lm5jYmkubmxt

Lm5paC5nb3YvcHVibWVkLzIzNzU3NDAxPC91cmw+PC9yZWxhdGVkLXVybHM+PC91cmxzPjxlbGVj

dHJvbmljLXJlc291cmNlLW51bT4xMC4xMDkzL2FqaC9ocHQwODc8L2VsZWN0cm9uaWMtcmVzb3Vy

Y2UtbnVtPjwvcmVjb3JkPjwvQ2l0ZT48Q2l0ZT48QXV0aG9yPk5hbWE8L0F1dGhvcj48WWVhcj4y

MDEyPC9ZZWFyPjxSZWNOdW0+MTQ3MTU8L1JlY051bT48cmVjb3JkPjxyZWMtbnVtYmVyPjE0NzE1

PC9yZWMtbnVtYmVyPjxmb3JlaWduLWtleXM+PGtleSBhcHA9IkVOIiBkYi1pZD0ienR6YXN4ZTVj

czAwdjRlZndycHZmdHJ3dGFmendlMjJ4ZXp0IiB0aW1lc3RhbXA9IjE0MDkwNDUzNDAiPjE0NzE1

PC9rZXk+PC9mb3JlaWduLWtleXM+PHJlZi10eXBlIG5hbWU9IkpvdXJuYWwgQXJ0aWNsZSI+MTc8

L3JlZi10eXBlPjxjb250cmlidXRvcnM+PGF1dGhvcnM+PGF1dGhvcj5OYW1hLCBWLjwvYXV0aG9y

PjxhdXRob3I+TWFueW9uZGEsIEkuIFQuPC9hdXRob3I+PGF1dGhvcj5Pbnd1ZGUsIEouPC9hdXRo

b3I+PGF1dGhvcj5BbnRvbmlvcywgVC4gRi48L2F1dGhvcj48L2F1dGhvcnM+PC9jb250cmlidXRv

cnM+PGF1dGgtYWRkcmVzcz5CbG9vZCBQcmVzc3VyZSBVbml0LCBEZXBhcnRtZW50IG9mIENsaW5p

Y2FsIFNjaWVuY2VzLCBTdCBHZW9yZ2UmYXBvcztzLCBVbml2ZXJzaXR5IG9mIExvbmRvbiwgTG9u

ZG9uLCBVbml0ZWQgS2luZ2RvbS4gZHJ2bmFtYUBnbWFpbC5jb208L2F1dGgtYWRkcmVzcz48dGl0

bGVzPjx0aXRsZT5TdHJ1Y3R1cmFsIGNhcGlsbGFyeSByYXJlZmFjdGlvbiBhbmQgdGhlIG9uc2V0

IG9mIHByZWVjbGFtcHNpYTwvdGl0bGU+PHNlY29uZGFyeS10aXRsZT5PYnN0ZXQgR3luZWNvbDwv

c2Vjb25kYXJ5LXRpdGxlPjxhbHQtdGl0bGU+T2JzdGV0cmljcyBhbmQgZ3luZWNvbG9neTwvYWx0

LXRpdGxlPjwvdGl0bGVzPjxwZXJpb2RpY2FsPjxmdWxsLXRpdGxlPk9ic3RldCBHeW5lY29sPC9m

dWxsLXRpdGxlPjwvcGVyaW9kaWNhbD48cGFnZXM+OTY3LTc0PC9wYWdlcz48dm9sdW1lPjExOTwv

dm9sdW1lPjxudW1iZXI+NTwvbnVtYmVyPjxrZXl3b3Jkcz48a2V5d29yZD5BZHVsdDwva2V5d29y

ZD48a2V5d29yZD5BbnRpZ2VucywgQ0QvYmxvb2Q8L2tleXdvcmQ+PGtleXdvcmQ+QmlvbG9naWNh

bCBNYXJrZXJzL2Jsb29kPC9rZXl3b3JkPjxrZXl3b3JkPkNhcGlsbGFyaWVzLypwaHlzaW9wYXRo

b2xvZ3k8L2tleXdvcmQ+PGtleXdvcmQ+RmVtYWxlPC9rZXl3b3JkPjxrZXl3b3JkPkh1bWFuczwv

a2V5d29yZD48a2V5d29yZD5Mb25naXR1ZGluYWwgU3R1ZGllczwva2V5d29yZD48a2V5d29yZD5N

aWNyb2NpcmN1bGF0aW9uPC9rZXl3b3JkPjxrZXl3b3JkPk1pY3Jvc2NvcHksIFZpZGVvPC9rZXl3

b3JkPjxrZXl3b3JkPlByZS1FY2xhbXBzaWEvYmxvb2QvKnBoeXNpb3BhdGhvbG9neTwva2V5d29y

ZD48a2V5d29yZD5QcmVnbmFuY3k8L2tleXdvcmQ+PGtleXdvcmQ+UHJvc3BlY3RpdmUgU3R1ZGll

czwva2V5d29yZD48a2V5d29yZD5SZWNlcHRvcnMsIENlbGwgU3VyZmFjZS9ibG9vZDwva2V5d29y

ZD48a2V5d29yZD5Ta2luLypibG9vZCBzdXBwbHk8L2tleXdvcmQ+PC9rZXl3b3Jkcz48ZGF0ZXM+

PHllYXI+MjAxMjwveWVhcj48cHViLWRhdGVzPjxkYXRlPk1heTwvZGF0ZT48L3B1Yi1kYXRlcz48

L2RhdGVzPjxpc2JuPjE4NzMtMjMzWCAoRWxlY3Ryb25pYykmI3hEOzAwMjktNzg0NCAoTGlua2lu

Zyk8L2lzYm4+PGFjY2Vzc2lvbi1udW0+MjI1MjU5MDc8L2FjY2Vzc2lvbi1udW0+PHVybHM+PHJl

bGF0ZWQtdXJscz48dXJsPmh0dHA6Ly93d3cubmNiaS5ubG0ubmloLmdvdi9wdWJtZWQvMjI1MjU5

MDc8L3VybD48L3JlbGF0ZWQtdXJscz48L3VybHM+PGVsZWN0cm9uaWMtcmVzb3VyY2UtbnVtPjEw

LjEwOTcvQU9HLjBiMDEzZTMxODI0ZWEwOTI8L2VsZWN0cm9uaWMtcmVzb3VyY2UtbnVtPjwvcmVj

b3JkPjwvQ2l0ZT48L0VuZE5vdGU+AG==

ADDIN EN.CITE.DATA 8, 9 Therefore the improvement of microvascular abnormalities represents pertinent therapeutic targets.PEVuZE5vdGU+PENpdGU+PEF1dGhvcj5EZSBDaXVjZWlzPC9BdXRob3I+PFllYXI+MjAxNDwvWWVh

cj48UmVjTnVtPjE1MzM4PC9SZWNOdW0+PERpc3BsYXlUZXh0PjxzdHlsZSBmYWNlPSJzdXBlcnNj

cmlwdCI+MTA8L3N0eWxlPjwvRGlzcGxheVRleHQ+PHJlY29yZD48cmVjLW51bWJlcj4xNTMzODwv

cmVjLW51bWJlcj48Zm9yZWlnbi1rZXlzPjxrZXkgYXBwPSJFTiIgZGItaWQ9Inp0emFzeGU1Y3Mw

MHY0ZWZ3cnB2ZnRyd3RhZnp3ZTIyeGV6dCIgdGltZXN0YW1wPSIxNDM5Mjg3MTU1Ij4xNTMzODwv

a2V5PjwvZm9yZWlnbi1rZXlzPjxyZWYtdHlwZSBuYW1lPSJKb3VybmFsIEFydGljbGUiPjE3PC9y

ZWYtdHlwZT48Y29udHJpYnV0b3JzPjxhdXRob3JzPjxhdXRob3I+RGUgQ2l1Y2VpcywgQy48L2F1

dGhvcj48YXV0aG9yPlNhbHZldHRpLCBNLjwvYXV0aG9yPjxhdXRob3I+Um9zc2luaSwgQy48L2F1

dGhvcj48YXV0aG9yPk11aWVzYW4sIE0uIEwuPC9hdXRob3I+PGF1dGhvcj5QYWluaSwgQS48L2F1

dGhvcj48YXV0aG9yPkR1c2UsIFMuPC9hdXRob3I+PGF1dGhvcj5MYSBCb3JpYSwgRS48L2F1dGhv

cj48YXV0aG9yPlNlbWVyYXJvLCBGLjwvYXV0aG9yPjxhdXRob3I+Q2FuY2FyaW5pLCBBLjwvYXV0

aG9yPjxhdXRob3I+Um9zZWksIEMuIEEuPC9hdXRob3I+PGF1dGhvcj5TYXJrYXIsIEEuPC9hdXRo

b3I+PGF1dGhvcj5SdWdnZXJpLCBHLjwvYXV0aG9yPjxhdXRob3I+Q2FpbWksIEwuPC9hdXRob3I+

PGF1dGhvcj5SaWNvdHRhLCBELjwvYXV0aG9yPjxhdXRob3I+Uml6em9uaSwgRC48L2F1dGhvcj48

YXV0aG9yPlJvc2VpLCBFLiBBLjwvYXV0aG9yPjwvYXV0aG9ycz48L2NvbnRyaWJ1dG9ycz48YXV0

aC1hZGRyZXNzPmFDbGluaWNhIE1lZGljYSwgRGVwYXJ0bWVudCBvZiBDbGluaWNhbCBhbmQgRXhw

ZXJpbWVudGFsIFNjaWVuY2VzIGJDaGFpciBvZiBPcGh0aGFsbW9sb2d5IGNDaGFpciBvZiBDbGlu

aWNhbCBCaW9jaGVtaXN0cnksIFVuaXZlcnNpdHkgb2YgQnJlc2NpYSwgSXRhbHkuPC9hdXRoLWFk

ZHJlc3M+PHRpdGxlcz48dGl0bGU+RWZmZWN0IG9mIGFudGloeXBlcnRlbnNpdmUgdHJlYXRtZW50

IG9uIG1pY3JvdmFzY3VsYXIgc3RydWN0dXJlLCBjZW50cmFsIGJsb29kIHByZXNzdXJlIGFuZCBv

eGlkYXRpdmUgc3RyZXNzIGluIHBhdGllbnRzIHdpdGggbWlsZCBlc3NlbnRpYWwgaHlwZXJ0ZW5z

aW9uPC90aXRsZT48c2Vjb25kYXJ5LXRpdGxlPkogSHlwZXJ0ZW5zPC9zZWNvbmRhcnktdGl0bGU+

PC90aXRsZXM+PHBlcmlvZGljYWw+PGZ1bGwtdGl0bGU+Sm91cm5hbCBvZiBIeXBlcnRlbnNpb248

L2Z1bGwtdGl0bGU+PGFiYnItMT5KIEh5cGVydGVuczwvYWJici0xPjwvcGVyaW9kaWNhbD48cGFn

ZXM+NTY1LTc0PC9wYWdlcz48dm9sdW1lPjMyPC92b2x1bWU+PG51bWJlcj4zPC9udW1iZXI+PGtl

eXdvcmRzPjxrZXl3b3JkPkFkdWx0PC9rZXl3b3JkPjxrZXl3b3JkPkFuZ2lvdGVuc2luLUNvbnZl

cnRpbmcgRW56eW1lIEluaGliaXRvcnMvYWRtaW5pc3RyYXRpb24gJmFtcDsgZG9zYWdlPC9rZXl3

b3JkPjxrZXl3b3JkPkFudGloeXBlcnRlbnNpdmUgQWdlbnRzLyphZG1pbmlzdHJhdGlvbiAmYW1w

OyBkb3NhZ2U8L2tleXdvcmQ+PGtleXdvcmQ+QXJ0ZXJpb2xlcy9kcnVnIGVmZmVjdHMvdWx0cmFz

b25vZ3JhcGh5PC9rZXl3b3JkPjxrZXl3b3JkPkJsb29kIFByZXNzdXJlL3BoeXNpb2xvZ3k8L2tl

eXdvcmQ+PGtleXdvcmQ+Q2FsY2l1bSBDaGFubmVsIEJsb2NrZXJzL2FkbWluaXN0cmF0aW9uICZh

bXA7IGRvc2FnZTwva2V5d29yZD48a2V5d29yZD5EaWh5ZHJvcHlyaWRpbmVzL2FkbWluaXN0cmF0

aW9uICZhbXA7IGRvc2FnZTwva2V5d29yZD48a2V5d29yZD5EaXVyZXRpY3MvYWRtaW5pc3RyYXRp

b24gJmFtcDsgZG9zYWdlPC9rZXl3b3JkPjxrZXl3b3JkPkRydWcgVGhlcmFweSwgQ29tYmluYXRp

b248L2tleXdvcmQ+PGtleXdvcmQ+RW5hbGFwcmlsL2FkbWluaXN0cmF0aW9uICZhbXA7IGRvc2Fn

ZTwva2V5d29yZD48a2V5d29yZD5GZW1hbGU8L2tleXdvcmQ+PGtleXdvcmQ+SHVtYW5zPC9rZXl3

b3JkPjxrZXl3b3JkPkh5ZHJvY2hsb3JvdGhpYXppZGUvYWRtaW5pc3RyYXRpb24gJmFtcDsgZG9z

YWdlPC9rZXl3b3JkPjxrZXl3b3JkPkh5cGVydGVuc2lvbi8qZHJ1ZyB0aGVyYXB5L3BoeXNpb3Bh

dGhvbG9neS91bHRyYXNvbm9ncmFwaHk8L2tleXdvcmQ+PGtleXdvcmQ+S2lkbmV5L2Jsb29kIHN1

cHBseS9kcnVnIGVmZmVjdHM8L2tleXdvcmQ+PGtleXdvcmQ+TGFzZXItRG9wcGxlciBGbG93bWV0

cnk8L2tleXdvcmQ+PGtleXdvcmQ+TWFsZTwva2V5d29yZD48a2V5d29yZD5NaWRkbGUgQWdlZDwv

a2V5d29yZD48a2V5d29yZD5PeGlkYXRpdmUgU3RyZXNzL2RydWcgZWZmZWN0czwva2V5d29yZD48

L2tleXdvcmRzPjxkYXRlcz48eWVhcj4yMDE0PC95ZWFyPjxwdWItZGF0ZXM+PGRhdGU+TWFyPC9k

YXRlPjwvcHViLWRhdGVzPjwvZGF0ZXM+PGlzYm4+MTQ3My01NTk4IChFbGVjdHJvbmljKSYjeEQ7

MDI2My02MzUyIChMaW5raW5nKTwvaXNibj48YWNjZXNzaW9uLW51bT4yNDM3ODk5OTwvYWNjZXNz

aW9uLW51bT48dXJscz48cmVsYXRlZC11cmxzPjx1cmw+aHR0cDovL3d3dy5uY2JpLm5sbS5uaWgu

Z292L3B1Ym1lZC8yNDM3ODk5OTwvdXJsPjx1cmw+aHR0cDovL292aWRzcC50eC5vdmlkLmNvbS9v

dmZ0cGRmcy9GUERETkNPQkZHR0RHTjAwL2ZzMDQ2L292ZnQvbGl2ZS9ndjAyMy8wMDAwNDg3Mi8w

MDAwNDg3Mi0yMDE0MDMwMDAtMDAwMTcucGRmPC91cmw+PC9yZWxhdGVkLXVybHM+PC91cmxzPjxl

bGVjdHJvbmljLXJlc291cmNlLW51bT4xMC4xMDk3L0hKSC4wMDAwMDAwMDAwMDAwMDY3PC9lbGVj

dHJvbmljLXJlc291cmNlLW51bT48L3JlY29yZD48L0NpdGU+PC9FbmROb3RlPn==

ADDIN EN.CITE PEVuZE5vdGU+PENpdGU+PEF1dGhvcj5EZSBDaXVjZWlzPC9BdXRob3I+PFllYXI+MjAxNDwvWWVh

cj48UmVjTnVtPjE1MzM4PC9SZWNOdW0+PERpc3BsYXlUZXh0PjxzdHlsZSBmYWNlPSJzdXBlcnNj

cmlwdCI+MTA8L3N0eWxlPjwvRGlzcGxheVRleHQ+PHJlY29yZD48cmVjLW51bWJlcj4xNTMzODwv

cmVjLW51bWJlcj48Zm9yZWlnbi1rZXlzPjxrZXkgYXBwPSJFTiIgZGItaWQ9Inp0emFzeGU1Y3Mw

MHY0ZWZ3cnB2ZnRyd3RhZnp3ZTIyeGV6dCIgdGltZXN0YW1wPSIxNDM5Mjg3MTU1Ij4xNTMzODwv

a2V5PjwvZm9yZWlnbi1rZXlzPjxyZWYtdHlwZSBuYW1lPSJKb3VybmFsIEFydGljbGUiPjE3PC9y

ZWYtdHlwZT48Y29udHJpYnV0b3JzPjxhdXRob3JzPjxhdXRob3I+RGUgQ2l1Y2VpcywgQy48L2F1

dGhvcj48YXV0aG9yPlNhbHZldHRpLCBNLjwvYXV0aG9yPjxhdXRob3I+Um9zc2luaSwgQy48L2F1

dGhvcj48YXV0aG9yPk11aWVzYW4sIE0uIEwuPC9hdXRob3I+PGF1dGhvcj5QYWluaSwgQS48L2F1

dGhvcj48YXV0aG9yPkR1c2UsIFMuPC9hdXRob3I+PGF1dGhvcj5MYSBCb3JpYSwgRS48L2F1dGhv

cj48YXV0aG9yPlNlbWVyYXJvLCBGLjwvYXV0aG9yPjxhdXRob3I+Q2FuY2FyaW5pLCBBLjwvYXV0

aG9yPjxhdXRob3I+Um9zZWksIEMuIEEuPC9hdXRob3I+PGF1dGhvcj5TYXJrYXIsIEEuPC9hdXRo

b3I+PGF1dGhvcj5SdWdnZXJpLCBHLjwvYXV0aG9yPjxhdXRob3I+Q2FpbWksIEwuPC9hdXRob3I+

PGF1dGhvcj5SaWNvdHRhLCBELjwvYXV0aG9yPjxhdXRob3I+Uml6em9uaSwgRC48L2F1dGhvcj48

YXV0aG9yPlJvc2VpLCBFLiBBLjwvYXV0aG9yPjwvYXV0aG9ycz48L2NvbnRyaWJ1dG9ycz48YXV0

aC1hZGRyZXNzPmFDbGluaWNhIE1lZGljYSwgRGVwYXJ0bWVudCBvZiBDbGluaWNhbCBhbmQgRXhw

ZXJpbWVudGFsIFNjaWVuY2VzIGJDaGFpciBvZiBPcGh0aGFsbW9sb2d5IGNDaGFpciBvZiBDbGlu

aWNhbCBCaW9jaGVtaXN0cnksIFVuaXZlcnNpdHkgb2YgQnJlc2NpYSwgSXRhbHkuPC9hdXRoLWFk

ZHJlc3M+PHRpdGxlcz48dGl0bGU+RWZmZWN0IG9mIGFudGloeXBlcnRlbnNpdmUgdHJlYXRtZW50

IG9uIG1pY3JvdmFzY3VsYXIgc3RydWN0dXJlLCBjZW50cmFsIGJsb29kIHByZXNzdXJlIGFuZCBv

eGlkYXRpdmUgc3RyZXNzIGluIHBhdGllbnRzIHdpdGggbWlsZCBlc3NlbnRpYWwgaHlwZXJ0ZW5z

aW9uPC90aXRsZT48c2Vjb25kYXJ5LXRpdGxlPkogSHlwZXJ0ZW5zPC9zZWNvbmRhcnktdGl0bGU+

PC90aXRsZXM+PHBlcmlvZGljYWw+PGZ1bGwtdGl0bGU+Sm91cm5hbCBvZiBIeXBlcnRlbnNpb248

L2Z1bGwtdGl0bGU+PGFiYnItMT5KIEh5cGVydGVuczwvYWJici0xPjwvcGVyaW9kaWNhbD48cGFn

ZXM+NTY1LTc0PC9wYWdlcz48dm9sdW1lPjMyPC92b2x1bWU+PG51bWJlcj4zPC9udW1iZXI+PGtl

eXdvcmRzPjxrZXl3b3JkPkFkdWx0PC9rZXl3b3JkPjxrZXl3b3JkPkFuZ2lvdGVuc2luLUNvbnZl

cnRpbmcgRW56eW1lIEluaGliaXRvcnMvYWRtaW5pc3RyYXRpb24gJmFtcDsgZG9zYWdlPC9rZXl3

b3JkPjxrZXl3b3JkPkFudGloeXBlcnRlbnNpdmUgQWdlbnRzLyphZG1pbmlzdHJhdGlvbiAmYW1w

OyBkb3NhZ2U8L2tleXdvcmQ+PGtleXdvcmQ+QXJ0ZXJpb2xlcy9kcnVnIGVmZmVjdHMvdWx0cmFz

b25vZ3JhcGh5PC9rZXl3b3JkPjxrZXl3b3JkPkJsb29kIFByZXNzdXJlL3BoeXNpb2xvZ3k8L2tl

eXdvcmQ+PGtleXdvcmQ+Q2FsY2l1bSBDaGFubmVsIEJsb2NrZXJzL2FkbWluaXN0cmF0aW9uICZh

bXA7IGRvc2FnZTwva2V5d29yZD48a2V5d29yZD5EaWh5ZHJvcHlyaWRpbmVzL2FkbWluaXN0cmF0

aW9uICZhbXA7IGRvc2FnZTwva2V5d29yZD48a2V5d29yZD5EaXVyZXRpY3MvYWRtaW5pc3RyYXRp

b24gJmFtcDsgZG9zYWdlPC9rZXl3b3JkPjxrZXl3b3JkPkRydWcgVGhlcmFweSwgQ29tYmluYXRp

b248L2tleXdvcmQ+PGtleXdvcmQ+RW5hbGFwcmlsL2FkbWluaXN0cmF0aW9uICZhbXA7IGRvc2Fn

ZTwva2V5d29yZD48a2V5d29yZD5GZW1hbGU8L2tleXdvcmQ+PGtleXdvcmQ+SHVtYW5zPC9rZXl3

b3JkPjxrZXl3b3JkPkh5ZHJvY2hsb3JvdGhpYXppZGUvYWRtaW5pc3RyYXRpb24gJmFtcDsgZG9z

YWdlPC9rZXl3b3JkPjxrZXl3b3JkPkh5cGVydGVuc2lvbi8qZHJ1ZyB0aGVyYXB5L3BoeXNpb3Bh

dGhvbG9neS91bHRyYXNvbm9ncmFwaHk8L2tleXdvcmQ+PGtleXdvcmQ+S2lkbmV5L2Jsb29kIHN1

cHBseS9kcnVnIGVmZmVjdHM8L2tleXdvcmQ+PGtleXdvcmQ+TGFzZXItRG9wcGxlciBGbG93bWV0

cnk8L2tleXdvcmQ+PGtleXdvcmQ+TWFsZTwva2V5d29yZD48a2V5d29yZD5NaWRkbGUgQWdlZDwv

a2V5d29yZD48a2V5d29yZD5PeGlkYXRpdmUgU3RyZXNzL2RydWcgZWZmZWN0czwva2V5d29yZD48

L2tleXdvcmRzPjxkYXRlcz48eWVhcj4yMDE0PC95ZWFyPjxwdWItZGF0ZXM+PGRhdGU+TWFyPC9k

YXRlPjwvcHViLWRhdGVzPjwvZGF0ZXM+PGlzYm4+MTQ3My01NTk4IChFbGVjdHJvbmljKSYjeEQ7

MDI2My02MzUyIChMaW5raW5nKTwvaXNibj48YWNjZXNzaW9uLW51bT4yNDM3ODk5OTwvYWNjZXNz

aW9uLW51bT48dXJscz48cmVsYXRlZC11cmxzPjx1cmw+aHR0cDovL3d3dy5uY2JpLm5sbS5uaWgu

Z292L3B1Ym1lZC8yNDM3ODk5OTwvdXJsPjx1cmw+aHR0cDovL292aWRzcC50eC5vdmlkLmNvbS9v

dmZ0cGRmcy9GUERETkNPQkZHR0RHTjAwL2ZzMDQ2L292ZnQvbGl2ZS9ndjAyMy8wMDAwNDg3Mi8w

MDAwNDg3Mi0yMDE0MDMwMDAtMDAwMTcucGRmPC91cmw+PC9yZWxhdGVkLXVybHM+PC91cmxzPjxl

bGVjdHJvbmljLXJlc291cmNlLW51bT4xMC4xMDk3L0hKSC4wMDAwMDAwMDAwMDAwMDY3PC9lbGVj

dHJvbmljLXJlc291cmNlLW51bT48L3JlY29yZD48L0NpdGU+PC9FbmROb3RlPn==

ADDIN EN.CITE.DATA 10 However, few observational and open label studies have shown non-consistent results about the reversal of microvascular rarefaction with antihypertensive treatments.PEVuZE5vdGU+PENpdGU+PEF1dGhvcj5BbnRvbmlvczwvQXV0aG9yPjxZZWFyPjIwMDE8L1llYXI+

PFJlY051bT4xMTM3MjwvUmVjTnVtPjxEaXNwbGF5VGV4dD48c3R5bGUgZmFjZT0ic3VwZXJzY3Jp

cHQiPjEwLTEzPC9zdHlsZT48L0Rpc3BsYXlUZXh0PjxyZWNvcmQ+PHJlYy1udW1iZXI+MTEzNzI8

L3JlYy1udW1iZXI+PGZvcmVpZ24ta2V5cz48a2V5IGFwcD0iRU4iIGRiLWlkPSJ6dHphc3hlNWNz

MDB2NGVmd3JwdmZ0cnd0YWZ6d2UyMnhlenQiIHRpbWVzdGFtcD0iMTM4Mjk1NDQwMSI+MTEzNzI8

L2tleT48L2ZvcmVpZ24ta2V5cz48cmVmLXR5cGUgbmFtZT0iSm91cm5hbCBBcnRpY2xlIj4xNzwv

cmVmLXR5cGU+PGNvbnRyaWJ1dG9ycz48YXV0aG9ycz48YXV0aG9yPkFudG9uaW9zLCBULiBGLjwv

YXV0aG9yPjxhdXRob3I+S2Fza2ksIEouIEMuPC9hdXRob3I+PGF1dGhvcj5IYXNhbiwgSy4gTS48

L2F1dGhvcj48YXV0aG9yPkJyb3duLCBTLiBKLjwvYXV0aG9yPjxhdXRob3I+U2luZ2VyLCBELiBS

LjwvYXV0aG9yPjwvYXV0aG9ycz48L2NvbnRyaWJ1dG9ycz48YXV0aC1hZGRyZXNzPkNsaW5pY2Fs

IFBoYXJtYWNvbG9neSBVbml0LCBEZXBhcnRtZW50IG9mIFBoYXJtYWNvbG9neSAmYW1wOyBDbGlu

aWNhbCBQaGFybWFjb2xvZ3ksIFN0IEdlb3JnZSZhcG9zO3MgSG9zcGl0YWwgTWVkaWNhbCBTY2hv

b2wsIENyYW5tZXIgVGVycmFjZSwgTG9uZG9uLCBVLksuPC9hdXRoLWFkZHJlc3M+PHRpdGxlcz48

dGl0bGU+UmFyZWZhY3Rpb24gb2Ygc2tpbiBjYXBpbGxhcmllcyBpbiBwYXRpZW50cyB3aXRoIGFu

Z2luYWwgY2hlc3QgcGFpbiBhbmQgbm9ybWFsIGNvcm9uYXJ5IGFydGVyaW9ncmFtczwvdGl0bGU+

PHNlY29uZGFyeS10aXRsZT5FdXIgSGVhcnQgSjwvc2Vjb25kYXJ5LXRpdGxlPjwvdGl0bGVzPjxw

ZXJpb2RpY2FsPjxmdWxsLXRpdGxlPkV1ciBIZWFydCBKPC9mdWxsLXRpdGxlPjwvcGVyaW9kaWNh

bD48cGFnZXM+MTE0NC0xMTQ4LjwvcGFnZXM+PHZvbHVtZT4yMjwvdm9sdW1lPjxudW1iZXI+MTM8

L251bWJlcj48ZGF0ZXM+PHllYXI+MjAwMTwveWVhcj48L2RhdGVzPjxhY2Nlc3Npb24tbnVtPjEx

NDI4ODU1PC9hY2Nlc3Npb24tbnVtPjx1cmxzPjxyZWxhdGVkLXVybHM+PHVybD5odHRwOi8vd3d3

Lm5jYmkubmxtLm5paC5nb3YvaHRiaW4tcG9zdC9FbnRyZXovcXVlcnk/ZGI9bSZhbXA7Zm9ybT02

JmFtcDtkb3B0PXImYW1wO3VpZD0xMTQyODg1NTwvdXJsPjwvcmVsYXRlZC11cmxzPjwvdXJscz48

L3JlY29yZD48L0NpdGU+PENpdGU+PEF1dGhvcj5QZW5uYTwvQXV0aG9yPjxZZWFyPjIwMDg8L1ll

YXI+PFJlY051bT4xMjE1MTwvUmVjTnVtPjxyZWNvcmQ+PHJlYy1udW1iZXI+MTIxNTE8L3JlYy1u

dW1iZXI+PGZvcmVpZ24ta2V5cz48a2V5IGFwcD0iRU4iIGRiLWlkPSJ6dHphc3hlNWNzMDB2NGVm

d3JwdmZ0cnd0YWZ6d2UyMnhlenQiIHRpbWVzdGFtcD0iMTM4Mjk1NDQwMSI+MTIxNTE8L2tleT48

L2ZvcmVpZ24ta2V5cz48cmVmLXR5cGUgbmFtZT0iSm91cm5hbCBBcnRpY2xlIj4xNzwvcmVmLXR5

cGU+PGNvbnRyaWJ1dG9ycz48YXV0aG9ycz48YXV0aG9yPlBlbm5hLCBHLiBMLjwvYXV0aG9yPjxh

dXRob3I+R2FyYmVybyBSZGUsIEYuPC9hdXRob3I+PGF1dGhvcj5OZXZlcywgTS4gRi48L2F1dGhv

cj48YXV0aG9yPk9pZ21hbiwgVy48L2F1dGhvcj48YXV0aG9yPkJvdHRpbm8sIEQuIEEuPC9hdXRo

b3I+PGF1dGhvcj5Cb3Vza2VsYSwgRS48L2F1dGhvcj48L2F1dGhvcnM+PC9jb250cmlidXRvcnM+

PGF1dGgtYWRkcmVzcz5EZXBhcnRtZW50IG9mIENsaW5pY2FsIE1lZGljaW5lLCBVbml2ZXJzaWRh

ZGUgZG8gRXN0YWRvIGRvIFJpbyBkZSBKYW5laXJvLCBSaW8gZGUgSmFuZWlybywgUkosIEJyYXpp

bC48L2F1dGgtYWRkcmVzcz48dGl0bGVzPjx0aXRsZT5UcmVhdG1lbnQgb2YgZXNzZW50aWFsIGh5

cGVydGVuc2lvbiBkb2VzIG5vdCBub3JtYWxpemUgY2FwaWxsYXJ5IHJhcmVmYWN0aW9uPC90aXRs

ZT48c2Vjb25kYXJ5LXRpdGxlPkNsaW5pY3MgKFNhbyBQYXVsbyk8L3NlY29uZGFyeS10aXRsZT48

L3RpdGxlcz48cGVyaW9kaWNhbD48ZnVsbC10aXRsZT5DbGluaWNzIChTYW8gUGF1bG8pPC9mdWxs

LXRpdGxlPjwvcGVyaW9kaWNhbD48cGFnZXM+NjEzLTg8L3BhZ2VzPjx2b2x1bWU+NjM8L3ZvbHVt

ZT48bnVtYmVyPjU8L251bWJlcj48ZGF0ZXM+PHllYXI+MjAwODwveWVhcj48cHViLWRhdGVzPjxk

YXRlPk9jdDwvZGF0ZT48L3B1Yi1kYXRlcz48L2RhdGVzPjxhY2Nlc3Npb24tbnVtPjE4OTI1MzIw

PC9hY2Nlc3Npb24tbnVtPjx1cmxzPjxyZWxhdGVkLXVybHM+PHVybD5odHRwOi8vd3d3Lm5jYmku

bmxtLm5paC5nb3YvZW50cmV6L3F1ZXJ5LmZjZ2k/Y21kPVJldHJpZXZlJmFtcDtkYj1QdWJNZWQm

YW1wO2RvcHQ9Q2l0YXRpb24mYW1wO2xpc3RfdWlkcz0xODkyNTMyMDwvdXJsPjx1cmw+aHR0cDov

L3d3dy5uY2JpLm5sbS5uaWguZ292L3BtYy9hcnRpY2xlcy9QTUMyNjY0NzE4L3BkZi9jbG42M181

cDA2MTMucGRmPC91cmw+PC9yZWxhdGVkLXVybHM+PC91cmxzPjwvcmVjb3JkPjwvQ2l0ZT48Q2l0

ZT48QXV0aG9yPkRlYmJhYmk8L0F1dGhvcj48WWVhcj4yMDEwPC9ZZWFyPjxSZWNOdW0+MTIyODM8

L1JlY051bT48cmVjb3JkPjxyZWMtbnVtYmVyPjEyMjgzPC9yZWMtbnVtYmVyPjxmb3JlaWduLWtl

eXM+PGtleSBhcHA9IkVOIiBkYi1pZD0ienR6YXN4ZTVjczAwdjRlZndycHZmdHJ3dGFmendlMjJ4

ZXp0IiB0aW1lc3RhbXA9IjEzODI5NTQ0MDEiPjEyMjgzPC9rZXk+PC9mb3JlaWduLWtleXM+PHJl

Zi10eXBlIG5hbWU9IkpvdXJuYWwgQXJ0aWNsZSI+MTc8L3JlZi10eXBlPjxjb250cmlidXRvcnM+

PGF1dGhvcnM+PGF1dGhvcj5EZWJiYWJpLCBILjwvYXV0aG9yPjxhdXRob3I+Qm9ubmluLCBQLjwv

YXV0aG9yPjxhdXRob3I+TGV2eSwgQi4gSS48L2F1dGhvcj48L2F1dGhvcnM+PC9jb250cmlidXRv

cnM+PGF1dGgtYWRkcmVzcz5EZXBhcnRtZW50IG9mIE5vbi1JbnZhc2l2ZSBJbnZlc3RpZ2F0aW9u

cywgUEFSQ0MgSW5zZXJtIFU3OTAsIEluc2VybSBVOTY1LCBMYXJpYm9pc2llcmUgSG9zcGl0YWws

IEFQLUhQLCBVbml2ZXJzaXR5IFBhcmlzIERpZGVyb3QsIFBhcmlzLCBGcmFuY2UuPC9hdXRoLWFk

ZHJlc3M+PHRpdGxlcz48dGl0bGU+RWZmZWN0cyBvZiBCbG9vZCBQcmVzc3VyZSBDb250cm9sIFdp

dGggUGVyaW5kb3ByaWwvSW5kYXBhbWlkZSBvbiB0aGUgTWljcm9jaXJjdWxhdGlvbiBpbiBIeXBl

cnRlbnNpdmUgUGF0aWVudHM8L3RpdGxlPjxzZWNvbmRhcnktdGl0bGU+QW0gSiBIeXBlcnRlbnM8

L3NlY29uZGFyeS10aXRsZT48L3RpdGxlcz48cGVyaW9kaWNhbD48ZnVsbC10aXRsZT5BbSBKIEh5

cGVydGVuczwvZnVsbC10aXRsZT48L3BlcmlvZGljYWw+PHBhZ2VzPjExMzYtMTE0MzwvcGFnZXM+

PHZvbHVtZT4yMzwvdm9sdW1lPjxudW1iZXI+MTA8L251bWJlcj48ZGF0ZXM+PHllYXI+MjAxMDwv

eWVhcj48cHViLWRhdGVzPjxkYXRlPk1heSAyNzwvZGF0ZT48L3B1Yi1kYXRlcz48L2RhdGVzPjxh

Y2Nlc3Npb24tbnVtPjIwNTA4NjI0PC9hY2Nlc3Npb24tbnVtPjx1cmxzPjxyZWxhdGVkLXVybHM+

PHVybD5odHRwOi8vd3d3Lm5jYmkubmxtLm5paC5nb3YvZW50cmV6L3F1ZXJ5LmZjZ2k/Y21kPVJl

dHJpZXZlJmFtcDtkYj1QdWJNZWQmYW1wO2RvcHQ9Q2l0YXRpb24mYW1wO2xpc3RfdWlkcz0yMDUw

ODYyNDwvdXJsPjwvcmVsYXRlZC11cmxzPjwvdXJscz48L3JlY29yZD48L0NpdGU+PENpdGU+PEF1

dGhvcj5EZSBDaXVjZWlzPC9BdXRob3I+PFllYXI+MjAxNDwvWWVhcj48UmVjTnVtPjE1MzM4PC9S

ZWNOdW0+PHJlY29yZD48cmVjLW51bWJlcj4xNTMzODwvcmVjLW51bWJlcj48Zm9yZWlnbi1rZXlz

PjxrZXkgYXBwPSJFTiIgZGItaWQ9Inp0emFzeGU1Y3MwMHY0ZWZ3cnB2ZnRyd3RhZnp3ZTIyeGV6

dCIgdGltZXN0YW1wPSIxNDM5Mjg3MTU1Ij4xNTMzODwva2V5PjwvZm9yZWlnbi1rZXlzPjxyZWYt

dHlwZSBuYW1lPSJKb3VybmFsIEFydGljbGUiPjE3PC9yZWYtdHlwZT48Y29udHJpYnV0b3JzPjxh

dXRob3JzPjxhdXRob3I+RGUgQ2l1Y2VpcywgQy48L2F1dGhvcj48YXV0aG9yPlNhbHZldHRpLCBN

LjwvYXV0aG9yPjxhdXRob3I+Um9zc2luaSwgQy48L2F1dGhvcj48YXV0aG9yPk11aWVzYW4sIE0u

IEwuPC9hdXRob3I+PGF1dGhvcj5QYWluaSwgQS48L2F1dGhvcj48YXV0aG9yPkR1c2UsIFMuPC9h

dXRob3I+PGF1dGhvcj5MYSBCb3JpYSwgRS48L2F1dGhvcj48YXV0aG9yPlNlbWVyYXJvLCBGLjwv

YXV0aG9yPjxhdXRob3I+Q2FuY2FyaW5pLCBBLjwvYXV0aG9yPjxhdXRob3I+Um9zZWksIEMuIEEu

PC9hdXRob3I+PGF1dGhvcj5TYXJrYXIsIEEuPC9hdXRob3I+PGF1dGhvcj5SdWdnZXJpLCBHLjwv

YXV0aG9yPjxhdXRob3I+Q2FpbWksIEwuPC9hdXRob3I+PGF1dGhvcj5SaWNvdHRhLCBELjwvYXV0

aG9yPjxhdXRob3I+Uml6em9uaSwgRC48L2F1dGhvcj48YXV0aG9yPlJvc2VpLCBFLiBBLjwvYXV0

aG9yPjwvYXV0aG9ycz48L2NvbnRyaWJ1dG9ycz48YXV0aC1hZGRyZXNzPmFDbGluaWNhIE1lZGlj

YSwgRGVwYXJ0bWVudCBvZiBDbGluaWNhbCBhbmQgRXhwZXJpbWVudGFsIFNjaWVuY2VzIGJDaGFp

ciBvZiBPcGh0aGFsbW9sb2d5IGNDaGFpciBvZiBDbGluaWNhbCBCaW9jaGVtaXN0cnksIFVuaXZl

cnNpdHkgb2YgQnJlc2NpYSwgSXRhbHkuPC9hdXRoLWFkZHJlc3M+PHRpdGxlcz48dGl0bGU+RWZm

ZWN0IG9mIGFudGloeXBlcnRlbnNpdmUgdHJlYXRtZW50IG9uIG1pY3JvdmFzY3VsYXIgc3RydWN0

dXJlLCBjZW50cmFsIGJsb29kIHByZXNzdXJlIGFuZCBveGlkYXRpdmUgc3RyZXNzIGluIHBhdGll

bnRzIHdpdGggbWlsZCBlc3NlbnRpYWwgaHlwZXJ0ZW5zaW9uPC90aXRsZT48c2Vjb25kYXJ5LXRp

dGxlPkogSHlwZXJ0ZW5zPC9zZWNvbmRhcnktdGl0bGU+PC90aXRsZXM+PHBlcmlvZGljYWw+PGZ1

bGwtdGl0bGU+Sm91cm5hbCBvZiBIeXBlcnRlbnNpb248L2Z1bGwtdGl0bGU+PGFiYnItMT5KIEh5

cGVydGVuczwvYWJici0xPjwvcGVyaW9kaWNhbD48cGFnZXM+NTY1LTc0PC9wYWdlcz48dm9sdW1l

PjMyPC92b2x1bWU+PG51bWJlcj4zPC9udW1iZXI+PGtleXdvcmRzPjxrZXl3b3JkPkFkdWx0PC9r

ZXl3b3JkPjxrZXl3b3JkPkFuZ2lvdGVuc2luLUNvbnZlcnRpbmcgRW56eW1lIEluaGliaXRvcnMv

YWRtaW5pc3RyYXRpb24gJmFtcDsgZG9zYWdlPC9rZXl3b3JkPjxrZXl3b3JkPkFudGloeXBlcnRl

bnNpdmUgQWdlbnRzLyphZG1pbmlzdHJhdGlvbiAmYW1wOyBkb3NhZ2U8L2tleXdvcmQ+PGtleXdv

cmQ+QXJ0ZXJpb2xlcy9kcnVnIGVmZmVjdHMvdWx0cmFzb25vZ3JhcGh5PC9rZXl3b3JkPjxrZXl3

b3JkPkJsb29kIFByZXNzdXJlL3BoeXNpb2xvZ3k8L2tleXdvcmQ+PGtleXdvcmQ+Q2FsY2l1bSBD

aGFubmVsIEJsb2NrZXJzL2FkbWluaXN0cmF0aW9uICZhbXA7IGRvc2FnZTwva2V5d29yZD48a2V5

d29yZD5EaWh5ZHJvcHlyaWRpbmVzL2FkbWluaXN0cmF0aW9uICZhbXA7IGRvc2FnZTwva2V5d29y

ZD48a2V5d29yZD5EaXVyZXRpY3MvYWRtaW5pc3RyYXRpb24gJmFtcDsgZG9zYWdlPC9rZXl3b3Jk

PjxrZXl3b3JkPkRydWcgVGhlcmFweSwgQ29tYmluYXRpb248L2tleXdvcmQ+PGtleXdvcmQ+RW5h

bGFwcmlsL2FkbWluaXN0cmF0aW9uICZhbXA7IGRvc2FnZTwva2V5d29yZD48a2V5d29yZD5GZW1h

bGU8L2tleXdvcmQ+PGtleXdvcmQ+SHVtYW5zPC9rZXl3b3JkPjxrZXl3b3JkPkh5ZHJvY2hsb3Jv

dGhpYXppZGUvYWRtaW5pc3RyYXRpb24gJmFtcDsgZG9zYWdlPC9rZXl3b3JkPjxrZXl3b3JkPkh5

cGVydGVuc2lvbi8qZHJ1ZyB0aGVyYXB5L3BoeXNpb3BhdGhvbG9neS91bHRyYXNvbm9ncmFwaHk8

L2tleXdvcmQ+PGtleXdvcmQ+S2lkbmV5L2Jsb29kIHN1cHBseS9kcnVnIGVmZmVjdHM8L2tleXdv

cmQ+PGtleXdvcmQ+TGFzZXItRG9wcGxlciBGbG93bWV0cnk8L2tleXdvcmQ+PGtleXdvcmQ+TWFs

ZTwva2V5d29yZD48a2V5d29yZD5NaWRkbGUgQWdlZDwva2V5d29yZD48a2V5d29yZD5PeGlkYXRp

dmUgU3RyZXNzL2RydWcgZWZmZWN0czwva2V5d29yZD48L2tleXdvcmRzPjxkYXRlcz48eWVhcj4y

MDE0PC95ZWFyPjxwdWItZGF0ZXM+PGRhdGU+TWFyPC9kYXRlPjwvcHViLWRhdGVzPjwvZGF0ZXM+

PGlzYm4+MTQ3My01NTk4IChFbGVjdHJvbmljKSYjeEQ7MDI2My02MzUyIChMaW5raW5nKTwvaXNi

bj48YWNjZXNzaW9uLW51bT4yNDM3ODk5OTwvYWNjZXNzaW9uLW51bT48dXJscz48cmVsYXRlZC11

cmxzPjx1cmw+aHR0cDovL3d3dy5uY2JpLm5sbS5uaWguZ292L3B1Ym1lZC8yNDM3ODk5OTwvdXJs

Pjx1cmw+aHR0cDovL292aWRzcC50eC5vdmlkLmNvbS9vdmZ0cGRmcy9GUERETkNPQkZHR0RHTjAw

L2ZzMDQ2L292ZnQvbGl2ZS9ndjAyMy8wMDAwNDg3Mi8wMDAwNDg3Mi0yMDE0MDMwMDAtMDAwMTcu

cGRmPC91cmw+PC9yZWxhdGVkLXVybHM+PC91cmxzPjxlbGVjdHJvbmljLXJlc291cmNlLW51bT4x

MC4xMDk3L0hKSC4wMDAwMDAwMDAwMDAwMDY3PC9lbGVjdHJvbmljLXJlc291cmNlLW51bT48L3Jl

Y29yZD48L0NpdGU+PC9FbmROb3RlPgB=

ADDIN EN.CITE PEVuZE5vdGU+PENpdGU+PEF1dGhvcj5BbnRvbmlvczwvQXV0aG9yPjxZZWFyPjIwMDE8L1llYXI+

PFJlY051bT4xMTM3MjwvUmVjTnVtPjxEaXNwbGF5VGV4dD48c3R5bGUgZmFjZT0ic3VwZXJzY3Jp

cHQiPjEwLTEzPC9zdHlsZT48L0Rpc3BsYXlUZXh0PjxyZWNvcmQ+PHJlYy1udW1iZXI+MTEzNzI8

L3JlYy1udW1iZXI+PGZvcmVpZ24ta2V5cz48a2V5IGFwcD0iRU4iIGRiLWlkPSJ6dHphc3hlNWNz

MDB2NGVmd3JwdmZ0cnd0YWZ6d2UyMnhlenQiIHRpbWVzdGFtcD0iMTM4Mjk1NDQwMSI+MTEzNzI8

L2tleT48L2ZvcmVpZ24ta2V5cz48cmVmLXR5cGUgbmFtZT0iSm91cm5hbCBBcnRpY2xlIj4xNzwv

cmVmLXR5cGU+PGNvbnRyaWJ1dG9ycz48YXV0aG9ycz48YXV0aG9yPkFudG9uaW9zLCBULiBGLjwv

YXV0aG9yPjxhdXRob3I+S2Fza2ksIEouIEMuPC9hdXRob3I+PGF1dGhvcj5IYXNhbiwgSy4gTS48

L2F1dGhvcj48YXV0aG9yPkJyb3duLCBTLiBKLjwvYXV0aG9yPjxhdXRob3I+U2luZ2VyLCBELiBS

LjwvYXV0aG9yPjwvYXV0aG9ycz48L2NvbnRyaWJ1dG9ycz48YXV0aC1hZGRyZXNzPkNsaW5pY2Fs

IFBoYXJtYWNvbG9neSBVbml0LCBEZXBhcnRtZW50IG9mIFBoYXJtYWNvbG9neSAmYW1wOyBDbGlu

aWNhbCBQaGFybWFjb2xvZ3ksIFN0IEdlb3JnZSZhcG9zO3MgSG9zcGl0YWwgTWVkaWNhbCBTY2hv

b2wsIENyYW5tZXIgVGVycmFjZSwgTG9uZG9uLCBVLksuPC9hdXRoLWFkZHJlc3M+PHRpdGxlcz48

dGl0bGU+UmFyZWZhY3Rpb24gb2Ygc2tpbiBjYXBpbGxhcmllcyBpbiBwYXRpZW50cyB3aXRoIGFu

Z2luYWwgY2hlc3QgcGFpbiBhbmQgbm9ybWFsIGNvcm9uYXJ5IGFydGVyaW9ncmFtczwvdGl0bGU+

PHNlY29uZGFyeS10aXRsZT5FdXIgSGVhcnQgSjwvc2Vjb25kYXJ5LXRpdGxlPjwvdGl0bGVzPjxw

ZXJpb2RpY2FsPjxmdWxsLXRpdGxlPkV1ciBIZWFydCBKPC9mdWxsLXRpdGxlPjwvcGVyaW9kaWNh

bD48cGFnZXM+MTE0NC0xMTQ4LjwvcGFnZXM+PHZvbHVtZT4yMjwvdm9sdW1lPjxudW1iZXI+MTM8

L251bWJlcj48ZGF0ZXM+PHllYXI+MjAwMTwveWVhcj48L2RhdGVzPjxhY2Nlc3Npb24tbnVtPjEx

NDI4ODU1PC9hY2Nlc3Npb24tbnVtPjx1cmxzPjxyZWxhdGVkLXVybHM+PHVybD5odHRwOi8vd3d3

Lm5jYmkubmxtLm5paC5nb3YvaHRiaW4tcG9zdC9FbnRyZXovcXVlcnk/ZGI9bSZhbXA7Zm9ybT02

JmFtcDtkb3B0PXImYW1wO3VpZD0xMTQyODg1NTwvdXJsPjwvcmVsYXRlZC11cmxzPjwvdXJscz48

L3JlY29yZD48L0NpdGU+PENpdGU+PEF1dGhvcj5QZW5uYTwvQXV0aG9yPjxZZWFyPjIwMDg8L1ll

YXI+PFJlY051bT4xMjE1MTwvUmVjTnVtPjxyZWNvcmQ+PHJlYy1udW1iZXI+MTIxNTE8L3JlYy1u

dW1iZXI+PGZvcmVpZ24ta2V5cz48a2V5IGFwcD0iRU4iIGRiLWlkPSJ6dHphc3hlNWNzMDB2NGVm

d3JwdmZ0cnd0YWZ6d2UyMnhlenQiIHRpbWVzdGFtcD0iMTM4Mjk1NDQwMSI+MTIxNTE8L2tleT48

L2ZvcmVpZ24ta2V5cz48cmVmLXR5cGUgbmFtZT0iSm91cm5hbCBBcnRpY2xlIj4xNzwvcmVmLXR5

cGU+PGNvbnRyaWJ1dG9ycz48YXV0aG9ycz48YXV0aG9yPlBlbm5hLCBHLiBMLjwvYXV0aG9yPjxh

dXRob3I+R2FyYmVybyBSZGUsIEYuPC9hdXRob3I+PGF1dGhvcj5OZXZlcywgTS4gRi48L2F1dGhv

cj48YXV0aG9yPk9pZ21hbiwgVy48L2F1dGhvcj48YXV0aG9yPkJvdHRpbm8sIEQuIEEuPC9hdXRo

b3I+PGF1dGhvcj5Cb3Vza2VsYSwgRS48L2F1dGhvcj48L2F1dGhvcnM+PC9jb250cmlidXRvcnM+

PGF1dGgtYWRkcmVzcz5EZXBhcnRtZW50IG9mIENsaW5pY2FsIE1lZGljaW5lLCBVbml2ZXJzaWRh

ZGUgZG8gRXN0YWRvIGRvIFJpbyBkZSBKYW5laXJvLCBSaW8gZGUgSmFuZWlybywgUkosIEJyYXpp

bC48L2F1dGgtYWRkcmVzcz48dGl0bGVzPjx0aXRsZT5UcmVhdG1lbnQgb2YgZXNzZW50aWFsIGh5

cGVydGVuc2lvbiBkb2VzIG5vdCBub3JtYWxpemUgY2FwaWxsYXJ5IHJhcmVmYWN0aW9uPC90aXRs

ZT48c2Vjb25kYXJ5LXRpdGxlPkNsaW5pY3MgKFNhbyBQYXVsbyk8L3NlY29uZGFyeS10aXRsZT48

L3RpdGxlcz48cGVyaW9kaWNhbD48ZnVsbC10aXRsZT5DbGluaWNzIChTYW8gUGF1bG8pPC9mdWxs

LXRpdGxlPjwvcGVyaW9kaWNhbD48cGFnZXM+NjEzLTg8L3BhZ2VzPjx2b2x1bWU+NjM8L3ZvbHVt

ZT48bnVtYmVyPjU8L251bWJlcj48ZGF0ZXM+PHllYXI+MjAwODwveWVhcj48cHViLWRhdGVzPjxk

YXRlPk9jdDwvZGF0ZT48L3B1Yi1kYXRlcz48L2RhdGVzPjxhY2Nlc3Npb24tbnVtPjE4OTI1MzIw

PC9hY2Nlc3Npb24tbnVtPjx1cmxzPjxyZWxhdGVkLXVybHM+PHVybD5odHRwOi8vd3d3Lm5jYmku

bmxtLm5paC5nb3YvZW50cmV6L3F1ZXJ5LmZjZ2k/Y21kPVJldHJpZXZlJmFtcDtkYj1QdWJNZWQm

YW1wO2RvcHQ9Q2l0YXRpb24mYW1wO2xpc3RfdWlkcz0xODkyNTMyMDwvdXJsPjx1cmw+aHR0cDov

L3d3dy5uY2JpLm5sbS5uaWguZ292L3BtYy9hcnRpY2xlcy9QTUMyNjY0NzE4L3BkZi9jbG42M181

cDA2MTMucGRmPC91cmw+PC9yZWxhdGVkLXVybHM+PC91cmxzPjwvcmVjb3JkPjwvQ2l0ZT48Q2l0

ZT48QXV0aG9yPkRlYmJhYmk8L0F1dGhvcj48WWVhcj4yMDEwPC9ZZWFyPjxSZWNOdW0+MTIyODM8

L1JlY051bT48cmVjb3JkPjxyZWMtbnVtYmVyPjEyMjgzPC9yZWMtbnVtYmVyPjxmb3JlaWduLWtl

eXM+PGtleSBhcHA9IkVOIiBkYi1pZD0ienR6YXN4ZTVjczAwdjRlZndycHZmdHJ3dGFmendlMjJ4

ZXp0IiB0aW1lc3RhbXA9IjEzODI5NTQ0MDEiPjEyMjgzPC9rZXk+PC9mb3JlaWduLWtleXM+PHJl

Zi10eXBlIG5hbWU9IkpvdXJuYWwgQXJ0aWNsZSI+MTc8L3JlZi10eXBlPjxjb250cmlidXRvcnM+

PGF1dGhvcnM+PGF1dGhvcj5EZWJiYWJpLCBILjwvYXV0aG9yPjxhdXRob3I+Qm9ubmluLCBQLjwv

YXV0aG9yPjxhdXRob3I+TGV2eSwgQi4gSS48L2F1dGhvcj48L2F1dGhvcnM+PC9jb250cmlidXRv

cnM+PGF1dGgtYWRkcmVzcz5EZXBhcnRtZW50IG9mIE5vbi1JbnZhc2l2ZSBJbnZlc3RpZ2F0aW9u

cywgUEFSQ0MgSW5zZXJtIFU3OTAsIEluc2VybSBVOTY1LCBMYXJpYm9pc2llcmUgSG9zcGl0YWws

IEFQLUhQLCBVbml2ZXJzaXR5IFBhcmlzIERpZGVyb3QsIFBhcmlzLCBGcmFuY2UuPC9hdXRoLWFk

ZHJlc3M+PHRpdGxlcz48dGl0bGU+RWZmZWN0cyBvZiBCbG9vZCBQcmVzc3VyZSBDb250cm9sIFdp

dGggUGVyaW5kb3ByaWwvSW5kYXBhbWlkZSBvbiB0aGUgTWljcm9jaXJjdWxhdGlvbiBpbiBIeXBl

cnRlbnNpdmUgUGF0aWVudHM8L3RpdGxlPjxzZWNvbmRhcnktdGl0bGU+QW0gSiBIeXBlcnRlbnM8

L3NlY29uZGFyeS10aXRsZT48L3RpdGxlcz48cGVyaW9kaWNhbD48ZnVsbC10aXRsZT5BbSBKIEh5

cGVydGVuczwvZnVsbC10aXRsZT48L3BlcmlvZGljYWw+PHBhZ2VzPjExMzYtMTE0MzwvcGFnZXM+

PHZvbHVtZT4yMzwvdm9sdW1lPjxudW1iZXI+MTA8L251bWJlcj48ZGF0ZXM+PHllYXI+MjAxMDwv

eWVhcj48cHViLWRhdGVzPjxkYXRlPk1heSAyNzwvZGF0ZT48L3B1Yi1kYXRlcz48L2RhdGVzPjxh

Y2Nlc3Npb24tbnVtPjIwNTA4NjI0PC9hY2Nlc3Npb24tbnVtPjx1cmxzPjxyZWxhdGVkLXVybHM+

PHVybD5odHRwOi8vd3d3Lm5jYmkubmxtLm5paC5nb3YvZW50cmV6L3F1ZXJ5LmZjZ2k/Y21kPVJl

dHJpZXZlJmFtcDtkYj1QdWJNZWQmYW1wO2RvcHQ9Q2l0YXRpb24mYW1wO2xpc3RfdWlkcz0yMDUw

ODYyNDwvdXJsPjwvcmVsYXRlZC11cmxzPjwvdXJscz48L3JlY29yZD48L0NpdGU+PENpdGU+PEF1

dGhvcj5EZSBDaXVjZWlzPC9BdXRob3I+PFllYXI+MjAxNDwvWWVhcj48UmVjTnVtPjE1MzM4PC9S

ZWNOdW0+PHJlY29yZD48cmVjLW51bWJlcj4xNTMzODwvcmVjLW51bWJlcj48Zm9yZWlnbi1rZXlz

PjxrZXkgYXBwPSJFTiIgZGItaWQ9Inp0emFzeGU1Y3MwMHY0ZWZ3cnB2ZnRyd3RhZnp3ZTIyeGV6

dCIgdGltZXN0YW1wPSIxNDM5Mjg3MTU1Ij4xNTMzODwva2V5PjwvZm9yZWlnbi1rZXlzPjxyZWYt

dHlwZSBuYW1lPSJKb3VybmFsIEFydGljbGUiPjE3PC9yZWYtdHlwZT48Y29udHJpYnV0b3JzPjxh

dXRob3JzPjxhdXRob3I+RGUgQ2l1Y2VpcywgQy48L2F1dGhvcj48YXV0aG9yPlNhbHZldHRpLCBN

LjwvYXV0aG9yPjxhdXRob3I+Um9zc2luaSwgQy48L2F1dGhvcj48YXV0aG9yPk11aWVzYW4sIE0u

IEwuPC9hdXRob3I+PGF1dGhvcj5QYWluaSwgQS48L2F1dGhvcj48YXV0aG9yPkR1c2UsIFMuPC9h

dXRob3I+PGF1dGhvcj5MYSBCb3JpYSwgRS48L2F1dGhvcj48YXV0aG9yPlNlbWVyYXJvLCBGLjwv

YXV0aG9yPjxhdXRob3I+Q2FuY2FyaW5pLCBBLjwvYXV0aG9yPjxhdXRob3I+Um9zZWksIEMuIEEu

PC9hdXRob3I+PGF1dGhvcj5TYXJrYXIsIEEuPC9hdXRob3I+PGF1dGhvcj5SdWdnZXJpLCBHLjwv

YXV0aG9yPjxhdXRob3I+Q2FpbWksIEwuPC9hdXRob3I+PGF1dGhvcj5SaWNvdHRhLCBELjwvYXV0

aG9yPjxhdXRob3I+Uml6em9uaSwgRC48L2F1dGhvcj48YXV0aG9yPlJvc2VpLCBFLiBBLjwvYXV0

aG9yPjwvYXV0aG9ycz48L2NvbnRyaWJ1dG9ycz48YXV0aC1hZGRyZXNzPmFDbGluaWNhIE1lZGlj

YSwgRGVwYXJ0bWVudCBvZiBDbGluaWNhbCBhbmQgRXhwZXJpbWVudGFsIFNjaWVuY2VzIGJDaGFp

ciBvZiBPcGh0aGFsbW9sb2d5IGNDaGFpciBvZiBDbGluaWNhbCBCaW9jaGVtaXN0cnksIFVuaXZl

cnNpdHkgb2YgQnJlc2NpYSwgSXRhbHkuPC9hdXRoLWFkZHJlc3M+PHRpdGxlcz48dGl0bGU+RWZm

ZWN0IG9mIGFudGloeXBlcnRlbnNpdmUgdHJlYXRtZW50IG9uIG1pY3JvdmFzY3VsYXIgc3RydWN0

dXJlLCBjZW50cmFsIGJsb29kIHByZXNzdXJlIGFuZCBveGlkYXRpdmUgc3RyZXNzIGluIHBhdGll

bnRzIHdpdGggbWlsZCBlc3NlbnRpYWwgaHlwZXJ0ZW5zaW9uPC90aXRsZT48c2Vjb25kYXJ5LXRp

dGxlPkogSHlwZXJ0ZW5zPC9zZWNvbmRhcnktdGl0bGU+PC90aXRsZXM+PHBlcmlvZGljYWw+PGZ1

bGwtdGl0bGU+Sm91cm5hbCBvZiBIeXBlcnRlbnNpb248L2Z1bGwtdGl0bGU+PGFiYnItMT5KIEh5

cGVydGVuczwvYWJici0xPjwvcGVyaW9kaWNhbD48cGFnZXM+NTY1LTc0PC9wYWdlcz48dm9sdW1l

PjMyPC92b2x1bWU+PG51bWJlcj4zPC9udW1iZXI+PGtleXdvcmRzPjxrZXl3b3JkPkFkdWx0PC9r

ZXl3b3JkPjxrZXl3b3JkPkFuZ2lvdGVuc2luLUNvbnZlcnRpbmcgRW56eW1lIEluaGliaXRvcnMv

YWRtaW5pc3RyYXRpb24gJmFtcDsgZG9zYWdlPC9rZXl3b3JkPjxrZXl3b3JkPkFudGloeXBlcnRl

bnNpdmUgQWdlbnRzLyphZG1pbmlzdHJhdGlvbiAmYW1wOyBkb3NhZ2U8L2tleXdvcmQ+PGtleXdv

cmQ+QXJ0ZXJpb2xlcy9kcnVnIGVmZmVjdHMvdWx0cmFzb25vZ3JhcGh5PC9rZXl3b3JkPjxrZXl3

b3JkPkJsb29kIFByZXNzdXJlL3BoeXNpb2xvZ3k8L2tleXdvcmQ+PGtleXdvcmQ+Q2FsY2l1bSBD

aGFubmVsIEJsb2NrZXJzL2FkbWluaXN0cmF0aW9uICZhbXA7IGRvc2FnZTwva2V5d29yZD48a2V5

d29yZD5EaWh5ZHJvcHlyaWRpbmVzL2FkbWluaXN0cmF0aW9uICZhbXA7IGRvc2FnZTwva2V5d29y

ZD48a2V5d29yZD5EaXVyZXRpY3MvYWRtaW5pc3RyYXRpb24gJmFtcDsgZG9zYWdlPC9rZXl3b3Jk

PjxrZXl3b3JkPkRydWcgVGhlcmFweSwgQ29tYmluYXRpb248L2tleXdvcmQ+PGtleXdvcmQ+RW5h

bGFwcmlsL2FkbWluaXN0cmF0aW9uICZhbXA7IGRvc2FnZTwva2V5d29yZD48a2V5d29yZD5GZW1h

bGU8L2tleXdvcmQ+PGtleXdvcmQ+SHVtYW5zPC9rZXl3b3JkPjxrZXl3b3JkPkh5ZHJvY2hsb3Jv

dGhpYXppZGUvYWRtaW5pc3RyYXRpb24gJmFtcDsgZG9zYWdlPC9rZXl3b3JkPjxrZXl3b3JkPkh5

cGVydGVuc2lvbi8qZHJ1ZyB0aGVyYXB5L3BoeXNpb3BhdGhvbG9neS91bHRyYXNvbm9ncmFwaHk8

L2tleXdvcmQ+PGtleXdvcmQ+S2lkbmV5L2Jsb29kIHN1cHBseS9kcnVnIGVmZmVjdHM8L2tleXdv

cmQ+PGtleXdvcmQ+TGFzZXItRG9wcGxlciBGbG93bWV0cnk8L2tleXdvcmQ+PGtleXdvcmQ+TWFs

ZTwva2V5d29yZD48a2V5d29yZD5NaWRkbGUgQWdlZDwva2V5d29yZD48a2V5d29yZD5PeGlkYXRp

dmUgU3RyZXNzL2RydWcgZWZmZWN0czwva2V5d29yZD48L2tleXdvcmRzPjxkYXRlcz48eWVhcj4y

MDE0PC95ZWFyPjxwdWItZGF0ZXM+PGRhdGU+TWFyPC9kYXRlPjwvcHViLWRhdGVzPjwvZGF0ZXM+

PGlzYm4+MTQ3My01NTk4IChFbGVjdHJvbmljKSYjeEQ7MDI2My02MzUyIChMaW5raW5nKTwvaXNi

bj48YWNjZXNzaW9uLW51bT4yNDM3ODk5OTwvYWNjZXNzaW9uLW51bT48dXJscz48cmVsYXRlZC11

cmxzPjx1cmw+aHR0cDovL3d3dy5uY2JpLm5sbS5uaWguZ292L3B1Ym1lZC8yNDM3ODk5OTwvdXJs

Pjx1cmw+aHR0cDovL292aWRzcC50eC5vdmlkLmNvbS9vdmZ0cGRmcy9GUERETkNPQkZHR0RHTjAw

L2ZzMDQ2L292ZnQvbGl2ZS9ndjAyMy8wMDAwNDg3Mi8wMDAwNDg3Mi0yMDE0MDMwMDAtMDAwMTcu

cGRmPC91cmw+PC9yZWxhdGVkLXVybHM+PC91cmxzPjxlbGVjdHJvbmljLXJlc291cmNlLW51bT4x

MC4xMDk3L0hKSC4wMDAwMDAwMDAwMDAwMDY3PC9lbGVjdHJvbmljLXJlc291cmNlLW51bT48L3Jl

Y29yZD48L0NpdGU+PC9FbmROb3RlPgB=

ADDIN EN.CITE.DATA 10-13 The aim of the CAMIRA trial was to assess in a randomized, double blind, placebo controlled two-arm parallel group clinical trial the effects of treatment of hypertension with the angiotensin receptor blocker (ARB) candesartan versus the dihydropyridine calcium channel blocker (CCB) amlodipine on microvascular rarefaction and other indices of vascular function in individuals with mild-to-moderate essential hypertension.Methodology: Participants: The CAMIRA trial (EudraCT number: 2008-005432-32, ISRCTN 62554526)?was a single center, randomized, double blind, placebo-controlled, parallel-group study performed at St. George’s Healthcare NHS Trust hospital (London, UK). The London-Surrey Borders Research Ethics Committee approved the study (number 08/H0806/72). Written informed consent was obtained from all participants. We recruited Caucasian individuals with mild-to-moderate uncomplicated essential hypertension (sitting systolic BP ≥140–<180 mmHg and/or sitting diastolic BP ≥ 90 - <110 mmHg) who have never been previously treated for their high BP or have been off their antihypertensive medications for at least 8 weeks. Patients were excluded from the study if they had diabetes mellitus (fasting plasma glucose ≥7.0mmol/L, random plasma glucose ≥11.1mmol/L or HbA1c >6.5%) secondary hypertension (excluded hyperaldosteronism, renal artery stenosis, pheochromocytoma by measuring plasma renin, plasma aldosterone, 24 hour urinary metanephrines, magnetic resonance imaging of renal arteries), chronic kidney or liver disease (normal renal & liver function tests), ischemic heart disease (normal ECG), heart failure (normal echocardiogram), skin diseases, or cold hands (measuring skin temperature). After a 2-weeks single-blind placebo run-in period, patients who remained hypertensive (systolic BP 140–180 mmHg and/or diastolic BP 90 -110 mmHg) were randomized to 8-weeks treatment with either candesartan 8mg orally once daily (with forced titration to 16mg once daily after 2 weeks) or amlodipine 5mg orally once daily (with forced titration to 10mg once daily after 2 weeks). Total study duration was 10 weeks. Blood pressure measurement: At each visit, subjects were seated with their backs supported for at least 10 minutes in a temperature-controlled room. All measurements were taken throughout the study from the same arm. Three sitting and 2 standing BP measurements were obtained at 2-minute intervals using appropriate cuff size using the Omron HEM705CP (Hutchings Health Care Ltd., Sussex, UK). Intravital capillary microscopy studies (Capillaroscopy):Previously validated methods PEVuZE5vdGU+PENpdGU+PEF1dGhvcj5BbnRvbmlvczwvQXV0aG9yPjxZZWFyPjE5OTk8L1llYXI+

PFJlY051bT4xMDg2NDwvUmVjTnVtPjxEaXNwbGF5VGV4dD48c3R5bGUgZmFjZT0ic3VwZXJzY3Jp

cHQiPjQtNiwgMTQ8L3N0eWxlPjwvRGlzcGxheVRleHQ+PHJlY29yZD48cmVjLW51bWJlcj4xMDg2

NDwvcmVjLW51bWJlcj48Zm9yZWlnbi1rZXlzPjxrZXkgYXBwPSJFTiIgZGItaWQ9Inp0emFzeGU1

Y3MwMHY0ZWZ3cnB2ZnRyd3RhZnp3ZTIyeGV6dCIgdGltZXN0YW1wPSIxMzgyOTU0NDAwIj4xMDg2

NDwva2V5PjwvZm9yZWlnbi1rZXlzPjxyZWYtdHlwZSBuYW1lPSJKb3VybmFsIEFydGljbGUiPjE3

PC9yZWYtdHlwZT48Y29udHJpYnV0b3JzPjxhdXRob3JzPjxhdXRob3I+QW50b25pb3MsIFQuIEYu

IFQuPC9hdXRob3I+PGF1dGhvcj5SYXR0cmF5LCBGLiBFLjwvYXV0aG9yPjxhdXRob3I+U2luZ2Vy

LCBELiBSLjwvYXV0aG9yPjxhdXRob3I+TWFya2FuZHUsIE4uIEQuPC9hdXRob3I+PGF1dGhvcj5N

b3J0aW1lciwgUC4gUy48L2F1dGhvcj48YXV0aG9yPk1hY0dyZWdvciwgRy4gQS48L2F1dGhvcj48

L2F1dGhvcnM+PC9jb250cmlidXRvcnM+PHRpdGxlcz48dGl0bGU+TWF4aW1pemF0aW9uIG9mIHNr

aW4gY2FwaWxsYXJpZXMgZHVyaW5nIGludHJhdml0YWwgdmlkZW8tbWljcm9zY29weSBpbiBlc3Nl

bnRpYWwgaHlwZXJ0ZW5zaW9uOiBjb21wYXJpc29uIGJldHdlZW4gdmVub3VzIGNvbmdlc3Rpb24s

IHJlYWN0aXZlIGh5cGVyYWVtaWEgYW5kIGNvcmUgaGVhdCBsb2FkIHRlc3RzPC90aXRsZT48c2Vj

b25kYXJ5LXRpdGxlPkNsaW4gU2NpPC9zZWNvbmRhcnktdGl0bGU+PC90aXRsZXM+PHBlcmlvZGlj

YWw+PGZ1bGwtdGl0bGU+Q2xpbmljYWwgU2NpZW5jZTwvZnVsbC10aXRsZT48YWJici0xPkNsaW4g

U2NpPC9hYmJyLTE+PC9wZXJpb2RpY2FsPjxwYWdlcz41MjMtNTI4PC9wYWdlcz48dm9sdW1lPjk3

PC92b2x1bWU+PG51bWJlcj40PC9udW1iZXI+PGRhdGVzPjx5ZWFyPjE5OTk8L3llYXI+PC9kYXRl

cz48bGFiZWw+MDwvbGFiZWw+PHVybHM+PHJlbGF0ZWQtdXJscz48dXJsPmh0dHA6Ly93d3cubmNi

aS5ubG0ubmloLmdvdi9jZ2ktYmluL0VudHJlei9yZWZlcmVyP2h0dHA6Ly9jcy5wb3J0bGFuZHBy

ZXNzLmNvbS9jcy8wOTcvMDUyMy9jczA5NzA1MjMuaHRtPC91cmw+PC9yZWxhdGVkLXVybHM+PC91

cmxzPjwvcmVjb3JkPjwvQ2l0ZT48Q2l0ZT48QXV0aG9yPkFudG9uaW9zPC9BdXRob3I+PFllYXI+

MTk5OTwvWWVhcj48UmVjTnVtPjEwMjc4PC9SZWNOdW0+PHJlY29yZD48cmVjLW51bWJlcj4xMDI3

ODwvcmVjLW51bWJlcj48Zm9yZWlnbi1rZXlzPjxrZXkgYXBwPSJFTiIgZGItaWQ9Inp0emFzeGU1

Y3MwMHY0ZWZ3cnB2ZnRyd3RhZnp3ZTIyeGV6dCIgdGltZXN0YW1wPSIxMzgyOTU0NDAwIj4xMDI3

ODwva2V5PjwvZm9yZWlnbi1rZXlzPjxyZWYtdHlwZSBuYW1lPSJKb3VybmFsIEFydGljbGUiPjE3

PC9yZWYtdHlwZT48Y29udHJpYnV0b3JzPjxhdXRob3JzPjxhdXRob3I+QW50b25pb3MsIFQuIEYu

IFQuPC9hdXRob3I+PGF1dGhvcj5TaW5nZXIsIEQuIFIuPC9hdXRob3I+PGF1dGhvcj5NYXJrYW5k

dSwgTi4gRC48L2F1dGhvcj48YXV0aG9yPk1vcnRpbWVyLCBQLiBTLjwvYXV0aG9yPjxhdXRob3I+

TWFjR3JlZ29yLCBHLiBBLjwvYXV0aG9yPjwvYXV0aG9ycz48L2NvbnRyaWJ1dG9ycz48dGl0bGVz

Pjx0aXRsZT5TdHJ1Y3R1cmFsIHNraW4gY2FwaWxsYXJ5IHJhcmVmYWN0aW9uIGluIGVzc2VudGlh

bCBoeXBlcnRlbnNpb248L3RpdGxlPjxzZWNvbmRhcnktdGl0bGU+SHlwZXJ0ZW5zaW9uPC9zZWNv

bmRhcnktdGl0bGU+PC90aXRsZXM+PHBlcmlvZGljYWw+PGZ1bGwtdGl0bGU+SHlwZXJ0ZW5zaW9u

PC9mdWxsLXRpdGxlPjwvcGVyaW9kaWNhbD48cGFnZXM+OTk4LTEwMDE8L3BhZ2VzPjx2b2x1bWU+

MzM8L3ZvbHVtZT48bnVtYmVyPjQ8L251bWJlcj48a2V5d29yZHM+PGtleXdvcmQ+QWR1bHQ8L2tl

eXdvcmQ+PGtleXdvcmQ+QWdlZDwva2V5d29yZD48a2V5d29yZD5DYXBpbGxhcmllcy9wYXRob2xv

Z3k8L2tleXdvcmQ+PGtleXdvcmQ+RmVtYWxlPC9rZXl3b3JkPjxrZXl3b3JkPkh1bWFuPC9rZXl3

b3JkPjxrZXl3b3JkPkh5cGVydGVuc2lvbi9ldGlvbG9neS8qcGF0aG9sb2d5L3BoeXNpb3BhdGhv

bG9neTwva2V5d29yZD48a2V5d29yZD5NYWxlPC9rZXl3b3JkPjxrZXl3b3JkPk1pZGRsZSBBZ2U8

L2tleXdvcmQ+PGtleXdvcmQ+TmVvdmFzY3VsYXJpemF0aW9uLCBQaHlzaW9sb2dpYzwva2V5d29y

ZD48a2V5d29yZD5Ta2luLypibG9vZCBzdXBwbHk8L2tleXdvcmQ+PGtleXdvcmQ+VmFzY3VsYXIg

UmVzaXN0YW5jZTwva2V5d29yZD48L2tleXdvcmRzPjxkYXRlcz48eWVhcj4xOTk5PC95ZWFyPjwv

ZGF0ZXM+PGxhYmVsPjk5MjIxNzE4PC9sYWJlbD48dXJscz48cmVsYXRlZC11cmxzPjx1cmw+aHR0

cDovL3d3dy5uY2JpLm5sbS5uaWguZ292L2NnaS1iaW4vRW50cmV6L3JlZmVyZXI/aHR0cDovL3d3

dy5oeXBlcnRlbnNpb25haGEub3JnL2NnaS9jb250ZW50L2Z1bGwvMzMvNC85OTg8L3VybD48L3Jl

bGF0ZWQtdXJscz48L3VybHM+PC9yZWNvcmQ+PC9DaXRlPjxDaXRlPjxBdXRob3I+QW50b25pb3M8

L0F1dGhvcj48WWVhcj4xOTk5PC9ZZWFyPjxSZWNOdW0+MTA4NjM8L1JlY051bT48cmVjb3JkPjxy

ZWMtbnVtYmVyPjEwODYzPC9yZWMtbnVtYmVyPjxmb3JlaWduLWtleXM+PGtleSBhcHA9IkVOIiBk

Yi1pZD0ienR6YXN4ZTVjczAwdjRlZndycHZmdHJ3dGFmendlMjJ4ZXp0IiB0aW1lc3RhbXA9IjEz

ODI5NTQ0MDAiPjEwODYzPC9rZXk+PC9mb3JlaWduLWtleXM+PHJlZi10eXBlIG5hbWU9IkpvdXJu

YWwgQXJ0aWNsZSI+MTc8L3JlZi10eXBlPjxjb250cmlidXRvcnM+PGF1dGhvcnM+PGF1dGhvcj5B

bnRvbmlvcywgVC4gRi4gVC48L2F1dGhvcj48YXV0aG9yPlNpbmdlciwgRC4gUi48L2F1dGhvcj48

YXV0aG9yPk1hcmthbmR1LCBOLiBELjwvYXV0aG9yPjxhdXRob3I+TW9ydGltZXIsIFAuIFMuPC9h

dXRob3I+PGF1dGhvcj5NYWNHcmVnb3IsIEcuIEEuPC9hdXRob3I+PC9hdXRob3JzPjwvY29udHJp

YnV0b3JzPjx0aXRsZXM+PHRpdGxlPlJhcmVmYWN0aW9uIG9mIHNraW4gY2FwaWxsYXJpZXMgaW4g

Ym9yZGVybGluZSBlc3NlbnRpYWwgaHlwZXJ0ZW5zaW9uIHN1Z2dlc3RzIGFuIGVhcmx5IHN0cnVj

dHVyYWwgYWJub3JtYWxpdHk8L3RpdGxlPjxzZWNvbmRhcnktdGl0bGU+SHlwZXJ0ZW5zaW9uPC9z

ZWNvbmRhcnktdGl0bGU+PC90aXRsZXM+PHBlcmlvZGljYWw+PGZ1bGwtdGl0bGU+SHlwZXJ0ZW5z

aW9uPC9mdWxsLXRpdGxlPjwvcGVyaW9kaWNhbD48cGFnZXM+NjU1LTY1ODwvcGFnZXM+PHZvbHVt

ZT4zNDwvdm9sdW1lPjxudW1iZXI+NCBQdCAxPC9udW1iZXI+PGRhdGVzPjx5ZWFyPjE5OTk8L3ll

YXI+PC9kYXRlcz48bGFiZWw+OTk0NTI4MjY8L2xhYmVsPjx1cmxzPjxyZWxhdGVkLXVybHM+PHVy

bD5odHRwOi8vd3d3Lm5jYmkubmxtLm5paC5nb3YvY2dpLWJpbi9FbnRyZXovcmVmZXJlcj9odHRw

Oi8vd3d3Lmh5cGVydGVuc2lvbmFoYS5vcmcvY2dpL2NvbnRlbnQvZnVsbC8zNC80LzY1NTwvdXJs

PjwvcmVsYXRlZC11cmxzPjwvdXJscz48L3JlY29yZD48L0NpdGU+PENpdGU+PEF1dGhvcj5BbnRv

bmlvczwvQXV0aG9yPjxZZWFyPjIwMDM8L1llYXI+PFJlY051bT4xMTQ4MjwvUmVjTnVtPjxyZWNv

cmQ+PHJlYy1udW1iZXI+MTE0ODI8L3JlYy1udW1iZXI+PGZvcmVpZ24ta2V5cz48a2V5IGFwcD0i

RU4iIGRiLWlkPSJ6dHphc3hlNWNzMDB2NGVmd3JwdmZ0cnd0YWZ6d2UyMnhlenQiIHRpbWVzdGFt

cD0iMTM4Mjk1NDQwMSI+MTE0ODI8L2tleT48L2ZvcmVpZ24ta2V5cz48cmVmLXR5cGUgbmFtZT0i

Sm91cm5hbCBBcnRpY2xlIj4xNzwvcmVmLXR5cGU+PGNvbnRyaWJ1dG9ycz48YXV0aG9ycz48YXV0

aG9yPkFudG9uaW9zLCBULiBGLjwvYXV0aG9yPjxhdXRob3I+UmF0dHJheSwgRi4gTS48L2F1dGhv

cj48YXV0aG9yPlNpbmdlciwgRC4gUi48L2F1dGhvcj48YXV0aG9yPk1hcmthbmR1LCBOLiBELjwv

YXV0aG9yPjxhdXRob3I+TW9ydGltZXIsIFAuIFMuPC9hdXRob3I+PGF1dGhvcj5NYWNHcmVnb3Is

IEcuIEEuPC9hdXRob3I+PC9hdXRob3JzPjwvY29udHJpYnV0b3JzPjxhdXRoLWFkZHJlc3M+Qmxv

b2QgUHJlc3N1cmUgVW5pdCwgU3QgR2VvcmdlJmFwb3M7cyBIb3NwaXRhbCBNZWRpY2FsIFNjaG9v

bCwgTG9uZG9uLCBVSy4gdC5hbnRvbmlvc0BzZ2htcy5hYy51azwvYXV0aC1hZGRyZXNzPjx0aXRs

ZXM+PHRpdGxlPlJhcmVmYWN0aW9uIG9mIHNraW4gY2FwaWxsYXJpZXMgaW4gbm9ybW90ZW5zaXZl

IG9mZnNwcmluZyBvZiBpbmRpdmlkdWFscyB3aXRoIGVzc2VudGlhbCBoeXBlcnRlbnNpb248L3Rp

dGxlPjxzZWNvbmRhcnktdGl0bGU+SGVhcnQ8L3NlY29uZGFyeS10aXRsZT48L3RpdGxlcz48cGVy

aW9kaWNhbD48ZnVsbC10aXRsZT5IZWFydDwvZnVsbC10aXRsZT48L3BlcmlvZGljYWw+PHBhZ2Vz

PjE3NS0xNzg8L3BhZ2VzPjx2b2x1bWU+ODk8L3ZvbHVtZT48bnVtYmVyPjI8L251bWJlcj48ZGF0

ZXM+PHllYXI+MjAwMzwveWVhcj48cHViLWRhdGVzPjxkYXRlPkZlYjwvZGF0ZT48L3B1Yi1kYXRl

cz48L2RhdGVzPjxhY2Nlc3Npb24tbnVtPjEyNTI3NjcxPC9hY2Nlc3Npb24tbnVtPjx1cmxzPjxy

ZWxhdGVkLXVybHM+PHVybD5odHRwOi8vd3d3Lm5jYmkubmxtLm5paC5nb3YvZW50cmV6L3F1ZXJ5

LmZjZ2k/Y21kPVJldHJpZXZlJmFtcDtkYj1QdWJNZWQmYW1wO2RvcHQ9Q2l0YXRpb24mYW1wO2xp

c3RfdWlkcz0xMjUyNzY3MTwvdXJsPjwvcmVsYXRlZC11cmxzPjwvdXJscz48L3JlY29yZD48L0Np

dGU+PC9FbmROb3RlPn==

ADDIN EN.CITE PEVuZE5vdGU+PENpdGU+PEF1dGhvcj5BbnRvbmlvczwvQXV0aG9yPjxZZWFyPjE5OTk8L1llYXI+

PFJlY051bT4xMDg2NDwvUmVjTnVtPjxEaXNwbGF5VGV4dD48c3R5bGUgZmFjZT0ic3VwZXJzY3Jp

cHQiPjQtNiwgMTQ8L3N0eWxlPjwvRGlzcGxheVRleHQ+PHJlY29yZD48cmVjLW51bWJlcj4xMDg2

NDwvcmVjLW51bWJlcj48Zm9yZWlnbi1rZXlzPjxrZXkgYXBwPSJFTiIgZGItaWQ9Inp0emFzeGU1

Y3MwMHY0ZWZ3cnB2ZnRyd3RhZnp3ZTIyeGV6dCIgdGltZXN0YW1wPSIxMzgyOTU0NDAwIj4xMDg2

NDwva2V5PjwvZm9yZWlnbi1rZXlzPjxyZWYtdHlwZSBuYW1lPSJKb3VybmFsIEFydGljbGUiPjE3

PC9yZWYtdHlwZT48Y29udHJpYnV0b3JzPjxhdXRob3JzPjxhdXRob3I+QW50b25pb3MsIFQuIEYu

IFQuPC9hdXRob3I+PGF1dGhvcj5SYXR0cmF5LCBGLiBFLjwvYXV0aG9yPjxhdXRob3I+U2luZ2Vy

LCBELiBSLjwvYXV0aG9yPjxhdXRob3I+TWFya2FuZHUsIE4uIEQuPC9hdXRob3I+PGF1dGhvcj5N

b3J0aW1lciwgUC4gUy48L2F1dGhvcj48YXV0aG9yPk1hY0dyZWdvciwgRy4gQS48L2F1dGhvcj48

L2F1dGhvcnM+PC9jb250cmlidXRvcnM+PHRpdGxlcz48dGl0bGU+TWF4aW1pemF0aW9uIG9mIHNr

aW4gY2FwaWxsYXJpZXMgZHVyaW5nIGludHJhdml0YWwgdmlkZW8tbWljcm9zY29weSBpbiBlc3Nl

bnRpYWwgaHlwZXJ0ZW5zaW9uOiBjb21wYXJpc29uIGJldHdlZW4gdmVub3VzIGNvbmdlc3Rpb24s

IHJlYWN0aXZlIGh5cGVyYWVtaWEgYW5kIGNvcmUgaGVhdCBsb2FkIHRlc3RzPC90aXRsZT48c2Vj

b25kYXJ5LXRpdGxlPkNsaW4gU2NpPC9zZWNvbmRhcnktdGl0bGU+PC90aXRsZXM+PHBlcmlvZGlj

YWw+PGZ1bGwtdGl0bGU+Q2xpbmljYWwgU2NpZW5jZTwvZnVsbC10aXRsZT48YWJici0xPkNsaW4g

U2NpPC9hYmJyLTE+PC9wZXJpb2RpY2FsPjxwYWdlcz41MjMtNTI4PC9wYWdlcz48dm9sdW1lPjk3

PC92b2x1bWU+PG51bWJlcj40PC9udW1iZXI+PGRhdGVzPjx5ZWFyPjE5OTk8L3llYXI+PC9kYXRl

cz48bGFiZWw+MDwvbGFiZWw+PHVybHM+PHJlbGF0ZWQtdXJscz48dXJsPmh0dHA6Ly93d3cubmNi

aS5ubG0ubmloLmdvdi9jZ2ktYmluL0VudHJlei9yZWZlcmVyP2h0dHA6Ly9jcy5wb3J0bGFuZHBy

ZXNzLmNvbS9jcy8wOTcvMDUyMy9jczA5NzA1MjMuaHRtPC91cmw+PC9yZWxhdGVkLXVybHM+PC91

cmxzPjwvcmVjb3JkPjwvQ2l0ZT48Q2l0ZT48QXV0aG9yPkFudG9uaW9zPC9BdXRob3I+PFllYXI+

MTk5OTwvWWVhcj48UmVjTnVtPjEwMjc4PC9SZWNOdW0+PHJlY29yZD48cmVjLW51bWJlcj4xMDI3

ODwvcmVjLW51bWJlcj48Zm9yZWlnbi1rZXlzPjxrZXkgYXBwPSJFTiIgZGItaWQ9Inp0emFzeGU1

Y3MwMHY0ZWZ3cnB2ZnRyd3RhZnp3ZTIyeGV6dCIgdGltZXN0YW1wPSIxMzgyOTU0NDAwIj4xMDI3

ODwva2V5PjwvZm9yZWlnbi1rZXlzPjxyZWYtdHlwZSBuYW1lPSJKb3VybmFsIEFydGljbGUiPjE3

PC9yZWYtdHlwZT48Y29udHJpYnV0b3JzPjxhdXRob3JzPjxhdXRob3I+QW50b25pb3MsIFQuIEYu

IFQuPC9hdXRob3I+PGF1dGhvcj5TaW5nZXIsIEQuIFIuPC9hdXRob3I+PGF1dGhvcj5NYXJrYW5k

dSwgTi4gRC48L2F1dGhvcj48YXV0aG9yPk1vcnRpbWVyLCBQLiBTLjwvYXV0aG9yPjxhdXRob3I+

TWFjR3JlZ29yLCBHLiBBLjwvYXV0aG9yPjwvYXV0aG9ycz48L2NvbnRyaWJ1dG9ycz48dGl0bGVz

Pjx0aXRsZT5TdHJ1Y3R1cmFsIHNraW4gY2FwaWxsYXJ5IHJhcmVmYWN0aW9uIGluIGVzc2VudGlh

bCBoeXBlcnRlbnNpb248L3RpdGxlPjxzZWNvbmRhcnktdGl0bGU+SHlwZXJ0ZW5zaW9uPC9zZWNv

bmRhcnktdGl0bGU+PC90aXRsZXM+PHBlcmlvZGljYWw+PGZ1bGwtdGl0bGU+SHlwZXJ0ZW5zaW9u

PC9mdWxsLXRpdGxlPjwvcGVyaW9kaWNhbD48cGFnZXM+OTk4LTEwMDE8L3BhZ2VzPjx2b2x1bWU+

MzM8L3ZvbHVtZT48bnVtYmVyPjQ8L251bWJlcj48a2V5d29yZHM+PGtleXdvcmQ+QWR1bHQ8L2tl

eXdvcmQ+PGtleXdvcmQ+QWdlZDwva2V5d29yZD48a2V5d29yZD5DYXBpbGxhcmllcy9wYXRob2xv

Z3k8L2tleXdvcmQ+PGtleXdvcmQ+RmVtYWxlPC9rZXl3b3JkPjxrZXl3b3JkPkh1bWFuPC9rZXl3

b3JkPjxrZXl3b3JkPkh5cGVydGVuc2lvbi9ldGlvbG9neS8qcGF0aG9sb2d5L3BoeXNpb3BhdGhv

bG9neTwva2V5d29yZD48a2V5d29yZD5NYWxlPC9rZXl3b3JkPjxrZXl3b3JkPk1pZGRsZSBBZ2U8

L2tleXdvcmQ+PGtleXdvcmQ+TmVvdmFzY3VsYXJpemF0aW9uLCBQaHlzaW9sb2dpYzwva2V5d29y

ZD48a2V5d29yZD5Ta2luLypibG9vZCBzdXBwbHk8L2tleXdvcmQ+PGtleXdvcmQ+VmFzY3VsYXIg

UmVzaXN0YW5jZTwva2V5d29yZD48L2tleXdvcmRzPjxkYXRlcz48eWVhcj4xOTk5PC95ZWFyPjwv

ZGF0ZXM+PGxhYmVsPjk5MjIxNzE4PC9sYWJlbD48dXJscz48cmVsYXRlZC11cmxzPjx1cmw+aHR0

cDovL3d3dy5uY2JpLm5sbS5uaWguZ292L2NnaS1iaW4vRW50cmV6L3JlZmVyZXI/aHR0cDovL3d3

dy5oeXBlcnRlbnNpb25haGEub3JnL2NnaS9jb250ZW50L2Z1bGwvMzMvNC85OTg8L3VybD48L3Jl

bGF0ZWQtdXJscz48L3VybHM+PC9yZWNvcmQ+PC9DaXRlPjxDaXRlPjxBdXRob3I+QW50b25pb3M8

L0F1dGhvcj48WWVhcj4xOTk5PC9ZZWFyPjxSZWNOdW0+MTA4NjM8L1JlY051bT48cmVjb3JkPjxy

ZWMtbnVtYmVyPjEwODYzPC9yZWMtbnVtYmVyPjxmb3JlaWduLWtleXM+PGtleSBhcHA9IkVOIiBk

Yi1pZD0ienR6YXN4ZTVjczAwdjRlZndycHZmdHJ3dGFmendlMjJ4ZXp0IiB0aW1lc3RhbXA9IjEz

ODI5NTQ0MDAiPjEwODYzPC9rZXk+PC9mb3JlaWduLWtleXM+PHJlZi10eXBlIG5hbWU9IkpvdXJu

YWwgQXJ0aWNsZSI+MTc8L3JlZi10eXBlPjxjb250cmlidXRvcnM+PGF1dGhvcnM+PGF1dGhvcj5B

bnRvbmlvcywgVC4gRi4gVC48L2F1dGhvcj48YXV0aG9yPlNpbmdlciwgRC4gUi48L2F1dGhvcj48

YXV0aG9yPk1hcmthbmR1LCBOLiBELjwvYXV0aG9yPjxhdXRob3I+TW9ydGltZXIsIFAuIFMuPC9h

dXRob3I+PGF1dGhvcj5NYWNHcmVnb3IsIEcuIEEuPC9hdXRob3I+PC9hdXRob3JzPjwvY29udHJp

YnV0b3JzPjx0aXRsZXM+PHRpdGxlPlJhcmVmYWN0aW9uIG9mIHNraW4gY2FwaWxsYXJpZXMgaW4g

Ym9yZGVybGluZSBlc3NlbnRpYWwgaHlwZXJ0ZW5zaW9uIHN1Z2dlc3RzIGFuIGVhcmx5IHN0cnVj

dHVyYWwgYWJub3JtYWxpdHk8L3RpdGxlPjxzZWNvbmRhcnktdGl0bGU+SHlwZXJ0ZW5zaW9uPC9z

ZWNvbmRhcnktdGl0bGU+PC90aXRsZXM+PHBlcmlvZGljYWw+PGZ1bGwtdGl0bGU+SHlwZXJ0ZW5z

aW9uPC9mdWxsLXRpdGxlPjwvcGVyaW9kaWNhbD48cGFnZXM+NjU1LTY1ODwvcGFnZXM+PHZvbHVt

ZT4zNDwvdm9sdW1lPjxudW1iZXI+NCBQdCAxPC9udW1iZXI+PGRhdGVzPjx5ZWFyPjE5OTk8L3ll

YXI+PC9kYXRlcz48bGFiZWw+OTk0NTI4MjY8L2xhYmVsPjx1cmxzPjxyZWxhdGVkLXVybHM+PHVy

bD5odHRwOi8vd3d3Lm5jYmkubmxtLm5paC5nb3YvY2dpLWJpbi9FbnRyZXovcmVmZXJlcj9odHRw

Oi8vd3d3Lmh5cGVydGVuc2lvbmFoYS5vcmcvY2dpL2NvbnRlbnQvZnVsbC8zNC80LzY1NTwvdXJs

PjwvcmVsYXRlZC11cmxzPjwvdXJscz48L3JlY29yZD48L0NpdGU+PENpdGU+PEF1dGhvcj5BbnRv

bmlvczwvQXV0aG9yPjxZZWFyPjIwMDM8L1llYXI+PFJlY051bT4xMTQ4MjwvUmVjTnVtPjxyZWNv

cmQ+PHJlYy1udW1iZXI+MTE0ODI8L3JlYy1udW1iZXI+PGZvcmVpZ24ta2V5cz48a2V5IGFwcD0i

RU4iIGRiLWlkPSJ6dHphc3hlNWNzMDB2NGVmd3JwdmZ0cnd0YWZ6d2UyMnhlenQiIHRpbWVzdGFt

cD0iMTM4Mjk1NDQwMSI+MTE0ODI8L2tleT48L2ZvcmVpZ24ta2V5cz48cmVmLXR5cGUgbmFtZT0i

Sm91cm5hbCBBcnRpY2xlIj4xNzwvcmVmLXR5cGU+PGNvbnRyaWJ1dG9ycz48YXV0aG9ycz48YXV0

aG9yPkFudG9uaW9zLCBULiBGLjwvYXV0aG9yPjxhdXRob3I+UmF0dHJheSwgRi4gTS48L2F1dGhv

cj48YXV0aG9yPlNpbmdlciwgRC4gUi48L2F1dGhvcj48YXV0aG9yPk1hcmthbmR1LCBOLiBELjwv

YXV0aG9yPjxhdXRob3I+TW9ydGltZXIsIFAuIFMuPC9hdXRob3I+PGF1dGhvcj5NYWNHcmVnb3Is

IEcuIEEuPC9hdXRob3I+PC9hdXRob3JzPjwvY29udHJpYnV0b3JzPjxhdXRoLWFkZHJlc3M+Qmxv

b2QgUHJlc3N1cmUgVW5pdCwgU3QgR2VvcmdlJmFwb3M7cyBIb3NwaXRhbCBNZWRpY2FsIFNjaG9v

bCwgTG9uZG9uLCBVSy4gdC5hbnRvbmlvc0BzZ2htcy5hYy51azwvYXV0aC1hZGRyZXNzPjx0aXRs

ZXM+PHRpdGxlPlJhcmVmYWN0aW9uIG9mIHNraW4gY2FwaWxsYXJpZXMgaW4gbm9ybW90ZW5zaXZl

IG9mZnNwcmluZyBvZiBpbmRpdmlkdWFscyB3aXRoIGVzc2VudGlhbCBoeXBlcnRlbnNpb248L3Rp

dGxlPjxzZWNvbmRhcnktdGl0bGU+SGVhcnQ8L3NlY29uZGFyeS10aXRsZT48L3RpdGxlcz48cGVy

aW9kaWNhbD48ZnVsbC10aXRsZT5IZWFydDwvZnVsbC10aXRsZT48L3BlcmlvZGljYWw+PHBhZ2Vz

PjE3NS0xNzg8L3BhZ2VzPjx2b2x1bWU+ODk8L3ZvbHVtZT48bnVtYmVyPjI8L251bWJlcj48ZGF0

ZXM+PHllYXI+MjAwMzwveWVhcj48cHViLWRhdGVzPjxkYXRlPkZlYjwvZGF0ZT48L3B1Yi1kYXRl

cz48L2RhdGVzPjxhY2Nlc3Npb24tbnVtPjEyNTI3NjcxPC9hY2Nlc3Npb24tbnVtPjx1cmxzPjxy

ZWxhdGVkLXVybHM+PHVybD5odHRwOi8vd3d3Lm5jYmkubmxtLm5paC5nb3YvZW50cmV6L3F1ZXJ5

LmZjZ2k/Y21kPVJldHJpZXZlJmFtcDtkYj1QdWJNZWQmYW1wO2RvcHQ9Q2l0YXRpb24mYW1wO2xp

c3RfdWlkcz0xMjUyNzY3MTwvdXJsPjwvcmVsYXRlZC11cmxzPjwvdXJscz48L3JlY29yZD48L0Np

dGU+PC9FbmROb3RlPn==

ADDIN EN.CITE.DATA 4-6, 14 were used to assess capillary density in the skin of the dorsum of the fingers. The studies were performed in a temperature-controlled laboratory (21°-24° C) after the study subjects had at least 20-minute rest for acclimatization. Subjects were seated with the left arm and hand supported at heart level. Microscopic images were obtained using the CapiScope system CAM1 and the number of capillaries was counted on-line using computer software (KK Technology, Exeter, UK). Basal capillary density (BCD) represents the number of capillaries that are “open” or “functioning” at the time of measurement, and was calculated as the mean of 4 microscopic fields.Maximization of capillaries: A miniature BP cuff was wrapped around the base of the finger and was then inflated to 60mmHg and further images were recorded using one of the above four fields chosen at random. Venous congestion was maintained for 2 minutes. ADDIN EN.CITE <EndNote><Cite><Author>Antonios</Author><Year>1999</Year><RecNum>10864</RecNum><DisplayText><style face="superscript">14</style></DisplayText><record><rec-number>10864</rec-number><foreign-keys><key app="EN" db-id="ztzasxe5cs00v4efwrpvftrwtafzwe22xezt" timestamp="1382954400">10864</key></foreign-keys><ref-type name="Journal Article">17</ref-type><contributors><authors><author>Antonios, T. F. T.</author><author>Rattray, F. E.</author><author>Singer, D. R.</author><author>Markandu, N. D.</author><author>Mortimer, P. S.</author><author>MacGregor, G. A.</author></authors></contributors><titles><title>Maximization of skin capillaries during intravital video-microscopy in essential hypertension: comparison between venous congestion, reactive hyperaemia and core heat load tests</title><secondary-title>Clin Sci</secondary-title></titles><periodical><full-title>Clinical Science</full-title><abbr-1>Clin Sci</abbr-1></periodical><pages>523-528</pages><volume>97</volume><number>4</number><dates><year>1999</year></dates><label>0</label><urls><related-urls><url> Skin and room temperatures were monitored at each visit. Capillaroscopy measurements were performed at the end of the placebo-run in visit, after 4-weeks and 8-weeks of active drug treatment. Carotid-Femoral Pulse Wave Velocity (PWV) measurements: PWV was measured non-invasively using the COMPLIOR device as previously described.PEVuZE5vdGU+PENpdGU+PEF1dGhvcj5Bc21hcjwvQXV0aG9yPjxZZWFyPjIwMDE8L1llYXI+PFJl

Y051bT4xNTM0MzwvUmVjTnVtPjxEaXNwbGF5VGV4dD48c3R5bGUgZmFjZT0ic3VwZXJzY3JpcHQi

PjE1PC9zdHlsZT48L0Rpc3BsYXlUZXh0PjxyZWNvcmQ+PHJlYy1udW1iZXI+MTUzNDM8L3JlYy1u

dW1iZXI+PGZvcmVpZ24ta2V5cz48a2V5IGFwcD0iRU4iIGRiLWlkPSJ6dHphc3hlNWNzMDB2NGVm

d3JwdmZ0cnd0YWZ6d2UyMnhlenQiIHRpbWVzdGFtcD0iMTQzOTM2OTIwNiI+MTUzNDM8L2tleT48

L2ZvcmVpZ24ta2V5cz48cmVmLXR5cGUgbmFtZT0iSm91cm5hbCBBcnRpY2xlIj4xNzwvcmVmLXR5

cGU+PGNvbnRyaWJ1dG9ycz48YXV0aG9ycz48YXV0aG9yPkFzbWFyLCBSLjwvYXV0aG9yPjxhdXRo

b3I+VG9wb3VjaGlhbiwgSi48L2F1dGhvcj48YXV0aG9yPlBhbm5pZXIsIEIuPC9hdXRob3I+PGF1

dGhvcj5CZW5ldG9zLCBBLjwvYXV0aG9yPjxhdXRob3I+U2FmYXIsIE0uPC9hdXRob3I+PGF1dGhv

cj5TY2llbnRpZmljLCBRdWFsaXR5IENvbnRyb2wgQ29vcmRpbmF0aW9uPC9hdXRob3I+PGF1dGhv

cj5JbnZlc3RpZ2F0aW9uIENvbW1pdHRlZXMgb2YgdGhlIENvbXBsaW9yLCBTdHVkeTwvYXV0aG9y

PjwvYXV0aG9ycz48L2NvbnRyaWJ1dG9ycz48YXV0aC1hZGRyZXNzPkwmYXBvcztJbnN0aXR1dCBD

YXJkaW9WYXNjdWxhaXJlLCBQYXJpcywgRnJhbmNlLiByYUBpY3Yub3JnPC9hdXRoLWFkZHJlc3M+

PHRpdGxlcz48dGl0bGU+UHVsc2Ugd2F2ZSB2ZWxvY2l0eSBhcyBlbmRwb2ludCBpbiBsYXJnZS1z

Y2FsZSBpbnRlcnZlbnRpb24gdHJpYWwuIFRoZSBDb21wbGlvciBzdHVkeS4gU2NpZW50aWZpYywg

UXVhbGl0eSBDb250cm9sLCBDb29yZGluYXRpb24gYW5kIEludmVzdGlnYXRpb24gQ29tbWl0dGVl

cyBvZiB0aGUgQ29tcGxpb3IgU3R1ZHk8L3RpdGxlPjxzZWNvbmRhcnktdGl0bGU+SiBIeXBlcnRl

bnM8L3NlY29uZGFyeS10aXRsZT48L3RpdGxlcz48cGVyaW9kaWNhbD48ZnVsbC10aXRsZT5Kb3Vy

bmFsIG9mIEh5cGVydGVuc2lvbjwvZnVsbC10aXRsZT48YWJici0xPkogSHlwZXJ0ZW5zPC9hYmJy

LTE+PC9wZXJpb2RpY2FsPjxwYWdlcz44MTMtODwvcGFnZXM+PHZvbHVtZT4xOTwvdm9sdW1lPjxu

dW1iZXI+NDwvbnVtYmVyPjxrZXl3b3Jkcz48a2V5d29yZD5BZHVsdDwva2V5d29yZD48a2V5d29y

ZD5BZ2VkPC9rZXl3b3JkPjxrZXl3b3JkPkFudGloeXBlcnRlbnNpdmUgQWdlbnRzL2FkbWluaXN0

cmF0aW9uICZhbXA7IGRvc2FnZS8qdGhlcmFwZXV0aWMgdXNlPC9rZXl3b3JkPjxrZXl3b3JkPkFy

dGVyaWVzL2RydWcgZWZmZWN0cy8qcGh5c2lvcGF0aG9sb2d5PC9rZXl3b3JkPjxrZXl3b3JkPkF1

dG9tYXRpb248L2tleXdvcmQ+PGtleXdvcmQ+Qmxvb2QgUHJlc3N1cmUvZHJ1ZyBlZmZlY3RzPC9r

ZXl3b3JkPjxrZXl3b3JkPkNhcm90aWQgQXJ0ZXJpZXMvcGh5c2lvcGF0aG9sb2d5PC9rZXl3b3Jk

PjxrZXl3b3JkPkRpdXJldGljcy9hZG1pbmlzdHJhdGlvbiAmYW1wOyBkb3NhZ2UvKnRoZXJhcGV1

dGljIHVzZTwva2V5d29yZD48a2V5d29yZD5EcnVnIEFkbWluaXN0cmF0aW9uIFNjaGVkdWxlPC9r

ZXl3b3JkPjxrZXl3b3JkPkRydWcgQ29tYmluYXRpb25zPC9rZXl3b3JkPjxrZXl3b3JkPkVsYXN0

aWNpdHk8L2tleXdvcmQ+PGtleXdvcmQ+RXF1aXBtZW50IGFuZCBTdXBwbGllczwva2V5d29yZD48

a2V5d29yZD5GZWFzaWJpbGl0eSBTdHVkaWVzPC9rZXl3b3JkPjxrZXl3b3JkPkZlbWFsZTwva2V5

d29yZD48a2V5d29yZD5GZW1vcmFsIEFydGVyeS9waHlzaW9wYXRob2xvZ3k8L2tleXdvcmQ+PGtl

eXdvcmQ+SHVtYW5zPC9rZXl3b3JkPjxrZXl3b3JkPkh5cGVydGVuc2lvbi8qZHJ1ZyB0aGVyYXB5

LypwaHlzaW9wYXRob2xvZ3k8L2tleXdvcmQ+PGtleXdvcmQ+SW5kYXBhbWlkZS9hZG1pbmlzdHJh

dGlvbiAmYW1wOyBkb3NhZ2UvKnRoZXJhcGV1dGljIHVzZTwva2V5d29yZD48a2V5d29yZD5NYWxl

PC9rZXl3b3JkPjxrZXl3b3JkPk1pZGRsZSBBZ2VkPC9rZXl3b3JkPjxrZXl3b3JkPlBlcmluZG9w

cmlsL2FkbWluaXN0cmF0aW9uICZhbXA7IGRvc2FnZS8qdGhlcmFwZXV0aWMgdXNlPC9rZXl3b3Jk

PjxrZXl3b3JkPipQdWxzZTwva2V5d29yZD48a2V5d29yZD5UaW1lIEZhY3RvcnM8L2tleXdvcmQ+

PC9rZXl3b3Jkcz48ZGF0ZXM+PHllYXI+MjAwMTwveWVhcj48cHViLWRhdGVzPjxkYXRlPkFwcjwv

ZGF0ZT48L3B1Yi1kYXRlcz48L2RhdGVzPjxpc2JuPjAyNjMtNjM1MiAoUHJpbnQpJiN4RDswMjYz

LTYzNTIgKExpbmtpbmcpPC9pc2JuPjxhY2Nlc3Npb24tbnVtPjExMzMwODg1PC9hY2Nlc3Npb24t

bnVtPjx1cmxzPjxyZWxhdGVkLXVybHM+PHVybD5odHRwOi8vd3d3Lm5jYmkubmxtLm5paC5nb3Yv

cHVibWVkLzExMzMwODg1PC91cmw+PC9yZWxhdGVkLXVybHM+PC91cmxzPjwvcmVjb3JkPjwvQ2l0

ZT48L0VuZE5vdGU+AG==

ADDIN EN.CITE PEVuZE5vdGU+PENpdGU+PEF1dGhvcj5Bc21hcjwvQXV0aG9yPjxZZWFyPjIwMDE8L1llYXI+PFJl

Y051bT4xNTM0MzwvUmVjTnVtPjxEaXNwbGF5VGV4dD48c3R5bGUgZmFjZT0ic3VwZXJzY3JpcHQi

PjE1PC9zdHlsZT48L0Rpc3BsYXlUZXh0PjxyZWNvcmQ+PHJlYy1udW1iZXI+MTUzNDM8L3JlYy1u

dW1iZXI+PGZvcmVpZ24ta2V5cz48a2V5IGFwcD0iRU4iIGRiLWlkPSJ6dHphc3hlNWNzMDB2NGVm

d3JwdmZ0cnd0YWZ6d2UyMnhlenQiIHRpbWVzdGFtcD0iMTQzOTM2OTIwNiI+MTUzNDM8L2tleT48

L2ZvcmVpZ24ta2V5cz48cmVmLXR5cGUgbmFtZT0iSm91cm5hbCBBcnRpY2xlIj4xNzwvcmVmLXR5

cGU+PGNvbnRyaWJ1dG9ycz48YXV0aG9ycz48YXV0aG9yPkFzbWFyLCBSLjwvYXV0aG9yPjxhdXRo

b3I+VG9wb3VjaGlhbiwgSi48L2F1dGhvcj48YXV0aG9yPlBhbm5pZXIsIEIuPC9hdXRob3I+PGF1

dGhvcj5CZW5ldG9zLCBBLjwvYXV0aG9yPjxhdXRob3I+U2FmYXIsIE0uPC9hdXRob3I+PGF1dGhv

cj5TY2llbnRpZmljLCBRdWFsaXR5IENvbnRyb2wgQ29vcmRpbmF0aW9uPC9hdXRob3I+PGF1dGhv

cj5JbnZlc3RpZ2F0aW9uIENvbW1pdHRlZXMgb2YgdGhlIENvbXBsaW9yLCBTdHVkeTwvYXV0aG9y

PjwvYXV0aG9ycz48L2NvbnRyaWJ1dG9ycz48YXV0aC1hZGRyZXNzPkwmYXBvcztJbnN0aXR1dCBD

YXJkaW9WYXNjdWxhaXJlLCBQYXJpcywgRnJhbmNlLiByYUBpY3Yub3JnPC9hdXRoLWFkZHJlc3M+

PHRpdGxlcz48dGl0bGU+UHVsc2Ugd2F2ZSB2ZWxvY2l0eSBhcyBlbmRwb2ludCBpbiBsYXJnZS1z

Y2FsZSBpbnRlcnZlbnRpb24gdHJpYWwuIFRoZSBDb21wbGlvciBzdHVkeS4gU2NpZW50aWZpYywg

UXVhbGl0eSBDb250cm9sLCBDb29yZGluYXRpb24gYW5kIEludmVzdGlnYXRpb24gQ29tbWl0dGVl

cyBvZiB0aGUgQ29tcGxpb3IgU3R1ZHk8L3RpdGxlPjxzZWNvbmRhcnktdGl0bGU+SiBIeXBlcnRl

bnM8L3NlY29uZGFyeS10aXRsZT48L3RpdGxlcz48cGVyaW9kaWNhbD48ZnVsbC10aXRsZT5Kb3Vy

bmFsIG9mIEh5cGVydGVuc2lvbjwvZnVsbC10aXRsZT48YWJici0xPkogSHlwZXJ0ZW5zPC9hYmJy

LTE+PC9wZXJpb2RpY2FsPjxwYWdlcz44MTMtODwvcGFnZXM+PHZvbHVtZT4xOTwvdm9sdW1lPjxu

dW1iZXI+NDwvbnVtYmVyPjxrZXl3b3Jkcz48a2V5d29yZD5BZHVsdDwva2V5d29yZD48a2V5d29y

ZD5BZ2VkPC9rZXl3b3JkPjxrZXl3b3JkPkFudGloeXBlcnRlbnNpdmUgQWdlbnRzL2FkbWluaXN0

cmF0aW9uICZhbXA7IGRvc2FnZS8qdGhlcmFwZXV0aWMgdXNlPC9rZXl3b3JkPjxrZXl3b3JkPkFy

dGVyaWVzL2RydWcgZWZmZWN0cy8qcGh5c2lvcGF0aG9sb2d5PC9rZXl3b3JkPjxrZXl3b3JkPkF1

dG9tYXRpb248L2tleXdvcmQ+PGtleXdvcmQ+Qmxvb2QgUHJlc3N1cmUvZHJ1ZyBlZmZlY3RzPC9r

ZXl3b3JkPjxrZXl3b3JkPkNhcm90aWQgQXJ0ZXJpZXMvcGh5c2lvcGF0aG9sb2d5PC9rZXl3b3Jk

PjxrZXl3b3JkPkRpdXJldGljcy9hZG1pbmlzdHJhdGlvbiAmYW1wOyBkb3NhZ2UvKnRoZXJhcGV1

dGljIHVzZTwva2V5d29yZD48a2V5d29yZD5EcnVnIEFkbWluaXN0cmF0aW9uIFNjaGVkdWxlPC9r

ZXl3b3JkPjxrZXl3b3JkPkRydWcgQ29tYmluYXRpb25zPC9rZXl3b3JkPjxrZXl3b3JkPkVsYXN0

aWNpdHk8L2tleXdvcmQ+PGtleXdvcmQ+RXF1aXBtZW50IGFuZCBTdXBwbGllczwva2V5d29yZD48

a2V5d29yZD5GZWFzaWJpbGl0eSBTdHVkaWVzPC9rZXl3b3JkPjxrZXl3b3JkPkZlbWFsZTwva2V5

d29yZD48a2V5d29yZD5GZW1vcmFsIEFydGVyeS9waHlzaW9wYXRob2xvZ3k8L2tleXdvcmQ+PGtl

eXdvcmQ+SHVtYW5zPC9rZXl3b3JkPjxrZXl3b3JkPkh5cGVydGVuc2lvbi8qZHJ1ZyB0aGVyYXB5

LypwaHlzaW9wYXRob2xvZ3k8L2tleXdvcmQ+PGtleXdvcmQ+SW5kYXBhbWlkZS9hZG1pbmlzdHJh

dGlvbiAmYW1wOyBkb3NhZ2UvKnRoZXJhcGV1dGljIHVzZTwva2V5d29yZD48a2V5d29yZD5NYWxl

PC9rZXl3b3JkPjxrZXl3b3JkPk1pZGRsZSBBZ2VkPC9rZXl3b3JkPjxrZXl3b3JkPlBlcmluZG9w

cmlsL2FkbWluaXN0cmF0aW9uICZhbXA7IGRvc2FnZS8qdGhlcmFwZXV0aWMgdXNlPC9rZXl3b3Jk

PjxrZXl3b3JkPipQdWxzZTwva2V5d29yZD48a2V5d29yZD5UaW1lIEZhY3RvcnM8L2tleXdvcmQ+

PC9rZXl3b3Jkcz48ZGF0ZXM+PHllYXI+MjAwMTwveWVhcj48cHViLWRhdGVzPjxkYXRlPkFwcjwv

ZGF0ZT48L3B1Yi1kYXRlcz48L2RhdGVzPjxpc2JuPjAyNjMtNjM1MiAoUHJpbnQpJiN4RDswMjYz

LTYzNTIgKExpbmtpbmcpPC9pc2JuPjxhY2Nlc3Npb24tbnVtPjExMzMwODg1PC9hY2Nlc3Npb24t

bnVtPjx1cmxzPjxyZWxhdGVkLXVybHM+PHVybD5odHRwOi8vd3d3Lm5jYmkubmxtLm5paC5nb3Yv

cHVibWVkLzExMzMwODg1PC91cmw+PC9yZWxhdGVkLXVybHM+PC91cmxzPjwvcmVjb3JkPjwvQ2l0

ZT48L0VuZE5vdGU+AG==

ADDIN EN.CITE.DATA 15 Two different pressure wave signals were recorded simultaneously using pressure sensitive transducers placed on the skin at two sites, the right common carotid artery and the right femoral artery. All calculations over 10 – 12 cardiac cycles were automated. Aortic Augmentation Index (AI) & Central Aortic Pressure (cSBP):AI and cSBP were measured using the Omron HEM-9000AI device (Omron Healthcare, Kyoto, Japan) ADDIN EN.CITE <EndNote><Cite><Author>Kips</Author><Year>2011</Year><RecNum>15345</RecNum><DisplayText><style face="superscript">16</style></DisplayText><record><rec-number>15345</rec-number><foreign-keys><key app="EN" db-id="ztzasxe5cs00v4efwrpvftrwtafzwe22xezt" timestamp="1439371150">15345</key></foreign-keys><ref-type name="Journal Article">17</ref-type><contributors><authors><author>Kips, J. G.</author><author>Schutte, A. E.</author><author>Vermeersch, S. J.</author><author>Huisman, H. W.</author><author>Van Rooyen, J. M.</author><author>Glyn, M. C.</author><author>Fourie, C. M.</author><author>Malan, L.</author><author>Schutte, R.</author><author>Van Bortel, L. M.</author><author>Segers, P.</author></authors></contributors><auth-address>Heymans Institute of Pharmacology, Belgium. Jan.Kips@UGent.be</auth-address><titles><title>Comparison of central pressure estimates obtained from SphygmoCor, Omron HEM-9000AI and carotid applanation tonometry</title><secondary-title>J Hypertens</secondary-title></titles><periodical><full-title>Journal of Hypertension</full-title><abbr-1>J Hypertens</abbr-1></periodical><pages>1115-20</pages><volume>29</volume><number>6</number><keywords><keyword>Adult</keyword><keyword>African Continental Ancestry Group</keyword><keyword>Aged</keyword><keyword>*Blood Pressure</keyword><keyword>Carotid Arteries/*physiology</keyword><keyword>Female</keyword><keyword>Humans</keyword><keyword>Male</keyword><keyword>Manometry/*methods</keyword><keyword>Middle Aged</keyword><keyword>*Sphygmomanometers</keyword></keywords><dates><year>2011</year><pub-dates><date>Jun</date></pub-dates></dates><isbn>1473-5598 (Electronic)&#xD;0263-6352 (Linking)</isbn><accession-num>21505351</accession-num><urls><related-urls><url>. Radial artery tonometry was performed on the left arm of each participant, and BP was measured. All vascular measurements were performed by a single experienced operator (R.R.) in a quiet temperature-controlled laboratory. Laboratory Tests:Blood and urine samples were obtained at entry to the study, end of placebo run-in period, and after 4 weeks and 8 weeks of active drug treatment. Variables measured were serum electrolytes, urea, creatinine, uric acid, glucose, total cholesterol, triglycerides and full blood count. 24hour urinary excretion of sodium, potassium and creatinine were measured as well. Statistical analysis: The primary outcome variable was the change in maximal (structural) skin capillary density during venous congestion after 8 weeks of active treatment. All other variables recorded were prospectively defined as secondary outcome criteria. The mean, standard deviation (SD), and range are reported for all continuous variables, which were normally distributed. For maximal capillary density during venous congestion, an analysis of covariance was performed adjusted on basal capillary density and age. Pairwise comparisons between groups and within groups were performed using this analysis of covariance model, without adjustment for multiple comparisons in this preliminary approach. All other parameters were analysed similarly. Student’s paired and unpaired t tests were used to evaluate differences between and among groups. For the other criteria, difference between groups was assessed with a two?tailed Student’s t?test for independent samples or with nonparametric test for non?normal distribution. A type error of 5% was set for all test procedures. Statistical significance was declared when the p-value was <0.05. All statistical analysis was carried out using the IBM SPSS 22, USA.Results: A total of 155 Caucasian subjects were invited to participate in the study, and subsequently 114 subjects were screened for eligibility. Of these, 42 individuals did not meet the inclusion criteria (mainly because of normalization of their BP on the follow-up visit), 38 subjects withdrew consent, 8 were found to be receiving antihypertensive medications from their general practitioner, and 4 had abnormal laboratory results. Eventually 22 subjects were recruited into the study but 1 subject withdrew consent during the run-in period. Table 1 shows the baseline characteristics of the recruited subjects. The average age of the subjects was 42.4 years (range 26-59 years) and the average BMI was 29.0 (range 20.0-43.2). At entry to the study mean±SD sitting and standing BP were 147/97±14/8mmHg and 147/96±16/8mmHg respectively. At the end of the 2 weeks single blind placebo run-in period mean sitting BP was 144/94±14/9mmHg (p=0.07 and p=0.057 respectively compared to baseline levels). In six subjects the BP dropped significantly on placebo, so much so they did not meet the inclusion criteria and were therefore excluded form the randomized phase. There were no significant changes in other clinical or laboratory parameters. Table 2 shows the baseline characteristics of the randomized subjects. In total 9 subjects were randomized to candesartan and 6 subjects were randomized to amlodipine. Table 3 shows the longitudinal changes in BMI, sitting and standing systolic and diastolic BP, pulse rate, central systolic BP, PWV, basal and maximal capillary densities, and Aortic augmentation from baseline. Blood Pressure Changes:In paired comparisons of sitting systolic BP, there was a significant decrease from the end of the placebo run-in period to 4 weeks active treatment (mean change -19.0 mmHg; 95% CI -11.1 to -26.9, p<0.0001), and to 8 weeks active treatment (mean change -26.3 mmHg; 95% CI -17.5 to -35.0, p<0.0001). (Table 3). Similarly there was a significant decrease in sitting diastolic BP at 4 weeks active treatment (mean change -13.8 mmHg; 95% CI -9.8 to -17.7, p<0.0001), and to 8 weeks active treatment (mean change -16.1 mmHg; 95% CI -13.1 to -19.0, p<0.0001). For standing systolic BP, there was also a significant decrease at 4 weeks active treatment (mean change -21.9 mmHg; 95% CI -11.1 to -32.7, p=0.001), and to 8 weeks active treatment (mean change -26.5 mmHg; 95% CI -15.8 to -37.3, p<0.0001). Standing diastolic BP decreased significantly after 4 weeks of active treatment (mean change -11.8 mmHg; 95% CI -6.4 to -17.3, p<0.0001), and to 8 weeks active treatment (mean change -16.1 mmHg; 95% CI -11.4 to -20.8, p<0.0001). There were no significant differences between the responses to amlodipine versus candesartan in all BP parameters.Central Systolic Blood Pressure and Aortic Augmentation Changes:cSBP decreased significantly after 4 weeks of treatment (mean change -18.4 mmHg; 95% CI -8.0 to -28.8, p=0.002), and after 8 weeks (mean change -22.6 mmHg; 95% CI -13.6 to -31.6, p<0.0001). AI also decreased significantly after 4 weeks of treatment (mean change -7.6 mmHg; 95% CI -2.2 to -13.0, p=0.010), and after 8 weeks (mean change -9.2 mmHg; 95% CI -4.7 to -13.6, p=0.001). There were no significant differences between the responses to amlodipine versus candesartan.Pulse Wave velocity:The changes in PWV were not significant at any point in the study. (Table 3) We could not rule out the possibility that we have not seen significant differences because of the small number of subjects. Capillary Density Changes: There were no significant changes in basal (i.e. before venous congestion) capillary density after 4 weeks (mean change -0.4 cap/field; 95% CI -3.5 to 2.6, p=0.76) or after 8 weeks of active treatment (mean change 1.2 cap/field; 95% CI -2.3 to 4.7, p=0.48). Similarly, there were no significant changes in maximal (i.e. with venous congestion) capillary density after 4 weeks (mean change 1.5 cap/field; 95% CI -2.1 to 5.2, p=0.38) or after 8 weeks of active treatment (mean change 1.8 cap/field; 95% CI -1.1 to 1.8, p=0.20). Discussion:This is the first randomized, double blind, placebo controlled, parallel-group study aimed at comparing the effects of treatment of hypertension with a CCB versus an ARB on skin capillary density in hypertensive patients using well-validated techniques. The study showed that after 4 weeks and 8 weeks treatment with either candesartan or amlodipine, there were significant reductions in both systolic and diastolic brachial BP and central systolic BP but there was no significant effect on basal (functional) or maximal (structural) capillary densities. The study also showed that both candesartan and amlodipine significantly reduced Aortic Augmentation Index but had no significant effect on pulse wave velocity. Preclinical studies have suggested that treatment with antihypertensive medications may reverse or even prevent microvascular rarefaction, although inconsistent results were obtained with different classes of drugs.PEVuZE5vdGU+PENpdGU+PEF1dGhvcj5SaXp6b25pPC9BdXRob3I+PFllYXI+MjAwODwvWWVhcj48

UmVjTnVtPjE1MzUyPC9SZWNOdW0+PERpc3BsYXlUZXh0PjxzdHlsZSBmYWNlPSJzdXBlcnNjcmlw

dCI+MTc8L3N0eWxlPjwvRGlzcGxheVRleHQ+PHJlY29yZD48cmVjLW51bWJlcj4xNTM1MjwvcmVj

LW51bWJlcj48Zm9yZWlnbi1rZXlzPjxrZXkgYXBwPSJFTiIgZGItaWQ9Inp0emFzeGU1Y3MwMHY0

ZWZ3cnB2ZnRyd3RhZnp3ZTIyeGV6dCIgdGltZXN0YW1wPSIxNDQwNDk1OTM5Ij4xNTM1Mjwva2V5

PjwvZm9yZWlnbi1rZXlzPjxyZWYtdHlwZSBuYW1lPSJKb3VybmFsIEFydGljbGUiPjE3PC9yZWYt

dHlwZT48Y29udHJpYnV0b3JzPjxhdXRob3JzPjxhdXRob3I+Uml6em9uaSwgRC48L2F1dGhvcj48

YXV0aG9yPlBhc2luaSwgRS48L2F1dGhvcj48YXV0aG9yPkZsYXRpLCBWLjwvYXV0aG9yPjxhdXRo

b3I+Um9kZWxsYSwgTC4gRi48L2F1dGhvcj48YXV0aG9yPlBhaWFyZGksIFMuPC9hdXRob3I+PGF1

dGhvcj5Bc3NhbmVsbGksIEQuPC9hdXRob3I+PGF1dGhvcj5EZSBDaXVjZWlzLCBDLjwvYXV0aG9y

PjxhdXRob3I+UG9ydGVyaSwgRS48L2F1dGhvcj48YXV0aG9yPkJvYXJpLCBHLiBFLjwvYXV0aG9y

PjxhdXRob3I+UmV6emFuaSwgUi48L2F1dGhvcj48YXV0aG9yPlNwZWNhLCBTLjwvYXV0aG9yPjxh

dXRob3I+RmF2ZXJvLCBHLjwvYXV0aG9yPjxhdXRob3I+TWFydGlub3R0aSwgUy48L2F1dGhvcj48

YXV0aG9yPlRvbmlhdG8sIEUuPC9hdXRob3I+PGF1dGhvcj5QbGF0dG8sIEMuPC9hdXRob3I+PGF1

dGhvcj5BZ2FiaXRpLVJvc2VpLCBFLjwvYXV0aG9yPjwvYXV0aG9ycz48L2NvbnRyaWJ1dG9ycz48

YXV0aC1hZGRyZXNzPkNsaW5pY2EgTWVkaWNhLCBEZXBhcnRtZW50IG9mIE1lZGljYWwgYW5kIFN1

cmdpY2FsIFNjaWVuY2VzLCBVbml2ZXJzaXR5IG9mIEJyZXNjaWEsIEJyZXNjaWEsIEl0YWx5LiBy

aXp6b25pQG1lZC51bmlicy5pdDwvYXV0aC1hZGRyZXNzPjx0aXRsZXM+PHRpdGxlPkFuZ2lvdGVu

c2luIHJlY2VwdG9yIGJsb2NrZXJzIGltcHJvdmUgaW5zdWxpbiBzaWduYWxpbmcgYW5kIHByZXZl

bnQgbWljcm92YXNjdWxhciByYXJlZmFjdGlvbiBpbiB0aGUgc2tlbGV0YWwgbXVzY2xlIG9mIHNw

b250YW5lb3VzbHkgaHlwZXJ0ZW5zaXZlIHJhdHM8L3RpdGxlPjxzZWNvbmRhcnktdGl0bGU+SiBI

eXBlcnRlbnM8L3NlY29uZGFyeS10aXRsZT48L3RpdGxlcz48cGVyaW9kaWNhbD48ZnVsbC10aXRs

ZT5Kb3VybmFsIG9mIEh5cGVydGVuc2lvbjwvZnVsbC10aXRsZT48YWJici0xPkogSHlwZXJ0ZW5z

PC9hYmJyLTE+PC9wZXJpb2RpY2FsPjxwYWdlcz4xNTk1LTYwMTwvcGFnZXM+PHZvbHVtZT4yNjwv

dm9sdW1lPjxudW1iZXI+ODwvbnVtYmVyPjxrZXl3b3Jkcz48a2V5d29yZD5BZGFwdG9yIFByb3Rl

aW5zLCBTaWduYWwgVHJhbnNkdWNpbmcvbWV0YWJvbGlzbTwva2V5d29yZD48a2V5d29yZD5Bbmdp

b3RlbnNpbiBJSSBUeXBlIDEgUmVjZXB0b3IgQmxvY2tlcnMvcGhhcm1hY29sb2d5PC9rZXl3b3Jk

PjxrZXl3b3JkPkFuZ2lvdGVuc2luLUNvbnZlcnRpbmcgRW56eW1lIEluaGliaXRvcnMvcGhhcm1h

Y29sb2d5PC9rZXl3b3JkPjxrZXl3b3JkPkFuaW1hbHM8L2tleXdvcmQ+PGtleXdvcmQ+Q2FwaWxs

YXJpZXMvZHJ1ZyBlZmZlY3RzPC9rZXl3b3JkPjxrZXl3b3JkPkVuYWxhcHJpbC8qcGhhcm1hY29s

b2d5PC9rZXl3b3JkPjxrZXl3b3JkPkdsdWNvc2UgVHJhbnNwb3J0ZXIgVHlwZSA0L21ldGFib2xp

c208L2tleXdvcmQ+PGtleXdvcmQ+SHlwZXJ0ZW5zaW9uLypkcnVnIHRoZXJhcHkvKm1ldGFib2xp

c208L2tleXdvcmQ+PGtleXdvcmQ+SW1pZGF6b2xlcy8qcGhhcm1hY29sb2d5PC9rZXl3b3JkPjxr

ZXl3b3JkPkluc3VsaW4vKm1ldGFib2xpc208L2tleXdvcmQ+PGtleXdvcmQ+SW5zdWxpbiBSZWNl

cHRvciBTdWJzdHJhdGUgUHJvdGVpbnM8L2tleXdvcmQ+PGtleXdvcmQ+SW5zdWxpbiBSZXNpc3Rh

bmNlPC9rZXl3b3JkPjxrZXl3b3JkPk1hbGU8L2tleXdvcmQ+PGtleXdvcmQ+TXlvY2FyZGl1bS9t

ZXRhYm9saXNtPC9rZXl3b3JkPjxrZXl3b3JkPlF1YWRyaWNlcHMgTXVzY2xlLypibG9vZCBzdXBw

bHkvbWV0YWJvbGlzbTwva2V5d29yZD48a2V5d29yZD5SYXRzPC9rZXl3b3JkPjxrZXl3b3JkPlJh

dHMsIEluYnJlZCBTSFI8L2tleXdvcmQ+PGtleXdvcmQ+UmF0cywgSW5icmVkIFdLWTwva2V5d29y

ZD48a2V5d29yZD5SZWNlcHRvciwgSW5zdWxpbi9tZXRhYm9saXNtPC9rZXl3b3JkPjxrZXl3b3Jk

PlJlbmluLUFuZ2lvdGVuc2luIFN5c3RlbS9kcnVnIGVmZmVjdHMvcGh5c2lvbG9neTwva2V5d29y

ZD48a2V5d29yZD5TaWduYWwgVHJhbnNkdWN0aW9uL2RydWcgZWZmZWN0czwva2V5d29yZD48a2V5

d29yZD5UZXRyYXpvbGVzLypwaGFybWFjb2xvZ3k8L2tleXdvcmQ+PGtleXdvcmQ+VHJhbnNjcmlw

dGlvbiBGYWN0b3JzL21ldGFib2xpc208L2tleXdvcmQ+PC9rZXl3b3Jkcz48ZGF0ZXM+PHllYXI+

MjAwODwveWVhcj48cHViLWRhdGVzPjxkYXRlPkF1ZzwvZGF0ZT48L3B1Yi1kYXRlcz48L2RhdGVz

Pjxpc2JuPjAyNjMtNjM1MiAoUHJpbnQpJiN4RDswMjYzLTYzNTIgKExpbmtpbmcpPC9pc2JuPjxh

Y2Nlc3Npb24tbnVtPjE4NjIyMjM4PC9hY2Nlc3Npb24tbnVtPjx1cmxzPjxyZWxhdGVkLXVybHM+

PHVybD5odHRwOi8vd3d3Lm5jYmkubmxtLm5paC5nb3YvcHVibWVkLzE4NjIyMjM4PC91cmw+PC9y

ZWxhdGVkLXVybHM+PC91cmxzPjxlbGVjdHJvbmljLXJlc291cmNlLW51bT4xMC4xMDk3L0hKSC4w

YjAxM2UzMjgzMDRiMDYwPC9lbGVjdHJvbmljLXJlc291cmNlLW51bT48L3JlY29yZD48L0NpdGU+

PC9FbmROb3RlPn==

ADDIN EN.CITE PEVuZE5vdGU+PENpdGU+PEF1dGhvcj5SaXp6b25pPC9BdXRob3I+PFllYXI+MjAwODwvWWVhcj48

UmVjTnVtPjE1MzUyPC9SZWNOdW0+PERpc3BsYXlUZXh0PjxzdHlsZSBmYWNlPSJzdXBlcnNjcmlw

dCI+MTc8L3N0eWxlPjwvRGlzcGxheVRleHQ+PHJlY29yZD48cmVjLW51bWJlcj4xNTM1MjwvcmVj

LW51bWJlcj48Zm9yZWlnbi1rZXlzPjxrZXkgYXBwPSJFTiIgZGItaWQ9Inp0emFzeGU1Y3MwMHY0

ZWZ3cnB2ZnRyd3RhZnp3ZTIyeGV6dCIgdGltZXN0YW1wPSIxNDQwNDk1OTM5Ij4xNTM1Mjwva2V5

PjwvZm9yZWlnbi1rZXlzPjxyZWYtdHlwZSBuYW1lPSJKb3VybmFsIEFydGljbGUiPjE3PC9yZWYt

dHlwZT48Y29udHJpYnV0b3JzPjxhdXRob3JzPjxhdXRob3I+Uml6em9uaSwgRC48L2F1dGhvcj48

YXV0aG9yPlBhc2luaSwgRS48L2F1dGhvcj48YXV0aG9yPkZsYXRpLCBWLjwvYXV0aG9yPjxhdXRo

b3I+Um9kZWxsYSwgTC4gRi48L2F1dGhvcj48YXV0aG9yPlBhaWFyZGksIFMuPC9hdXRob3I+PGF1

dGhvcj5Bc3NhbmVsbGksIEQuPC9hdXRob3I+PGF1dGhvcj5EZSBDaXVjZWlzLCBDLjwvYXV0aG9y

PjxhdXRob3I+UG9ydGVyaSwgRS48L2F1dGhvcj48YXV0aG9yPkJvYXJpLCBHLiBFLjwvYXV0aG9y

PjxhdXRob3I+UmV6emFuaSwgUi48L2F1dGhvcj48YXV0aG9yPlNwZWNhLCBTLjwvYXV0aG9yPjxh

dXRob3I+RmF2ZXJvLCBHLjwvYXV0aG9yPjxhdXRob3I+TWFydGlub3R0aSwgUy48L2F1dGhvcj48

YXV0aG9yPlRvbmlhdG8sIEUuPC9hdXRob3I+PGF1dGhvcj5QbGF0dG8sIEMuPC9hdXRob3I+PGF1

dGhvcj5BZ2FiaXRpLVJvc2VpLCBFLjwvYXV0aG9yPjwvYXV0aG9ycz48L2NvbnRyaWJ1dG9ycz48

YXV0aC1hZGRyZXNzPkNsaW5pY2EgTWVkaWNhLCBEZXBhcnRtZW50IG9mIE1lZGljYWwgYW5kIFN1

cmdpY2FsIFNjaWVuY2VzLCBVbml2ZXJzaXR5IG9mIEJyZXNjaWEsIEJyZXNjaWEsIEl0YWx5LiBy

aXp6b25pQG1lZC51bmlicy5pdDwvYXV0aC1hZGRyZXNzPjx0aXRsZXM+PHRpdGxlPkFuZ2lvdGVu

c2luIHJlY2VwdG9yIGJsb2NrZXJzIGltcHJvdmUgaW5zdWxpbiBzaWduYWxpbmcgYW5kIHByZXZl

bnQgbWljcm92YXNjdWxhciByYXJlZmFjdGlvbiBpbiB0aGUgc2tlbGV0YWwgbXVzY2xlIG9mIHNw

b250YW5lb3VzbHkgaHlwZXJ0ZW5zaXZlIHJhdHM8L3RpdGxlPjxzZWNvbmRhcnktdGl0bGU+SiBI

eXBlcnRlbnM8L3NlY29uZGFyeS10aXRsZT48L3RpdGxlcz48cGVyaW9kaWNhbD48ZnVsbC10aXRs

ZT5Kb3VybmFsIG9mIEh5cGVydGVuc2lvbjwvZnVsbC10aXRsZT48YWJici0xPkogSHlwZXJ0ZW5z

PC9hYmJyLTE+PC9wZXJpb2RpY2FsPjxwYWdlcz4xNTk1LTYwMTwvcGFnZXM+PHZvbHVtZT4yNjwv

dm9sdW1lPjxudW1iZXI+ODwvbnVtYmVyPjxrZXl3b3Jkcz48a2V5d29yZD5BZGFwdG9yIFByb3Rl

aW5zLCBTaWduYWwgVHJhbnNkdWNpbmcvbWV0YWJvbGlzbTwva2V5d29yZD48a2V5d29yZD5Bbmdp

b3RlbnNpbiBJSSBUeXBlIDEgUmVjZXB0b3IgQmxvY2tlcnMvcGhhcm1hY29sb2d5PC9rZXl3b3Jk

PjxrZXl3b3JkPkFuZ2lvdGVuc2luLUNvbnZlcnRpbmcgRW56eW1lIEluaGliaXRvcnMvcGhhcm1h

Y29sb2d5PC9rZXl3b3JkPjxrZXl3b3JkPkFuaW1hbHM8L2tleXdvcmQ+PGtleXdvcmQ+Q2FwaWxs

YXJpZXMvZHJ1ZyBlZmZlY3RzPC9rZXl3b3JkPjxrZXl3b3JkPkVuYWxhcHJpbC8qcGhhcm1hY29s

b2d5PC9rZXl3b3JkPjxrZXl3b3JkPkdsdWNvc2UgVHJhbnNwb3J0ZXIgVHlwZSA0L21ldGFib2xp

c208L2tleXdvcmQ+PGtleXdvcmQ+SHlwZXJ0ZW5zaW9uLypkcnVnIHRoZXJhcHkvKm1ldGFib2xp

c208L2tleXdvcmQ+PGtleXdvcmQ+SW1pZGF6b2xlcy8qcGhhcm1hY29sb2d5PC9rZXl3b3JkPjxr

ZXl3b3JkPkluc3VsaW4vKm1ldGFib2xpc208L2tleXdvcmQ+PGtleXdvcmQ+SW5zdWxpbiBSZWNl

cHRvciBTdWJzdHJhdGUgUHJvdGVpbnM8L2tleXdvcmQ+PGtleXdvcmQ+SW5zdWxpbiBSZXNpc3Rh

bmNlPC9rZXl3b3JkPjxrZXl3b3JkPk1hbGU8L2tleXdvcmQ+PGtleXdvcmQ+TXlvY2FyZGl1bS9t

ZXRhYm9saXNtPC9rZXl3b3JkPjxrZXl3b3JkPlF1YWRyaWNlcHMgTXVzY2xlLypibG9vZCBzdXBw

bHkvbWV0YWJvbGlzbTwva2V5d29yZD48a2V5d29yZD5SYXRzPC9rZXl3b3JkPjxrZXl3b3JkPlJh

dHMsIEluYnJlZCBTSFI8L2tleXdvcmQ+PGtleXdvcmQ+UmF0cywgSW5icmVkIFdLWTwva2V5d29y

ZD48a2V5d29yZD5SZWNlcHRvciwgSW5zdWxpbi9tZXRhYm9saXNtPC9rZXl3b3JkPjxrZXl3b3Jk

PlJlbmluLUFuZ2lvdGVuc2luIFN5c3RlbS9kcnVnIGVmZmVjdHMvcGh5c2lvbG9neTwva2V5d29y

ZD48a2V5d29yZD5TaWduYWwgVHJhbnNkdWN0aW9uL2RydWcgZWZmZWN0czwva2V5d29yZD48a2V5

d29yZD5UZXRyYXpvbGVzLypwaGFybWFjb2xvZ3k8L2tleXdvcmQ+PGtleXdvcmQ+VHJhbnNjcmlw

dGlvbiBGYWN0b3JzL21ldGFib2xpc208L2tleXdvcmQ+PC9rZXl3b3Jkcz48ZGF0ZXM+PHllYXI+

MjAwODwveWVhcj48cHViLWRhdGVzPjxkYXRlPkF1ZzwvZGF0ZT48L3B1Yi1kYXRlcz48L2RhdGVz

Pjxpc2JuPjAyNjMtNjM1MiAoUHJpbnQpJiN4RDswMjYzLTYzNTIgKExpbmtpbmcpPC9pc2JuPjxh

Y2Nlc3Npb24tbnVtPjE4NjIyMjM4PC9hY2Nlc3Npb24tbnVtPjx1cmxzPjxyZWxhdGVkLXVybHM+

PHVybD5odHRwOi8vd3d3Lm5jYmkubmxtLm5paC5nb3YvcHVibWVkLzE4NjIyMjM4PC91cmw+PC9y

ZWxhdGVkLXVybHM+PC91cmxzPjxlbGVjdHJvbmljLXJlc291cmNlLW51bT4xMC4xMDk3L0hKSC4w

YjAxM2UzMjgzMDRiMDYwPC9lbGVjdHJvbmljLXJlc291cmNlLW51bT48L3JlY29yZD48L0NpdGU+

PC9FbmROb3RlPn==

ADDIN EN.CITE.DATA 17 One study that compared the effects of different antihypertensive treatments on capillary density in spontaneously hypertensive rats (SHR) led to the conclusion that despite their similar effectiveness in decreasing BP, functional rarefaction was reversed by losartan, nifedipine, and enalapril, while structural rarefaction was normalized only by losartan and enalapril while atenolol had no noticeable effect.PEVuZE5vdGU+PENpdGU+PEF1dGhvcj5TYWJpbm88L0F1dGhvcj48WWVhcj4yMDA4PC9ZZWFyPjxS

ZWNOdW0+MTUzNDE8L1JlY051bT48RGlzcGxheVRleHQ+PHN0eWxlIGZhY2U9InN1cGVyc2NyaXB0

Ij4xODwvc3R5bGU+PC9EaXNwbGF5VGV4dD48cmVjb3JkPjxyZWMtbnVtYmVyPjE1MzQxPC9yZWMt

bnVtYmVyPjxmb3JlaWduLWtleXM+PGtleSBhcHA9IkVOIiBkYi1pZD0ienR6YXN4ZTVjczAwdjRl

ZndycHZmdHJ3dGFmendlMjJ4ZXp0IiB0aW1lc3RhbXA9IjE0MzkzMDA4MzYiPjE1MzQxPC9rZXk+

PC9mb3JlaWduLWtleXM+PHJlZi10eXBlIG5hbWU9IkpvdXJuYWwgQXJ0aWNsZSI+MTc8L3JlZi10

eXBlPjxjb250cmlidXRvcnM+PGF1dGhvcnM+PGF1dGhvcj5TYWJpbm8sIEIuPC9hdXRob3I+PGF1

dGhvcj5MZXNzYSwgTS4gQS48L2F1dGhvcj48YXV0aG9yPk5hc2NpbWVudG8sIEEuIFIuPC9hdXRo

b3I+PGF1dGhvcj5Sb2RyaWd1ZXMsIEMuIEEuPC9hdXRob3I+PGF1dGhvcj5IZW5yaXF1ZXMsIE1k

PC9hdXRob3I+PGF1dGhvcj5HYXJ6b25pLCBMLiBSLjwvYXV0aG9yPjxhdXRob3I+TGV2eSwgQi4g

SS48L2F1dGhvcj48YXV0aG9yPlRpYmlyaWNhLCBFLjwvYXV0aG9yPjwvYXV0aG9ycz48L2NvbnRy

aWJ1dG9ycz48YXV0aC1hZGRyZXNzPkxhYm9yYXRvcnkgb2YgTmV1cm8tQ2FyZGlvdmFzY3VsYXIg

UGhhcm1hY29sb2d5LCBPc3dhbGRvIENydXogSW5zdGl0dXRlLCBSaW8gZGUgSmFuZWlybywgQnJh

emlsLjwvYXV0aC1hZGRyZXNzPjx0aXRsZXM+PHRpdGxlPkVmZmVjdHMgb2YgYW50aWh5cGVydGVu

c2l2ZSBkcnVncyBvbiBjYXBpbGxhcnkgcmFyZWZhY3Rpb24gaW4gc3BvbnRhbmVvdXNseSBoeXBl

cnRlbnNpdmUgcmF0czogaW50cmF2aXRhbCBtaWNyb3Njb3B5IGFuZCBoaXN0b2xvZ2ljIGFuYWx5

c2lzPC90aXRsZT48c2Vjb25kYXJ5LXRpdGxlPkogQ2FyZGlvdmFzYyBQaGFybWFjb2w8L3NlY29u

ZGFyeS10aXRsZT48L3RpdGxlcz48cGVyaW9kaWNhbD48ZnVsbC10aXRsZT5Kb3VybmFsIG9mIENh

cmRpb3Zhc2N1bGFyIFBoYXJtYWNvbG9neTwvZnVsbC10aXRsZT48YWJici0xPkogQ2FyZGlvdmFz

YyBQaGFybWFjb2w8L2FiYnItMT48L3BlcmlvZGljYWw+PHBhZ2VzPjQwMi05PC9wYWdlcz48dm9s

dW1lPjUxPC92b2x1bWU+PG51bWJlcj40PC9udW1iZXI+PGtleXdvcmRzPjxrZXl3b3JkPkFuZ2lv

dGVuc2luIElJIFR5cGUgMSBSZWNlcHRvciBCbG9ja2Vycy9waGFybWFjb2xvZ3k8L2tleXdvcmQ+

PGtleXdvcmQ+QW5pbWFsczwva2V5d29yZD48a2V5d29yZD5BbnRpaHlwZXJ0ZW5zaXZlIEFnZW50

cy8qcGhhcm1hY29sb2d5L3RoZXJhcGV1dGljIHVzZTwva2V5d29yZD48a2V5d29yZD5BdGVub2xv

bC9waGFybWFjb2xvZ3k8L2tleXdvcmQ+PGtleXdvcmQ+Qmxvb2QgUHJlc3N1cmUvZHJ1ZyBlZmZl

Y3RzPC9rZXl3b3JkPjxrZXl3b3JkPkNhcGlsbGFyaWVzL3BhdGhvbG9neTwva2V5d29yZD48a2V5

d29yZD5EaXNlYXNlIE1vZGVscywgQW5pbWFsPC9rZXl3b3JkPjxrZXl3b3JkPkVuYWxhcHJpbC9w

aGFybWFjb2xvZ3k8L2tleXdvcmQ+PGtleXdvcmQ+SGVhcnQgVmVudHJpY2xlcy9jeXRvbG9neTwv

a2V5d29yZD48a2V5d29yZD5IeXBlcnRlbnNpb24vZHJ1ZyB0aGVyYXB5LypwYXRob2xvZ3kvKnBo

eXNpb3BhdGhvbG9neTwva2V5d29yZD48a2V5d29yZD5Mb3NhcnRhbi9waGFybWFjb2xvZ3k8L2tl

eXdvcmQ+PGtleXdvcmQ+TWFsZTwva2V5d29yZD48a2V5d29yZD5NaWNyb2NpcmN1bGF0aW9uL3Bh

dGhvbG9neTwva2V5d29yZD48a2V5d29yZD5NaWNyb3Njb3B5LCBWaWRlbzwva2V5d29yZD48a2V5

d29yZD5NdXNjbGUsIFNrZWxldGFsL2Jsb29kIHN1cHBseTwva2V5d29yZD48a2V5d29yZD5OaWZl

ZGlwaW5lL3BoYXJtYWNvbG9neTwva2V5d29yZD48a2V5d29yZD5SYXRzPC9rZXl3b3JkPjxrZXl3

b3JkPlJhdHMsIEluYnJlZCBTSFI8L2tleXdvcmQ+PGtleXdvcmQ+UmF0cywgSW5icmVkIFdLWTwv

a2V5d29yZD48a2V5d29yZD5Ta2luL2Jsb29kIHN1cHBseTwva2V5d29yZD48L2tleXdvcmRzPjxk

YXRlcz48eWVhcj4yMDA4PC95ZWFyPjxwdWItZGF0ZXM+PGRhdGU+QXByPC9kYXRlPjwvcHViLWRh

dGVzPjwvZGF0ZXM+PGlzYm4+MDE2MC0yNDQ2IChQcmludCkmI3hEOzAxNjAtMjQ0NiAoTGlua2lu

Zyk8L2lzYm4+PGFjY2Vzc2lvbi1udW0+MTg0MjcyODQ8L2FjY2Vzc2lvbi1udW0+PHVybHM+PHJl

bGF0ZWQtdXJscz48dXJsPmh0dHA6Ly93d3cubmNiaS5ubG0ubmloLmdvdi9wdWJtZWQvMTg0Mjcy

ODQ8L3VybD48L3JlbGF0ZWQtdXJscz48L3VybHM+PGVsZWN0cm9uaWMtcmVzb3VyY2UtbnVtPjEw

LjEwOTcvRkpDLjBiMDEzZTMxODE2NzNiYzU8L2VsZWN0cm9uaWMtcmVzb3VyY2UtbnVtPjwvcmVj

b3JkPjwvQ2l0ZT48L0VuZE5vdGU+AG==

ADDIN EN.CITE PEVuZE5vdGU+PENpdGU+PEF1dGhvcj5TYWJpbm88L0F1dGhvcj48WWVhcj4yMDA4PC9ZZWFyPjxS

ZWNOdW0+MTUzNDE8L1JlY051bT48RGlzcGxheVRleHQ+PHN0eWxlIGZhY2U9InN1cGVyc2NyaXB0

Ij4xODwvc3R5bGU+PC9EaXNwbGF5VGV4dD48cmVjb3JkPjxyZWMtbnVtYmVyPjE1MzQxPC9yZWMt

bnVtYmVyPjxmb3JlaWduLWtleXM+PGtleSBhcHA9IkVOIiBkYi1pZD0ienR6YXN4ZTVjczAwdjRl

ZndycHZmdHJ3dGFmendlMjJ4ZXp0IiB0aW1lc3RhbXA9IjE0MzkzMDA4MzYiPjE1MzQxPC9rZXk+

PC9mb3JlaWduLWtleXM+PHJlZi10eXBlIG5hbWU9IkpvdXJuYWwgQXJ0aWNsZSI+MTc8L3JlZi10

eXBlPjxjb250cmlidXRvcnM+PGF1dGhvcnM+PGF1dGhvcj5TYWJpbm8sIEIuPC9hdXRob3I+PGF1

dGhvcj5MZXNzYSwgTS4gQS48L2F1dGhvcj48YXV0aG9yPk5hc2NpbWVudG8sIEEuIFIuPC9hdXRo

b3I+PGF1dGhvcj5Sb2RyaWd1ZXMsIEMuIEEuPC9hdXRob3I+PGF1dGhvcj5IZW5yaXF1ZXMsIE1k

PC9hdXRob3I+PGF1dGhvcj5HYXJ6b25pLCBMLiBSLjwvYXV0aG9yPjxhdXRob3I+TGV2eSwgQi4g

SS48L2F1dGhvcj48YXV0aG9yPlRpYmlyaWNhLCBFLjwvYXV0aG9yPjwvYXV0aG9ycz48L2NvbnRy

aWJ1dG9ycz48YXV0aC1hZGRyZXNzPkxhYm9yYXRvcnkgb2YgTmV1cm8tQ2FyZGlvdmFzY3VsYXIg

UGhhcm1hY29sb2d5LCBPc3dhbGRvIENydXogSW5zdGl0dXRlLCBSaW8gZGUgSmFuZWlybywgQnJh

emlsLjwvYXV0aC1hZGRyZXNzPjx0aXRsZXM+PHRpdGxlPkVmZmVjdHMgb2YgYW50aWh5cGVydGVu

c2l2ZSBkcnVncyBvbiBjYXBpbGxhcnkgcmFyZWZhY3Rpb24gaW4gc3BvbnRhbmVvdXNseSBoeXBl

cnRlbnNpdmUgcmF0czogaW50cmF2aXRhbCBtaWNyb3Njb3B5IGFuZCBoaXN0b2xvZ2ljIGFuYWx5

c2lzPC90aXRsZT48c2Vjb25kYXJ5LXRpdGxlPkogQ2FyZGlvdmFzYyBQaGFybWFjb2w8L3NlY29u

ZGFyeS10aXRsZT48L3RpdGxlcz48cGVyaW9kaWNhbD48ZnVsbC10aXRsZT5Kb3VybmFsIG9mIENh

cmRpb3Zhc2N1bGFyIFBoYXJtYWNvbG9neTwvZnVsbC10aXRsZT48YWJici0xPkogQ2FyZGlvdmFz

YyBQaGFybWFjb2w8L2FiYnItMT48L3BlcmlvZGljYWw+PHBhZ2VzPjQwMi05PC9wYWdlcz48dm9s

dW1lPjUxPC92b2x1bWU+PG51bWJlcj40PC9udW1iZXI+PGtleXdvcmRzPjxrZXl3b3JkPkFuZ2lv

dGVuc2luIElJIFR5cGUgMSBSZWNlcHRvciBCbG9ja2Vycy9waGFybWFjb2xvZ3k8L2tleXdvcmQ+

PGtleXdvcmQ+QW5pbWFsczwva2V5d29yZD48a2V5d29yZD5BbnRpaHlwZXJ0ZW5zaXZlIEFnZW50

cy8qcGhhcm1hY29sb2d5L3RoZXJhcGV1dGljIHVzZTwva2V5d29yZD48a2V5d29yZD5BdGVub2xv

bC9waGFybWFjb2xvZ3k8L2tleXdvcmQ+PGtleXdvcmQ+Qmxvb2QgUHJlc3N1cmUvZHJ1ZyBlZmZl

Y3RzPC9rZXl3b3JkPjxrZXl3b3JkPkNhcGlsbGFyaWVzL3BhdGhvbG9neTwva2V5d29yZD48a2V5

d29yZD5EaXNlYXNlIE1vZGVscywgQW5pbWFsPC9rZXl3b3JkPjxrZXl3b3JkPkVuYWxhcHJpbC9w

aGFybWFjb2xvZ3k8L2tleXdvcmQ+PGtleXdvcmQ+SGVhcnQgVmVudHJpY2xlcy9jeXRvbG9neTwv

a2V5d29yZD48a2V5d29yZD5IeXBlcnRlbnNpb24vZHJ1ZyB0aGVyYXB5LypwYXRob2xvZ3kvKnBo

eXNpb3BhdGhvbG9neTwva2V5d29yZD48a2V5d29yZD5Mb3NhcnRhbi9waGFybWFjb2xvZ3k8L2tl

eXdvcmQ+PGtleXdvcmQ+TWFsZTwva2V5d29yZD48a2V5d29yZD5NaWNyb2NpcmN1bGF0aW9uL3Bh

dGhvbG9neTwva2V5d29yZD48a2V5d29yZD5NaWNyb3Njb3B5LCBWaWRlbzwva2V5d29yZD48a2V5

d29yZD5NdXNjbGUsIFNrZWxldGFsL2Jsb29kIHN1cHBseTwva2V5d29yZD48a2V5d29yZD5OaWZl

ZGlwaW5lL3BoYXJtYWNvbG9neTwva2V5d29yZD48a2V5d29yZD5SYXRzPC9rZXl3b3JkPjxrZXl3

b3JkPlJhdHMsIEluYnJlZCBTSFI8L2tleXdvcmQ+PGtleXdvcmQ+UmF0cywgSW5icmVkIFdLWTwv

a2V5d29yZD48a2V5d29yZD5Ta2luL2Jsb29kIHN1cHBseTwva2V5d29yZD48L2tleXdvcmRzPjxk

YXRlcz48eWVhcj4yMDA4PC95ZWFyPjxwdWItZGF0ZXM+PGRhdGU+QXByPC9kYXRlPjwvcHViLWRh

dGVzPjwvZGF0ZXM+PGlzYm4+MDE2MC0yNDQ2IChQcmludCkmI3hEOzAxNjAtMjQ0NiAoTGlua2lu

Zyk8L2lzYm4+PGFjY2Vzc2lvbi1udW0+MTg0MjcyODQ8L2FjY2Vzc2lvbi1udW0+PHVybHM+PHJl

bGF0ZWQtdXJscz48dXJsPmh0dHA6Ly93d3cubmNiaS5ubG0ubmloLmdvdi9wdWJtZWQvMTg0Mjcy

ODQ8L3VybD48L3JlbGF0ZWQtdXJscz48L3VybHM+PGVsZWN0cm9uaWMtcmVzb3VyY2UtbnVtPjEw

LjEwOTcvRkpDLjBiMDEzZTMxODE2NzNiYzU8L2VsZWN0cm9uaWMtcmVzb3VyY2UtbnVtPjwvcmVj

b3JkPjwvQ2l0ZT48L0VuZE5vdGU+AG==

ADDIN EN.CITE.DATA 18 It was therefore suggested that dihydropyridine CCB and renin–angiotensin system blockers were effective in this regard, while data on diuretics and beta-blockers were inconclusive. These selective desirable effects on the microcirculation have been implicated in explaining the beneficial effects of these drugs in reducing micro albuminuria and preserving renal function. Very little, however, is known about the effects of treatment of human essential hypertension on capillary rarefaction which may be related to end-organ damage, as suggested by the association between hypertensive myocardial disease and reduced myocardial capillary density. ADDIN EN.CITE <EndNote><Cite><Author>Strauer</Author><Year>1990</Year><RecNum>15353</RecNum><DisplayText><style face="superscript">19</style></DisplayText><record><rec-number>15353</rec-number><foreign-keys><key app="EN" db-id="ztzasxe5cs00v4efwrpvftrwtafzwe22xezt" timestamp="1440503969">15353</key></foreign-keys><ref-type name="Journal Article">17</ref-type><contributors><authors><author>Strauer, B. E.</author></authors></contributors><auth-address>Department of Medicine, University of Duesseldorf, Federal Republic of West Germany.</auth-address><titles><title>Significance of coronary circulation in hypertensive heart disease for development and prevention of heart failure</title><secondary-title>Am J Cardiol</secondary-title></titles><periodical><full-title>Am J Cardiol</full-title></periodical><pages>34G-41G</pages><volume>65</volume><number>14</number><keywords><keyword>Adult</keyword><keyword>Animals</keyword><keyword>Cardiac Output, Low/*etiology/prevention &amp; control</keyword><keyword>Cardiomegaly/etiology/*physiopathology/prevention &amp; control</keyword><keyword>Coronary Circulation/drug effects/*physiology</keyword><keyword>Coronary Disease/complications/*physiopathology</keyword><keyword>Coronary Vessels/physiopathology</keyword><keyword>Felodipine/therapeutic use</keyword><keyword>Humans</keyword><keyword>Hydralazine/therapeutic use</keyword><keyword>Hypertension/complications/*physiopathology/prevention &amp; control</keyword><keyword>Metoprolol/therapeutic use</keyword><keyword>Nifedipine/therapeutic use</keyword><keyword>Rats</keyword><keyword>Rats, Inbred SHR</keyword><keyword>Rats, Inbred WKY</keyword><keyword>Vascular Resistance/drug effects/physiology</keyword></keywords><dates><year>1990</year><pub-dates><date>Apr 3</date></pub-dates></dates><isbn>0002-9149 (Print)&#xD;0002-9149 (Linking)</isbn><accession-num>2138855</accession-num><urls><related-urls><url> Few observational and open label studies have shown inconsistent or even contradictory results about the reversal of microvascular rarefaction with antihypertensive treatments.PEVuZE5vdGU+PENpdGU+PEF1dGhvcj5EZWJiYWJpPC9BdXRob3I+PFllYXI+MjAwNjwvWWVhcj48

UmVjTnVtPjExODAzPC9SZWNOdW0+PERpc3BsYXlUZXh0PjxzdHlsZSBmYWNlPSJzdXBlcnNjcmlw

dCI+MTAsIDEzLCAyMCwgMjE8L3N0eWxlPjwvRGlzcGxheVRleHQ+PHJlY29yZD48cmVjLW51bWJl

cj4xMTgwMzwvcmVjLW51bWJlcj48Zm9yZWlnbi1rZXlzPjxrZXkgYXBwPSJFTiIgZGItaWQ9Inp0

emFzeGU1Y3MwMHY0ZWZ3cnB2ZnRyd3RhZnp3ZTIyeGV6dCIgdGltZXN0YW1wPSIxMzgyOTU0NDAx

Ij4xMTgwMzwva2V5PjwvZm9yZWlnbi1rZXlzPjxyZWYtdHlwZSBuYW1lPSJKb3VybmFsIEFydGlj

bGUiPjE3PC9yZWYtdHlwZT48Y29udHJpYnV0b3JzPjxhdXRob3JzPjxhdXRob3I+RGViYmFiaSwg

SC48L2F1dGhvcj48YXV0aG9yPlV6YW4sIEwuPC9hdXRob3I+PGF1dGhvcj5Nb3VyYWQsIEouIEou

PC9hdXRob3I+PGF1dGhvcj5TYWZhciwgTS48L2F1dGhvcj48YXV0aG9yPkxldnksIEIuIEkuPC9h

dXRob3I+PGF1dGhvcj5UaWJpcmljYSwgRS48L2F1dGhvcj48L2F1dGhvcnM+PC9jb250cmlidXRv

cnM+PGF1dGgtYWRkcmVzcz5EZXBhcnRtZW50IG9mIFBoeXNpb2xvZ3kgYW5kIG5vbi1pbnZhc2l2

ZSBpbnZlc3RpZ2F0aW9ucywgSW5zZXJtIFU2ODksIEhvcGl0YWwgTGFyaWJvaXNpZXJlLCBQYXJp

cywgRnJhbmNlLjwvYXV0aC1hZGRyZXNzPjx0aXRsZXM+PHRpdGxlPkluY3JlYXNlZCBza2luIGNh

cGlsbGFyeSBkZW5zaXR5IGluIHRyZWF0ZWQgZXNzZW50aWFsIGh5cGVydGVuc2l2ZSBwYXRpZW50

czwvdGl0bGU+PHNlY29uZGFyeS10aXRsZT5BbSBKIEh5cGVydGVuczwvc2Vjb25kYXJ5LXRpdGxl

PjwvdGl0bGVzPjxwZXJpb2RpY2FsPjxmdWxsLXRpdGxlPkFtIEogSHlwZXJ0ZW5zPC9mdWxsLXRp

dGxlPjwvcGVyaW9kaWNhbD48cGFnZXM+NDc3LTgzPC9wYWdlcz48dm9sdW1lPjE5PC92b2x1bWU+

PG51bWJlcj41PC9udW1iZXI+PGRhdGVzPjx5ZWFyPjIwMDY8L3llYXI+PHB1Yi1kYXRlcz48ZGF0

ZT5NYXk8L2RhdGU+PC9wdWItZGF0ZXM+PC9kYXRlcz48YWNjZXNzaW9uLW51bT4xNjY0NzYxODwv

YWNjZXNzaW9uLW51bT48dXJscz48cmVsYXRlZC11cmxzPjx1cmw+aHR0cDovL3d3dy5uY2JpLm5s

bS5uaWguZ292L2VudHJlei9xdWVyeS5mY2dpP2NtZD1SZXRyaWV2ZSZhbXA7ZGI9UHViTWVkJmFt

cDtkb3B0PUNpdGF0aW9uJmFtcDtsaXN0X3VpZHM9MTY2NDc2MTg8L3VybD48L3JlbGF0ZWQtdXJs

cz48L3VybHM+PC9yZWNvcmQ+PC9DaXRlPjxDaXRlPjxBdXRob3I+QW50b25pb3M8L0F1dGhvcj48

WWVhcj4yMDA2PC9ZZWFyPjxSZWNOdW0+MTE4MDQ8L1JlY051bT48cmVjb3JkPjxyZWMtbnVtYmVy

PjExODA0PC9yZWMtbnVtYmVyPjxmb3JlaWduLWtleXM+PGtleSBhcHA9IkVOIiBkYi1pZD0ienR6

YXN4ZTVjczAwdjRlZndycHZmdHJ3dGFmendlMjJ4ZXp0IiB0aW1lc3RhbXA9IjEzODI5NTQ0MDEi

PjExODA0PC9rZXk+PC9mb3JlaWduLWtleXM+PHJlZi10eXBlIG5hbWU9IkpvdXJuYWwgQXJ0aWNs

ZSI+MTc8L3JlZi10eXBlPjxjb250cmlidXRvcnM+PGF1dGhvcnM+PGF1dGhvcj5BbnRvbmlvcywg

VC4gRi48L2F1dGhvcj48L2F1dGhvcnM+PC9jb250cmlidXRvcnM+PGF1dGgtYWRkcmVzcz5CbG9v

ZCBQcmVzc3VyZSBVbml0LCBEZXBhcnRtZW50IG9mIENhcmRpYWMgYW5kIFZhc2N1bGFyIFNjaWVu

Y2VzLCBTdC4gR2VvcmdlJmFwb3M7cywgVW5pdmVyc2l0eSBvZiBMb25kb24sIExvbmRvbiwgRW5n

bGFuZC48L2F1dGgtYWRkcmVzcz48dGl0bGVzPjx0aXRsZT5NaWNyb3Zhc2N1bGFyIFJhcmVmYWN0

aW9uIGluIEh5cGVydGVuc2lvbi1SZXZlcnNhbCBvciBPdmVyLUNvcnJlY3Rpb24gYnkgVHJlYXRt

ZW50PzwvdGl0bGU+PHNlY29uZGFyeS10aXRsZT5BbSBKIEh5cGVydGVuczwvc2Vjb25kYXJ5LXRp

dGxlPjwvdGl0bGVzPjxwZXJpb2RpY2FsPjxmdWxsLXRpdGxlPkFtIEogSHlwZXJ0ZW5zPC9mdWxs

LXRpdGxlPjwvcGVyaW9kaWNhbD48cGFnZXM+NDg0LTQ4NTwvcGFnZXM+PHZvbHVtZT4xOTwvdm9s

dW1lPjxudW1iZXI+NTwvbnVtYmVyPjxkYXRlcz48eWVhcj4yMDA2PC95ZWFyPjxwdWItZGF0ZXM+

PGRhdGU+TWF5PC9kYXRlPjwvcHViLWRhdGVzPjwvZGF0ZXM+PGFjY2Vzc2lvbi1udW0+MTY2NDc2

MTk8L2FjY2Vzc2lvbi1udW0+PHVybHM+PHJlbGF0ZWQtdXJscz48dXJsPmh0dHA6Ly93d3cubmNi

aS5ubG0ubmloLmdvdi9lbnRyZXovcXVlcnkuZmNnaT9jbWQ9UmV0cmlldmUmYW1wO2RiPVB1Yk1l

ZCZhbXA7ZG9wdD1DaXRhdGlvbiZhbXA7bGlzdF91aWRzPTE2NjQ3NjE5PC91cmw+PC9yZWxhdGVk

LXVybHM+PC91cmxzPjwvcmVjb3JkPjwvQ2l0ZT48Q2l0ZT48QXV0aG9yPkRlYmJhYmk8L0F1dGhv

cj48WWVhcj4yMDEwPC9ZZWFyPjxSZWNOdW0+MTIyODM8L1JlY051bT48cmVjb3JkPjxyZWMtbnVt

YmVyPjEyMjgzPC9yZWMtbnVtYmVyPjxmb3JlaWduLWtleXM+PGtleSBhcHA9IkVOIiBkYi1pZD0i

enR6YXN4ZTVjczAwdjRlZndycHZmdHJ3dGFmendlMjJ4ZXp0IiB0aW1lc3RhbXA9IjEzODI5NTQ0

MDEiPjEyMjgzPC9rZXk+PC9mb3JlaWduLWtleXM+PHJlZi10eXBlIG5hbWU9IkpvdXJuYWwgQXJ0

aWNsZSI+MTc8L3JlZi10eXBlPjxjb250cmlidXRvcnM+PGF1dGhvcnM+PGF1dGhvcj5EZWJiYWJp

LCBILjwvYXV0aG9yPjxhdXRob3I+Qm9ubmluLCBQLjwvYXV0aG9yPjxhdXRob3I+TGV2eSwgQi4g

SS48L2F1dGhvcj48L2F1dGhvcnM+PC9jb250cmlidXRvcnM+PGF1dGgtYWRkcmVzcz5EZXBhcnRt

ZW50IG9mIE5vbi1JbnZhc2l2ZSBJbnZlc3RpZ2F0aW9ucywgUEFSQ0MgSW5zZXJtIFU3OTAsIElu

c2VybSBVOTY1LCBMYXJpYm9pc2llcmUgSG9zcGl0YWwsIEFQLUhQLCBVbml2ZXJzaXR5IFBhcmlz

IERpZGVyb3QsIFBhcmlzLCBGcmFuY2UuPC9hdXRoLWFkZHJlc3M+PHRpdGxlcz48dGl0bGU+RWZm

ZWN0cyBvZiBCbG9vZCBQcmVzc3VyZSBDb250cm9sIFdpdGggUGVyaW5kb3ByaWwvSW5kYXBhbWlk

ZSBvbiB0aGUgTWljcm9jaXJjdWxhdGlvbiBpbiBIeXBlcnRlbnNpdmUgUGF0aWVudHM8L3RpdGxl

PjxzZWNvbmRhcnktdGl0bGU+QW0gSiBIeXBlcnRlbnM8L3NlY29uZGFyeS10aXRsZT48L3RpdGxl

cz48cGVyaW9kaWNhbD48ZnVsbC10aXRsZT5BbSBKIEh5cGVydGVuczwvZnVsbC10aXRsZT48L3Bl

cmlvZGljYWw+PHBhZ2VzPjExMzYtMTE0MzwvcGFnZXM+PHZvbHVtZT4yMzwvdm9sdW1lPjxudW1i

ZXI+MTA8L251bWJlcj48ZGF0ZXM+PHllYXI+MjAxMDwveWVhcj48cHViLWRhdGVzPjxkYXRlPk1h

eSAyNzwvZGF0ZT48L3B1Yi1kYXRlcz48L2RhdGVzPjxhY2Nlc3Npb24tbnVtPjIwNTA4NjI0PC9h

Y2Nlc3Npb24tbnVtPjx1cmxzPjxyZWxhdGVkLXVybHM+PHVybD5odHRwOi8vd3d3Lm5jYmkubmxt

Lm5paC5nb3YvZW50cmV6L3F1ZXJ5LmZjZ2k/Y21kPVJldHJpZXZlJmFtcDtkYj1QdWJNZWQmYW1w

O2RvcHQ9Q2l0YXRpb24mYW1wO2xpc3RfdWlkcz0yMDUwODYyNDwvdXJsPjwvcmVsYXRlZC11cmxz

PjwvdXJscz48L3JlY29yZD48L0NpdGU+PENpdGU+PEF1dGhvcj5EZSBDaXVjZWlzPC9BdXRob3I+

PFllYXI+MjAxNDwvWWVhcj48UmVjTnVtPjE1MzM4PC9SZWNOdW0+PHJlY29yZD48cmVjLW51bWJl

cj4xNTMzODwvcmVjLW51bWJlcj48Zm9yZWlnbi1rZXlzPjxrZXkgYXBwPSJFTiIgZGItaWQ9Inp0

emFzeGU1Y3MwMHY0ZWZ3cnB2ZnRyd3RhZnp3ZTIyeGV6dCIgdGltZXN0YW1wPSIxNDM5Mjg3MTU1

Ij4xNTMzODwva2V5PjwvZm9yZWlnbi1rZXlzPjxyZWYtdHlwZSBuYW1lPSJKb3VybmFsIEFydGlj

bGUiPjE3PC9yZWYtdHlwZT48Y29udHJpYnV0b3JzPjxhdXRob3JzPjxhdXRob3I+RGUgQ2l1Y2Vp

cywgQy48L2F1dGhvcj48YXV0aG9yPlNhbHZldHRpLCBNLjwvYXV0aG9yPjxhdXRob3I+Um9zc2lu

aSwgQy48L2F1dGhvcj48YXV0aG9yPk11aWVzYW4sIE0uIEwuPC9hdXRob3I+PGF1dGhvcj5QYWlu

aSwgQS48L2F1dGhvcj48YXV0aG9yPkR1c2UsIFMuPC9hdXRob3I+PGF1dGhvcj5MYSBCb3JpYSwg

RS48L2F1dGhvcj48YXV0aG9yPlNlbWVyYXJvLCBGLjwvYXV0aG9yPjxhdXRob3I+Q2FuY2FyaW5p

LCBBLjwvYXV0aG9yPjxhdXRob3I+Um9zZWksIEMuIEEuPC9hdXRob3I+PGF1dGhvcj5TYXJrYXIs

IEEuPC9hdXRob3I+PGF1dGhvcj5SdWdnZXJpLCBHLjwvYXV0aG9yPjxhdXRob3I+Q2FpbWksIEwu

PC9hdXRob3I+PGF1dGhvcj5SaWNvdHRhLCBELjwvYXV0aG9yPjxhdXRob3I+Uml6em9uaSwgRC48

L2F1dGhvcj48YXV0aG9yPlJvc2VpLCBFLiBBLjwvYXV0aG9yPjwvYXV0aG9ycz48L2NvbnRyaWJ1

dG9ycz48YXV0aC1hZGRyZXNzPmFDbGluaWNhIE1lZGljYSwgRGVwYXJ0bWVudCBvZiBDbGluaWNh

bCBhbmQgRXhwZXJpbWVudGFsIFNjaWVuY2VzIGJDaGFpciBvZiBPcGh0aGFsbW9sb2d5IGNDaGFp

ciBvZiBDbGluaWNhbCBCaW9jaGVtaXN0cnksIFVuaXZlcnNpdHkgb2YgQnJlc2NpYSwgSXRhbHku

PC9hdXRoLWFkZHJlc3M+PHRpdGxlcz48dGl0bGU+RWZmZWN0IG9mIGFudGloeXBlcnRlbnNpdmUg

dHJlYXRtZW50IG9uIG1pY3JvdmFzY3VsYXIgc3RydWN0dXJlLCBjZW50cmFsIGJsb29kIHByZXNz

dXJlIGFuZCBveGlkYXRpdmUgc3RyZXNzIGluIHBhdGllbnRzIHdpdGggbWlsZCBlc3NlbnRpYWwg

aHlwZXJ0ZW5zaW9uPC90aXRsZT48c2Vjb25kYXJ5LXRpdGxlPkogSHlwZXJ0ZW5zPC9zZWNvbmRh

cnktdGl0bGU+PC90aXRsZXM+PHBlcmlvZGljYWw+PGZ1bGwtdGl0bGU+Sm91cm5hbCBvZiBIeXBl

cnRlbnNpb248L2Z1bGwtdGl0bGU+PGFiYnItMT5KIEh5cGVydGVuczwvYWJici0xPjwvcGVyaW9k

aWNhbD48cGFnZXM+NTY1LTc0PC9wYWdlcz48dm9sdW1lPjMyPC92b2x1bWU+PG51bWJlcj4zPC9u

dW1iZXI+PGtleXdvcmRzPjxrZXl3b3JkPkFkdWx0PC9rZXl3b3JkPjxrZXl3b3JkPkFuZ2lvdGVu

c2luLUNvbnZlcnRpbmcgRW56eW1lIEluaGliaXRvcnMvYWRtaW5pc3RyYXRpb24gJmFtcDsgZG9z

YWdlPC9rZXl3b3JkPjxrZXl3b3JkPkFudGloeXBlcnRlbnNpdmUgQWdlbnRzLyphZG1pbmlzdHJh

dGlvbiAmYW1wOyBkb3NhZ2U8L2tleXdvcmQ+PGtleXdvcmQ+QXJ0ZXJpb2xlcy9kcnVnIGVmZmVj

dHMvdWx0cmFzb25vZ3JhcGh5PC9rZXl3b3JkPjxrZXl3b3JkPkJsb29kIFByZXNzdXJlL3BoeXNp

b2xvZ3k8L2tleXdvcmQ+PGtleXdvcmQ+Q2FsY2l1bSBDaGFubmVsIEJsb2NrZXJzL2FkbWluaXN0

cmF0aW9uICZhbXA7IGRvc2FnZTwva2V5d29yZD48a2V5d29yZD5EaWh5ZHJvcHlyaWRpbmVzL2Fk

bWluaXN0cmF0aW9uICZhbXA7IGRvc2FnZTwva2V5d29yZD48a2V5d29yZD5EaXVyZXRpY3MvYWRt

aW5pc3RyYXRpb24gJmFtcDsgZG9zYWdlPC9rZXl3b3JkPjxrZXl3b3JkPkRydWcgVGhlcmFweSwg

Q29tYmluYXRpb248L2tleXdvcmQ+PGtleXdvcmQ+RW5hbGFwcmlsL2FkbWluaXN0cmF0aW9uICZh

bXA7IGRvc2FnZTwva2V5d29yZD48a2V5d29yZD5GZW1hbGU8L2tleXdvcmQ+PGtleXdvcmQ+SHVt

YW5zPC9rZXl3b3JkPjxrZXl3b3JkPkh5ZHJvY2hsb3JvdGhpYXppZGUvYWRtaW5pc3RyYXRpb24g

JmFtcDsgZG9zYWdlPC9rZXl3b3JkPjxrZXl3b3JkPkh5cGVydGVuc2lvbi8qZHJ1ZyB0aGVyYXB5

L3BoeXNpb3BhdGhvbG9neS91bHRyYXNvbm9ncmFwaHk8L2tleXdvcmQ+PGtleXdvcmQ+S2lkbmV5

L2Jsb29kIHN1cHBseS9kcnVnIGVmZmVjdHM8L2tleXdvcmQ+PGtleXdvcmQ+TGFzZXItRG9wcGxl

ciBGbG93bWV0cnk8L2tleXdvcmQ+PGtleXdvcmQ+TWFsZTwva2V5d29yZD48a2V5d29yZD5NaWRk

bGUgQWdlZDwva2V5d29yZD48a2V5d29yZD5PeGlkYXRpdmUgU3RyZXNzL2RydWcgZWZmZWN0czwv

a2V5d29yZD48L2tleXdvcmRzPjxkYXRlcz48eWVhcj4yMDE0PC95ZWFyPjxwdWItZGF0ZXM+PGRh

dGU+TWFyPC9kYXRlPjwvcHViLWRhdGVzPjwvZGF0ZXM+PGlzYm4+MTQ3My01NTk4IChFbGVjdHJv

bmljKSYjeEQ7MDI2My02MzUyIChMaW5raW5nKTwvaXNibj48YWNjZXNzaW9uLW51bT4yNDM3ODk5

OTwvYWNjZXNzaW9uLW51bT48dXJscz48cmVsYXRlZC11cmxzPjx1cmw+aHR0cDovL3d3dy5uY2Jp

Lm5sbS5uaWguZ292L3B1Ym1lZC8yNDM3ODk5OTwvdXJsPjx1cmw+aHR0cDovL292aWRzcC50eC5v

dmlkLmNvbS9vdmZ0cGRmcy9GUERETkNPQkZHR0RHTjAwL2ZzMDQ2L292ZnQvbGl2ZS9ndjAyMy8w

MDAwNDg3Mi8wMDAwNDg3Mi0yMDE0MDMwMDAtMDAwMTcucGRmPC91cmw+PC9yZWxhdGVkLXVybHM+

PC91cmxzPjxlbGVjdHJvbmljLXJlc291cmNlLW51bT4xMC4xMDk3L0hKSC4wMDAwMDAwMDAwMDAw

MDY3PC9lbGVjdHJvbmljLXJlc291cmNlLW51bT48L3JlY29yZD48L0NpdGU+PC9FbmROb3RlPn==

ADDIN EN.CITE PEVuZE5vdGU+PENpdGU+PEF1dGhvcj5EZWJiYWJpPC9BdXRob3I+PFllYXI+MjAwNjwvWWVhcj48

UmVjTnVtPjExODAzPC9SZWNOdW0+PERpc3BsYXlUZXh0PjxzdHlsZSBmYWNlPSJzdXBlcnNjcmlw

dCI+MTAsIDEzLCAyMCwgMjE8L3N0eWxlPjwvRGlzcGxheVRleHQ+PHJlY29yZD48cmVjLW51bWJl

cj4xMTgwMzwvcmVjLW51bWJlcj48Zm9yZWlnbi1rZXlzPjxrZXkgYXBwPSJFTiIgZGItaWQ9Inp0

emFzeGU1Y3MwMHY0ZWZ3cnB2ZnRyd3RhZnp3ZTIyeGV6dCIgdGltZXN0YW1wPSIxMzgyOTU0NDAx

Ij4xMTgwMzwva2V5PjwvZm9yZWlnbi1rZXlzPjxyZWYtdHlwZSBuYW1lPSJKb3VybmFsIEFydGlj

bGUiPjE3PC9yZWYtdHlwZT48Y29udHJpYnV0b3JzPjxhdXRob3JzPjxhdXRob3I+RGViYmFiaSwg

SC48L2F1dGhvcj48YXV0aG9yPlV6YW4sIEwuPC9hdXRob3I+PGF1dGhvcj5Nb3VyYWQsIEouIEou

PC9hdXRob3I+PGF1dGhvcj5TYWZhciwgTS48L2F1dGhvcj48YXV0aG9yPkxldnksIEIuIEkuPC9h

dXRob3I+PGF1dGhvcj5UaWJpcmljYSwgRS48L2F1dGhvcj48L2F1dGhvcnM+PC9jb250cmlidXRv

cnM+PGF1dGgtYWRkcmVzcz5EZXBhcnRtZW50IG9mIFBoeXNpb2xvZ3kgYW5kIG5vbi1pbnZhc2l2

ZSBpbnZlc3RpZ2F0aW9ucywgSW5zZXJtIFU2ODksIEhvcGl0YWwgTGFyaWJvaXNpZXJlLCBQYXJp

cywgRnJhbmNlLjwvYXV0aC1hZGRyZXNzPjx0aXRsZXM+PHRpdGxlPkluY3JlYXNlZCBza2luIGNh

cGlsbGFyeSBkZW5zaXR5IGluIHRyZWF0ZWQgZXNzZW50aWFsIGh5cGVydGVuc2l2ZSBwYXRpZW50

czwvdGl0bGU+PHNlY29uZGFyeS10aXRsZT5BbSBKIEh5cGVydGVuczwvc2Vjb25kYXJ5LXRpdGxl

PjwvdGl0bGVzPjxwZXJpb2RpY2FsPjxmdWxsLXRpdGxlPkFtIEogSHlwZXJ0ZW5zPC9mdWxsLXRp

dGxlPjwvcGVyaW9kaWNhbD48cGFnZXM+NDc3LTgzPC9wYWdlcz48dm9sdW1lPjE5PC92b2x1bWU+

PG51bWJlcj41PC9udW1iZXI+PGRhdGVzPjx5ZWFyPjIwMDY8L3llYXI+PHB1Yi1kYXRlcz48ZGF0

ZT5NYXk8L2RhdGU+PC9wdWItZGF0ZXM+PC9kYXRlcz48YWNjZXNzaW9uLW51bT4xNjY0NzYxODwv

YWNjZXNzaW9uLW51bT48dXJscz48cmVsYXRlZC11cmxzPjx1cmw+aHR0cDovL3d3dy5uY2JpLm5s

bS5uaWguZ292L2VudHJlei9xdWVyeS5mY2dpP2NtZD1SZXRyaWV2ZSZhbXA7ZGI9UHViTWVkJmFt

cDtkb3B0PUNpdGF0aW9uJmFtcDtsaXN0X3VpZHM9MTY2NDc2MTg8L3VybD48L3JlbGF0ZWQtdXJs

cz48L3VybHM+PC9yZWNvcmQ+PC9DaXRlPjxDaXRlPjxBdXRob3I+QW50b25pb3M8L0F1dGhvcj48

WWVhcj4yMDA2PC9ZZWFyPjxSZWNOdW0+MTE4MDQ8L1JlY051bT48cmVjb3JkPjxyZWMtbnVtYmVy

PjExODA0PC9yZWMtbnVtYmVyPjxmb3JlaWduLWtleXM+PGtleSBhcHA9IkVOIiBkYi1pZD0ienR6

YXN4ZTVjczAwdjRlZndycHZmdHJ3dGFmendlMjJ4ZXp0IiB0aW1lc3RhbXA9IjEzODI5NTQ0MDEi

PjExODA0PC9rZXk+PC9mb3JlaWduLWtleXM+PHJlZi10eXBlIG5hbWU9IkpvdXJuYWwgQXJ0aWNs

ZSI+MTc8L3JlZi10eXBlPjxjb250cmlidXRvcnM+PGF1dGhvcnM+PGF1dGhvcj5BbnRvbmlvcywg

VC4gRi48L2F1dGhvcj48L2F1dGhvcnM+PC9jb250cmlidXRvcnM+PGF1dGgtYWRkcmVzcz5CbG9v

ZCBQcmVzc3VyZSBVbml0LCBEZXBhcnRtZW50IG9mIENhcmRpYWMgYW5kIFZhc2N1bGFyIFNjaWVu

Y2VzLCBTdC4gR2VvcmdlJmFwb3M7cywgVW5pdmVyc2l0eSBvZiBMb25kb24sIExvbmRvbiwgRW5n

bGFuZC48L2F1dGgtYWRkcmVzcz48dGl0bGVzPjx0aXRsZT5NaWNyb3Zhc2N1bGFyIFJhcmVmYWN0

aW9uIGluIEh5cGVydGVuc2lvbi1SZXZlcnNhbCBvciBPdmVyLUNvcnJlY3Rpb24gYnkgVHJlYXRt

ZW50PzwvdGl0bGU+PHNlY29uZGFyeS10aXRsZT5BbSBKIEh5cGVydGVuczwvc2Vjb25kYXJ5LXRp

dGxlPjwvdGl0bGVzPjxwZXJpb2RpY2FsPjxmdWxsLXRpdGxlPkFtIEogSHlwZXJ0ZW5zPC9mdWxs

LXRpdGxlPjwvcGVyaW9kaWNhbD48cGFnZXM+NDg0LTQ4NTwvcGFnZXM+PHZvbHVtZT4xOTwvdm9s

dW1lPjxudW1iZXI+NTwvbnVtYmVyPjxkYXRlcz48eWVhcj4yMDA2PC95ZWFyPjxwdWItZGF0ZXM+

PGRhdGU+TWF5PC9kYXRlPjwvcHViLWRhdGVzPjwvZGF0ZXM+PGFjY2Vzc2lvbi1udW0+MTY2NDc2

MTk8L2FjY2Vzc2lvbi1udW0+PHVybHM+PHJlbGF0ZWQtdXJscz48dXJsPmh0dHA6Ly93d3cubmNi

aS5ubG0ubmloLmdvdi9lbnRyZXovcXVlcnkuZmNnaT9jbWQ9UmV0cmlldmUmYW1wO2RiPVB1Yk1l

ZCZhbXA7ZG9wdD1DaXRhdGlvbiZhbXA7bGlzdF91aWRzPTE2NjQ3NjE5PC91cmw+PC9yZWxhdGVk

LXVybHM+PC91cmxzPjwvcmVjb3JkPjwvQ2l0ZT48Q2l0ZT48QXV0aG9yPkRlYmJhYmk8L0F1dGhv

cj48WWVhcj4yMDEwPC9ZZWFyPjxSZWNOdW0+MTIyODM8L1JlY051bT48cmVjb3JkPjxyZWMtbnVt

YmVyPjEyMjgzPC9yZWMtbnVtYmVyPjxmb3JlaWduLWtleXM+PGtleSBhcHA9IkVOIiBkYi1pZD0i

enR6YXN4ZTVjczAwdjRlZndycHZmdHJ3dGFmendlMjJ4ZXp0IiB0aW1lc3RhbXA9IjEzODI5NTQ0

MDEiPjEyMjgzPC9rZXk+PC9mb3JlaWduLWtleXM+PHJlZi10eXBlIG5hbWU9IkpvdXJuYWwgQXJ0

aWNsZSI+MTc8L3JlZi10eXBlPjxjb250cmlidXRvcnM+PGF1dGhvcnM+PGF1dGhvcj5EZWJiYWJp

LCBILjwvYXV0aG9yPjxhdXRob3I+Qm9ubmluLCBQLjwvYXV0aG9yPjxhdXRob3I+TGV2eSwgQi4g

SS48L2F1dGhvcj48L2F1dGhvcnM+PC9jb250cmlidXRvcnM+PGF1dGgtYWRkcmVzcz5EZXBhcnRt

ZW50IG9mIE5vbi1JbnZhc2l2ZSBJbnZlc3RpZ2F0aW9ucywgUEFSQ0MgSW5zZXJtIFU3OTAsIElu

c2VybSBVOTY1LCBMYXJpYm9pc2llcmUgSG9zcGl0YWwsIEFQLUhQLCBVbml2ZXJzaXR5IFBhcmlz

IERpZGVyb3QsIFBhcmlzLCBGcmFuY2UuPC9hdXRoLWFkZHJlc3M+PHRpdGxlcz48dGl0bGU+RWZm

ZWN0cyBvZiBCbG9vZCBQcmVzc3VyZSBDb250cm9sIFdpdGggUGVyaW5kb3ByaWwvSW5kYXBhbWlk

ZSBvbiB0aGUgTWljcm9jaXJjdWxhdGlvbiBpbiBIeXBlcnRlbnNpdmUgUGF0aWVudHM8L3RpdGxl

PjxzZWNvbmRhcnktdGl0bGU+QW0gSiBIeXBlcnRlbnM8L3NlY29uZGFyeS10aXRsZT48L3RpdGxl

cz48cGVyaW9kaWNhbD48ZnVsbC10aXRsZT5BbSBKIEh5cGVydGVuczwvZnVsbC10aXRsZT48L3Bl

cmlvZGljYWw+PHBhZ2VzPjExMzYtMTE0MzwvcGFnZXM+PHZvbHVtZT4yMzwvdm9sdW1lPjxudW1i

ZXI+MTA8L251bWJlcj48ZGF0ZXM+PHllYXI+MjAxMDwveWVhcj48cHViLWRhdGVzPjxkYXRlPk1h

eSAyNzwvZGF0ZT48L3B1Yi1kYXRlcz48L2RhdGVzPjxhY2Nlc3Npb24tbnVtPjIwNTA4NjI0PC9h

Y2Nlc3Npb24tbnVtPjx1cmxzPjxyZWxhdGVkLXVybHM+PHVybD5odHRwOi8vd3d3Lm5jYmkubmxt

Lm5paC5nb3YvZW50cmV6L3F1ZXJ5LmZjZ2k/Y21kPVJldHJpZXZlJmFtcDtkYj1QdWJNZWQmYW1w

O2RvcHQ9Q2l0YXRpb24mYW1wO2xpc3RfdWlkcz0yMDUwODYyNDwvdXJsPjwvcmVsYXRlZC11cmxz

PjwvdXJscz48L3JlY29yZD48L0NpdGU+PENpdGU+PEF1dGhvcj5EZSBDaXVjZWlzPC9BdXRob3I+

PFllYXI+MjAxNDwvWWVhcj48UmVjTnVtPjE1MzM4PC9SZWNOdW0+PHJlY29yZD48cmVjLW51bWJl

cj4xNTMzODwvcmVjLW51bWJlcj48Zm9yZWlnbi1rZXlzPjxrZXkgYXBwPSJFTiIgZGItaWQ9Inp0

emFzeGU1Y3MwMHY0ZWZ3cnB2ZnRyd3RhZnp3ZTIyeGV6dCIgdGltZXN0YW1wPSIxNDM5Mjg3MTU1

Ij4xNTMzODwva2V5PjwvZm9yZWlnbi1rZXlzPjxyZWYtdHlwZSBuYW1lPSJKb3VybmFsIEFydGlj

bGUiPjE3PC9yZWYtdHlwZT48Y29udHJpYnV0b3JzPjxhdXRob3JzPjxhdXRob3I+RGUgQ2l1Y2Vp

cywgQy48L2F1dGhvcj48YXV0aG9yPlNhbHZldHRpLCBNLjwvYXV0aG9yPjxhdXRob3I+Um9zc2lu

aSwgQy48L2F1dGhvcj48YXV0aG9yPk11aWVzYW4sIE0uIEwuPC9hdXRob3I+PGF1dGhvcj5QYWlu

aSwgQS48L2F1dGhvcj48YXV0aG9yPkR1c2UsIFMuPC9hdXRob3I+PGF1dGhvcj5MYSBCb3JpYSwg

RS48L2F1dGhvcj48YXV0aG9yPlNlbWVyYXJvLCBGLjwvYXV0aG9yPjxhdXRob3I+Q2FuY2FyaW5p

LCBBLjwvYXV0aG9yPjxhdXRob3I+Um9zZWksIEMuIEEuPC9hdXRob3I+PGF1dGhvcj5TYXJrYXIs

IEEuPC9hdXRob3I+PGF1dGhvcj5SdWdnZXJpLCBHLjwvYXV0aG9yPjxhdXRob3I+Q2FpbWksIEwu

PC9hdXRob3I+PGF1dGhvcj5SaWNvdHRhLCBELjwvYXV0aG9yPjxhdXRob3I+Uml6em9uaSwgRC48

L2F1dGhvcj48YXV0aG9yPlJvc2VpLCBFLiBBLjwvYXV0aG9yPjwvYXV0aG9ycz48L2NvbnRyaWJ1

dG9ycz48YXV0aC1hZGRyZXNzPmFDbGluaWNhIE1lZGljYSwgRGVwYXJ0bWVudCBvZiBDbGluaWNh

bCBhbmQgRXhwZXJpbWVudGFsIFNjaWVuY2VzIGJDaGFpciBvZiBPcGh0aGFsbW9sb2d5IGNDaGFp

ciBvZiBDbGluaWNhbCBCaW9jaGVtaXN0cnksIFVuaXZlcnNpdHkgb2YgQnJlc2NpYSwgSXRhbHku

PC9hdXRoLWFkZHJlc3M+PHRpdGxlcz48dGl0bGU+RWZmZWN0IG9mIGFudGloeXBlcnRlbnNpdmUg

dHJlYXRtZW50IG9uIG1pY3JvdmFzY3VsYXIgc3RydWN0dXJlLCBjZW50cmFsIGJsb29kIHByZXNz

dXJlIGFuZCBveGlkYXRpdmUgc3RyZXNzIGluIHBhdGllbnRzIHdpdGggbWlsZCBlc3NlbnRpYWwg

aHlwZXJ0ZW5zaW9uPC90aXRsZT48c2Vjb25kYXJ5LXRpdGxlPkogSHlwZXJ0ZW5zPC9zZWNvbmRh

cnktdGl0bGU+PC90aXRsZXM+PHBlcmlvZGljYWw+PGZ1bGwtdGl0bGU+Sm91cm5hbCBvZiBIeXBl

cnRlbnNpb248L2Z1bGwtdGl0bGU+PGFiYnItMT5KIEh5cGVydGVuczwvYWJici0xPjwvcGVyaW9k

aWNhbD48cGFnZXM+NTY1LTc0PC9wYWdlcz48dm9sdW1lPjMyPC92b2x1bWU+PG51bWJlcj4zPC9u

dW1iZXI+PGtleXdvcmRzPjxrZXl3b3JkPkFkdWx0PC9rZXl3b3JkPjxrZXl3b3JkPkFuZ2lvdGVu

c2luLUNvbnZlcnRpbmcgRW56eW1lIEluaGliaXRvcnMvYWRtaW5pc3RyYXRpb24gJmFtcDsgZG9z

YWdlPC9rZXl3b3JkPjxrZXl3b3JkPkFudGloeXBlcnRlbnNpdmUgQWdlbnRzLyphZG1pbmlzdHJh

dGlvbiAmYW1wOyBkb3NhZ2U8L2tleXdvcmQ+PGtleXdvcmQ+QXJ0ZXJpb2xlcy9kcnVnIGVmZmVj

dHMvdWx0cmFzb25vZ3JhcGh5PC9rZXl3b3JkPjxrZXl3b3JkPkJsb29kIFByZXNzdXJlL3BoeXNp

b2xvZ3k8L2tleXdvcmQ+PGtleXdvcmQ+Q2FsY2l1bSBDaGFubmVsIEJsb2NrZXJzL2FkbWluaXN0

cmF0aW9uICZhbXA7IGRvc2FnZTwva2V5d29yZD48a2V5d29yZD5EaWh5ZHJvcHlyaWRpbmVzL2Fk

bWluaXN0cmF0aW9uICZhbXA7IGRvc2FnZTwva2V5d29yZD48a2V5d29yZD5EaXVyZXRpY3MvYWRt

aW5pc3RyYXRpb24gJmFtcDsgZG9zYWdlPC9rZXl3b3JkPjxrZXl3b3JkPkRydWcgVGhlcmFweSwg

Q29tYmluYXRpb248L2tleXdvcmQ+PGtleXdvcmQ+RW5hbGFwcmlsL2FkbWluaXN0cmF0aW9uICZh

bXA7IGRvc2FnZTwva2V5d29yZD48a2V5d29yZD5GZW1hbGU8L2tleXdvcmQ+PGtleXdvcmQ+SHVt

YW5zPC9rZXl3b3JkPjxrZXl3b3JkPkh5ZHJvY2hsb3JvdGhpYXppZGUvYWRtaW5pc3RyYXRpb24g

JmFtcDsgZG9zYWdlPC9rZXl3b3JkPjxrZXl3b3JkPkh5cGVydGVuc2lvbi8qZHJ1ZyB0aGVyYXB5

L3BoeXNpb3BhdGhvbG9neS91bHRyYXNvbm9ncmFwaHk8L2tleXdvcmQ+PGtleXdvcmQ+S2lkbmV5

L2Jsb29kIHN1cHBseS9kcnVnIGVmZmVjdHM8L2tleXdvcmQ+PGtleXdvcmQ+TGFzZXItRG9wcGxl

ciBGbG93bWV0cnk8L2tleXdvcmQ+PGtleXdvcmQ+TWFsZTwva2V5d29yZD48a2V5d29yZD5NaWRk

bGUgQWdlZDwva2V5d29yZD48a2V5d29yZD5PeGlkYXRpdmUgU3RyZXNzL2RydWcgZWZmZWN0czwv

a2V5d29yZD48L2tleXdvcmRzPjxkYXRlcz48eWVhcj4yMDE0PC95ZWFyPjxwdWItZGF0ZXM+PGRh

dGU+TWFyPC9kYXRlPjwvcHViLWRhdGVzPjwvZGF0ZXM+PGlzYm4+MTQ3My01NTk4IChFbGVjdHJv

bmljKSYjeEQ7MDI2My02MzUyIChMaW5raW5nKTwvaXNibj48YWNjZXNzaW9uLW51bT4yNDM3ODk5

OTwvYWNjZXNzaW9uLW51bT48dXJscz48cmVsYXRlZC11cmxzPjx1cmw+aHR0cDovL3d3dy5uY2Jp

Lm5sbS5uaWguZ292L3B1Ym1lZC8yNDM3ODk5OTwvdXJsPjx1cmw+aHR0cDovL292aWRzcC50eC5v

dmlkLmNvbS9vdmZ0cGRmcy9GUERETkNPQkZHR0RHTjAwL2ZzMDQ2L292ZnQvbGl2ZS9ndjAyMy8w

MDAwNDg3Mi8wMDAwNDg3Mi0yMDE0MDMwMDAtMDAwMTcucGRmPC91cmw+PC9yZWxhdGVkLXVybHM+

PC91cmxzPjxlbGVjdHJvbmljLXJlc291cmNlLW51bT4xMC4xMDk3L0hKSC4wMDAwMDAwMDAwMDAw

MDY3PC9lbGVjdHJvbmljLXJlc291cmNlLW51bT48L3JlY29yZD48L0NpdGU+PC9FbmROb3RlPn==

ADDIN EN.CITE.DATA 10, 13, 20, 21 It was postulated that treatment of hypertension and a reduction in BP represents a necessary but not a sufficient circumstance for inducing a regression in microvascular abnormalities, because drugs with similar hemodynamic profile may have dissimilar effects on small artery morphology. ADDIN EN.CITE <EndNote><Cite><Author>Agabiti-Rosei</Author><Year>2009</Year><RecNum>15347</RecNum><DisplayText><style face="superscript">22</style></DisplayText><record><rec-number>15347</rec-number><foreign-keys><key app="EN" db-id="ztzasxe5cs00v4efwrpvftrwtafzwe22xezt" timestamp="1440147142">15347</key></foreign-keys><ref-type name="Journal Article">17</ref-type><contributors><authors><author>Agabiti-Rosei, E.</author><author>Heagerty, A. M.</author><author>Rizzoni, D.</author></authors></contributors><auth-address>Clinica Medica, Department of Medical and Surgical Sciences, University of Brescia, Italy.</auth-address><titles><title>Effects of antihypertensive treatment on small artery remodelling</title><secondary-title>J Hypertens</secondary-title></titles><periodical><full-title>Journal of Hypertension</full-title><abbr-1>J Hypertens</abbr-1></periodical><pages>1107-14</pages><volume>27</volume><number>6</number><keywords><keyword>Animals</keyword><keyword>Antihypertensive Agents/*therapeutic use</keyword><keyword>Arteries/*drug effects/*pathology/physiopathology</keyword><keyword>Cardiovascular Diseases/etiology/pathology</keyword><keyword>Humans</keyword><keyword>Hypertension/complications/*drug therapy/*pathology/physiopathology</keyword><keyword>Hypertrophy</keyword><keyword>Prognosis</keyword><keyword>Risk Factors</keyword><keyword>Vascular Resistance/drug effects</keyword></keywords><dates><year>2009</year><pub-dates><date>Jun</date></pub-dates></dates><isbn>1473-5598 (Electronic)&#xD;0263-6352 (Linking)</isbn><accession-num>19293726</accession-num><urls><related-urls><url> In a previous open-label pilot study in individuals with treatment-na?ve mild-to-moderate essential hypertension, we found that 6-weeks treatment with the ARB irbesartan resulted in significant lowering of both systolic and diastolic BP and significant increase in maximal capillary density (with venous congestion). ADDIN EN.CITE <EndNote><Cite><Author>Rattray</Author><Year>2004</Year><RecNum>11801</RecNum><DisplayText><style face="superscript">23</style></DisplayText><record><rec-number>11801</rec-number><foreign-keys><key app="EN" db-id="ztzasxe5cs00v4efwrpvftrwtafzwe22xezt" timestamp="1382954401">11801</key></foreign-keys><ref-type name="Journal Article">17</ref-type><contributors><authors><author>Rattray, F.E.</author><author>Coltart, R.A.</author><author>Markandu, N.D.</author><author>MacGregor, G.A.</author><author>Antonios, T.F.T.</author></authors></contributors><titles><title>Effect of an angiotensin II antagonist; irbesartan on blood pressure and skin capillary density in patients with essential hypertension</title><secondary-title>Journal of Hypertens</secondary-title></titles><periodical><full-title>Journal of Hypertens</full-title></periodical><pages>S25</pages><volume>22</volume><number>S1</number><dates><year>2004</year></dates><urls></urls></record></Cite></EndNote>23 In another observational study we reported that capillary density was 25- 30% higher in treated compared with untreated hypertensive patients but was significantly lower than in age-matched normotensive controls. ADDIN EN.CITE <EndNote><Cite><Author>Antonios</Author><Year>2001</Year><RecNum>11372</RecNum><DisplayText><style face="superscript">11</style></DisplayText><record><rec-number>11372</rec-number><foreign-keys><key app="EN" db-id="ztzasxe5cs00v4efwrpvftrwtafzwe22xezt" timestamp="1382954401">11372</key></foreign-keys><ref-type name="Journal Article">17</ref-type><contributors><authors><author>Antonios, T. F.</author><author>Kaski, J. C.</author><author>Hasan, K. M.</author><author>Brown, S. J.</author><author>Singer, D. R.</author></authors></contributors><auth-address>Clinical Pharmacology Unit, Department of Pharmacology &amp; Clinical Pharmacology, St George&apos;s Hospital Medical School, Cranmer Terrace, London, U.K.</auth-address><titles><title>Rarefaction of skin capillaries in patients with anginal chest pain and normal coronary arteriograms</title><secondary-title>Eur Heart J</secondary-title></titles><periodical><full-title>Eur Heart J</full-title></periodical><pages>1144-1148.</pages><volume>22</volume><number>13</number><dates><year>2001</year></dates><accession-num>11428855</accession-num><urls><related-urls><url> Debbabi and colleagues, in an observational study, evaluated skin capillary density in hypertensive patients who were treated with different antihypertensive drugs and who had their BP well controlled below 140/90mmHg for at least 12 months. They found that basal (functional) and maximal (structural) skin capillary densities in treated hypertensive patients were significantly higher when compared to never-treated hypertensive patients or to normotensive subjects. ADDIN EN.CITE <EndNote><Cite><Author>Debbabi</Author><Year>2006</Year><RecNum>11803</RecNum><DisplayText><style face="superscript">20</style></DisplayText><record><rec-number>11803</rec-number><foreign-keys><key app="EN" db-id="ztzasxe5cs00v4efwrpvftrwtafzwe22xezt" timestamp="1382954401">11803</key></foreign-keys><ref-type name="Journal Article">17</ref-type><contributors><authors><author>Debbabi, H.</author><author>Uzan, L.</author><author>Mourad, J. J.</author><author>Safar, M.</author><author>Levy, B. I.</author><author>Tibirica, E.</author></authors></contributors><auth-address>Department of Physiology and non-invasive investigations, Inserm U689, Hopital Lariboisiere, Paris, France.</auth-address><titles><title>Increased skin capillary density in treated essential hypertensive patients</title><secondary-title>Am J Hypertens</secondary-title></titles><periodical><full-title>Am J Hypertens</full-title></periodical><pages>477-83</pages><volume>19</volume><number>5</number><dates><year>2006</year><pub-dates><date>May</date></pub-dates></dates><accession-num>16647618</accession-num><urls><related-urls><url> The finding of a higher capillary density in treated hypertensive patients is very curious and rather difficult to construe. ADDIN EN.CITE <EndNote><Cite><Author>Antonios</Author><Year>2006</Year><RecNum>11804</RecNum><DisplayText><style face="superscript">21</style></DisplayText><record><rec-number>11804</rec-number><foreign-keys><key app="EN" db-id="ztzasxe5cs00v4efwrpvftrwtafzwe22xezt" timestamp="1382954401">11804</key></foreign-keys><ref-type name="Journal Article">17</ref-type><contributors><authors><author>Antonios, T. F.</author></authors></contributors><auth-address>Blood Pressure Unit, Department of Cardiac and Vascular Sciences, St. George&apos;s, University of London, London, England.</auth-address><titles><title>Microvascular Rarefaction in Hypertension-Reversal or Over-Correction by Treatment?</title><secondary-title>Am J Hypertens</secondary-title></titles><periodical><full-title>Am J Hypertens</full-title></periodical><pages>484-485</pages><volume>19</volume><number>5</number><dates><year>2006</year><pub-dates><date>May</date></pub-dates></dates><accession-num>16647619</accession-num><urls><related-urls><url> In another open-label cross-sectional study the same group reported that only hypertensive patients who were treated and adequately controlled with perindopril / indapamide combination for more than 6 months had significantly higher maximal capillary density than both patients treated and controlled by other drugs, and normotensive individuals. ADDIN EN.CITE <EndNote><Cite><Author>Debbabi</Author><Year>2010</Year><RecNum>12283</RecNum><DisplayText><style face="superscript">13</style></DisplayText><record><rec-number>12283</rec-number><foreign-keys><key app="EN" db-id="ztzasxe5cs00v4efwrpvftrwtafzwe22xezt" timestamp="1382954401">12283</key></foreign-keys><ref-type name="Journal Article">17</ref-type><contributors><authors><author>Debbabi, H.</author><author>Bonnin, P.</author><author>Levy, B. I.</author></authors></contributors><auth-address>Department of Non-Invasive Investigations, PARCC Inserm U790, Inserm U965, Lariboisiere Hospital, AP-HP, University Paris Diderot, Paris, France.</auth-address><titles><title>Effects of Blood Pressure Control With Perindopril/Indapamide on the Microcirculation in Hypertensive Patients</title><secondary-title>Am J Hypertens</secondary-title></titles><periodical><full-title>Am J Hypertens</full-title></periodical><pages>1136-1143</pages><volume>23</volume><number>10</number><dates><year>2010</year><pub-dates><date>May 27</date></pub-dates></dates><accession-num>20508624</accession-num><urls><related-urls><url> They suggested that the normalization of the skin capillary density could be, at least partially, BP independent as equivalent BP control is not synonymous with equivalent microvascular benefits and suggest different long-term results for end-organ damage. Of interest in their study is that most of the patients in the controlled-other group (48%) were treated with an ARB. ADDIN EN.CITE <EndNote><Cite><Author>Debbabi</Author><Year>2010</Year><RecNum>12283</RecNum><DisplayText><style face="superscript">13</style></DisplayText><record><rec-number>12283</rec-number><foreign-keys><key app="EN" db-id="ztzasxe5cs00v4efwrpvftrwtafzwe22xezt" timestamp="1382954401">12283</key></foreign-keys><ref-type name="Journal Article">17</ref-type><contributors><authors><author>Debbabi, H.</author><author>Bonnin, P.</author><author>Levy, B. I.</author></authors></contributors><auth-address>Department of Non-Invasive Investigations, PARCC Inserm U790, Inserm U965, Lariboisiere Hospital, AP-HP, University Paris Diderot, Paris, France.</auth-address><titles><title>Effects of Blood Pressure Control With Perindopril/Indapamide on the Microcirculation in Hypertensive Patients</title><secondary-title>Am J Hypertens</secondary-title></titles><periodical><full-title>Am J Hypertens</full-title></periodical><pages>1136-1143</pages><volume>23</volume><number>10</number><dates><year>2010</year><pub-dates><date>May 27</date></pub-dates></dates><accession-num>20508624</accession-num><urls><related-urls><url> Several other studies have shown similar negative effects of ARBs on capillary rarefaction. Kaiser and colleagues in an open-label randomized design studied skin capillary density in 44 subjects with mild to moderate essential hypertension before and after six months treatment with either a beta-blocker (metoprolol) or an ARB (olmesartan). ADDIN EN.CITE <EndNote><Cite><Author>Kaiser</Author><Year>2013</Year><RecNum>14565</RecNum><DisplayText><style face="superscript">24</style></DisplayText><record><rec-number>14565</rec-number><foreign-keys><key app="EN" db-id="ztzasxe5cs00v4efwrpvftrwtafzwe22xezt" timestamp="1404729702">14565</key></foreign-keys><ref-type name="Journal Article">17</ref-type><contributors><authors><author>Kaiser, S. E.</author><author>Sanjuliani, A. F.</author><author>Estato, V.</author><author>Gomes, M. B.</author><author>Tibirica, E.</author></authors></contributors><auth-address>Clinical and Experimental Pathophysiology Unit, State University of Rio de Janeiro, Rio de Janeiro, Brazil.</auth-address><titles><title>Antihypertensive treatment improves microvascular rarefaction and reactivity in low-risk hypertensive individuals</title><secondary-title>Microcirculation</secondary-title><alt-title>Microcirculation</alt-title></titles><periodical><full-title>Microcirculation</full-title></periodical><alt-periodical><full-title>Microcirculation</full-title></alt-periodical><pages>703-16</pages><volume>20</volume><number>8</number><dates><year>2013</year><pub-dates><date>Nov</date></pub-dates></dates><isbn>1549-8719 (Electronic)&#xD;1073-9688 (Linking)</isbn><accession-num>23692260</accession-num><urls><related-urls><url> Interestingly, they found that only treatment with metoprolol resulted in a significant reversal of rarefaction and an increase in capillary density whilst treatment with olmesartan had no significant effect on capillary density. Treatment with valsartan showed conflicting results as one study showing significant increase in capillary density after only 4 weeks ADDIN EN.CITE <EndNote><Cite><Author>Jumar</Author><Year>2016</Year><RecNum>16291</RecNum><DisplayText><style face="superscript">25</style></DisplayText><record><rec-number>16291</rec-number><foreign-keys><key app="EN" db-id="ztzasxe5cs00v4efwrpvftrwtafzwe22xezt" timestamp="1468493365">16291</key></foreign-keys><ref-type name="Journal Article">17</ref-type><contributors><authors><author>Jumar, A.</author><author>Harazny, J. M.</author><author>Ott, C.</author><author>Kistner, I.</author><author>Friedrich, S.</author><author>Schmieder, R. E.</author></authors></contributors><auth-address>Department of Nephrology and Hypertension, Friedrich-Alexander-University Erlangen-Nurnberg (FAU), Erlangen, Germany.&#xD;Department of Pathophysiology, University of Warmia and Mazury Olsztyn, Olsztyn, Poland.</auth-address><titles><title>Improvement in Retinal Capillary Rarefaction After Valsartan Treatment in Hypertensive Patients</title><secondary-title>J Clin Hypertens (Greenwich)</secondary-title></titles><periodical><full-title>J Clin Hypertens (Greenwich)</full-title></periodical><dates><year>2016</year><pub-dates><date>Jun 16</date></pub-dates></dates><isbn>1751-7176 (Electronic)&#xD;1524-6175 (Linking)</isbn><accession-num>27306560</accession-num><urls><related-urls><url> while another study showed no significant effect on capillary density.PEVuZE5vdGU+PENpdGU+PEF1dGhvcj52YW4gZGVyIFppamw8L0F1dGhvcj48WWVhcj4yMDExPC9Z

ZWFyPjxSZWNOdW0+MTYyOTY8L1JlY051bT48RGlzcGxheVRleHQ+PHN0eWxlIGZhY2U9InN1cGVy

c2NyaXB0Ij4yNjwvc3R5bGU+PC9EaXNwbGF5VGV4dD48cmVjb3JkPjxyZWMtbnVtYmVyPjE2Mjk2

PC9yZWMtbnVtYmVyPjxmb3JlaWduLWtleXM+PGtleSBhcHA9IkVOIiBkYi1pZD0ienR6YXN4ZTVj

czAwdjRlZndycHZmdHJ3dGFmendlMjJ4ZXp0IiB0aW1lc3RhbXA9IjE0NzE4NzgxMzYiPjE2Mjk2

PC9rZXk+PC9mb3JlaWduLWtleXM+PHJlZi10eXBlIG5hbWU9IkpvdXJuYWwgQXJ0aWNsZSI+MTc8

L3JlZi10eXBlPjxjb250cmlidXRvcnM+PGF1dGhvcnM+PGF1dGhvcj52YW4gZGVyIFppamwsIE4u

IEouPC9hdXRob3I+PGF1dGhvcj5TZXJuZSwgRS4gSC48L2F1dGhvcj48YXV0aG9yPkdvb3NzZW5z

LCBHLiBILjwvYXV0aG9yPjxhdXRob3I+TW9vcnMsIEMuIEMuPC9hdXRob3I+PGF1dGhvcj5Janpl

cm1hbiwgUi4gRy48L2F1dGhvcj48YXV0aG9yPkJsYWFrLCBFLiBFLjwvYXV0aG9yPjxhdXRob3I+

RGlhbWFudCwgTS48L2F1dGhvcj48L2F1dGhvcnM+PC9jb250cmlidXRvcnM+PGF1dGgtYWRkcmVz

cz5EaWFiZXRlcyBDZW50cmUsIERlcGFydG1lbnQgb2YgSW50ZXJuYWwgTWVkaWNpbmUsIFZVIFVu

aXZlcnNpdHkgTWVkaWNhbCBDZW50cmUsIEFtc3RlcmRhbSwgVGhlIE5ldGhlcmxhbmRzLiBuai52

ZHppamxAdnVtYy5ubDwvYXV0aC1hZGRyZXNzPjx0aXRsZXM+PHRpdGxlPlZhbHNhcnRhbi1pbmR1

Y2VkIGltcHJvdmVtZW50IGluIGluc3VsaW4gc2Vuc2l0aXZpdHkgaXMgbm90IHBhcmFsbGVsZWQg

YnkgY2hhbmdlcyBpbiBtaWNyb3Zhc2N1bGFyIGZ1bmN0aW9uIGluIGluZGl2aWR1YWxzIHdpdGgg

aW1wYWlyZWQgZ2x1Y29zZSBtZXRhYm9saXNtPC90aXRsZT48c2Vjb25kYXJ5LXRpdGxlPkogSHlw

ZXJ0ZW5zPC9zZWNvbmRhcnktdGl0bGU+PC90aXRsZXM+PHBlcmlvZGljYWw+PGZ1bGwtdGl0bGU+

Sm91cm5hbCBvZiBIeXBlcnRlbnNpb248L2Z1bGwtdGl0bGU+PGFiYnItMT5KIEh5cGVydGVuczwv

YWJici0xPjwvcGVyaW9kaWNhbD48cGFnZXM+MTk1NS02MjwvcGFnZXM+PHZvbHVtZT4yOTwvdm9s

dW1lPjxudW1iZXI+MTA8L251bWJlcj48a2V5d29yZHM+PGtleXdvcmQ+QWRpcG9raW5lcy9ibG9v

ZDwva2V5d29yZD48a2V5d29yZD5Bbmdpb3RlbnNpbiBJSSBUeXBlIDEgUmVjZXB0b3IgQmxvY2tl

cnMvKnBoYXJtYWNvbG9neTwva2V5d29yZD48a2V5d29yZD5CbG9vZCBHbHVjb3NlL21ldGFib2xp

c208L2tleXdvcmQ+PGtleXdvcmQ+Q2FwaWxsYXJpZXMvZHJ1ZyBlZmZlY3RzL3BhdGhvbG9neS9w

aHlzaW9sb2d5PC9rZXl3b3JkPjxrZXl3b3JkPkN5dG9raW5lcy9ibG9vZDwva2V5d29yZD48a2V5

d29yZD5EaWFiZXRlcyBNZWxsaXR1cywgVHlwZSAyL3BoeXNpb3BhdGhvbG9neS9wcmV2ZW50aW9u

ICZhbXA7IGNvbnRyb2w8L2tleXdvcmQ+PGtleXdvcmQ+RmVtYWxlPC9rZXl3b3JkPjxrZXl3b3Jk

Pkh1bWFuczwva2V5d29yZD48a2V5d29yZD5JbmZsYW1tYXRpb24gTWVkaWF0b3JzL2Jsb29kPC9r

ZXl3b3JkPjxrZXl3b3JkPkluc3VsaW4gUmVzaXN0YW5jZS8qcGh5c2lvbG9neTwva2V5d29yZD48

a2V5d29yZD5NYWxlPC9rZXl3b3JkPjxrZXl3b3JkPk1pY3JvdmVzc2Vscy8qZHJ1ZyBlZmZlY3Rz

L3BhdGhvbG9neS8qcGh5c2lvbG9neTwva2V5d29yZD48a2V5d29yZD5NaWRkbGUgQWdlZDwva2V5

d29yZD48a2V5d29yZD5UZXRyYXpvbGVzLypwaGFybWFjb2xvZ3k8L2tleXdvcmQ+PGtleXdvcmQ+

VmFsaW5lLyphbmFsb2dzICZhbXA7IGRlcml2YXRpdmVzL3BoYXJtYWNvbG9neTwva2V5d29yZD48

a2V5d29yZD5WYWxzYXJ0YW48L2tleXdvcmQ+PC9rZXl3b3Jkcz48ZGF0ZXM+PHllYXI+MjAxMTwv

eWVhcj48cHViLWRhdGVzPjxkYXRlPk9jdDwvZGF0ZT48L3B1Yi1kYXRlcz48L2RhdGVzPjxpc2Ju

PjE0NzMtNTU5OCAoRWxlY3Ryb25pYykmI3hEOzAyNjMtNjM1MiAoTGlua2luZyk8L2lzYm4+PGFj

Y2Vzc2lvbi1udW0+MjE4NDQ4MjE8L2FjY2Vzc2lvbi1udW0+PHVybHM+PHJlbGF0ZWQtdXJscz48

dXJsPmh0dHA6Ly93d3cubmNiaS5ubG0ubmloLmdvdi9wdWJtZWQvMjE4NDQ4MjE8L3VybD48L3Jl

bGF0ZWQtdXJscz48L3VybHM+PGVsZWN0cm9uaWMtcmVzb3VyY2UtbnVtPjEwLjEwOTcvSEpILjBi

MDEzZTMyODM0YTc2Njc8L2VsZWN0cm9uaWMtcmVzb3VyY2UtbnVtPjwvcmVjb3JkPjwvQ2l0ZT48

L0VuZE5vdGU+AG==

ADDIN EN.CITE PEVuZE5vdGU+PENpdGU+PEF1dGhvcj52YW4gZGVyIFppamw8L0F1dGhvcj48WWVhcj4yMDExPC9Z

ZWFyPjxSZWNOdW0+MTYyOTY8L1JlY051bT48RGlzcGxheVRleHQ+PHN0eWxlIGZhY2U9InN1cGVy

c2NyaXB0Ij4yNjwvc3R5bGU+PC9EaXNwbGF5VGV4dD48cmVjb3JkPjxyZWMtbnVtYmVyPjE2Mjk2

PC9yZWMtbnVtYmVyPjxmb3JlaWduLWtleXM+PGtleSBhcHA9IkVOIiBkYi1pZD0ienR6YXN4ZTVj

czAwdjRlZndycHZmdHJ3dGFmendlMjJ4ZXp0IiB0aW1lc3RhbXA9IjE0NzE4NzgxMzYiPjE2Mjk2

PC9rZXk+PC9mb3JlaWduLWtleXM+PHJlZi10eXBlIG5hbWU9IkpvdXJuYWwgQXJ0aWNsZSI+MTc8

L3JlZi10eXBlPjxjb250cmlidXRvcnM+PGF1dGhvcnM+PGF1dGhvcj52YW4gZGVyIFppamwsIE4u

IEouPC9hdXRob3I+PGF1dGhvcj5TZXJuZSwgRS4gSC48L2F1dGhvcj48YXV0aG9yPkdvb3NzZW5z

LCBHLiBILjwvYXV0aG9yPjxhdXRob3I+TW9vcnMsIEMuIEMuPC9hdXRob3I+PGF1dGhvcj5Janpl

cm1hbiwgUi4gRy48L2F1dGhvcj48YXV0aG9yPkJsYWFrLCBFLiBFLjwvYXV0aG9yPjxhdXRob3I+

RGlhbWFudCwgTS48L2F1dGhvcj48L2F1dGhvcnM+PC9jb250cmlidXRvcnM+PGF1dGgtYWRkcmVz

cz5EaWFiZXRlcyBDZW50cmUsIERlcGFydG1lbnQgb2YgSW50ZXJuYWwgTWVkaWNpbmUsIFZVIFVu

aXZlcnNpdHkgTWVkaWNhbCBDZW50cmUsIEFtc3RlcmRhbSwgVGhlIE5ldGhlcmxhbmRzLiBuai52

ZHppamxAdnVtYy5ubDwvYXV0aC1hZGRyZXNzPjx0aXRsZXM+PHRpdGxlPlZhbHNhcnRhbi1pbmR1

Y2VkIGltcHJvdmVtZW50IGluIGluc3VsaW4gc2Vuc2l0aXZpdHkgaXMgbm90IHBhcmFsbGVsZWQg

YnkgY2hhbmdlcyBpbiBtaWNyb3Zhc2N1bGFyIGZ1bmN0aW9uIGluIGluZGl2aWR1YWxzIHdpdGgg

aW1wYWlyZWQgZ2x1Y29zZSBtZXRhYm9saXNtPC90aXRsZT48c2Vjb25kYXJ5LXRpdGxlPkogSHlw

ZXJ0ZW5zPC9zZWNvbmRhcnktdGl0bGU+PC90aXRsZXM+PHBlcmlvZGljYWw+PGZ1bGwtdGl0bGU+

Sm91cm5hbCBvZiBIeXBlcnRlbnNpb248L2Z1bGwtdGl0bGU+PGFiYnItMT5KIEh5cGVydGVuczwv

YWJici0xPjwvcGVyaW9kaWNhbD48cGFnZXM+MTk1NS02MjwvcGFnZXM+PHZvbHVtZT4yOTwvdm9s

dW1lPjxudW1iZXI+MTA8L251bWJlcj48a2V5d29yZHM+PGtleXdvcmQ+QWRpcG9raW5lcy9ibG9v

ZDwva2V5d29yZD48a2V5d29yZD5Bbmdpb3RlbnNpbiBJSSBUeXBlIDEgUmVjZXB0b3IgQmxvY2tl

cnMvKnBoYXJtYWNvbG9neTwva2V5d29yZD48a2V5d29yZD5CbG9vZCBHbHVjb3NlL21ldGFib2xp

c208L2tleXdvcmQ+PGtleXdvcmQ+Q2FwaWxsYXJpZXMvZHJ1ZyBlZmZlY3RzL3BhdGhvbG9neS9w

aHlzaW9sb2d5PC9rZXl3b3JkPjxrZXl3b3JkPkN5dG9raW5lcy9ibG9vZDwva2V5d29yZD48a2V5

d29yZD5EaWFiZXRlcyBNZWxsaXR1cywgVHlwZSAyL3BoeXNpb3BhdGhvbG9neS9wcmV2ZW50aW9u

ICZhbXA7IGNvbnRyb2w8L2tleXdvcmQ+PGtleXdvcmQ+RmVtYWxlPC9rZXl3b3JkPjxrZXl3b3Jk

Pkh1bWFuczwva2V5d29yZD48a2V5d29yZD5JbmZsYW1tYXRpb24gTWVkaWF0b3JzL2Jsb29kPC9r

ZXl3b3JkPjxrZXl3b3JkPkluc3VsaW4gUmVzaXN0YW5jZS8qcGh5c2lvbG9neTwva2V5d29yZD48

a2V5d29yZD5NYWxlPC9rZXl3b3JkPjxrZXl3b3JkPk1pY3JvdmVzc2Vscy8qZHJ1ZyBlZmZlY3Rz

L3BhdGhvbG9neS8qcGh5c2lvbG9neTwva2V5d29yZD48a2V5d29yZD5NaWRkbGUgQWdlZDwva2V5

d29yZD48a2V5d29yZD5UZXRyYXpvbGVzLypwaGFybWFjb2xvZ3k8L2tleXdvcmQ+PGtleXdvcmQ+

VmFsaW5lLyphbmFsb2dzICZhbXA7IGRlcml2YXRpdmVzL3BoYXJtYWNvbG9neTwva2V5d29yZD48

a2V5d29yZD5WYWxzYXJ0YW48L2tleXdvcmQ+PC9rZXl3b3Jkcz48ZGF0ZXM+PHllYXI+MjAxMTwv

eWVhcj48cHViLWRhdGVzPjxkYXRlPk9jdDwvZGF0ZT48L3B1Yi1kYXRlcz48L2RhdGVzPjxpc2Ju

PjE0NzMtNTU5OCAoRWxlY3Ryb25pYykmI3hEOzAyNjMtNjM1MiAoTGlua2luZyk8L2lzYm4+PGFj

Y2Vzc2lvbi1udW0+MjE4NDQ4MjE8L2FjY2Vzc2lvbi1udW0+PHVybHM+PHJlbGF0ZWQtdXJscz48

dXJsPmh0dHA6Ly93d3cubmNiaS5ubG0ubmloLmdvdi9wdWJtZWQvMjE4NDQ4MjE8L3VybD48L3Jl

bGF0ZWQtdXJscz48L3VybHM+PGVsZWN0cm9uaWMtcmVzb3VyY2UtbnVtPjEwLjEwOTcvSEpILjBi

MDEzZTMyODM0YTc2Njc8L2VsZWN0cm9uaWMtcmVzb3VyY2UtbnVtPjwvcmVjb3JkPjwvQ2l0ZT48

L0VuZE5vdGU+AG==

ADDIN EN.CITE.DATA 26 These results are interesting in that they contradict what has been suggested that drugs that block the renin-angiotensin system e.g. ACEi and ARBs may be more efficacious than other drugs such as beta-blockers in reversing the microcirculatory abnormalities in hypertension.PEVuZE5vdGU+PENpdGU+PEF1dGhvcj5PbHNlbjwvQXV0aG9yPjxZZWFyPjIwMDU8L1llYXI+PFJl

Y051bT4xMjAwMjwvUmVjTnVtPjxEaXNwbGF5VGV4dD48c3R5bGUgZmFjZT0ic3VwZXJzY3JpcHQi

PjI3PC9zdHlsZT48L0Rpc3BsYXlUZXh0PjxyZWNvcmQ+PHJlYy1udW1iZXI+MTIwMDI8L3JlYy1u

dW1iZXI+PGZvcmVpZ24ta2V5cz48a2V5IGFwcD0iRU4iIGRiLWlkPSJ6dHphc3hlNWNzMDB2NGVm

d3JwdmZ0cnd0YWZ6d2UyMnhlenQiIHRpbWVzdGFtcD0iMTM4Mjk1NDQwMSI+MTIwMDI8L2tleT48

L2ZvcmVpZ24ta2V5cz48cmVmLXR5cGUgbmFtZT0iSm91cm5hbCBBcnRpY2xlIj4xNzwvcmVmLXR5

cGU+PGNvbnRyaWJ1dG9ycz48YXV0aG9ycz48YXV0aG9yPk9sc2VuLCBNLiBILjwvYXV0aG9yPjxh

dXRob3I+Rm9zc3VtLCBFLjwvYXV0aG9yPjxhdXRob3I+SG9pZWdnZW4sIEEuPC9hdXRob3I+PGF1

dGhvcj5XYWNodGVsbCwgSy48L2F1dGhvcj48YXV0aG9yPkhqZXJraW5uLCBFLjwvYXV0aG9yPjxh

dXRob3I+TmVzYml0dCwgUy4gRC48L2F1dGhvcj48YXV0aG9yPkFuZGVyc2VuLCBVLiBCLjwvYXV0

aG9yPjxhdXRob3I+UGhpbGxpcHMsIFIuIEEuPC9hdXRob3I+PGF1dGhvcj5HYWJvdXJ5LCBDLiBM

LjwvYXV0aG9yPjxhdXRob3I+SWJzZW4sIEguPC9hdXRob3I+PGF1dGhvcj5LamVsZHNlbiwgUy4g

RS48L2F1dGhvcj48YXV0aG9yPkp1bGl1cywgUy48L2F1dGhvcj48L2F1dGhvcnM+PC9jb250cmli

dXRvcnM+PGF1dGgtYWRkcmVzcz5EZXBhcnRtZW50IG9mIENsaW5pY2FsIFBoeXNpb2xvZ3kgYW5k

IE51Y2xlYXIgTWVkaWNpbmUsIEdsb3N0cnVwIFVuaXZlcnNpdHkgSG9zcGl0YWwsIENvcGVuaGFn

ZW4sIERlbm1hcmsuIG1ob0BkYWRsbmV0LmRrPC9hdXRoLWFkZHJlc3M+PHRpdGxlcz48dGl0bGU+

TG9uZy10ZXJtIHRyZWF0bWVudCB3aXRoIGxvc2FydGFuIHZlcnN1cyBhdGVub2xvbCBpbXByb3Zl

cyBpbnN1bGluIHNlbnNpdGl2aXR5IGluIGh5cGVydGVuc2lvbjogSUNBUlVTLCBhIExJRkUgc3Vi

c3R1ZHk8L3RpdGxlPjxzZWNvbmRhcnktdGl0bGU+SiBIeXBlcnRlbnM8L3NlY29uZGFyeS10aXRs

ZT48L3RpdGxlcz48cGVyaW9kaWNhbD48ZnVsbC10aXRsZT5Kb3VybmFsIG9mIEh5cGVydGVuc2lv

bjwvZnVsbC10aXRsZT48YWJici0xPkogSHlwZXJ0ZW5zPC9hYmJyLTE+PC9wZXJpb2RpY2FsPjxw

YWdlcz44OTEtODwvcGFnZXM+PHZvbHVtZT4yMzwvdm9sdW1lPjxudW1iZXI+NDwvbnVtYmVyPjxr

ZXl3b3Jkcz48a2V5d29yZD5BZ2VkPC9rZXl3b3JkPjxrZXl3b3JkPkFudGloeXBlcnRlbnNpdmUg

QWdlbnRzLyphZG1pbmlzdHJhdGlvbiAmYW1wOyBkb3NhZ2U8L2tleXdvcmQ+PGtleXdvcmQ+QXRl

bm9sb2wvKmFkbWluaXN0cmF0aW9uICZhbXA7IGRvc2FnZTwva2V5d29yZD48a2V5d29yZD5CbG9v

ZCBHbHVjb3NlPC9rZXl3b3JkPjxrZXl3b3JkPkJsb29kIFByZXNzdXJlL2RydWcgZWZmZWN0czwv

a2V5d29yZD48a2V5d29yZD5EaWFiZXRlcyBNZWxsaXR1cywgVHlwZSAyL3ByZXZlbnRpb24gJmFt

cDsgY29udHJvbDwva2V5d29yZD48a2V5d29yZD5Gb3JlYXJtL2Jsb29kIHN1cHBseTwva2V5d29y

ZD48a2V5d29yZD5IdW1hbnM8L2tleXdvcmQ+PGtleXdvcmQ+SHlwZXJ0ZW5zaW9uLypkcnVnIHRo

ZXJhcHk8L2tleXdvcmQ+PGtleXdvcmQ+SW5zdWxpbi9ibG9vZDwva2V5d29yZD48a2V5d29yZD4q

SW5zdWxpbiBSZXNpc3RhbmNlPC9rZXl3b3JkPjxrZXl3b3JkPkxvc2FydGFuLyphZG1pbmlzdHJh

dGlvbiAmYW1wOyBkb3NhZ2U8L2tleXdvcmQ+PGtleXdvcmQ+TWlkZGxlIEFnZWQ8L2tleXdvcmQ+

PGtleXdvcmQ+UGVyaXBoZXJhbCBWYXNjdWxhciBEaXNlYXNlcy8qZHJ1ZyB0aGVyYXB5PC9rZXl3

b3JkPjxrZXl3b3JkPlZhc2N1bGFyIFJlc2lzdGFuY2UvZHJ1ZyBlZmZlY3RzPC9rZXl3b3JkPjwv

a2V5d29yZHM+PGRhdGVzPjx5ZWFyPjIwMDU8L3llYXI+PHB1Yi1kYXRlcz48ZGF0ZT5BcHI8L2Rh

dGU+PC9wdWItZGF0ZXM+PC9kYXRlcz48YWNjZXNzaW9uLW51bT4xNTc3NTc5NjwvYWNjZXNzaW9u

LW51bT48dXJscz48cmVsYXRlZC11cmxzPjx1cmw+aHR0cDovL3d3dy5uY2JpLm5sbS5uaWguZ292

L2VudHJlei9xdWVyeS5mY2dpP2NtZD1SZXRyaWV2ZSZhbXA7ZGI9UHViTWVkJmFtcDtkb3B0PUNp

dGF0aW9uJmFtcDtsaXN0X3VpZHM9MTU3NzU3OTY8L3VybD48L3JlbGF0ZWQtdXJscz48L3VybHM+

PC9yZWNvcmQ+PC9DaXRlPjwvRW5kTm90ZT4A

ADDIN EN.CITE PEVuZE5vdGU+PENpdGU+PEF1dGhvcj5PbHNlbjwvQXV0aG9yPjxZZWFyPjIwMDU8L1llYXI+PFJl

Y051bT4xMjAwMjwvUmVjTnVtPjxEaXNwbGF5VGV4dD48c3R5bGUgZmFjZT0ic3VwZXJzY3JpcHQi

PjI3PC9zdHlsZT48L0Rpc3BsYXlUZXh0PjxyZWNvcmQ+PHJlYy1udW1iZXI+MTIwMDI8L3JlYy1u

dW1iZXI+PGZvcmVpZ24ta2V5cz48a2V5IGFwcD0iRU4iIGRiLWlkPSJ6dHphc3hlNWNzMDB2NGVm

d3JwdmZ0cnd0YWZ6d2UyMnhlenQiIHRpbWVzdGFtcD0iMTM4Mjk1NDQwMSI+MTIwMDI8L2tleT48

L2ZvcmVpZ24ta2V5cz48cmVmLXR5cGUgbmFtZT0iSm91cm5hbCBBcnRpY2xlIj4xNzwvcmVmLXR5

cGU+PGNvbnRyaWJ1dG9ycz48YXV0aG9ycz48YXV0aG9yPk9sc2VuLCBNLiBILjwvYXV0aG9yPjxh

dXRob3I+Rm9zc3VtLCBFLjwvYXV0aG9yPjxhdXRob3I+SG9pZWdnZW4sIEEuPC9hdXRob3I+PGF1

dGhvcj5XYWNodGVsbCwgSy48L2F1dGhvcj48YXV0aG9yPkhqZXJraW5uLCBFLjwvYXV0aG9yPjxh

dXRob3I+TmVzYml0dCwgUy4gRC48L2F1dGhvcj48YXV0aG9yPkFuZGVyc2VuLCBVLiBCLjwvYXV0

aG9yPjxhdXRob3I+UGhpbGxpcHMsIFIuIEEuPC9hdXRob3I+PGF1dGhvcj5HYWJvdXJ5LCBDLiBM

LjwvYXV0aG9yPjxhdXRob3I+SWJzZW4sIEguPC9hdXRob3I+PGF1dGhvcj5LamVsZHNlbiwgUy4g

RS48L2F1dGhvcj48YXV0aG9yPkp1bGl1cywgUy48L2F1dGhvcj48L2F1dGhvcnM+PC9jb250cmli

dXRvcnM+PGF1dGgtYWRkcmVzcz5EZXBhcnRtZW50IG9mIENsaW5pY2FsIFBoeXNpb2xvZ3kgYW5k

IE51Y2xlYXIgTWVkaWNpbmUsIEdsb3N0cnVwIFVuaXZlcnNpdHkgSG9zcGl0YWwsIENvcGVuaGFn

ZW4sIERlbm1hcmsuIG1ob0BkYWRsbmV0LmRrPC9hdXRoLWFkZHJlc3M+PHRpdGxlcz48dGl0bGU+

TG9uZy10ZXJtIHRyZWF0bWVudCB3aXRoIGxvc2FydGFuIHZlcnN1cyBhdGVub2xvbCBpbXByb3Zl

cyBpbnN1bGluIHNlbnNpdGl2aXR5IGluIGh5cGVydGVuc2lvbjogSUNBUlVTLCBhIExJRkUgc3Vi

c3R1ZHk8L3RpdGxlPjxzZWNvbmRhcnktdGl0bGU+SiBIeXBlcnRlbnM8L3NlY29uZGFyeS10aXRs

ZT48L3RpdGxlcz48cGVyaW9kaWNhbD48ZnVsbC10aXRsZT5Kb3VybmFsIG9mIEh5cGVydGVuc2lv

bjwvZnVsbC10aXRsZT48YWJici0xPkogSHlwZXJ0ZW5zPC9hYmJyLTE+PC9wZXJpb2RpY2FsPjxw

YWdlcz44OTEtODwvcGFnZXM+PHZvbHVtZT4yMzwvdm9sdW1lPjxudW1iZXI+NDwvbnVtYmVyPjxr

ZXl3b3Jkcz48a2V5d29yZD5BZ2VkPC9rZXl3b3JkPjxrZXl3b3JkPkFudGloeXBlcnRlbnNpdmUg

QWdlbnRzLyphZG1pbmlzdHJhdGlvbiAmYW1wOyBkb3NhZ2U8L2tleXdvcmQ+PGtleXdvcmQ+QXRl

bm9sb2wvKmFkbWluaXN0cmF0aW9uICZhbXA7IGRvc2FnZTwva2V5d29yZD48a2V5d29yZD5CbG9v

ZCBHbHVjb3NlPC9rZXl3b3JkPjxrZXl3b3JkPkJsb29kIFByZXNzdXJlL2RydWcgZWZmZWN0czwv

a2V5d29yZD48a2V5d29yZD5EaWFiZXRlcyBNZWxsaXR1cywgVHlwZSAyL3ByZXZlbnRpb24gJmFt

cDsgY29udHJvbDwva2V5d29yZD48a2V5d29yZD5Gb3JlYXJtL2Jsb29kIHN1cHBseTwva2V5d29y

ZD48a2V5d29yZD5IdW1hbnM8L2tleXdvcmQ+PGtleXdvcmQ+SHlwZXJ0ZW5zaW9uLypkcnVnIHRo

ZXJhcHk8L2tleXdvcmQ+PGtleXdvcmQ+SW5zdWxpbi9ibG9vZDwva2V5d29yZD48a2V5d29yZD4q

SW5zdWxpbiBSZXNpc3RhbmNlPC9rZXl3b3JkPjxrZXl3b3JkPkxvc2FydGFuLyphZG1pbmlzdHJh

dGlvbiAmYW1wOyBkb3NhZ2U8L2tleXdvcmQ+PGtleXdvcmQ+TWlkZGxlIEFnZWQ8L2tleXdvcmQ+

PGtleXdvcmQ+UGVyaXBoZXJhbCBWYXNjdWxhciBEaXNlYXNlcy8qZHJ1ZyB0aGVyYXB5PC9rZXl3

b3JkPjxrZXl3b3JkPlZhc2N1bGFyIFJlc2lzdGFuY2UvZHJ1ZyBlZmZlY3RzPC9rZXl3b3JkPjwv

a2V5d29yZHM+PGRhdGVzPjx5ZWFyPjIwMDU8L3llYXI+PHB1Yi1kYXRlcz48ZGF0ZT5BcHI8L2Rh

dGU+PC9wdWItZGF0ZXM+PC9kYXRlcz48YWNjZXNzaW9uLW51bT4xNTc3NTc5NjwvYWNjZXNzaW9u

LW51bT48dXJscz48cmVsYXRlZC11cmxzPjx1cmw+aHR0cDovL3d3dy5uY2JpLm5sbS5uaWguZ292

L2VudHJlei9xdWVyeS5mY2dpP2NtZD1SZXRyaWV2ZSZhbXA7ZGI9UHViTWVkJmFtcDtkb3B0PUNp

dGF0aW9uJmFtcDtsaXN0X3VpZHM9MTU3NzU3OTY8L3VybD48L3JlbGF0ZWQtdXJscz48L3VybHM+

PC9yZWNvcmQ+PC9DaXRlPjwvRW5kTm90ZT4A

ADDIN EN.CITE.DATA 27 On the other hand, several other studies have shown no effect of hypertension treatment on capillary rarefaction. Penna et al evaluated functional and structural capillary density in treated and well-controlled patients with essential hypertension. ADDIN EN.CITE <EndNote><Cite><Author>Penna</Author><Year>2008</Year><RecNum>12151</RecNum><DisplayText><style face="superscript">12</style></DisplayText><record><rec-number>12151</rec-number><foreign-keys><key app="EN" db-id="ztzasxe5cs00v4efwrpvftrwtafzwe22xezt" timestamp="1382954401">12151</key></foreign-keys><ref-type name="Journal Article">17</ref-type><contributors><authors><author>Penna, G. L.</author><author>Garbero Rde, F.</author><author>Neves, M. F.</author><author>Oigman, W.</author><author>Bottino, D. A.</author><author>Bouskela, E.</author></authors></contributors><auth-address>Department of Clinical Medicine, Universidade do Estado do Rio de Janeiro, Rio de Janeiro, RJ, Brazil.</auth-address><titles><title>Treatment of essential hypertension does not normalize capillary rarefaction</title><secondary-title>Clinics (Sao Paulo)</secondary-title></titles><periodical><full-title>Clinics (Sao Paulo)</full-title></periodical><pages>613-8</pages><volume>63</volume><number>5</number><dates><year>2008</year><pub-dates><date>Oct</date></pub-dates></dates><accession-num>18925320</accession-num><urls><related-urls><url> They found that treated hypertensive patients had lower mean functional capillary density at baseline, during post-occlusive reactive hyperemia, and during venous congestion suggesting that treatment and control of BP, regardless of the type of therapy used, does not necessarily results in reversing capillary rarefaction. De Ciuceis and colleagues, in an open-label design, studied the effects of treatment of hypertension on structural alterations of retinal arterioles, skin capillary density, arterial distensibility, and oxidative stress with a CCB alone and the combination of a CCB with either an ACE inhibitor or a diuretic in patients with mild to moderate essential hypertension.PEVuZE5vdGU+PENpdGU+PEF1dGhvcj5EZSBDaXVjZWlzPC9BdXRob3I+PFllYXI+MjAxNDwvWWVh

cj48UmVjTnVtPjE1MzM4PC9SZWNOdW0+PERpc3BsYXlUZXh0PjxzdHlsZSBmYWNlPSJzdXBlcnNj

cmlwdCI+MTA8L3N0eWxlPjwvRGlzcGxheVRleHQ+PHJlY29yZD48cmVjLW51bWJlcj4xNTMzODwv

cmVjLW51bWJlcj48Zm9yZWlnbi1rZXlzPjxrZXkgYXBwPSJFTiIgZGItaWQ9Inp0emFzeGU1Y3Mw

MHY0ZWZ3cnB2ZnRyd3RhZnp3ZTIyeGV6dCIgdGltZXN0YW1wPSIxNDM5Mjg3MTU1Ij4xNTMzODwv

a2V5PjwvZm9yZWlnbi1rZXlzPjxyZWYtdHlwZSBuYW1lPSJKb3VybmFsIEFydGljbGUiPjE3PC9y

ZWYtdHlwZT48Y29udHJpYnV0b3JzPjxhdXRob3JzPjxhdXRob3I+RGUgQ2l1Y2VpcywgQy48L2F1

dGhvcj48YXV0aG9yPlNhbHZldHRpLCBNLjwvYXV0aG9yPjxhdXRob3I+Um9zc2luaSwgQy48L2F1

dGhvcj48YXV0aG9yPk11aWVzYW4sIE0uIEwuPC9hdXRob3I+PGF1dGhvcj5QYWluaSwgQS48L2F1

dGhvcj48YXV0aG9yPkR1c2UsIFMuPC9hdXRob3I+PGF1dGhvcj5MYSBCb3JpYSwgRS48L2F1dGhv

cj48YXV0aG9yPlNlbWVyYXJvLCBGLjwvYXV0aG9yPjxhdXRob3I+Q2FuY2FyaW5pLCBBLjwvYXV0

aG9yPjxhdXRob3I+Um9zZWksIEMuIEEuPC9hdXRob3I+PGF1dGhvcj5TYXJrYXIsIEEuPC9hdXRo

b3I+PGF1dGhvcj5SdWdnZXJpLCBHLjwvYXV0aG9yPjxhdXRob3I+Q2FpbWksIEwuPC9hdXRob3I+

PGF1dGhvcj5SaWNvdHRhLCBELjwvYXV0aG9yPjxhdXRob3I+Uml6em9uaSwgRC48L2F1dGhvcj48

YXV0aG9yPlJvc2VpLCBFLiBBLjwvYXV0aG9yPjwvYXV0aG9ycz48L2NvbnRyaWJ1dG9ycz48YXV0

aC1hZGRyZXNzPmFDbGluaWNhIE1lZGljYSwgRGVwYXJ0bWVudCBvZiBDbGluaWNhbCBhbmQgRXhw

ZXJpbWVudGFsIFNjaWVuY2VzIGJDaGFpciBvZiBPcGh0aGFsbW9sb2d5IGNDaGFpciBvZiBDbGlu

aWNhbCBCaW9jaGVtaXN0cnksIFVuaXZlcnNpdHkgb2YgQnJlc2NpYSwgSXRhbHkuPC9hdXRoLWFk

ZHJlc3M+PHRpdGxlcz48dGl0bGU+RWZmZWN0IG9mIGFudGloeXBlcnRlbnNpdmUgdHJlYXRtZW50

IG9uIG1pY3JvdmFzY3VsYXIgc3RydWN0dXJlLCBjZW50cmFsIGJsb29kIHByZXNzdXJlIGFuZCBv

eGlkYXRpdmUgc3RyZXNzIGluIHBhdGllbnRzIHdpdGggbWlsZCBlc3NlbnRpYWwgaHlwZXJ0ZW5z

aW9uPC90aXRsZT48c2Vjb25kYXJ5LXRpdGxlPkogSHlwZXJ0ZW5zPC9zZWNvbmRhcnktdGl0bGU+

PC90aXRsZXM+PHBlcmlvZGljYWw+PGZ1bGwtdGl0bGU+Sm91cm5hbCBvZiBIeXBlcnRlbnNpb248

L2Z1bGwtdGl0bGU+PGFiYnItMT5KIEh5cGVydGVuczwvYWJici0xPjwvcGVyaW9kaWNhbD48cGFn

ZXM+NTY1LTc0PC9wYWdlcz48dm9sdW1lPjMyPC92b2x1bWU+PG51bWJlcj4zPC9udW1iZXI+PGtl

eXdvcmRzPjxrZXl3b3JkPkFkdWx0PC9rZXl3b3JkPjxrZXl3b3JkPkFuZ2lvdGVuc2luLUNvbnZl

cnRpbmcgRW56eW1lIEluaGliaXRvcnMvYWRtaW5pc3RyYXRpb24gJmFtcDsgZG9zYWdlPC9rZXl3

b3JkPjxrZXl3b3JkPkFudGloeXBlcnRlbnNpdmUgQWdlbnRzLyphZG1pbmlzdHJhdGlvbiAmYW1w

OyBkb3NhZ2U8L2tleXdvcmQ+PGtleXdvcmQ+QXJ0ZXJpb2xlcy9kcnVnIGVmZmVjdHMvdWx0cmFz

b25vZ3JhcGh5PC9rZXl3b3JkPjxrZXl3b3JkPkJsb29kIFByZXNzdXJlL3BoeXNpb2xvZ3k8L2tl

eXdvcmQ+PGtleXdvcmQ+Q2FsY2l1bSBDaGFubmVsIEJsb2NrZXJzL2FkbWluaXN0cmF0aW9uICZh

bXA7IGRvc2FnZTwva2V5d29yZD48a2V5d29yZD5EaWh5ZHJvcHlyaWRpbmVzL2FkbWluaXN0cmF0

aW9uICZhbXA7IGRvc2FnZTwva2V5d29yZD48a2V5d29yZD5EaXVyZXRpY3MvYWRtaW5pc3RyYXRp

b24gJmFtcDsgZG9zYWdlPC9rZXl3b3JkPjxrZXl3b3JkPkRydWcgVGhlcmFweSwgQ29tYmluYXRp

b248L2tleXdvcmQ+PGtleXdvcmQ+RW5hbGFwcmlsL2FkbWluaXN0cmF0aW9uICZhbXA7IGRvc2Fn

ZTwva2V5d29yZD48a2V5d29yZD5GZW1hbGU8L2tleXdvcmQ+PGtleXdvcmQ+SHVtYW5zPC9rZXl3

b3JkPjxrZXl3b3JkPkh5ZHJvY2hsb3JvdGhpYXppZGUvYWRtaW5pc3RyYXRpb24gJmFtcDsgZG9z

YWdlPC9rZXl3b3JkPjxrZXl3b3JkPkh5cGVydGVuc2lvbi8qZHJ1ZyB0aGVyYXB5L3BoeXNpb3Bh

dGhvbG9neS91bHRyYXNvbm9ncmFwaHk8L2tleXdvcmQ+PGtleXdvcmQ+S2lkbmV5L2Jsb29kIHN1

cHBseS9kcnVnIGVmZmVjdHM8L2tleXdvcmQ+PGtleXdvcmQ+TGFzZXItRG9wcGxlciBGbG93bWV0

cnk8L2tleXdvcmQ+PGtleXdvcmQ+TWFsZTwva2V5d29yZD48a2V5d29yZD5NaWRkbGUgQWdlZDwv

a2V5d29yZD48a2V5d29yZD5PeGlkYXRpdmUgU3RyZXNzL2RydWcgZWZmZWN0czwva2V5d29yZD48

L2tleXdvcmRzPjxkYXRlcz48eWVhcj4yMDE0PC95ZWFyPjxwdWItZGF0ZXM+PGRhdGU+TWFyPC9k

YXRlPjwvcHViLWRhdGVzPjwvZGF0ZXM+PGlzYm4+MTQ3My01NTk4IChFbGVjdHJvbmljKSYjeEQ7

MDI2My02MzUyIChMaW5raW5nKTwvaXNibj48YWNjZXNzaW9uLW51bT4yNDM3ODk5OTwvYWNjZXNz

aW9uLW51bT48dXJscz48cmVsYXRlZC11cmxzPjx1cmw+aHR0cDovL3d3dy5uY2JpLm5sbS5uaWgu

Z292L3B1Ym1lZC8yNDM3ODk5OTwvdXJsPjx1cmw+aHR0cDovL292aWRzcC50eC5vdmlkLmNvbS9v

dmZ0cGRmcy9GUERETkNPQkZHR0RHTjAwL2ZzMDQ2L292ZnQvbGl2ZS9ndjAyMy8wMDAwNDg3Mi8w

MDAwNDg3Mi0yMDE0MDMwMDAtMDAwMTcucGRmPC91cmw+PC9yZWxhdGVkLXVybHM+PC91cmxzPjxl

bGVjdHJvbmljLXJlc291cmNlLW51bT4xMC4xMDk3L0hKSC4wMDAwMDAwMDAwMDAwMDY3PC9lbGVj

dHJvbmljLXJlc291cmNlLW51bT48L3JlY29yZD48L0NpdGU+PC9FbmROb3RlPn==

ADDIN EN.CITE PEVuZE5vdGU+PENpdGU+PEF1dGhvcj5EZSBDaXVjZWlzPC9BdXRob3I+PFllYXI+MjAxNDwvWWVh

cj48UmVjTnVtPjE1MzM4PC9SZWNOdW0+PERpc3BsYXlUZXh0PjxzdHlsZSBmYWNlPSJzdXBlcnNj

cmlwdCI+MTA8L3N0eWxlPjwvRGlzcGxheVRleHQ+PHJlY29yZD48cmVjLW51bWJlcj4xNTMzODwv

cmVjLW51bWJlcj48Zm9yZWlnbi1rZXlzPjxrZXkgYXBwPSJFTiIgZGItaWQ9Inp0emFzeGU1Y3Mw

MHY0ZWZ3cnB2ZnRyd3RhZnp3ZTIyeGV6dCIgdGltZXN0YW1wPSIxNDM5Mjg3MTU1Ij4xNTMzODwv

a2V5PjwvZm9yZWlnbi1rZXlzPjxyZWYtdHlwZSBuYW1lPSJKb3VybmFsIEFydGljbGUiPjE3PC9y

ZWYtdHlwZT48Y29udHJpYnV0b3JzPjxhdXRob3JzPjxhdXRob3I+RGUgQ2l1Y2VpcywgQy48L2F1

dGhvcj48YXV0aG9yPlNhbHZldHRpLCBNLjwvYXV0aG9yPjxhdXRob3I+Um9zc2luaSwgQy48L2F1

dGhvcj48YXV0aG9yPk11aWVzYW4sIE0uIEwuPC9hdXRob3I+PGF1dGhvcj5QYWluaSwgQS48L2F1

dGhvcj48YXV0aG9yPkR1c2UsIFMuPC9hdXRob3I+PGF1dGhvcj5MYSBCb3JpYSwgRS48L2F1dGhv

cj48YXV0aG9yPlNlbWVyYXJvLCBGLjwvYXV0aG9yPjxhdXRob3I+Q2FuY2FyaW5pLCBBLjwvYXV0

aG9yPjxhdXRob3I+Um9zZWksIEMuIEEuPC9hdXRob3I+PGF1dGhvcj5TYXJrYXIsIEEuPC9hdXRo

b3I+PGF1dGhvcj5SdWdnZXJpLCBHLjwvYXV0aG9yPjxhdXRob3I+Q2FpbWksIEwuPC9hdXRob3I+

PGF1dGhvcj5SaWNvdHRhLCBELjwvYXV0aG9yPjxhdXRob3I+Uml6em9uaSwgRC48L2F1dGhvcj48

YXV0aG9yPlJvc2VpLCBFLiBBLjwvYXV0aG9yPjwvYXV0aG9ycz48L2NvbnRyaWJ1dG9ycz48YXV0

aC1hZGRyZXNzPmFDbGluaWNhIE1lZGljYSwgRGVwYXJ0bWVudCBvZiBDbGluaWNhbCBhbmQgRXhw

ZXJpbWVudGFsIFNjaWVuY2VzIGJDaGFpciBvZiBPcGh0aGFsbW9sb2d5IGNDaGFpciBvZiBDbGlu

aWNhbCBCaW9jaGVtaXN0cnksIFVuaXZlcnNpdHkgb2YgQnJlc2NpYSwgSXRhbHkuPC9hdXRoLWFk

ZHJlc3M+PHRpdGxlcz48dGl0bGU+RWZmZWN0IG9mIGFudGloeXBlcnRlbnNpdmUgdHJlYXRtZW50

IG9uIG1pY3JvdmFzY3VsYXIgc3RydWN0dXJlLCBjZW50cmFsIGJsb29kIHByZXNzdXJlIGFuZCBv

eGlkYXRpdmUgc3RyZXNzIGluIHBhdGllbnRzIHdpdGggbWlsZCBlc3NlbnRpYWwgaHlwZXJ0ZW5z

aW9uPC90aXRsZT48c2Vjb25kYXJ5LXRpdGxlPkogSHlwZXJ0ZW5zPC9zZWNvbmRhcnktdGl0bGU+

PC90aXRsZXM+PHBlcmlvZGljYWw+PGZ1bGwtdGl0bGU+Sm91cm5hbCBvZiBIeXBlcnRlbnNpb248

L2Z1bGwtdGl0bGU+PGFiYnItMT5KIEh5cGVydGVuczwvYWJici0xPjwvcGVyaW9kaWNhbD48cGFn

ZXM+NTY1LTc0PC9wYWdlcz48dm9sdW1lPjMyPC92b2x1bWU+PG51bWJlcj4zPC9udW1iZXI+PGtl

eXdvcmRzPjxrZXl3b3JkPkFkdWx0PC9rZXl3b3JkPjxrZXl3b3JkPkFuZ2lvdGVuc2luLUNvbnZl

cnRpbmcgRW56eW1lIEluaGliaXRvcnMvYWRtaW5pc3RyYXRpb24gJmFtcDsgZG9zYWdlPC9rZXl3

b3JkPjxrZXl3b3JkPkFudGloeXBlcnRlbnNpdmUgQWdlbnRzLyphZG1pbmlzdHJhdGlvbiAmYW1w

OyBkb3NhZ2U8L2tleXdvcmQ+PGtleXdvcmQ+QXJ0ZXJpb2xlcy9kcnVnIGVmZmVjdHMvdWx0cmFz

b25vZ3JhcGh5PC9rZXl3b3JkPjxrZXl3b3JkPkJsb29kIFByZXNzdXJlL3BoeXNpb2xvZ3k8L2tl

eXdvcmQ+PGtleXdvcmQ+Q2FsY2l1bSBDaGFubmVsIEJsb2NrZXJzL2FkbWluaXN0cmF0aW9uICZh

bXA7IGRvc2FnZTwva2V5d29yZD48a2V5d29yZD5EaWh5ZHJvcHlyaWRpbmVzL2FkbWluaXN0cmF0

aW9uICZhbXA7IGRvc2FnZTwva2V5d29yZD48a2V5d29yZD5EaXVyZXRpY3MvYWRtaW5pc3RyYXRp

b24gJmFtcDsgZG9zYWdlPC9rZXl3b3JkPjxrZXl3b3JkPkRydWcgVGhlcmFweSwgQ29tYmluYXRp

b248L2tleXdvcmQ+PGtleXdvcmQ+RW5hbGFwcmlsL2FkbWluaXN0cmF0aW9uICZhbXA7IGRvc2Fn

ZTwva2V5d29yZD48a2V5d29yZD5GZW1hbGU8L2tleXdvcmQ+PGtleXdvcmQ+SHVtYW5zPC9rZXl3

b3JkPjxrZXl3b3JkPkh5ZHJvY2hsb3JvdGhpYXppZGUvYWRtaW5pc3RyYXRpb24gJmFtcDsgZG9z

YWdlPC9rZXl3b3JkPjxrZXl3b3JkPkh5cGVydGVuc2lvbi8qZHJ1ZyB0aGVyYXB5L3BoeXNpb3Bh

dGhvbG9neS91bHRyYXNvbm9ncmFwaHk8L2tleXdvcmQ+PGtleXdvcmQ+S2lkbmV5L2Jsb29kIHN1

cHBseS9kcnVnIGVmZmVjdHM8L2tleXdvcmQ+PGtleXdvcmQ+TGFzZXItRG9wcGxlciBGbG93bWV0

cnk8L2tleXdvcmQ+PGtleXdvcmQ+TWFsZTwva2V5d29yZD48a2V5d29yZD5NaWRkbGUgQWdlZDwv

a2V5d29yZD48a2V5d29yZD5PeGlkYXRpdmUgU3RyZXNzL2RydWcgZWZmZWN0czwva2V5d29yZD48

L2tleXdvcmRzPjxkYXRlcz48eWVhcj4yMDE0PC95ZWFyPjxwdWItZGF0ZXM+PGRhdGU+TWFyPC9k

YXRlPjwvcHViLWRhdGVzPjwvZGF0ZXM+PGlzYm4+MTQ3My01NTk4IChFbGVjdHJvbmljKSYjeEQ7

MDI2My02MzUyIChMaW5raW5nKTwvaXNibj48YWNjZXNzaW9uLW51bT4yNDM3ODk5OTwvYWNjZXNz

aW9uLW51bT48dXJscz48cmVsYXRlZC11cmxzPjx1cmw+aHR0cDovL3d3dy5uY2JpLm5sbS5uaWgu

Z292L3B1Ym1lZC8yNDM3ODk5OTwvdXJsPjx1cmw+aHR0cDovL292aWRzcC50eC5vdmlkLmNvbS9v

dmZ0cGRmcy9GUERETkNPQkZHR0RHTjAwL2ZzMDQ2L292ZnQvbGl2ZS9ndjAyMy8wMDAwNDg3Mi8w

MDAwNDg3Mi0yMDE0MDMwMDAtMDAwMTcucGRmPC91cmw+PC9yZWxhdGVkLXVybHM+PC91cmxzPjxl

bGVjdHJvbmljLXJlc291cmNlLW51bT4xMC4xMDk3L0hKSC4wMDAwMDAwMDAwMDAwMDY3PC9lbGVj

dHJvbmljLXJlc291cmNlLW51bT48L3JlY29yZD48L0NpdGU+PC9FbmROb3RlPn==

ADDIN EN.CITE.DATA 10 All their patients were treated with lercanidipine for 4 weeks and then either enalapril (n=10) or hydrochlorothiazide (n=10) was added for 6 months. They found no change in basal capillary density at any point in the study. After 4 weeks of treatment with lercanidipine alone, maximal capillary density was slightly but not significantly increased. After 6 months of treatment with the combination of lercanidipine and enalapril, the increase in maximal capillary density was statistically significant. The change in maximal capillary density with the combination of lercanidipine and hydrochlorothiazide was not statistically significant. Similar to our study, the authors found no change in PWV between groups or between any time points despite the fact that central SBP was significantly reduced. More recently, the same group, in another randomized open-label design, studied the effects of one-year treatment of hypertension with either ramipril or aliskiren and found no significant effects on capillary rarefaction.PEVuZE5vdGU+PENpdGU+PEF1dGhvcj5EZSBDaXVjZWlzPC9BdXRob3I+PFllYXI+MjAxNDwvWWVh

cj48UmVjTnVtPjE2MzAxPC9SZWNOdW0+PERpc3BsYXlUZXh0PjxzdHlsZSBmYWNlPSJzdXBlcnNj

cmlwdCI+Mjg8L3N0eWxlPjwvRGlzcGxheVRleHQ+PHJlY29yZD48cmVjLW51bWJlcj4xNjMwMTwv

cmVjLW51bWJlcj48Zm9yZWlnbi1rZXlzPjxrZXkgYXBwPSJFTiIgZGItaWQ9Inp0emFzeGU1Y3Mw

MHY0ZWZ3cnB2ZnRyd3RhZnp3ZTIyeGV6dCIgdGltZXN0YW1wPSIxNDcyMDQzODA1Ij4xNjMwMTwv

a2V5PjwvZm9yZWlnbi1rZXlzPjxyZWYtdHlwZSBuYW1lPSJKb3VybmFsIEFydGljbGUiPjE3PC9y

ZWYtdHlwZT48Y29udHJpYnV0b3JzPjxhdXRob3JzPjxhdXRob3I+RGUgQ2l1Y2VpcywgQy48L2F1

dGhvcj48YXV0aG9yPlNhdm9pYSwgQy48L2F1dGhvcj48YXV0aG9yPkFycmFiaXRvLCBFLjwvYXV0

aG9yPjxhdXRob3I+UG9ydGVyaSwgRS48L2F1dGhvcj48YXV0aG9yPk1henphLCBNLjwvYXV0aG9y

PjxhdXRob3I+Um9zc2luaSwgQy48L2F1dGhvcj48YXV0aG9yPkR1c2UsIFMuPC9hdXRob3I+PGF1

dGhvcj5TZW1lcmFybywgRi48L2F1dGhvcj48YXV0aG9yPkFnYWJpdGkgUm9zZWksIEMuPC9hdXRo

b3I+PGF1dGhvcj5BbG9uem8sIEEuPC9hdXRob3I+PGF1dGhvcj5TYWRhLCBMLjwvYXV0aG9yPjxh

dXRob3I+TGEgQm9yaWEsIEUuPC9hdXRob3I+PGF1dGhvcj5TYXJrYXIsIEEuPC9hdXRob3I+PGF1

dGhvcj5QZXRyb2JvbmksIEIuPC9hdXRob3I+PGF1dGhvcj5NZXJjYW50aW5pLCBQLjwvYXV0aG9y

PjxhdXRob3I+Vm9scGUsIE0uPC9hdXRob3I+PGF1dGhvcj5SaXp6b25pLCBELjwvYXV0aG9yPjxh

dXRob3I+QWdhYml0aSBSb3NlaSwgRS48L2F1dGhvcj48L2F1dGhvcnM+PC9jb250cmlidXRvcnM+

PGF1dGgtYWRkcmVzcz5Gcm9tIHRoZSBDbGluaWNhIE1lZGljYSwgRGVwYXJ0bWVudCBvZiBDbGlu

aWNhbCBhbmQgRXhwZXJpbWVudGFsIFNjaWVuY2VzIChDLkQuQy4sIEUuUC4sIE0uTS4sIEMuUi4s

IEMuQS5SLiwgRS5MLkIuLCBBLlMuLCBCLlAuLCBELlIuLCBFLkEuUi4pIGFuZCBEaXZpc2lvbiBv

ZiBPcGh0aGFsbW9sb2d5IChTLkQuLCBGLlMuKSwgVW5pdmVyc2l0eSBvZiBCcmVzY2lhLCBCcmVz

Y2lhLCBJdGFseTsgYW5kIERpdmlzaW9uIG9mIENhcmRpb2xvZ3ksIERlcGFydG1lbnQgb2YgQ2xp

bmljYWwgYW5kIE1vbGVjdWxhciBNZWRpY2luZSAoQy5TLiwgRS5BLiwgQS5BLiwgTC5TLiwgTS5W

LikgYW5kIFN1cmdpY2FsIERlcGFydG1lbnQgb2YgQ2xpbmljYWwgU2NpZW5jZXMgKFAuTS4pLCBC

aW9tZWRpY2FsIFRlY2hub2xvZ2llcyBhbmQgVHJhbnNsYXRpb25hbCBNZWRpY2luZSwgU2FudCZh

cG9zO0FuZHJlYSBIb3NwaXRhbCwgU2FwaWVuemEgVW5pdmVyc2l0eSBvZiBSb21lLCBSb21lLCBJ

dGFseS4mI3hEO0Zyb20gdGhlIENsaW5pY2EgTWVkaWNhLCBEZXBhcnRtZW50IG9mIENsaW5pY2Fs

IGFuZCBFeHBlcmltZW50YWwgU2NpZW5jZXMgKEMuRC5DLiwgRS5QLiwgTS5NLiwgQy5SLiwgQy5B

LlIuLCBFLkwuQi4sIEEuUy4sIEIuUC4sIEQuUi4sIEUuQS5SLikgYW5kIERpdmlzaW9uIG9mIE9w

aHRoYWxtb2xvZ3kgKFMuRC4sIEYuUy4pLCBVbml2ZXJzaXR5IG9mIEJyZXNjaWEsIEJyZXNjaWEs

IEl0YWx5OyBhbmQgRGl2aXNpb24gb2YgQ2FyZGlvbG9neSwgRGVwYXJ0bWVudCBvZiBDbGluaWNh

bCBhbmQgTW9sZWN1bGFyIE1lZGljaW5lIChDLlMuLCBFLkEuLCBBLkEuLCBMLlMuLCBNLlYuKSBh

bmQgU3VyZ2ljYWwgRGVwYXJ0bWVudCBvZiBDbGluaWNhbCBTY2llbmNlcyAoUC5NLiksIEJpb21l

ZGljYWwgVGVjaG5vbG9naWVzIGFuZCBUcmFuc2xhdGlvbmFsIE1lZGljaW5lLCBTYW50JmFwb3M7

QW5kcmVhIEhvc3BpdGFsLCBTYXBpZW56YSBVbml2ZXJzaXR5IG9mIFJvbWUsIFJvbWUsIEl0YWx5

LiBkYW1pYW5vLnJpenpvbmlAdW5pYnMuaXQuPC9hdXRoLWFkZHJlc3M+PHRpdGxlcz48dGl0bGU+

RWZmZWN0cyBvZiBhIGxvbmctdGVybSB0cmVhdG1lbnQgd2l0aCBhbGlza2lyZW4gb3IgcmFtaXBy

aWwgb24gc3RydWN0dXJhbCBhbHRlcmF0aW9ucyBvZiBzdWJjdXRhbmVvdXMgc21hbGwtcmVzaXN0

YW5jZSBhcnRlcmllcyBvZiBkaWFiZXRpYyBoeXBlcnRlbnNpdmUgcGF0aWVudHM8L3RpdGxlPjxz

ZWNvbmRhcnktdGl0bGU+SHlwZXJ0ZW5zaW9uPC9zZWNvbmRhcnktdGl0bGU+PC90aXRsZXM+PHBl

cmlvZGljYWw+PGZ1bGwtdGl0bGU+SHlwZXJ0ZW5zaW9uPC9mdWxsLXRpdGxlPjwvcGVyaW9kaWNh

bD48cGFnZXM+NzE3LTI0PC9wYWdlcz48dm9sdW1lPjY0PC92b2x1bWU+PG51bWJlcj40PC9udW1i

ZXI+PGtleXdvcmRzPjxrZXl3b3JkPkFnZWQ8L2tleXdvcmQ+PGtleXdvcmQ+QW1pZGVzLyp0aGVy

YXBldXRpYyB1c2U8L2tleXdvcmQ+PGtleXdvcmQ+QW5naW90ZW5zaW4tQ29udmVydGluZyBFbnp5

bWUgSW5oaWJpdG9ycy90aGVyYXBldXRpYyB1c2U8L2tleXdvcmQ+PGtleXdvcmQ+QW50aWh5cGVy

dGVuc2l2ZSBBZ2VudHMvdGhlcmFwZXV0aWMgdXNlPC9rZXl3b3JkPjxrZXl3b3JkPkFydGVyaWVz

LypkcnVnIGVmZmVjdHMvcGF0aG9sb2d5L3BoeXNpb3BhdGhvbG9neTwva2V5d29yZD48a2V5d29y

ZD5CbG9vZCBQcmVzc3VyZS9kcnVnIGVmZmVjdHM8L2tleXdvcmQ+PGtleXdvcmQ+RGlhYmV0ZXMg

TWVsbGl0dXMsIFR5cGUgMi9jb21wbGljYXRpb25zLypkcnVnIHRoZXJhcHkvcGh5c2lvcGF0aG9s

b2d5PC9rZXl3b3JkPjxrZXl3b3JkPkZlbWFsZTwva2V5d29yZD48a2V5d29yZD5GdW1hcmF0ZXMv

KnRoZXJhcGV1dGljIHVzZTwva2V5d29yZD48a2V5d29yZD5IdW1hbnM8L2tleXdvcmQ+PGtleXdv

cmQ+SHlwZXJ0ZW5zaW9uL2NvbXBsaWNhdGlvbnMvKmRydWcgdGhlcmFweS9waHlzaW9wYXRob2xv

Z3k8L2tleXdvcmQ+PGtleXdvcmQ+TWFsZTwva2V5d29yZD48a2V5d29yZD5NaWRkbGUgQWdlZDwv

a2V5d29yZD48a2V5d29yZD5Qcm9zcGVjdGl2ZSBTdHVkaWVzPC9rZXl3b3JkPjxrZXl3b3JkPlJh

bWlwcmlsLyp0aGVyYXBldXRpYyB1c2U8L2tleXdvcmQ+PGtleXdvcmQ+U2tpbi9ibG9vZCBzdXBw

bHk8L2tleXdvcmQ+PGtleXdvcmQ+VGltZSBGYWN0b3JzPC9rZXl3b3JkPjxrZXl3b3JkPlRyZWF0

bWVudCBPdXRjb21lPC9rZXl3b3JkPjxrZXl3b3JkPlZhc2N1bGFyIFJlc2lzdGFuY2U8L2tleXdv

cmQ+PGtleXdvcmQ+YWxpc2tpcmVuPC9rZXl3b3JkPjxrZXl3b3JkPmFudGloeXBlcnRlbnNpdmUg

YWdlbnRzPC9rZXl3b3JkPjxrZXl3b3JkPmNhcGlsbGFyaWVzPC9rZXl3b3JkPjxrZXl3b3JkPm1p

Y3JvdmVzc2Vsczwva2V5d29yZD48a2V5d29yZD5ub24taW5zdWxpbi1kZXBlbmRlbnQgZGlhYmV0

ZXMgbWVsbGl0dXM8L2tleXdvcmQ+PGtleXdvcmQ+cmFtaXByaWw8L2tleXdvcmQ+PC9rZXl3b3Jk

cz48ZGF0ZXM+PHllYXI+MjAxNDwveWVhcj48cHViLWRhdGVzPjxkYXRlPk9jdDwvZGF0ZT48L3B1

Yi1kYXRlcz48L2RhdGVzPjxpc2JuPjE1MjQtNDU2MyAoRWxlY3Ryb25pYykmI3hEOzAxOTQtOTEx

WCAoTGlua2luZyk8L2lzYm4+PGFjY2Vzc2lvbi1udW0+MjQ5ODA2NzI8L2FjY2Vzc2lvbi1udW0+

PHVybHM+PHJlbGF0ZWQtdXJscz48dXJsPmh0dHA6Ly93d3cubmNiaS5ubG0ubmloLmdvdi9wdWJt

ZWQvMjQ5ODA2NzI8L3VybD48dXJsPmh0dHA6Ly9oeXBlci5haGFqb3VybmFscy5vcmcvY29udGVu

dC82NC80LzcxNy5mdWxsLnBkZjwvdXJsPjwvcmVsYXRlZC11cmxzPjwvdXJscz48ZWxlY3Ryb25p

Yy1yZXNvdXJjZS1udW0+MTAuMTE2MS9IWVBFUlRFTlNJT05BSEEuMTE0LjAzMzgwPC9lbGVjdHJv

bmljLXJlc291cmNlLW51bT48L3JlY29yZD48L0NpdGU+PC9FbmROb3RlPn==

ADDIN EN.CITE PEVuZE5vdGU+PENpdGU+PEF1dGhvcj5EZSBDaXVjZWlzPC9BdXRob3I+PFllYXI+MjAxNDwvWWVh

cj48UmVjTnVtPjE2MzAxPC9SZWNOdW0+PERpc3BsYXlUZXh0PjxzdHlsZSBmYWNlPSJzdXBlcnNj

cmlwdCI+Mjg8L3N0eWxlPjwvRGlzcGxheVRleHQ+PHJlY29yZD48cmVjLW51bWJlcj4xNjMwMTwv

cmVjLW51bWJlcj48Zm9yZWlnbi1rZXlzPjxrZXkgYXBwPSJFTiIgZGItaWQ9Inp0emFzeGU1Y3Mw

MHY0ZWZ3cnB2ZnRyd3RhZnp3ZTIyeGV6dCIgdGltZXN0YW1wPSIxNDcyMDQzODA1Ij4xNjMwMTwv

a2V5PjwvZm9yZWlnbi1rZXlzPjxyZWYtdHlwZSBuYW1lPSJKb3VybmFsIEFydGljbGUiPjE3PC9y

ZWYtdHlwZT48Y29udHJpYnV0b3JzPjxhdXRob3JzPjxhdXRob3I+RGUgQ2l1Y2VpcywgQy48L2F1

dGhvcj48YXV0aG9yPlNhdm9pYSwgQy48L2F1dGhvcj48YXV0aG9yPkFycmFiaXRvLCBFLjwvYXV0

aG9yPjxhdXRob3I+UG9ydGVyaSwgRS48L2F1dGhvcj48YXV0aG9yPk1henphLCBNLjwvYXV0aG9y

PjxhdXRob3I+Um9zc2luaSwgQy48L2F1dGhvcj48YXV0aG9yPkR1c2UsIFMuPC9hdXRob3I+PGF1

dGhvcj5TZW1lcmFybywgRi48L2F1dGhvcj48YXV0aG9yPkFnYWJpdGkgUm9zZWksIEMuPC9hdXRo

b3I+PGF1dGhvcj5BbG9uem8sIEEuPC9hdXRob3I+PGF1dGhvcj5TYWRhLCBMLjwvYXV0aG9yPjxh

dXRob3I+TGEgQm9yaWEsIEUuPC9hdXRob3I+PGF1dGhvcj5TYXJrYXIsIEEuPC9hdXRob3I+PGF1

dGhvcj5QZXRyb2JvbmksIEIuPC9hdXRob3I+PGF1dGhvcj5NZXJjYW50aW5pLCBQLjwvYXV0aG9y

PjxhdXRob3I+Vm9scGUsIE0uPC9hdXRob3I+PGF1dGhvcj5SaXp6b25pLCBELjwvYXV0aG9yPjxh

dXRob3I+QWdhYml0aSBSb3NlaSwgRS48L2F1dGhvcj48L2F1dGhvcnM+PC9jb250cmlidXRvcnM+

PGF1dGgtYWRkcmVzcz5Gcm9tIHRoZSBDbGluaWNhIE1lZGljYSwgRGVwYXJ0bWVudCBvZiBDbGlu

aWNhbCBhbmQgRXhwZXJpbWVudGFsIFNjaWVuY2VzIChDLkQuQy4sIEUuUC4sIE0uTS4sIEMuUi4s

IEMuQS5SLiwgRS5MLkIuLCBBLlMuLCBCLlAuLCBELlIuLCBFLkEuUi4pIGFuZCBEaXZpc2lvbiBv

ZiBPcGh0aGFsbW9sb2d5IChTLkQuLCBGLlMuKSwgVW5pdmVyc2l0eSBvZiBCcmVzY2lhLCBCcmVz

Y2lhLCBJdGFseTsgYW5kIERpdmlzaW9uIG9mIENhcmRpb2xvZ3ksIERlcGFydG1lbnQgb2YgQ2xp

bmljYWwgYW5kIE1vbGVjdWxhciBNZWRpY2luZSAoQy5TLiwgRS5BLiwgQS5BLiwgTC5TLiwgTS5W

LikgYW5kIFN1cmdpY2FsIERlcGFydG1lbnQgb2YgQ2xpbmljYWwgU2NpZW5jZXMgKFAuTS4pLCBC

aW9tZWRpY2FsIFRlY2hub2xvZ2llcyBhbmQgVHJhbnNsYXRpb25hbCBNZWRpY2luZSwgU2FudCZh

cG9zO0FuZHJlYSBIb3NwaXRhbCwgU2FwaWVuemEgVW5pdmVyc2l0eSBvZiBSb21lLCBSb21lLCBJ

dGFseS4mI3hEO0Zyb20gdGhlIENsaW5pY2EgTWVkaWNhLCBEZXBhcnRtZW50IG9mIENsaW5pY2Fs

IGFuZCBFeHBlcmltZW50YWwgU2NpZW5jZXMgKEMuRC5DLiwgRS5QLiwgTS5NLiwgQy5SLiwgQy5B

LlIuLCBFLkwuQi4sIEEuUy4sIEIuUC4sIEQuUi4sIEUuQS5SLikgYW5kIERpdmlzaW9uIG9mIE9w

aHRoYWxtb2xvZ3kgKFMuRC4sIEYuUy4pLCBVbml2ZXJzaXR5IG9mIEJyZXNjaWEsIEJyZXNjaWEs

IEl0YWx5OyBhbmQgRGl2aXNpb24gb2YgQ2FyZGlvbG9neSwgRGVwYXJ0bWVudCBvZiBDbGluaWNh

bCBhbmQgTW9sZWN1bGFyIE1lZGljaW5lIChDLlMuLCBFLkEuLCBBLkEuLCBMLlMuLCBNLlYuKSBh

bmQgU3VyZ2ljYWwgRGVwYXJ0bWVudCBvZiBDbGluaWNhbCBTY2llbmNlcyAoUC5NLiksIEJpb21l

ZGljYWwgVGVjaG5vbG9naWVzIGFuZCBUcmFuc2xhdGlvbmFsIE1lZGljaW5lLCBTYW50JmFwb3M7

QW5kcmVhIEhvc3BpdGFsLCBTYXBpZW56YSBVbml2ZXJzaXR5IG9mIFJvbWUsIFJvbWUsIEl0YWx5

LiBkYW1pYW5vLnJpenpvbmlAdW5pYnMuaXQuPC9hdXRoLWFkZHJlc3M+PHRpdGxlcz48dGl0bGU+

RWZmZWN0cyBvZiBhIGxvbmctdGVybSB0cmVhdG1lbnQgd2l0aCBhbGlza2lyZW4gb3IgcmFtaXBy

aWwgb24gc3RydWN0dXJhbCBhbHRlcmF0aW9ucyBvZiBzdWJjdXRhbmVvdXMgc21hbGwtcmVzaXN0

YW5jZSBhcnRlcmllcyBvZiBkaWFiZXRpYyBoeXBlcnRlbnNpdmUgcGF0aWVudHM8L3RpdGxlPjxz

ZWNvbmRhcnktdGl0bGU+SHlwZXJ0ZW5zaW9uPC9zZWNvbmRhcnktdGl0bGU+PC90aXRsZXM+PHBl

cmlvZGljYWw+PGZ1bGwtdGl0bGU+SHlwZXJ0ZW5zaW9uPC9mdWxsLXRpdGxlPjwvcGVyaW9kaWNh

bD48cGFnZXM+NzE3LTI0PC9wYWdlcz48dm9sdW1lPjY0PC92b2x1bWU+PG51bWJlcj40PC9udW1i

ZXI+PGtleXdvcmRzPjxrZXl3b3JkPkFnZWQ8L2tleXdvcmQ+PGtleXdvcmQ+QW1pZGVzLyp0aGVy

YXBldXRpYyB1c2U8L2tleXdvcmQ+PGtleXdvcmQ+QW5naW90ZW5zaW4tQ29udmVydGluZyBFbnp5

bWUgSW5oaWJpdG9ycy90aGVyYXBldXRpYyB1c2U8L2tleXdvcmQ+PGtleXdvcmQ+QW50aWh5cGVy

dGVuc2l2ZSBBZ2VudHMvdGhlcmFwZXV0aWMgdXNlPC9rZXl3b3JkPjxrZXl3b3JkPkFydGVyaWVz

LypkcnVnIGVmZmVjdHMvcGF0aG9sb2d5L3BoeXNpb3BhdGhvbG9neTwva2V5d29yZD48a2V5d29y

ZD5CbG9vZCBQcmVzc3VyZS9kcnVnIGVmZmVjdHM8L2tleXdvcmQ+PGtleXdvcmQ+RGlhYmV0ZXMg

TWVsbGl0dXMsIFR5cGUgMi9jb21wbGljYXRpb25zLypkcnVnIHRoZXJhcHkvcGh5c2lvcGF0aG9s

b2d5PC9rZXl3b3JkPjxrZXl3b3JkPkZlbWFsZTwva2V5d29yZD48a2V5d29yZD5GdW1hcmF0ZXMv

KnRoZXJhcGV1dGljIHVzZTwva2V5d29yZD48a2V5d29yZD5IdW1hbnM8L2tleXdvcmQ+PGtleXdv

cmQ+SHlwZXJ0ZW5zaW9uL2NvbXBsaWNhdGlvbnMvKmRydWcgdGhlcmFweS9waHlzaW9wYXRob2xv

Z3k8L2tleXdvcmQ+PGtleXdvcmQ+TWFsZTwva2V5d29yZD48a2V5d29yZD5NaWRkbGUgQWdlZDwv

a2V5d29yZD48a2V5d29yZD5Qcm9zcGVjdGl2ZSBTdHVkaWVzPC9rZXl3b3JkPjxrZXl3b3JkPlJh

bWlwcmlsLyp0aGVyYXBldXRpYyB1c2U8L2tleXdvcmQ+PGtleXdvcmQ+U2tpbi9ibG9vZCBzdXBw

bHk8L2tleXdvcmQ+PGtleXdvcmQ+VGltZSBGYWN0b3JzPC9rZXl3b3JkPjxrZXl3b3JkPlRyZWF0

bWVudCBPdXRjb21lPC9rZXl3b3JkPjxrZXl3b3JkPlZhc2N1bGFyIFJlc2lzdGFuY2U8L2tleXdv

cmQ+PGtleXdvcmQ+YWxpc2tpcmVuPC9rZXl3b3JkPjxrZXl3b3JkPmFudGloeXBlcnRlbnNpdmUg

YWdlbnRzPC9rZXl3b3JkPjxrZXl3b3JkPmNhcGlsbGFyaWVzPC9rZXl3b3JkPjxrZXl3b3JkPm1p

Y3JvdmVzc2Vsczwva2V5d29yZD48a2V5d29yZD5ub24taW5zdWxpbi1kZXBlbmRlbnQgZGlhYmV0

ZXMgbWVsbGl0dXM8L2tleXdvcmQ+PGtleXdvcmQ+cmFtaXByaWw8L2tleXdvcmQ+PC9rZXl3b3Jk

cz48ZGF0ZXM+PHllYXI+MjAxNDwveWVhcj48cHViLWRhdGVzPjxkYXRlPk9jdDwvZGF0ZT48L3B1

Yi1kYXRlcz48L2RhdGVzPjxpc2JuPjE1MjQtNDU2MyAoRWxlY3Ryb25pYykmI3hEOzAxOTQtOTEx

WCAoTGlua2luZyk8L2lzYm4+PGFjY2Vzc2lvbi1udW0+MjQ5ODA2NzI8L2FjY2Vzc2lvbi1udW0+

PHVybHM+PHJlbGF0ZWQtdXJscz48dXJsPmh0dHA6Ly93d3cubmNiaS5ubG0ubmloLmdvdi9wdWJt

ZWQvMjQ5ODA2NzI8L3VybD48dXJsPmh0dHA6Ly9oeXBlci5haGFqb3VybmFscy5vcmcvY29udGVu

dC82NC80LzcxNy5mdWxsLnBkZjwvdXJsPjwvcmVsYXRlZC11cmxzPjwvdXJscz48ZWxlY3Ryb25p

Yy1yZXNvdXJjZS1udW0+MTAuMTE2MS9IWVBFUlRFTlNJT05BSEEuMTE0LjAzMzgwPC9lbGVjdHJv

bmljLXJlc291cmNlLW51bT48L3JlY29yZD48L0NpdGU+PC9FbmROb3RlPn==

ADDIN EN.CITE.DATA 28 The results from our present study and the aforementioned studies suggest that the reduction and normalization of BP values may not be sufficient for obtaining a regression of microvascular rarefaction in essential hypertension even after one year.PEVuZE5vdGU+PENpdGU+PEF1dGhvcj5TY2hpZmZyaW48L0F1dGhvcj48WWVhcj4xOTk2PC9ZZWFy

PjxSZWNOdW0+MTUzNTQ8L1JlY051bT48RGlzcGxheVRleHQ+PHN0eWxlIGZhY2U9InN1cGVyc2Ny

aXB0Ij4yOTwvc3R5bGU+PC9EaXNwbGF5VGV4dD48cmVjb3JkPjxyZWMtbnVtYmVyPjE1MzU0PC9y

ZWMtbnVtYmVyPjxmb3JlaWduLWtleXM+PGtleSBhcHA9IkVOIiBkYi1pZD0ienR6YXN4ZTVjczAw

djRlZndycHZmdHJ3dGFmendlMjJ4ZXp0IiB0aW1lc3RhbXA9IjE0NDA1MDkwNDMiPjE1MzU0PC9r

ZXk+PC9mb3JlaWduLWtleXM+PHJlZi10eXBlIG5hbWU9IkpvdXJuYWwgQXJ0aWNsZSI+MTc8L3Jl

Zi10eXBlPjxjb250cmlidXRvcnM+PGF1dGhvcnM+PGF1dGhvcj5TY2hpZmZyaW4sIEUuIEwuPC9h

dXRob3I+PGF1dGhvcj5EZW5nLCBMLiBZLjwvYXV0aG9yPjwvYXV0aG9ycz48L2NvbnRyaWJ1dG9y

cz48YXV0aC1hZGRyZXNzPk1SQyBNdWx0aWRpc2NpcGxpbmFyeSBSZXNlYXJjaCBHcm91cCBvbiBI

eXBlcnRlbnNpb24sIENsaW5pY2FsIFJlc2VhcmNoIEluc3RpdHV0ZSBvZiBNb250cmVhbCwgSG90

ZWwtRGlldSBkZSBNb250cmVhbCBIb3NwaXRhbCwgVW5pdmVyc2l0eSBvZiBNb250cmVhbCwgUXVl

YmVjLCBDYW5hZGEuPC9hdXRoLWFkZHJlc3M+PHRpdGxlcz48dGl0bGU+U3RydWN0dXJlIGFuZCBm

dW5jdGlvbiBvZiByZXNpc3RhbmNlIGFydGVyaWVzIG9mIGh5cGVydGVuc2l2ZSBwYXRpZW50cyB0

cmVhdGVkIHdpdGggYSBiZXRhLWJsb2NrZXIgb3IgYSBjYWxjaXVtIGNoYW5uZWwgYW50YWdvbmlz

dDwvdGl0bGU+PHNlY29uZGFyeS10aXRsZT5KIEh5cGVydGVuczwvc2Vjb25kYXJ5LXRpdGxlPjwv

dGl0bGVzPjxwZXJpb2RpY2FsPjxmdWxsLXRpdGxlPkpvdXJuYWwgb2YgSHlwZXJ0ZW5zaW9uPC9m

dWxsLXRpdGxlPjxhYmJyLTE+SiBIeXBlcnRlbnM8L2FiYnItMT48L3BlcmlvZGljYWw+PHBhZ2Vz

PjEyNDctNTU8L3BhZ2VzPjx2b2x1bWU+MTQ8L3ZvbHVtZT48bnVtYmVyPjEwPC9udW1iZXI+PGtl

eXdvcmRzPjxrZXl3b3JkPkFkcmVuZXJnaWMgYmV0YS1BbnRhZ29uaXN0cy8qYWRtaW5pc3RyYXRp

b24gJmFtcDsgZG9zYWdlPC9rZXl3b3JkPjxrZXl3b3JkPkFkdWx0PC9rZXl3b3JkPjxrZXl3b3Jk

PkFnZWQ8L2tleXdvcmQ+PGtleXdvcmQ+QXJ0ZXJpZXMvZHJ1ZyBlZmZlY3RzLypwYXRob2xvZ3kv

KnBoeXNpb3BhdGhvbG9neTwva2V5d29yZD48a2V5d29yZD5BdGVub2xvbC8qYWRtaW5pc3RyYXRp

b24gJmFtcDsgZG9zYWdlPC9rZXl3b3JkPjxrZXl3b3JkPkNhbGNpdW0gQ2hhbm5lbCBCbG9ja2Vy

cy8qYWRtaW5pc3RyYXRpb24gJmFtcDsgZG9zYWdlPC9rZXl3b3JkPjxrZXl3b3JkPkZlbWFsZTwv

a2V5d29yZD48a2V5d29yZD5IdW1hbnM8L2tleXdvcmQ+PGtleXdvcmQ+SHlwZXJ0ZW5zaW9uL2Ry

dWcgdGhlcmFweS9wYXRob2xvZ3kvKnBoeXNpb3BhdGhvbG9neTwva2V5d29yZD48a2V5d29yZD5I

eXBlcnRyb3BoeTwva2V5d29yZD48a2V5d29yZD5NYWxlPC9rZXl3b3JkPjxrZXl3b3JkPk1hdGNo

ZWQtUGFpciBBbmFseXNpczwva2V5d29yZD48a2V5d29yZD5NaWRkbGUgQWdlZDwva2V5d29yZD48

a2V5d29yZD5NdXNjbGUgQ29udHJhY3Rpb248L2tleXdvcmQ+PGtleXdvcmQ+TXVzY2xlLCBTbW9v

dGgsIFZhc2N1bGFyLypwYXRob2xvZ3kvcGh5c2lvcGF0aG9sb2d5PC9rZXl3b3JkPjxrZXl3b3Jk

Pk5pZmVkaXBpbmUvKmFkbWluaXN0cmF0aW9uICZhbXA7IGRvc2FnZTwva2V5d29yZD48a2V5d29y

ZD4qVmFzY3VsYXIgUmVzaXN0YW5jZTwva2V5d29yZD48L2tleXdvcmRzPjxkYXRlcz48eWVhcj4x

OTk2PC95ZWFyPjxwdWItZGF0ZXM+PGRhdGU+T2N0PC9kYXRlPjwvcHViLWRhdGVzPjwvZGF0ZXM+

PGlzYm4+MDI2My02MzUyIChQcmludCkmI3hEOzAyNjMtNjM1MiAoTGlua2luZyk8L2lzYm4+PGFj

Y2Vzc2lvbi1udW0+ODkwNjUyNTwvYWNjZXNzaW9uLW51bT48dXJscz48cmVsYXRlZC11cmxzPjx1

cmw+aHR0cDovL3d3dy5uY2JpLm5sbS5uaWguZ292L3B1Ym1lZC84OTA2NTI1PC91cmw+PC9yZWxh

dGVkLXVybHM+PC91cmxzPjwvcmVjb3JkPjwvQ2l0ZT48L0VuZE5vdGU+

ADDIN EN.CITE PEVuZE5vdGU+PENpdGU+PEF1dGhvcj5TY2hpZmZyaW48L0F1dGhvcj48WWVhcj4xOTk2PC9ZZWFy

PjxSZWNOdW0+MTUzNTQ8L1JlY051bT48RGlzcGxheVRleHQ+PHN0eWxlIGZhY2U9InN1cGVyc2Ny

aXB0Ij4yOTwvc3R5bGU+PC9EaXNwbGF5VGV4dD48cmVjb3JkPjxyZWMtbnVtYmVyPjE1MzU0PC9y

ZWMtbnVtYmVyPjxmb3JlaWduLWtleXM+PGtleSBhcHA9IkVOIiBkYi1pZD0ienR6YXN4ZTVjczAw

djRlZndycHZmdHJ3dGFmendlMjJ4ZXp0IiB0aW1lc3RhbXA9IjE0NDA1MDkwNDMiPjE1MzU0PC9r

ZXk+PC9mb3JlaWduLWtleXM+PHJlZi10eXBlIG5hbWU9IkpvdXJuYWwgQXJ0aWNsZSI+MTc8L3Jl

Zi10eXBlPjxjb250cmlidXRvcnM+PGF1dGhvcnM+PGF1dGhvcj5TY2hpZmZyaW4sIEUuIEwuPC9h

dXRob3I+PGF1dGhvcj5EZW5nLCBMLiBZLjwvYXV0aG9yPjwvYXV0aG9ycz48L2NvbnRyaWJ1dG9y

cz48YXV0aC1hZGRyZXNzPk1SQyBNdWx0aWRpc2NpcGxpbmFyeSBSZXNlYXJjaCBHcm91cCBvbiBI

eXBlcnRlbnNpb24sIENsaW5pY2FsIFJlc2VhcmNoIEluc3RpdHV0ZSBvZiBNb250cmVhbCwgSG90

ZWwtRGlldSBkZSBNb250cmVhbCBIb3NwaXRhbCwgVW5pdmVyc2l0eSBvZiBNb250cmVhbCwgUXVl

YmVjLCBDYW5hZGEuPC9hdXRoLWFkZHJlc3M+PHRpdGxlcz48dGl0bGU+U3RydWN0dXJlIGFuZCBm

dW5jdGlvbiBvZiByZXNpc3RhbmNlIGFydGVyaWVzIG9mIGh5cGVydGVuc2l2ZSBwYXRpZW50cyB0

cmVhdGVkIHdpdGggYSBiZXRhLWJsb2NrZXIgb3IgYSBjYWxjaXVtIGNoYW5uZWwgYW50YWdvbmlz

dDwvdGl0bGU+PHNlY29uZGFyeS10aXRsZT5KIEh5cGVydGVuczwvc2Vjb25kYXJ5LXRpdGxlPjwv

dGl0bGVzPjxwZXJpb2RpY2FsPjxmdWxsLXRpdGxlPkpvdXJuYWwgb2YgSHlwZXJ0ZW5zaW9uPC9m

dWxsLXRpdGxlPjxhYmJyLTE+SiBIeXBlcnRlbnM8L2FiYnItMT48L3BlcmlvZGljYWw+PHBhZ2Vz

PjEyNDctNTU8L3BhZ2VzPjx2b2x1bWU+MTQ8L3ZvbHVtZT48bnVtYmVyPjEwPC9udW1iZXI+PGtl

eXdvcmRzPjxrZXl3b3JkPkFkcmVuZXJnaWMgYmV0YS1BbnRhZ29uaXN0cy8qYWRtaW5pc3RyYXRp

b24gJmFtcDsgZG9zYWdlPC9rZXl3b3JkPjxrZXl3b3JkPkFkdWx0PC9rZXl3b3JkPjxrZXl3b3Jk

PkFnZWQ8L2tleXdvcmQ+PGtleXdvcmQ+QXJ0ZXJpZXMvZHJ1ZyBlZmZlY3RzLypwYXRob2xvZ3kv

KnBoeXNpb3BhdGhvbG9neTwva2V5d29yZD48a2V5d29yZD5BdGVub2xvbC8qYWRtaW5pc3RyYXRp

b24gJmFtcDsgZG9zYWdlPC9rZXl3b3JkPjxrZXl3b3JkPkNhbGNpdW0gQ2hhbm5lbCBCbG9ja2Vy

cy8qYWRtaW5pc3RyYXRpb24gJmFtcDsgZG9zYWdlPC9rZXl3b3JkPjxrZXl3b3JkPkZlbWFsZTwv

a2V5d29yZD48a2V5d29yZD5IdW1hbnM8L2tleXdvcmQ+PGtleXdvcmQ+SHlwZXJ0ZW5zaW9uL2Ry

dWcgdGhlcmFweS9wYXRob2xvZ3kvKnBoeXNpb3BhdGhvbG9neTwva2V5d29yZD48a2V5d29yZD5I

eXBlcnRyb3BoeTwva2V5d29yZD48a2V5d29yZD5NYWxlPC9rZXl3b3JkPjxrZXl3b3JkPk1hdGNo

ZWQtUGFpciBBbmFseXNpczwva2V5d29yZD48a2V5d29yZD5NaWRkbGUgQWdlZDwva2V5d29yZD48

a2V5d29yZD5NdXNjbGUgQ29udHJhY3Rpb248L2tleXdvcmQ+PGtleXdvcmQ+TXVzY2xlLCBTbW9v

dGgsIFZhc2N1bGFyLypwYXRob2xvZ3kvcGh5c2lvcGF0aG9sb2d5PC9rZXl3b3JkPjxrZXl3b3Jk

Pk5pZmVkaXBpbmUvKmFkbWluaXN0cmF0aW9uICZhbXA7IGRvc2FnZTwva2V5d29yZD48a2V5d29y

ZD4qVmFzY3VsYXIgUmVzaXN0YW5jZTwva2V5d29yZD48L2tleXdvcmRzPjxkYXRlcz48eWVhcj4x

OTk2PC95ZWFyPjxwdWItZGF0ZXM+PGRhdGU+T2N0PC9kYXRlPjwvcHViLWRhdGVzPjwvZGF0ZXM+

PGlzYm4+MDI2My02MzUyIChQcmludCkmI3hEOzAyNjMtNjM1MiAoTGlua2luZyk8L2lzYm4+PGFj

Y2Vzc2lvbi1udW0+ODkwNjUyNTwvYWNjZXNzaW9uLW51bT48dXJscz48cmVsYXRlZC11cmxzPjx1

cmw+aHR0cDovL3d3dy5uY2JpLm5sbS5uaWguZ292L3B1Ym1lZC84OTA2NTI1PC91cmw+PC9yZWxh

dGVkLXVybHM+PC91cmxzPjwvcmVjb3JkPjwvQ2l0ZT48L0VuZE5vdGU+

ADDIN EN.CITE.DATA 29 These findings also suggest that the improvement of capillary rarefaction and other microcirculatory abnormalities with selective ARBs or ACEi drugs may not represent a class effect but rather drug-specific additional properties of these particular drugs on the microcirculation. ADDIN EN.CITE <EndNote><Cite><Author>Debbabi</Author><Year>2010</Year><RecNum>12283</RecNum><DisplayText><style face="superscript">13</style></DisplayText><record><rec-number>12283</rec-number><foreign-keys><key app="EN" db-id="ztzasxe5cs00v4efwrpvftrwtafzwe22xezt" timestamp="1382954401">12283</key></foreign-keys><ref-type name="Journal Article">17</ref-type><contributors><authors><author>Debbabi, H.</author><author>Bonnin, P.</author><author>Levy, B. I.</author></authors></contributors><auth-address>Department of Non-Invasive Investigations, PARCC Inserm U790, Inserm U965, Lariboisiere Hospital, AP-HP, University Paris Diderot, Paris, France.</auth-address><titles><title>Effects of Blood Pressure Control With Perindopril/Indapamide on the Microcirculation in Hypertensive Patients</title><secondary-title>Am J Hypertens</secondary-title></titles><periodical><full-title>Am J Hypertens</full-title></periodical><pages>1136-1143</pages><volume>23</volume><number>10</number><dates><year>2010</year><pub-dates><date>May 27</date></pub-dates></dates><accession-num>20508624</accession-num><urls><related-urls><url> Our finding of no significant change in PWV in treated hypertensive patients is not novel, as other groups have found similar results.PEVuZE5vdGU+PENpdGU+PEF1dGhvcj5SYWp6ZXI8L0F1dGhvcj48WWVhcj4yMDAzPC9ZZWFyPjxS

ZWNOdW0+MTIxMjI8L1JlY051bT48RGlzcGxheVRleHQ+PHN0eWxlIGZhY2U9InN1cGVyc2NyaXB0

Ij4xMCwgMzAtMzI8L3N0eWxlPjwvRGlzcGxheVRleHQ+PHJlY29yZD48cmVjLW51bWJlcj4xMjEy

MjwvcmVjLW51bWJlcj48Zm9yZWlnbi1rZXlzPjxrZXkgYXBwPSJFTiIgZGItaWQ9Inp0emFzeGU1

Y3MwMHY0ZWZ3cnB2ZnRyd3RhZnp3ZTIyeGV6dCIgdGltZXN0YW1wPSIxMzgyOTU0NDAxIj4xMjEy

Mjwva2V5PjwvZm9yZWlnbi1rZXlzPjxyZWYtdHlwZSBuYW1lPSJKb3VybmFsIEFydGljbGUiPjE3

PC9yZWYtdHlwZT48Y29udHJpYnV0b3JzPjxhdXRob3JzPjxhdXRob3I+UmFqemVyLCBNLjwvYXV0

aG9yPjxhdXRob3I+S2xvY2VrLCBNLjwvYXV0aG9yPjxhdXRob3I+S2F3ZWNrYS1KYXN6Y3osIEsu

PC9hdXRob3I+PC9hdXRob3JzPjwvY29udHJpYnV0b3JzPjxhdXRoLWFkZHJlc3M+MXN0IENhcmRp

YWMgRGVwYXJ0bWVudCwgTWVkaWNhbCBDb2xsZWdlIG9mIEphZ2llbGxvbmlhbiBVbml2ZXJzaXR5

LCBLcmFrb3csIFBvbGFuZC4gcmFqemVyQGVuZG8uY20tdWoua3Jha293LnBsPC9hdXRoLWFkZHJl

c3M+PHRpdGxlcz48dGl0bGU+RWZmZWN0IG9mIGFtbG9kaXBpbmUsIHF1aW5hcHJpbCwgYW5kIGxv

c2FydGFuIG9uIHB1bHNlIHdhdmUgdmVsb2NpdHkgYW5kIHBsYXNtYSBjb2xsYWdlbiBtYXJrZXJz

IGluIHBhdGllbnRzIHdpdGggbWlsZC10by1tb2RlcmF0ZSBhcnRlcmlhbCBoeXBlcnRlbnNpb248

L3RpdGxlPjxzZWNvbmRhcnktdGl0bGU+QW0gSiBIeXBlcnRlbnM8L3NlY29uZGFyeS10aXRsZT48

L3RpdGxlcz48cGVyaW9kaWNhbD48ZnVsbC10aXRsZT5BbSBKIEh5cGVydGVuczwvZnVsbC10aXRs

ZT48L3BlcmlvZGljYWw+PHBhZ2VzPjQzOS00NDwvcGFnZXM+PHZvbHVtZT4xNjwvdm9sdW1lPjxu

dW1iZXI+NjwvbnVtYmVyPjxrZXl3b3Jkcz48a2V5d29yZD5BZHVsdDwva2V5d29yZD48a2V5d29y

ZD5BbGRvc3Rlcm9uZS9ibG9vZDwva2V5d29yZD48a2V5d29yZD5BbWxvZGlwaW5lLyphZG1pbmlz

dHJhdGlvbiAmYW1wOyBkb3NhZ2U8L2tleXdvcmQ+PGtleXdvcmQ+QW50aWh5cGVydGVuc2l2ZSBB

Z2VudHMvKmFkbWluaXN0cmF0aW9uICZhbXA7IGRvc2FnZTwva2V5d29yZD48a2V5d29yZD5CaW9s

b2dpY2FsIE1hcmtlcnM8L2tleXdvcmQ+PGtleXdvcmQ+Qmxvb2QgRmxvdyBWZWxvY2l0eS9kcnVn

IGVmZmVjdHM8L2tleXdvcmQ+PGtleXdvcmQ+Qmxvb2QgUHJlc3N1cmUvZHJ1ZyBlZmZlY3RzPC9r

ZXl3b3JkPjxrZXl3b3JkPkJsb29kIFByZXNzdXJlIE1vbml0b3JpbmcsIEFtYnVsYXRvcnk8L2tl

eXdvcmQ+PGtleXdvcmQ+Q29sbGFnZW4vYmxvb2Q8L2tleXdvcmQ+PGtleXdvcmQ+Q29tcGxpYW5j

ZTwva2V5d29yZD48a2V5d29yZD5FY2hvY2FyZGlvZ3JhcGh5PC9rZXl3b3JkPjxrZXl3b3JkPkVs

YXN0aWNpdHk8L2tleXdvcmQ+PGtleXdvcmQ+RmVtYWxlPC9rZXl3b3JkPjxrZXl3b3JkPkh1bWFu

czwva2V5d29yZD48a2V5d29yZD5IeXBlcnRlbnNpb24vKmRydWcgdGhlcmFweTwva2V5d29yZD48

a2V5d29yZD5Mb3NhcnRhbi8qYWRtaW5pc3RyYXRpb24gJmFtcDsgZG9zYWdlPC9rZXl3b3JkPjxr

ZXl3b3JkPk1hbGU8L2tleXdvcmQ+PGtleXdvcmQ+TWlkZGxlIEFnZWQ8L2tleXdvcmQ+PGtleXdv

cmQ+UHVsc2F0aWxlIEZsb3cvZHJ1ZyBlZmZlY3RzPC9rZXl3b3JkPjxrZXl3b3JkPlNldmVyaXR5

IG9mIElsbG5lc3MgSW5kZXg8L2tleXdvcmQ+PGtleXdvcmQ+VGV0cmFoeWRyb2lzb3F1aW5vbGlu

ZXMvKmFkbWluaXN0cmF0aW9uICZhbXA7IGRvc2FnZTwva2V5d29yZD48L2tleXdvcmRzPjxkYXRl

cz48eWVhcj4yMDAzPC95ZWFyPjxwdWItZGF0ZXM+PGRhdGU+SnVuPC9kYXRlPjwvcHViLWRhdGVz

PjwvZGF0ZXM+PGFjY2Vzc2lvbi1udW0+MTI3OTkwOTE8L2FjY2Vzc2lvbi1udW0+PHVybHM+PHJl

bGF0ZWQtdXJscz48dXJsPmh0dHA6Ly93d3cubmNiaS5ubG0ubmloLmdvdi9lbnRyZXovcXVlcnku

ZmNnaT9jbWQ9UmV0cmlldmUmYW1wO2RiPVB1Yk1lZCZhbXA7ZG9wdD1DaXRhdGlvbiZhbXA7bGlz

dF91aWRzPTEyNzk5MDkxPC91cmw+PHVybD5odHRwOi8vYWMuZWxzLWNkbi5jb20vUzA4OTU3MDYx

MDMwMDA1MjkvMS1zMi4wLVMwODk1NzA2MTAzMDAwNTI5LW1haW4ucGRmP190aWQ9MTk4OTU3ZDQt

ODNmMi0xMWU2LTlhN2ItMDAwMDBhYWIwZjZjJmFtcDthY2RuYXQ9MTQ3NDg5ODgzMV82NDAwOTcz

OGQ1ODVlMWM5NjI5YTViZmY1ZDU5MmY3YjwvdXJsPjwvcmVsYXRlZC11cmxzPjwvdXJscz48L3Jl

Y29yZD48L0NpdGU+PENpdGU+PEF1dGhvcj5EZSBDaXVjZWlzPC9BdXRob3I+PFllYXI+MjAxNDwv

WWVhcj48UmVjTnVtPjE1MzM4PC9SZWNOdW0+PHJlY29yZD48cmVjLW51bWJlcj4xNTMzODwvcmVj

LW51bWJlcj48Zm9yZWlnbi1rZXlzPjxrZXkgYXBwPSJFTiIgZGItaWQ9Inp0emFzeGU1Y3MwMHY0

ZWZ3cnB2ZnRyd3RhZnp3ZTIyeGV6dCIgdGltZXN0YW1wPSIxNDM5Mjg3MTU1Ij4xNTMzODwva2V5

PjwvZm9yZWlnbi1rZXlzPjxyZWYtdHlwZSBuYW1lPSJKb3VybmFsIEFydGljbGUiPjE3PC9yZWYt

dHlwZT48Y29udHJpYnV0b3JzPjxhdXRob3JzPjxhdXRob3I+RGUgQ2l1Y2VpcywgQy48L2F1dGhv

cj48YXV0aG9yPlNhbHZldHRpLCBNLjwvYXV0aG9yPjxhdXRob3I+Um9zc2luaSwgQy48L2F1dGhv

cj48YXV0aG9yPk11aWVzYW4sIE0uIEwuPC9hdXRob3I+PGF1dGhvcj5QYWluaSwgQS48L2F1dGhv

cj48YXV0aG9yPkR1c2UsIFMuPC9hdXRob3I+PGF1dGhvcj5MYSBCb3JpYSwgRS48L2F1dGhvcj48

YXV0aG9yPlNlbWVyYXJvLCBGLjwvYXV0aG9yPjxhdXRob3I+Q2FuY2FyaW5pLCBBLjwvYXV0aG9y

PjxhdXRob3I+Um9zZWksIEMuIEEuPC9hdXRob3I+PGF1dGhvcj5TYXJrYXIsIEEuPC9hdXRob3I+

PGF1dGhvcj5SdWdnZXJpLCBHLjwvYXV0aG9yPjxhdXRob3I+Q2FpbWksIEwuPC9hdXRob3I+PGF1

dGhvcj5SaWNvdHRhLCBELjwvYXV0aG9yPjxhdXRob3I+Uml6em9uaSwgRC48L2F1dGhvcj48YXV0

aG9yPlJvc2VpLCBFLiBBLjwvYXV0aG9yPjwvYXV0aG9ycz48L2NvbnRyaWJ1dG9ycz48YXV0aC1h

ZGRyZXNzPmFDbGluaWNhIE1lZGljYSwgRGVwYXJ0bWVudCBvZiBDbGluaWNhbCBhbmQgRXhwZXJp

bWVudGFsIFNjaWVuY2VzIGJDaGFpciBvZiBPcGh0aGFsbW9sb2d5IGNDaGFpciBvZiBDbGluaWNh

bCBCaW9jaGVtaXN0cnksIFVuaXZlcnNpdHkgb2YgQnJlc2NpYSwgSXRhbHkuPC9hdXRoLWFkZHJl

c3M+PHRpdGxlcz48dGl0bGU+RWZmZWN0IG9mIGFudGloeXBlcnRlbnNpdmUgdHJlYXRtZW50IG9u

IG1pY3JvdmFzY3VsYXIgc3RydWN0dXJlLCBjZW50cmFsIGJsb29kIHByZXNzdXJlIGFuZCBveGlk

YXRpdmUgc3RyZXNzIGluIHBhdGllbnRzIHdpdGggbWlsZCBlc3NlbnRpYWwgaHlwZXJ0ZW5zaW9u

PC90aXRsZT48c2Vjb25kYXJ5LXRpdGxlPkogSHlwZXJ0ZW5zPC9zZWNvbmRhcnktdGl0bGU+PC90

aXRsZXM+PHBlcmlvZGljYWw+PGZ1bGwtdGl0bGU+Sm91cm5hbCBvZiBIeXBlcnRlbnNpb248L2Z1

bGwtdGl0bGU+PGFiYnItMT5KIEh5cGVydGVuczwvYWJici0xPjwvcGVyaW9kaWNhbD48cGFnZXM+

NTY1LTc0PC9wYWdlcz48dm9sdW1lPjMyPC92b2x1bWU+PG51bWJlcj4zPC9udW1iZXI+PGtleXdv

cmRzPjxrZXl3b3JkPkFkdWx0PC9rZXl3b3JkPjxrZXl3b3JkPkFuZ2lvdGVuc2luLUNvbnZlcnRp

bmcgRW56eW1lIEluaGliaXRvcnMvYWRtaW5pc3RyYXRpb24gJmFtcDsgZG9zYWdlPC9rZXl3b3Jk

PjxrZXl3b3JkPkFudGloeXBlcnRlbnNpdmUgQWdlbnRzLyphZG1pbmlzdHJhdGlvbiAmYW1wOyBk

b3NhZ2U8L2tleXdvcmQ+PGtleXdvcmQ+QXJ0ZXJpb2xlcy9kcnVnIGVmZmVjdHMvdWx0cmFzb25v

Z3JhcGh5PC9rZXl3b3JkPjxrZXl3b3JkPkJsb29kIFByZXNzdXJlL3BoeXNpb2xvZ3k8L2tleXdv

cmQ+PGtleXdvcmQ+Q2FsY2l1bSBDaGFubmVsIEJsb2NrZXJzL2FkbWluaXN0cmF0aW9uICZhbXA7

IGRvc2FnZTwva2V5d29yZD48a2V5d29yZD5EaWh5ZHJvcHlyaWRpbmVzL2FkbWluaXN0cmF0aW9u

ICZhbXA7IGRvc2FnZTwva2V5d29yZD48a2V5d29yZD5EaXVyZXRpY3MvYWRtaW5pc3RyYXRpb24g

JmFtcDsgZG9zYWdlPC9rZXl3b3JkPjxrZXl3b3JkPkRydWcgVGhlcmFweSwgQ29tYmluYXRpb248

L2tleXdvcmQ+PGtleXdvcmQ+RW5hbGFwcmlsL2FkbWluaXN0cmF0aW9uICZhbXA7IGRvc2FnZTwv

a2V5d29yZD48a2V5d29yZD5GZW1hbGU8L2tleXdvcmQ+PGtleXdvcmQ+SHVtYW5zPC9rZXl3b3Jk

PjxrZXl3b3JkPkh5ZHJvY2hsb3JvdGhpYXppZGUvYWRtaW5pc3RyYXRpb24gJmFtcDsgZG9zYWdl

PC9rZXl3b3JkPjxrZXl3b3JkPkh5cGVydGVuc2lvbi8qZHJ1ZyB0aGVyYXB5L3BoeXNpb3BhdGhv

bG9neS91bHRyYXNvbm9ncmFwaHk8L2tleXdvcmQ+PGtleXdvcmQ+S2lkbmV5L2Jsb29kIHN1cHBs

eS9kcnVnIGVmZmVjdHM8L2tleXdvcmQ+PGtleXdvcmQ+TGFzZXItRG9wcGxlciBGbG93bWV0cnk8

L2tleXdvcmQ+PGtleXdvcmQ+TWFsZTwva2V5d29yZD48a2V5d29yZD5NaWRkbGUgQWdlZDwva2V5

d29yZD48a2V5d29yZD5PeGlkYXRpdmUgU3RyZXNzL2RydWcgZWZmZWN0czwva2V5d29yZD48L2tl

eXdvcmRzPjxkYXRlcz48eWVhcj4yMDE0PC95ZWFyPjxwdWItZGF0ZXM+PGRhdGU+TWFyPC9kYXRl

PjwvcHViLWRhdGVzPjwvZGF0ZXM+PGlzYm4+MTQ3My01NTk4IChFbGVjdHJvbmljKSYjeEQ7MDI2

My02MzUyIChMaW5raW5nKTwvaXNibj48YWNjZXNzaW9uLW51bT4yNDM3ODk5OTwvYWNjZXNzaW9u

LW51bT48dXJscz48cmVsYXRlZC11cmxzPjx1cmw+aHR0cDovL3d3dy5uY2JpLm5sbS5uaWguZ292

L3B1Ym1lZC8yNDM3ODk5OTwvdXJsPjx1cmw+aHR0cDovL292aWRzcC50eC5vdmlkLmNvbS9vdmZ0

cGRmcy9GUERETkNPQkZHR0RHTjAwL2ZzMDQ2L292ZnQvbGl2ZS9ndjAyMy8wMDAwNDg3Mi8wMDAw

NDg3Mi0yMDE0MDMwMDAtMDAwMTcucGRmPC91cmw+PC9yZWxhdGVkLXVybHM+PC91cmxzPjxlbGVj

dHJvbmljLXJlc291cmNlLW51bT4xMC4xMDk3L0hKSC4wMDAwMDAwMDAwMDAwMDY3PC9lbGVjdHJv

bmljLXJlc291cmNlLW51bT48L3JlY29yZD48L0NpdGU+PENpdGU+PEF1dGhvcj5NYWNrZW56aWU8

L0F1dGhvcj48WWVhcj4yMDA5PC9ZZWFyPjxSZWNOdW0+MTYzMTA8L1JlY051bT48cmVjb3JkPjxy

ZWMtbnVtYmVyPjE2MzEwPC9yZWMtbnVtYmVyPjxmb3JlaWduLWtleXM+PGtleSBhcHA9IkVOIiBk

Yi1pZD0ienR6YXN4ZTVjczAwdjRlZndycHZmdHJ3dGFmendlMjJ4ZXp0IiB0aW1lc3RhbXA9IjE0

NzQ5MDA0MzYiPjE2MzEwPC9rZXk+PC9mb3JlaWduLWtleXM+PHJlZi10eXBlIG5hbWU9IkpvdXJu

YWwgQXJ0aWNsZSI+MTc8L3JlZi10eXBlPjxjb250cmlidXRvcnM+PGF1dGhvcnM+PGF1dGhvcj5N

YWNrZW56aWUsIEkuIFMuPC9hdXRob3I+PGF1dGhvcj5NY0VuaWVyeSwgQy4gTS48L2F1dGhvcj48

YXV0aG9yPkRoYWthbSwgWi48L2F1dGhvcj48YXV0aG9yPkJyb3duLCBNLiBKLjwvYXV0aG9yPjxh

dXRob3I+Q29ja2Nyb2Z0LCBKLiBSLjwvYXV0aG9yPjxhdXRob3I+V2lsa2luc29uLCBJLiBCLjwv

YXV0aG9yPjwvYXV0aG9ycz48L2NvbnRyaWJ1dG9ycz48YXV0aC1hZGRyZXNzPkNsaW5pY2FsIFBo

YXJtYWNvbG9neSBVbml0LCBBZGRlbmJyb29rZSZhcG9zO3MgSG9zcGl0YWwgQm94IDExMCwgQ2Ft

YnJpZGdlLCBDQjIgMFFRIFVuaXRlZCBLaW5nZG9tLjwvYXV0aC1hZGRyZXNzPjx0aXRsZXM+PHRp

dGxlPkNvbXBhcmlzb24gb2YgdGhlIGVmZmVjdHMgb2YgYW50aWh5cGVydGVuc2l2ZSBhZ2VudHMg

b24gY2VudHJhbCBibG9vZCBwcmVzc3VyZSBhbmQgYXJ0ZXJpYWwgc3RpZmZuZXNzIGluIGlzb2xh

dGVkIHN5c3RvbGljIGh5cGVydGVuc2lvbjwvdGl0bGU+PHNlY29uZGFyeS10aXRsZT5IeXBlcnRl

bnNpb248L3NlY29uZGFyeS10aXRsZT48L3RpdGxlcz48cGVyaW9kaWNhbD48ZnVsbC10aXRsZT5I

eXBlcnRlbnNpb248L2Z1bGwtdGl0bGU+PC9wZXJpb2RpY2FsPjxwYWdlcz40MDktMTM8L3BhZ2Vz

Pjx2b2x1bWU+NTQ8L3ZvbHVtZT48bnVtYmVyPjI8L251bWJlcj48a2V5d29yZHM+PGtleXdvcmQ+

QWRtaW5pc3RyYXRpb24sIE9yYWw8L2tleXdvcmQ+PGtleXdvcmQ+QWdlZDwva2V5d29yZD48a2V5

d29yZD5BbmFseXNpcyBvZiBWYXJpYW5jZTwva2V5d29yZD48a2V5d29yZD5BbnRpaHlwZXJ0ZW5z

aXZlIEFnZW50cy8qYWRtaW5pc3RyYXRpb24gJmFtcDsgZG9zYWdlPC9rZXl3b3JkPjxrZXl3b3Jk

PkFydGVyaWVzL2RydWcgZWZmZWN0cy8qcGh5c2lvcGF0aG9sb2d5PC9rZXl3b3JkPjxrZXl3b3Jk

PkF0ZW5vbG9sL2FkbWluaXN0cmF0aW9uICZhbXA7IGRvc2FnZTwva2V5d29yZD48a2V5d29yZD5C

ZW5kcm9mbHVtZXRoaWF6aWRlL2FkbWluaXN0cmF0aW9uICZhbXA7IGRvc2FnZTwva2V5d29yZD48

a2V5d29yZD5CbG9vZCBQcmVzc3VyZSBEZXRlcm1pbmF0aW9uL21ldGhvZHM8L2tleXdvcmQ+PGtl

eXdvcmQ+RGloeWRyb3B5cmlkaW5lcy9hZG1pbmlzdHJhdGlvbiAmYW1wOyBkb3NhZ2U8L2tleXdv

cmQ+PGtleXdvcmQ+RG9zZS1SZXNwb25zZSBSZWxhdGlvbnNoaXAsIERydWc8L2tleXdvcmQ+PGtl

eXdvcmQ+RG91YmxlLUJsaW5kIE1ldGhvZDwva2V5d29yZD48a2V5d29yZD5EcnVnIEFkbWluaXN0

cmF0aW9uIFNjaGVkdWxlPC9rZXl3b3JkPjxrZXl3b3JkPkVsYXN0aWNpdHkvZHJ1ZyBlZmZlY3Rz

PC9rZXl3b3JkPjxrZXl3b3JkPkZlbWFsZTwva2V5d29yZD48a2V5d29yZD5Gb2xsb3ctVXAgU3R1

ZGllczwva2V5d29yZD48a2V5d29yZD5IZW1vZHluYW1pY3MvKmRydWcgZWZmZWN0cy9waHlzaW9s

b2d5PC9rZXl3b3JkPjxrZXl3b3JkPkh1bWFuczwva2V5d29yZD48a2V5d29yZD5IeXBlcnRlbnNp

b24vKmRpYWdub3Npcy8qZHJ1ZyB0aGVyYXB5PC9rZXl3b3JkPjxrZXl3b3JkPk1hbGU8L2tleXdv

cmQ+PGtleXdvcmQ+TWlkZGxlIEFnZWQ8L2tleXdvcmQ+PGtleXdvcmQ+TXVsdGl2YXJpYXRlIEFu

YWx5c2lzPC9rZXl3b3JkPjxrZXl3b3JkPlBhdGllbnQgQ29tcGxpYW5jZTwva2V5d29yZD48a2V5

d29yZD5QZXJpbmRvcHJpbC9hZG1pbmlzdHJhdGlvbiAmYW1wOyBkb3NhZ2U8L2tleXdvcmQ+PGtl

eXdvcmQ+UHJvYmFiaWxpdHk8L2tleXdvcmQ+PGtleXdvcmQ+UmVncmVzc2lvbiBBbmFseXNpczwv

a2V5d29yZD48a2V5d29yZD5SaXNrIEFzc2Vzc21lbnQ8L2tleXdvcmQ+PGtleXdvcmQ+U3lzdG9s

ZS9kcnVnIGVmZmVjdHMvcGh5c2lvbG9neTwva2V5d29yZD48a2V5d29yZD5UcmVhdG1lbnQgT3V0

Y29tZTwva2V5d29yZD48L2tleXdvcmRzPjxkYXRlcz48eWVhcj4yMDA5PC95ZWFyPjxwdWItZGF0

ZXM+PGRhdGU+QXVnPC9kYXRlPjwvcHViLWRhdGVzPjwvZGF0ZXM+PGlzYm4+MTUyNC00NTYzIChF

bGVjdHJvbmljKSYjeEQ7MDE5NC05MTFYIChMaW5raW5nKTwvaXNibj48YWNjZXNzaW9uLW51bT4x

OTQ4NzU4MjwvYWNjZXNzaW9uLW51bT48dXJscz48cmVsYXRlZC11cmxzPjx1cmw+aHR0cDovL3d3

dy5uY2JpLm5sbS5uaWguZ292L3B1Ym1lZC8xOTQ4NzU4MjwvdXJsPjx1cmw+aHR0cDovL2h5cGVy

LmFoYWpvdXJuYWxzLm9yZy9jb250ZW50L2h5cGVydGVuc2lvbmFoYS81NC8yLzQwOS5mdWxsLnBk

ZjwvdXJsPjwvcmVsYXRlZC11cmxzPjwvdXJscz48ZWxlY3Ryb25pYy1yZXNvdXJjZS1udW0+MTAu

MTE2MS9IWVBFUlRFTlNJT05BSEEuMTA5LjEzMzgwMTwvZWxlY3Ryb25pYy1yZXNvdXJjZS1udW0+

PC9yZWNvcmQ+PC9DaXRlPjxDaXRlPjxBdXRob3I+QWdub2xldHRpPC9BdXRob3I+PFllYXI+MjAx

MzwvWWVhcj48UmVjTnVtPjE2MzA4PC9SZWNOdW0+PHJlY29yZD48cmVjLW51bWJlcj4xNjMwODwv

cmVjLW51bWJlcj48Zm9yZWlnbi1rZXlzPjxrZXkgYXBwPSJFTiIgZGItaWQ9Inp0emFzeGU1Y3Mw

MHY0ZWZ3cnB2ZnRyd3RhZnp3ZTIyeGV6dCIgdGltZXN0YW1wPSIxNDc0OTAwMjQyIj4xNjMwODwv

a2V5PjwvZm9yZWlnbi1rZXlzPjxyZWYtdHlwZSBuYW1lPSJKb3VybmFsIEFydGljbGUiPjE3PC9y

ZWYtdHlwZT48Y29udHJpYnV0b3JzPjxhdXRob3JzPjxhdXRob3I+QWdub2xldHRpLCBELjwvYXV0

aG9yPjxhdXRob3I+WmhhbmcsIFkuPC9hdXRob3I+PGF1dGhvcj5Cb3JnaGksIEMuPC9hdXRob3I+

PGF1dGhvcj5CbGFjaGVyLCBKLjwvYXV0aG9yPjxhdXRob3I+U2FmYXIsIE0uIEUuPC9hdXRob3I+

PC9hdXRob3JzPjwvY29udHJpYnV0b3JzPjxhdXRoLWFkZHJlc3M+UGFyaXMgRGVzY2FydGVzIFVu

aXZlcnNpdHksIEFQLUhQLCBEaWFnbm9zaXMgYW5kIFRoZXJhcGV1dGljIENlbnRlciwgSG90ZWwt

RGlldSwgUGFyaXMsIEZyYW5jZS48L2F1dGgtYWRkcmVzcz48dGl0bGVzPjx0aXRsZT5FZmZlY3Rz

IG9mIGFudGloeXBlcnRlbnNpdmUgZHJ1Z3Mgb24gY2VudHJhbCBibG9vZCBwcmVzc3VyZSBpbiBo

dW1hbnM6IGEgcHJlbGltaW5hcnkgb2JzZXJ2YXRpb248L3RpdGxlPjxzZWNvbmRhcnktdGl0bGU+

QW0gSiBIeXBlcnRlbnM8L3NlY29uZGFyeS10aXRsZT48L3RpdGxlcz48cGVyaW9kaWNhbD48ZnVs

bC10aXRsZT5BbSBKIEh5cGVydGVuczwvZnVsbC10aXRsZT48L3BlcmlvZGljYWw+PHBhZ2VzPjEw

NDUtNTI8L3BhZ2VzPjx2b2x1bWU+MjY8L3ZvbHVtZT48bnVtYmVyPjg8L251bWJlcj48a2V5d29y

ZHM+PGtleXdvcmQ+QWdlZDwva2V5d29yZD48a2V5d29yZD5BbWxvZGlwaW5lLyp0aGVyYXBldXRp

YyB1c2U8L2tleXdvcmQ+PGtleXdvcmQ+QW50aWh5cGVydGVuc2l2ZSBBZ2VudHMvKnRoZXJhcGV1

dGljIHVzZTwva2V5d29yZD48a2V5d29yZD5Bb3J0YS9kcnVnIGVmZmVjdHMvcGh5c2lvcGF0aG9s

b2d5PC9rZXl3b3JkPjxrZXl3b3JkPkFydGVyaWFsIFByZXNzdXJlL2RydWcgZWZmZWN0czwva2V5

d29yZD48a2V5d29yZD5CZW56aW1pZGF6b2xlcy8qdGhlcmFwZXV0aWMgdXNlPC9rZXl3b3JkPjxr

ZXl3b3JkPkJsb29kIFByZXNzdXJlL2RydWcgZWZmZWN0czwva2V5d29yZD48a2V5d29yZD5CbG9v

ZCBQcmVzc3VyZSBEZXRlcm1pbmF0aW9uPC9rZXl3b3JkPjxrZXl3b3JkPkJyYWNoaWFsIEFydGVy

eS9kcnVnIGVmZmVjdHMvcGh5c2lvcGF0aG9sb2d5PC9rZXl3b3JkPjxrZXl3b3JkPkRvdWJsZS1C

bGluZCBNZXRob2Q8L2tleXdvcmQ+PGtleXdvcmQ+RmVtYWxlPC9rZXl3b3JkPjxrZXl3b3JkPkh1

bWFuczwva2V5d29yZD48a2V5d29yZD5IeXBlcnRlbnNpb24vKmRydWcgdGhlcmFweTwva2V5d29y

ZD48a2V5d29yZD5JbmRhcGFtaWRlLyp0aGVyYXBldXRpYyB1c2U8L2tleXdvcmQ+PGtleXdvcmQ+

TWFsZTwva2V5d29yZD48a2V5d29yZD5NYW5vbWV0cnk8L2tleXdvcmQ+PGtleXdvcmQ+TWlkZGxl

IEFnZWQ8L2tleXdvcmQ+PGtleXdvcmQ+UHVsc2UgV2F2ZSBBbmFseXNpczwva2V5d29yZD48a2V5

d29yZD5UZXRyYXpvbGVzLyp0aGVyYXBldXRpYyB1c2U8L2tleXdvcmQ+PGtleXdvcmQ+VHJlYXRt

ZW50IE91dGNvbWU8L2tleXdvcmQ+PGtleXdvcmQ+VmFzY3VsYXIgU3RpZmZuZXNzL2RydWcgZWZm

ZWN0czwva2V5d29yZD48a2V5d29yZD5hbnRpaHlwZXJ0ZW5zaXZlIGFnZW50czwva2V5d29yZD48

a2V5d29yZD5hcnRlcmlhbCBzdGlmZm5lc3M8L2tleXdvcmQ+PGtleXdvcmQ+Ymxvb2QgcHJlc3N1

cmU8L2tleXdvcmQ+PGtleXdvcmQ+Y2VudHJhbCBibG9vZCBwcmVzc3VyZTwva2V5d29yZD48a2V5

d29yZD5oeXBlcnRlbnNpb248L2tleXdvcmQ+PGtleXdvcmQ+cHJlc3N1cmUgYW1wbGlmaWNhdGlv

bjwva2V5d29yZD48a2V5d29yZD53YXZlIHJlZmxlY3Rpb24uPC9rZXl3b3JkPjwva2V5d29yZHM+

PGRhdGVzPjx5ZWFyPjIwMTM8L3llYXI+PHB1Yi1kYXRlcz48ZGF0ZT5BdWc8L2RhdGU+PC9wdWIt

ZGF0ZXM+PC9kYXRlcz48aXNibj4xOTQxLTcyMjUgKEVsZWN0cm9uaWMpJiN4RDswODk1LTcwNjEg

KExpbmtpbmcpPC9pc2JuPjxhY2Nlc3Npb24tbnVtPjIzNzM2MTEyPC9hY2Nlc3Npb24tbnVtPjx1

cmxzPjxyZWxhdGVkLXVybHM+PHVybD5odHRwOi8vd3d3Lm5jYmkubmxtLm5paC5nb3YvcHVibWVk

LzIzNzM2MTEyPC91cmw+PC9yZWxhdGVkLXVybHM+PC91cmxzPjxlbGVjdHJvbmljLXJlc291cmNl

LW51bT4xMC4xMDkzL2FqaC9ocHQwODE8L2VsZWN0cm9uaWMtcmVzb3VyY2UtbnVtPjwvcmVjb3Jk

PjwvQ2l0ZT48L0VuZE5vdGU+AG==

ADDIN EN.CITE PEVuZE5vdGU+PENpdGU+PEF1dGhvcj5SYWp6ZXI8L0F1dGhvcj48WWVhcj4yMDAzPC9ZZWFyPjxS

ZWNOdW0+MTIxMjI8L1JlY051bT48RGlzcGxheVRleHQ+PHN0eWxlIGZhY2U9InN1cGVyc2NyaXB0

Ij4xMCwgMzAtMzI8L3N0eWxlPjwvRGlzcGxheVRleHQ+PHJlY29yZD48cmVjLW51bWJlcj4xMjEy

MjwvcmVjLW51bWJlcj48Zm9yZWlnbi1rZXlzPjxrZXkgYXBwPSJFTiIgZGItaWQ9Inp0emFzeGU1

Y3MwMHY0ZWZ3cnB2ZnRyd3RhZnp3ZTIyeGV6dCIgdGltZXN0YW1wPSIxMzgyOTU0NDAxIj4xMjEy

Mjwva2V5PjwvZm9yZWlnbi1rZXlzPjxyZWYtdHlwZSBuYW1lPSJKb3VybmFsIEFydGljbGUiPjE3

PC9yZWYtdHlwZT48Y29udHJpYnV0b3JzPjxhdXRob3JzPjxhdXRob3I+UmFqemVyLCBNLjwvYXV0

aG9yPjxhdXRob3I+S2xvY2VrLCBNLjwvYXV0aG9yPjxhdXRob3I+S2F3ZWNrYS1KYXN6Y3osIEsu

PC9hdXRob3I+PC9hdXRob3JzPjwvY29udHJpYnV0b3JzPjxhdXRoLWFkZHJlc3M+MXN0IENhcmRp

YWMgRGVwYXJ0bWVudCwgTWVkaWNhbCBDb2xsZWdlIG9mIEphZ2llbGxvbmlhbiBVbml2ZXJzaXR5

LCBLcmFrb3csIFBvbGFuZC4gcmFqemVyQGVuZG8uY20tdWoua3Jha293LnBsPC9hdXRoLWFkZHJl

c3M+PHRpdGxlcz48dGl0bGU+RWZmZWN0IG9mIGFtbG9kaXBpbmUsIHF1aW5hcHJpbCwgYW5kIGxv

c2FydGFuIG9uIHB1bHNlIHdhdmUgdmVsb2NpdHkgYW5kIHBsYXNtYSBjb2xsYWdlbiBtYXJrZXJz

IGluIHBhdGllbnRzIHdpdGggbWlsZC10by1tb2RlcmF0ZSBhcnRlcmlhbCBoeXBlcnRlbnNpb248

L3RpdGxlPjxzZWNvbmRhcnktdGl0bGU+QW0gSiBIeXBlcnRlbnM8L3NlY29uZGFyeS10aXRsZT48

L3RpdGxlcz48cGVyaW9kaWNhbD48ZnVsbC10aXRsZT5BbSBKIEh5cGVydGVuczwvZnVsbC10aXRs

ZT48L3BlcmlvZGljYWw+PHBhZ2VzPjQzOS00NDwvcGFnZXM+PHZvbHVtZT4xNjwvdm9sdW1lPjxu

dW1iZXI+NjwvbnVtYmVyPjxrZXl3b3Jkcz48a2V5d29yZD5BZHVsdDwva2V5d29yZD48a2V5d29y

ZD5BbGRvc3Rlcm9uZS9ibG9vZDwva2V5d29yZD48a2V5d29yZD5BbWxvZGlwaW5lLyphZG1pbmlz

dHJhdGlvbiAmYW1wOyBkb3NhZ2U8L2tleXdvcmQ+PGtleXdvcmQ+QW50aWh5cGVydGVuc2l2ZSBB

Z2VudHMvKmFkbWluaXN0cmF0aW9uICZhbXA7IGRvc2FnZTwva2V5d29yZD48a2V5d29yZD5CaW9s

b2dpY2FsIE1hcmtlcnM8L2tleXdvcmQ+PGtleXdvcmQ+Qmxvb2QgRmxvdyBWZWxvY2l0eS9kcnVn

IGVmZmVjdHM8L2tleXdvcmQ+PGtleXdvcmQ+Qmxvb2QgUHJlc3N1cmUvZHJ1ZyBlZmZlY3RzPC9r

ZXl3b3JkPjxrZXl3b3JkPkJsb29kIFByZXNzdXJlIE1vbml0b3JpbmcsIEFtYnVsYXRvcnk8L2tl

eXdvcmQ+PGtleXdvcmQ+Q29sbGFnZW4vYmxvb2Q8L2tleXdvcmQ+PGtleXdvcmQ+Q29tcGxpYW5j

ZTwva2V5d29yZD48a2V5d29yZD5FY2hvY2FyZGlvZ3JhcGh5PC9rZXl3b3JkPjxrZXl3b3JkPkVs

YXN0aWNpdHk8L2tleXdvcmQ+PGtleXdvcmQ+RmVtYWxlPC9rZXl3b3JkPjxrZXl3b3JkPkh1bWFu

czwva2V5d29yZD48a2V5d29yZD5IeXBlcnRlbnNpb24vKmRydWcgdGhlcmFweTwva2V5d29yZD48

a2V5d29yZD5Mb3NhcnRhbi8qYWRtaW5pc3RyYXRpb24gJmFtcDsgZG9zYWdlPC9rZXl3b3JkPjxr

ZXl3b3JkPk1hbGU8L2tleXdvcmQ+PGtleXdvcmQ+TWlkZGxlIEFnZWQ8L2tleXdvcmQ+PGtleXdv

cmQ+UHVsc2F0aWxlIEZsb3cvZHJ1ZyBlZmZlY3RzPC9rZXl3b3JkPjxrZXl3b3JkPlNldmVyaXR5

IG9mIElsbG5lc3MgSW5kZXg8L2tleXdvcmQ+PGtleXdvcmQ+VGV0cmFoeWRyb2lzb3F1aW5vbGlu

ZXMvKmFkbWluaXN0cmF0aW9uICZhbXA7IGRvc2FnZTwva2V5d29yZD48L2tleXdvcmRzPjxkYXRl

cz48eWVhcj4yMDAzPC95ZWFyPjxwdWItZGF0ZXM+PGRhdGU+SnVuPC9kYXRlPjwvcHViLWRhdGVz

PjwvZGF0ZXM+PGFjY2Vzc2lvbi1udW0+MTI3OTkwOTE8L2FjY2Vzc2lvbi1udW0+PHVybHM+PHJl

bGF0ZWQtdXJscz48dXJsPmh0dHA6Ly93d3cubmNiaS5ubG0ubmloLmdvdi9lbnRyZXovcXVlcnku

ZmNnaT9jbWQ9UmV0cmlldmUmYW1wO2RiPVB1Yk1lZCZhbXA7ZG9wdD1DaXRhdGlvbiZhbXA7bGlz

dF91aWRzPTEyNzk5MDkxPC91cmw+PHVybD5odHRwOi8vYWMuZWxzLWNkbi5jb20vUzA4OTU3MDYx

MDMwMDA1MjkvMS1zMi4wLVMwODk1NzA2MTAzMDAwNTI5LW1haW4ucGRmP190aWQ9MTk4OTU3ZDQt

ODNmMi0xMWU2LTlhN2ItMDAwMDBhYWIwZjZjJmFtcDthY2RuYXQ9MTQ3NDg5ODgzMV82NDAwOTcz

OGQ1ODVlMWM5NjI5YTViZmY1ZDU5MmY3YjwvdXJsPjwvcmVsYXRlZC11cmxzPjwvdXJscz48L3Jl

Y29yZD48L0NpdGU+PENpdGU+PEF1dGhvcj5EZSBDaXVjZWlzPC9BdXRob3I+PFllYXI+MjAxNDwv

WWVhcj48UmVjTnVtPjE1MzM4PC9SZWNOdW0+PHJlY29yZD48cmVjLW51bWJlcj4xNTMzODwvcmVj

LW51bWJlcj48Zm9yZWlnbi1rZXlzPjxrZXkgYXBwPSJFTiIgZGItaWQ9Inp0emFzeGU1Y3MwMHY0

ZWZ3cnB2ZnRyd3RhZnp3ZTIyeGV6dCIgdGltZXN0YW1wPSIxNDM5Mjg3MTU1Ij4xNTMzODwva2V5

PjwvZm9yZWlnbi1rZXlzPjxyZWYtdHlwZSBuYW1lPSJKb3VybmFsIEFydGljbGUiPjE3PC9yZWYt

dHlwZT48Y29udHJpYnV0b3JzPjxhdXRob3JzPjxhdXRob3I+RGUgQ2l1Y2VpcywgQy48L2F1dGhv

cj48YXV0aG9yPlNhbHZldHRpLCBNLjwvYXV0aG9yPjxhdXRob3I+Um9zc2luaSwgQy48L2F1dGhv

cj48YXV0aG9yPk11aWVzYW4sIE0uIEwuPC9hdXRob3I+PGF1dGhvcj5QYWluaSwgQS48L2F1dGhv

cj48YXV0aG9yPkR1c2UsIFMuPC9hdXRob3I+PGF1dGhvcj5MYSBCb3JpYSwgRS48L2F1dGhvcj48

YXV0aG9yPlNlbWVyYXJvLCBGLjwvYXV0aG9yPjxhdXRob3I+Q2FuY2FyaW5pLCBBLjwvYXV0aG9y

PjxhdXRob3I+Um9zZWksIEMuIEEuPC9hdXRob3I+PGF1dGhvcj5TYXJrYXIsIEEuPC9hdXRob3I+

PGF1dGhvcj5SdWdnZXJpLCBHLjwvYXV0aG9yPjxhdXRob3I+Q2FpbWksIEwuPC9hdXRob3I+PGF1

dGhvcj5SaWNvdHRhLCBELjwvYXV0aG9yPjxhdXRob3I+Uml6em9uaSwgRC48L2F1dGhvcj48YXV0

aG9yPlJvc2VpLCBFLiBBLjwvYXV0aG9yPjwvYXV0aG9ycz48L2NvbnRyaWJ1dG9ycz48YXV0aC1h

ZGRyZXNzPmFDbGluaWNhIE1lZGljYSwgRGVwYXJ0bWVudCBvZiBDbGluaWNhbCBhbmQgRXhwZXJp

bWVudGFsIFNjaWVuY2VzIGJDaGFpciBvZiBPcGh0aGFsbW9sb2d5IGNDaGFpciBvZiBDbGluaWNh

bCBCaW9jaGVtaXN0cnksIFVuaXZlcnNpdHkgb2YgQnJlc2NpYSwgSXRhbHkuPC9hdXRoLWFkZHJl

c3M+PHRpdGxlcz48dGl0bGU+RWZmZWN0IG9mIGFudGloeXBlcnRlbnNpdmUgdHJlYXRtZW50IG9u

IG1pY3JvdmFzY3VsYXIgc3RydWN0dXJlLCBjZW50cmFsIGJsb29kIHByZXNzdXJlIGFuZCBveGlk

YXRpdmUgc3RyZXNzIGluIHBhdGllbnRzIHdpdGggbWlsZCBlc3NlbnRpYWwgaHlwZXJ0ZW5zaW9u

PC90aXRsZT48c2Vjb25kYXJ5LXRpdGxlPkogSHlwZXJ0ZW5zPC9zZWNvbmRhcnktdGl0bGU+PC90

aXRsZXM+PHBlcmlvZGljYWw+PGZ1bGwtdGl0bGU+Sm91cm5hbCBvZiBIeXBlcnRlbnNpb248L2Z1

bGwtdGl0bGU+PGFiYnItMT5KIEh5cGVydGVuczwvYWJici0xPjwvcGVyaW9kaWNhbD48cGFnZXM+

NTY1LTc0PC9wYWdlcz48dm9sdW1lPjMyPC92b2x1bWU+PG51bWJlcj4zPC9udW1iZXI+PGtleXdv

cmRzPjxrZXl3b3JkPkFkdWx0PC9rZXl3b3JkPjxrZXl3b3JkPkFuZ2lvdGVuc2luLUNvbnZlcnRp

bmcgRW56eW1lIEluaGliaXRvcnMvYWRtaW5pc3RyYXRpb24gJmFtcDsgZG9zYWdlPC9rZXl3b3Jk

PjxrZXl3b3JkPkFudGloeXBlcnRlbnNpdmUgQWdlbnRzLyphZG1pbmlzdHJhdGlvbiAmYW1wOyBk

b3NhZ2U8L2tleXdvcmQ+PGtleXdvcmQ+QXJ0ZXJpb2xlcy9kcnVnIGVmZmVjdHMvdWx0cmFzb25v

Z3JhcGh5PC9rZXl3b3JkPjxrZXl3b3JkPkJsb29kIFByZXNzdXJlL3BoeXNpb2xvZ3k8L2tleXdv

cmQ+PGtleXdvcmQ+Q2FsY2l1bSBDaGFubmVsIEJsb2NrZXJzL2FkbWluaXN0cmF0aW9uICZhbXA7

IGRvc2FnZTwva2V5d29yZD48a2V5d29yZD5EaWh5ZHJvcHlyaWRpbmVzL2FkbWluaXN0cmF0aW9u

ICZhbXA7IGRvc2FnZTwva2V5d29yZD48a2V5d29yZD5EaXVyZXRpY3MvYWRtaW5pc3RyYXRpb24g

JmFtcDsgZG9zYWdlPC9rZXl3b3JkPjxrZXl3b3JkPkRydWcgVGhlcmFweSwgQ29tYmluYXRpb248

L2tleXdvcmQ+PGtleXdvcmQ+RW5hbGFwcmlsL2FkbWluaXN0cmF0aW9uICZhbXA7IGRvc2FnZTwv

a2V5d29yZD48a2V5d29yZD5GZW1hbGU8L2tleXdvcmQ+PGtleXdvcmQ+SHVtYW5zPC9rZXl3b3Jk

PjxrZXl3b3JkPkh5ZHJvY2hsb3JvdGhpYXppZGUvYWRtaW5pc3RyYXRpb24gJmFtcDsgZG9zYWdl

PC9rZXl3b3JkPjxrZXl3b3JkPkh5cGVydGVuc2lvbi8qZHJ1ZyB0aGVyYXB5L3BoeXNpb3BhdGhv

bG9neS91bHRyYXNvbm9ncmFwaHk8L2tleXdvcmQ+PGtleXdvcmQ+S2lkbmV5L2Jsb29kIHN1cHBs

eS9kcnVnIGVmZmVjdHM8L2tleXdvcmQ+PGtleXdvcmQ+TGFzZXItRG9wcGxlciBGbG93bWV0cnk8

L2tleXdvcmQ+PGtleXdvcmQ+TWFsZTwva2V5d29yZD48a2V5d29yZD5NaWRkbGUgQWdlZDwva2V5

d29yZD48a2V5d29yZD5PeGlkYXRpdmUgU3RyZXNzL2RydWcgZWZmZWN0czwva2V5d29yZD48L2tl

eXdvcmRzPjxkYXRlcz48eWVhcj4yMDE0PC95ZWFyPjxwdWItZGF0ZXM+PGRhdGU+TWFyPC9kYXRl

PjwvcHViLWRhdGVzPjwvZGF0ZXM+PGlzYm4+MTQ3My01NTk4IChFbGVjdHJvbmljKSYjeEQ7MDI2

My02MzUyIChMaW5raW5nKTwvaXNibj48YWNjZXNzaW9uLW51bT4yNDM3ODk5OTwvYWNjZXNzaW9u

LW51bT48dXJscz48cmVsYXRlZC11cmxzPjx1cmw+aHR0cDovL3d3dy5uY2JpLm5sbS5uaWguZ292

L3B1Ym1lZC8yNDM3ODk5OTwvdXJsPjx1cmw+aHR0cDovL292aWRzcC50eC5vdmlkLmNvbS9vdmZ0

cGRmcy9GUERETkNPQkZHR0RHTjAwL2ZzMDQ2L292ZnQvbGl2ZS9ndjAyMy8wMDAwNDg3Mi8wMDAw

NDg3Mi0yMDE0MDMwMDAtMDAwMTcucGRmPC91cmw+PC9yZWxhdGVkLXVybHM+PC91cmxzPjxlbGVj

dHJvbmljLXJlc291cmNlLW51bT4xMC4xMDk3L0hKSC4wMDAwMDAwMDAwMDAwMDY3PC9lbGVjdHJv

bmljLXJlc291cmNlLW51bT48L3JlY29yZD48L0NpdGU+PENpdGU+PEF1dGhvcj5NYWNrZW56aWU8

L0F1dGhvcj48WWVhcj4yMDA5PC9ZZWFyPjxSZWNOdW0+MTYzMTA8L1JlY051bT48cmVjb3JkPjxy

ZWMtbnVtYmVyPjE2MzEwPC9yZWMtbnVtYmVyPjxmb3JlaWduLWtleXM+PGtleSBhcHA9IkVOIiBk

Yi1pZD0ienR6YXN4ZTVjczAwdjRlZndycHZmdHJ3dGFmendlMjJ4ZXp0IiB0aW1lc3RhbXA9IjE0

NzQ5MDA0MzYiPjE2MzEwPC9rZXk+PC9mb3JlaWduLWtleXM+PHJlZi10eXBlIG5hbWU9IkpvdXJu

YWwgQXJ0aWNsZSI+MTc8L3JlZi10eXBlPjxjb250cmlidXRvcnM+PGF1dGhvcnM+PGF1dGhvcj5N

YWNrZW56aWUsIEkuIFMuPC9hdXRob3I+PGF1dGhvcj5NY0VuaWVyeSwgQy4gTS48L2F1dGhvcj48

YXV0aG9yPkRoYWthbSwgWi48L2F1dGhvcj48YXV0aG9yPkJyb3duLCBNLiBKLjwvYXV0aG9yPjxh

dXRob3I+Q29ja2Nyb2Z0LCBKLiBSLjwvYXV0aG9yPjxhdXRob3I+V2lsa2luc29uLCBJLiBCLjwv

YXV0aG9yPjwvYXV0aG9ycz48L2NvbnRyaWJ1dG9ycz48YXV0aC1hZGRyZXNzPkNsaW5pY2FsIFBo

YXJtYWNvbG9neSBVbml0LCBBZGRlbmJyb29rZSZhcG9zO3MgSG9zcGl0YWwgQm94IDExMCwgQ2Ft

YnJpZGdlLCBDQjIgMFFRIFVuaXRlZCBLaW5nZG9tLjwvYXV0aC1hZGRyZXNzPjx0aXRsZXM+PHRp

dGxlPkNvbXBhcmlzb24gb2YgdGhlIGVmZmVjdHMgb2YgYW50aWh5cGVydGVuc2l2ZSBhZ2VudHMg

b24gY2VudHJhbCBibG9vZCBwcmVzc3VyZSBhbmQgYXJ0ZXJpYWwgc3RpZmZuZXNzIGluIGlzb2xh

dGVkIHN5c3RvbGljIGh5cGVydGVuc2lvbjwvdGl0bGU+PHNlY29uZGFyeS10aXRsZT5IeXBlcnRl

bnNpb248L3NlY29uZGFyeS10aXRsZT48L3RpdGxlcz48cGVyaW9kaWNhbD48ZnVsbC10aXRsZT5I

eXBlcnRlbnNpb248L2Z1bGwtdGl0bGU+PC9wZXJpb2RpY2FsPjxwYWdlcz40MDktMTM8L3BhZ2Vz

Pjx2b2x1bWU+NTQ8L3ZvbHVtZT48bnVtYmVyPjI8L251bWJlcj48a2V5d29yZHM+PGtleXdvcmQ+

QWRtaW5pc3RyYXRpb24sIE9yYWw8L2tleXdvcmQ+PGtleXdvcmQ+QWdlZDwva2V5d29yZD48a2V5

d29yZD5BbmFseXNpcyBvZiBWYXJpYW5jZTwva2V5d29yZD48a2V5d29yZD5BbnRpaHlwZXJ0ZW5z

aXZlIEFnZW50cy8qYWRtaW5pc3RyYXRpb24gJmFtcDsgZG9zYWdlPC9rZXl3b3JkPjxrZXl3b3Jk

PkFydGVyaWVzL2RydWcgZWZmZWN0cy8qcGh5c2lvcGF0aG9sb2d5PC9rZXl3b3JkPjxrZXl3b3Jk

PkF0ZW5vbG9sL2FkbWluaXN0cmF0aW9uICZhbXA7IGRvc2FnZTwva2V5d29yZD48a2V5d29yZD5C

ZW5kcm9mbHVtZXRoaWF6aWRlL2FkbWluaXN0cmF0aW9uICZhbXA7IGRvc2FnZTwva2V5d29yZD48

a2V5d29yZD5CbG9vZCBQcmVzc3VyZSBEZXRlcm1pbmF0aW9uL21ldGhvZHM8L2tleXdvcmQ+PGtl

eXdvcmQ+RGloeWRyb3B5cmlkaW5lcy9hZG1pbmlzdHJhdGlvbiAmYW1wOyBkb3NhZ2U8L2tleXdv

cmQ+PGtleXdvcmQ+RG9zZS1SZXNwb25zZSBSZWxhdGlvbnNoaXAsIERydWc8L2tleXdvcmQ+PGtl

eXdvcmQ+RG91YmxlLUJsaW5kIE1ldGhvZDwva2V5d29yZD48a2V5d29yZD5EcnVnIEFkbWluaXN0

cmF0aW9uIFNjaGVkdWxlPC9rZXl3b3JkPjxrZXl3b3JkPkVsYXN0aWNpdHkvZHJ1ZyBlZmZlY3Rz

PC9rZXl3b3JkPjxrZXl3b3JkPkZlbWFsZTwva2V5d29yZD48a2V5d29yZD5Gb2xsb3ctVXAgU3R1

ZGllczwva2V5d29yZD48a2V5d29yZD5IZW1vZHluYW1pY3MvKmRydWcgZWZmZWN0cy9waHlzaW9s

b2d5PC9rZXl3b3JkPjxrZXl3b3JkPkh1bWFuczwva2V5d29yZD48a2V5d29yZD5IeXBlcnRlbnNp

b24vKmRpYWdub3Npcy8qZHJ1ZyB0aGVyYXB5PC9rZXl3b3JkPjxrZXl3b3JkPk1hbGU8L2tleXdv

cmQ+PGtleXdvcmQ+TWlkZGxlIEFnZWQ8L2tleXdvcmQ+PGtleXdvcmQ+TXVsdGl2YXJpYXRlIEFu

YWx5c2lzPC9rZXl3b3JkPjxrZXl3b3JkPlBhdGllbnQgQ29tcGxpYW5jZTwva2V5d29yZD48a2V5

d29yZD5QZXJpbmRvcHJpbC9hZG1pbmlzdHJhdGlvbiAmYW1wOyBkb3NhZ2U8L2tleXdvcmQ+PGtl

eXdvcmQ+UHJvYmFiaWxpdHk8L2tleXdvcmQ+PGtleXdvcmQ+UmVncmVzc2lvbiBBbmFseXNpczwv

a2V5d29yZD48a2V5d29yZD5SaXNrIEFzc2Vzc21lbnQ8L2tleXdvcmQ+PGtleXdvcmQ+U3lzdG9s

ZS9kcnVnIGVmZmVjdHMvcGh5c2lvbG9neTwva2V5d29yZD48a2V5d29yZD5UcmVhdG1lbnQgT3V0

Y29tZTwva2V5d29yZD48L2tleXdvcmRzPjxkYXRlcz48eWVhcj4yMDA5PC95ZWFyPjxwdWItZGF0

ZXM+PGRhdGU+QXVnPC9kYXRlPjwvcHViLWRhdGVzPjwvZGF0ZXM+PGlzYm4+MTUyNC00NTYzIChF

bGVjdHJvbmljKSYjeEQ7MDE5NC05MTFYIChMaW5raW5nKTwvaXNibj48YWNjZXNzaW9uLW51bT4x

OTQ4NzU4MjwvYWNjZXNzaW9uLW51bT48dXJscz48cmVsYXRlZC11cmxzPjx1cmw+aHR0cDovL3d3

dy5uY2JpLm5sbS5uaWguZ292L3B1Ym1lZC8xOTQ4NzU4MjwvdXJsPjx1cmw+aHR0cDovL2h5cGVy

LmFoYWpvdXJuYWxzLm9yZy9jb250ZW50L2h5cGVydGVuc2lvbmFoYS81NC8yLzQwOS5mdWxsLnBk

ZjwvdXJsPjwvcmVsYXRlZC11cmxzPjwvdXJscz48ZWxlY3Ryb25pYy1yZXNvdXJjZS1udW0+MTAu

MTE2MS9IWVBFUlRFTlNJT05BSEEuMTA5LjEzMzgwMTwvZWxlY3Ryb25pYy1yZXNvdXJjZS1udW0+

PC9yZWNvcmQ+PC9DaXRlPjxDaXRlPjxBdXRob3I+QWdub2xldHRpPC9BdXRob3I+PFllYXI+MjAx

MzwvWWVhcj48UmVjTnVtPjE2MzA4PC9SZWNOdW0+PHJlY29yZD48cmVjLW51bWJlcj4xNjMwODwv

cmVjLW51bWJlcj48Zm9yZWlnbi1rZXlzPjxrZXkgYXBwPSJFTiIgZGItaWQ9Inp0emFzeGU1Y3Mw

MHY0ZWZ3cnB2ZnRyd3RhZnp3ZTIyeGV6dCIgdGltZXN0YW1wPSIxNDc0OTAwMjQyIj4xNjMwODwv

a2V5PjwvZm9yZWlnbi1rZXlzPjxyZWYtdHlwZSBuYW1lPSJKb3VybmFsIEFydGljbGUiPjE3PC9y

ZWYtdHlwZT48Y29udHJpYnV0b3JzPjxhdXRob3JzPjxhdXRob3I+QWdub2xldHRpLCBELjwvYXV0

aG9yPjxhdXRob3I+WmhhbmcsIFkuPC9hdXRob3I+PGF1dGhvcj5Cb3JnaGksIEMuPC9hdXRob3I+

PGF1dGhvcj5CbGFjaGVyLCBKLjwvYXV0aG9yPjxhdXRob3I+U2FmYXIsIE0uIEUuPC9hdXRob3I+

PC9hdXRob3JzPjwvY29udHJpYnV0b3JzPjxhdXRoLWFkZHJlc3M+UGFyaXMgRGVzY2FydGVzIFVu

aXZlcnNpdHksIEFQLUhQLCBEaWFnbm9zaXMgYW5kIFRoZXJhcGV1dGljIENlbnRlciwgSG90ZWwt

RGlldSwgUGFyaXMsIEZyYW5jZS48L2F1dGgtYWRkcmVzcz48dGl0bGVzPjx0aXRsZT5FZmZlY3Rz

IG9mIGFudGloeXBlcnRlbnNpdmUgZHJ1Z3Mgb24gY2VudHJhbCBibG9vZCBwcmVzc3VyZSBpbiBo

dW1hbnM6IGEgcHJlbGltaW5hcnkgb2JzZXJ2YXRpb248L3RpdGxlPjxzZWNvbmRhcnktdGl0bGU+

QW0gSiBIeXBlcnRlbnM8L3NlY29uZGFyeS10aXRsZT48L3RpdGxlcz48cGVyaW9kaWNhbD48ZnVs

bC10aXRsZT5BbSBKIEh5cGVydGVuczwvZnVsbC10aXRsZT48L3BlcmlvZGljYWw+PHBhZ2VzPjEw

NDUtNTI8L3BhZ2VzPjx2b2x1bWU+MjY8L3ZvbHVtZT48bnVtYmVyPjg8L251bWJlcj48a2V5d29y

ZHM+PGtleXdvcmQ+QWdlZDwva2V5d29yZD48a2V5d29yZD5BbWxvZGlwaW5lLyp0aGVyYXBldXRp

YyB1c2U8L2tleXdvcmQ+PGtleXdvcmQ+QW50aWh5cGVydGVuc2l2ZSBBZ2VudHMvKnRoZXJhcGV1

dGljIHVzZTwva2V5d29yZD48a2V5d29yZD5Bb3J0YS9kcnVnIGVmZmVjdHMvcGh5c2lvcGF0aG9s

b2d5PC9rZXl3b3JkPjxrZXl3b3JkPkFydGVyaWFsIFByZXNzdXJlL2RydWcgZWZmZWN0czwva2V5

d29yZD48a2V5d29yZD5CZW56aW1pZGF6b2xlcy8qdGhlcmFwZXV0aWMgdXNlPC9rZXl3b3JkPjxr

ZXl3b3JkPkJsb29kIFByZXNzdXJlL2RydWcgZWZmZWN0czwva2V5d29yZD48a2V5d29yZD5CbG9v

ZCBQcmVzc3VyZSBEZXRlcm1pbmF0aW9uPC9rZXl3b3JkPjxrZXl3b3JkPkJyYWNoaWFsIEFydGVy

eS9kcnVnIGVmZmVjdHMvcGh5c2lvcGF0aG9sb2d5PC9rZXl3b3JkPjxrZXl3b3JkPkRvdWJsZS1C

bGluZCBNZXRob2Q8L2tleXdvcmQ+PGtleXdvcmQ+RmVtYWxlPC9rZXl3b3JkPjxrZXl3b3JkPkh1

bWFuczwva2V5d29yZD48a2V5d29yZD5IeXBlcnRlbnNpb24vKmRydWcgdGhlcmFweTwva2V5d29y

ZD48a2V5d29yZD5JbmRhcGFtaWRlLyp0aGVyYXBldXRpYyB1c2U8L2tleXdvcmQ+PGtleXdvcmQ+

TWFsZTwva2V5d29yZD48a2V5d29yZD5NYW5vbWV0cnk8L2tleXdvcmQ+PGtleXdvcmQ+TWlkZGxl

IEFnZWQ8L2tleXdvcmQ+PGtleXdvcmQ+UHVsc2UgV2F2ZSBBbmFseXNpczwva2V5d29yZD48a2V5

d29yZD5UZXRyYXpvbGVzLyp0aGVyYXBldXRpYyB1c2U8L2tleXdvcmQ+PGtleXdvcmQ+VHJlYXRt

ZW50IE91dGNvbWU8L2tleXdvcmQ+PGtleXdvcmQ+VmFzY3VsYXIgU3RpZmZuZXNzL2RydWcgZWZm

ZWN0czwva2V5d29yZD48a2V5d29yZD5hbnRpaHlwZXJ0ZW5zaXZlIGFnZW50czwva2V5d29yZD48

a2V5d29yZD5hcnRlcmlhbCBzdGlmZm5lc3M8L2tleXdvcmQ+PGtleXdvcmQ+Ymxvb2QgcHJlc3N1

cmU8L2tleXdvcmQ+PGtleXdvcmQ+Y2VudHJhbCBibG9vZCBwcmVzc3VyZTwva2V5d29yZD48a2V5

d29yZD5oeXBlcnRlbnNpb248L2tleXdvcmQ+PGtleXdvcmQ+cHJlc3N1cmUgYW1wbGlmaWNhdGlv

bjwva2V5d29yZD48a2V5d29yZD53YXZlIHJlZmxlY3Rpb24uPC9rZXl3b3JkPjwva2V5d29yZHM+

PGRhdGVzPjx5ZWFyPjIwMTM8L3llYXI+PHB1Yi1kYXRlcz48ZGF0ZT5BdWc8L2RhdGU+PC9wdWIt

ZGF0ZXM+PC9kYXRlcz48aXNibj4xOTQxLTcyMjUgKEVsZWN0cm9uaWMpJiN4RDswODk1LTcwNjEg

KExpbmtpbmcpPC9pc2JuPjxhY2Nlc3Npb24tbnVtPjIzNzM2MTEyPC9hY2Nlc3Npb24tbnVtPjx1

cmxzPjxyZWxhdGVkLXVybHM+PHVybD5odHRwOi8vd3d3Lm5jYmkubmxtLm5paC5nb3YvcHVibWVk

LzIzNzM2MTEyPC91cmw+PC9yZWxhdGVkLXVybHM+PC91cmxzPjxlbGVjdHJvbmljLXJlc291cmNl

LW51bT4xMC4xMDkzL2FqaC9ocHQwODE8L2VsZWN0cm9uaWMtcmVzb3VyY2UtbnVtPjwvcmVjb3Jk

PjwvQ2l0ZT48L0VuZE5vdGU+AG==

ADDIN EN.CITE.DATA 10, 30-32 We acknowledge that our study has several limitations. Our inability to find a significant effect of both candesartan and amlodipine treatment on capillary rarefaction can be feasibly explained by the small number of subjects who completed the study (type 2 error) or the shorter duration of active treatment with these 2 drugs. Additionally we could not rule out any persisting effects of previous antihypertensive medications our subjects received before enrolling in this study. It is also conceivable that amlodipine and candesartan may genuinely lack substantial microvascular effects as other studies have shown that treatment with amlodipine did not improve coronary flow reserve in hypertensive patientsPEVuZE5vdGU+PENpdGU+PEF1dGhvcj5OYXlhPC9BdXRob3I+PFllYXI+MjAwNzwvWWVhcj48UmVj

TnVtPjE2Mjk4PC9SZWNOdW0+PERpc3BsYXlUZXh0PjxzdHlsZSBmYWNlPSJzdXBlcnNjcmlwdCI+

MzMsIDM0PC9zdHlsZT48L0Rpc3BsYXlUZXh0PjxyZWNvcmQ+PHJlYy1udW1iZXI+MTYyOTg8L3Jl

Yy1udW1iZXI+PGZvcmVpZ24ta2V5cz48a2V5IGFwcD0iRU4iIGRiLWlkPSJ6dHphc3hlNWNzMDB2

NGVmd3JwdmZ0cnd0YWZ6d2UyMnhlenQiIHRpbWVzdGFtcD0iMTQ3MjAzMjQxMSI+MTYyOTg8L2tl

eT48L2ZvcmVpZ24ta2V5cz48cmVmLXR5cGUgbmFtZT0iSm91cm5hbCBBcnRpY2xlIj4xNzwvcmVm

LXR5cGU+PGNvbnRyaWJ1dG9ycz48YXV0aG9ycz48YXV0aG9yPk5heWEsIE0uPC9hdXRob3I+PGF1

dGhvcj5Uc3VrYW1vdG8sIFQuPC9hdXRob3I+PGF1dGhvcj5Nb3JpdGEsIEsuPC9hdXRob3I+PGF1

dGhvcj5LYXRvaCwgQy48L2F1dGhvcj48YXV0aG9yPkZ1cnVtb3RvLCBULjwvYXV0aG9yPjxhdXRo

b3I+RnVqaWksIFMuPC9hdXRob3I+PGF1dGhvcj5UYW1ha2ksIE4uPC9hdXRob3I+PGF1dGhvcj5U

c3V0c3VpLCBILjwvYXV0aG9yPjwvYXV0aG9ycz48L2NvbnRyaWJ1dG9ycz48YXV0aC1hZGRyZXNz

PkRlcGFydG1lbnQgb2YgQ2FyZGlvdmFzY3VsYXIgTWVkaWNpbmUsIEhva2thaWRvIFVuaXZlcnNp

dHkgR3JhZHVhdGUgU2Nob29sIG9mIE1lZGljaW5lLCBTYXBwb3JvLCBKYXBhbi48L2F1dGgtYWRk

cmVzcz48dGl0bGVzPjx0aXRsZT5PbG1lc2FydGFuLCBidXQgbm90IGFtbG9kaXBpbmUsIGltcHJv

dmVzIGVuZG90aGVsaXVtLWRlcGVuZGVudCBjb3JvbmFyeSBkaWxhdGlvbiBpbiBoeXBlcnRlbnNp

dmUgcGF0aWVudHM8L3RpdGxlPjxzZWNvbmRhcnktdGl0bGU+SiBBbSBDb2xsIENhcmRpb2w8L3Nl

Y29uZGFyeS10aXRsZT48L3RpdGxlcz48cGVyaW9kaWNhbD48ZnVsbC10aXRsZT5KIEFtIENvbGwg

Q2FyZGlvbDwvZnVsbC10aXRsZT48L3BlcmlvZGljYWw+PHBhZ2VzPjExNDQtOTwvcGFnZXM+PHZv

bHVtZT41MDwvdm9sdW1lPjxudW1iZXI+MTI8L251bWJlcj48a2V5d29yZHM+PGtleXdvcmQ+QWR1

bHQ8L2tleXdvcmQ+PGtleXdvcmQ+QW1sb2RpcGluZS8qYWRtaW5pc3RyYXRpb24gJmFtcDsgZG9z

YWdlPC9rZXl3b3JkPjxrZXl3b3JkPkJsb29kIENoZW1pY2FsIEFuYWx5c2lzPC9rZXl3b3JkPjxr

ZXl3b3JkPkNvaG9ydCBTdHVkaWVzPC9rZXl3b3JkPjxrZXl3b3JkPkNvcm9uYXJ5IENpcmN1bGF0

aW9uLypkcnVnIGVmZmVjdHM8L2tleXdvcmQ+PGtleXdvcmQ+Q29yb25hcnkgU3Rlbm9zaXMvcHJl

dmVudGlvbiAmYW1wOyBjb250cm9sPC9rZXl3b3JkPjxrZXl3b3JkPkRvc2UtUmVzcG9uc2UgUmVs

YXRpb25zaGlwLCBEcnVnPC9rZXl3b3JkPjxrZXl3b3JkPkRydWcgQWRtaW5pc3RyYXRpb24gU2No

ZWR1bGU8L2tleXdvcmQ+PGtleXdvcmQ+RWNob2NhcmRpb2dyYXBoeTwva2V5d29yZD48a2V5d29y

ZD5FbmRvdGhlbGl1bSwgVmFzY3VsYXIvZHJ1ZyBlZmZlY3RzPC9rZXl3b3JkPjxrZXl3b3JkPkZl

bWFsZTwva2V5d29yZD48a2V5d29yZD5Gb2xsb3ctVXAgU3R1ZGllczwva2V5d29yZD48a2V5d29y

ZD5IdW1hbnM8L2tleXdvcmQ+PGtleXdvcmQ+SHlwZXJ0ZW5zaW9uL2RpYWdub3Npcy8qZHJ1ZyB0

aGVyYXB5PC9rZXl3b3JkPjxrZXl3b3JkPkltaWRhem9sZXMvKmFkbWluaXN0cmF0aW9uICZhbXA7

IGRvc2FnZTwva2V5d29yZD48a2V5d29yZD5NYWxlPC9rZXl3b3JkPjxrZXl3b3JkPk1pZGRsZSBB

Z2VkPC9rZXl3b3JkPjxrZXl3b3JkPlBvc2l0cm9uLUVtaXNzaW9uIFRvbW9ncmFwaHk8L2tleXdv

cmQ+PGtleXdvcmQ+UHJvYmFiaWxpdHk8L2tleXdvcmQ+PGtleXdvcmQ+UHJvc3BlY3RpdmUgU3R1

ZGllczwva2V5d29yZD48a2V5d29yZD5SaXNrIEFzc2Vzc21lbnQ8L2tleXdvcmQ+PGtleXdvcmQ+

VGV0cmF6b2xlcy8qYWRtaW5pc3RyYXRpb24gJmFtcDsgZG9zYWdlPC9rZXl3b3JkPjxrZXl3b3Jk

PlRyZWF0bWVudCBPdXRjb21lPC9rZXl3b3JkPjxrZXl3b3JkPlZhc29kaWxhdGlvbi9kcnVnIGVm

ZmVjdHM8L2tleXdvcmQ+PC9rZXl3b3Jkcz48ZGF0ZXM+PHllYXI+MjAwNzwveWVhcj48cHViLWRh

dGVzPjxkYXRlPlNlcCAxODwvZGF0ZT48L3B1Yi1kYXRlcz48L2RhdGVzPjxpc2JuPjE1NTgtMzU5

NyAoRWxlY3Ryb25pYykmI3hEOzA3MzUtMTA5NyAoTGlua2luZyk8L2lzYm4+PGFjY2Vzc2lvbi1u

dW0+MTc4Njg4MDU8L2FjY2Vzc2lvbi1udW0+PHVybHM+PHJlbGF0ZWQtdXJscz48dXJsPmh0dHA6

Ly93d3cubmNiaS5ubG0ubmloLmdvdi9wdWJtZWQvMTc4Njg4MDU8L3VybD48L3JlbGF0ZWQtdXJs

cz48L3VybHM+PGVsZWN0cm9uaWMtcmVzb3VyY2UtbnVtPjEwLjEwMTYvai5qYWNjLjIwMDcuMDYu

MDEzPC9lbGVjdHJvbmljLXJlc291cmNlLW51bT48L3JlY29yZD48L0NpdGU+PENpdGU+PEF1dGhv

cj5Ub3lhbWE8L0F1dGhvcj48WWVhcj4yMDEyPC9ZZWFyPjxSZWNOdW0+MTYyOTk8L1JlY051bT48

cmVjb3JkPjxyZWMtbnVtYmVyPjE2Mjk5PC9yZWMtbnVtYmVyPjxmb3JlaWduLWtleXM+PGtleSBh

cHA9IkVOIiBkYi1pZD0ienR6YXN4ZTVjczAwdjRlZndycHZmdHJ3dGFmendlMjJ4ZXp0IiB0aW1l

c3RhbXA9IjE0NzIwMzI1NTQiPjE2Mjk5PC9rZXk+PC9mb3JlaWduLWtleXM+PHJlZi10eXBlIG5h

bWU9IkpvdXJuYWwgQXJ0aWNsZSI+MTc8L3JlZi10eXBlPjxjb250cmlidXRvcnM+PGF1dGhvcnM+

PGF1dGhvcj5Ub3lhbWEsIFQuPC9hdXRob3I+PGF1dGhvcj5TYXRvLCBDLjwvYXV0aG9yPjxhdXRo

b3I+S295YW1hLCBLLjwvYXV0aG9yPjxhdXRob3I+S2FzYW1hLCBTLjwvYXV0aG9yPjxhdXRob3I+

TXVyYWthbWksIEouPC9hdXRob3I+PGF1dGhvcj5ZYW1hc2hpdGEsIEUuPC9hdXRob3I+PGF1dGhv

cj5LYXdhZ3VjaGksIFIuPC9hdXRob3I+PGF1dGhvcj5BZGFjaGksIEguPC9hdXRob3I+PGF1dGhv

cj5Ib3NoaXpha2ksIEguPC9hdXRob3I+PGF1dGhvcj5Pc2hpbWEsIFMuPC9hdXRob3I+PC9hdXRo

b3JzPjwvY29udHJpYnV0b3JzPjxhdXRoLWFkZHJlc3M+R3VubWEgUHJlZmVjdHVyYWwgQ2FyZGlv

dmFzY3VsYXIgQ2VudGVyLCBNYWViYXNoaSwgSmFwYW4uIHRveWFtYS10b3lhbWFAY3ZjLnByZWYu

Z3VubWEuanA8L2F1dGgtYWRkcmVzcz48dGl0bGVzPjx0aXRsZT5PbG1lc2FydGFuIGltcHJvdmVz

IGNvcm9uYXJ5IGZsb3cgcmVzZXJ2ZSBvZiBoeXBlcnRlbnNpdmUgcGF0aWVudHMgdXNpbmcgY29y

b25hcnkgbWFnbmV0aWMgcmVzb25hbmNlIGltYWdpbmcgY29tcGFyZWQgd2l0aCBhbWxvZGlwaW5l

PC90aXRsZT48c2Vjb25kYXJ5LXRpdGxlPkNhcmRpb2xvZ3k8L3NlY29uZGFyeS10aXRsZT48L3Rp

dGxlcz48cGVyaW9kaWNhbD48ZnVsbC10aXRsZT5DYXJkaW9sb2d5PC9mdWxsLXRpdGxlPjwvcGVy

aW9kaWNhbD48cGFnZXM+MjMwLTY8L3BhZ2VzPjx2b2x1bWU+MTIyPC92b2x1bWU+PG51bWJlcj40

PC9udW1iZXI+PGtleXdvcmRzPjxrZXl3b3JkPkFkZW5vc2luZS9waGFybWFjb2xvZ3k8L2tleXdv

cmQ+PGtleXdvcmQ+QWR1bHQ8L2tleXdvcmQ+PGtleXdvcmQ+QWdlZDwva2V5d29yZD48a2V5d29y

ZD5BbWxvZGlwaW5lLyp0aGVyYXBldXRpYyB1c2U8L2tleXdvcmQ+PGtleXdvcmQ+QW50aWh5cGVy

dGVuc2l2ZSBBZ2VudHMvKnRoZXJhcGV1dGljIHVzZTwva2V5d29yZD48a2V5d29yZD5Db3JvbmFy

eSBDaXJjdWxhdGlvbi8qZHJ1ZyBlZmZlY3RzPC9rZXl3b3JkPjxrZXl3b3JkPkVjaG9jYXJkaW9n

cmFwaHkvbWV0aG9kczwva2V5d29yZD48a2V5d29yZD5GZW1hbGU8L2tleXdvcmQ+PGtleXdvcmQ+

SHVtYW5zPC9rZXl3b3JkPjxrZXl3b3JkPkh5cGVydGVuc2lvbi8qZHJ1ZyB0aGVyYXB5L3BoeXNp

b3BhdGhvbG9neTwva2V5d29yZD48a2V5d29yZD5JbWlkYXpvbGVzLyp0aGVyYXBldXRpYyB1c2U8

L2tleXdvcmQ+PGtleXdvcmQ+TWFnbmV0aWMgUmVzb25hbmNlIEFuZ2lvZ3JhcGh5L21ldGhvZHM8

L2tleXdvcmQ+PGtleXdvcmQ+TWFsZTwva2V5d29yZD48a2V5d29yZD5NaWRkbGUgQWdlZDwva2V5

d29yZD48a2V5d29yZD5TdHJva2UgVm9sdW1lL2RydWcgZWZmZWN0czwva2V5d29yZD48a2V5d29y

ZD5UZXRyYXpvbGVzLyp0aGVyYXBldXRpYyB1c2U8L2tleXdvcmQ+PGtleXdvcmQ+VmFzb2RpbGF0

b3IgQWdlbnRzL3BoYXJtYWNvbG9neTwva2V5d29yZD48a2V5d29yZD5WZW50cmljdWxhciBGdW5j

dGlvbiwgTGVmdC9kcnVnIGVmZmVjdHM8L2tleXdvcmQ+PC9rZXl3b3Jkcz48ZGF0ZXM+PHllYXI+

MjAxMjwveWVhcj48L2RhdGVzPjxpc2JuPjE0MjEtOTc1MSAoRWxlY3Ryb25pYykmI3hEOzAwMDgt

NjMxMiAoTGlua2luZyk8L2lzYm4+PGFjY2Vzc2lvbi1udW0+MjI5MDY4NDc8L2FjY2Vzc2lvbi1u

dW0+PHVybHM+PHJlbGF0ZWQtdXJscz48dXJsPmh0dHA6Ly93d3cubmNiaS5ubG0ubmloLmdvdi9w

dWJtZWQvMjI5MDY4NDc8L3VybD48L3JlbGF0ZWQtdXJscz48L3VybHM+PGVsZWN0cm9uaWMtcmVz

b3VyY2UtbnVtPjEwLjExNTkvMDAwMzM5NzYyPC9lbGVjdHJvbmljLXJlc291cmNlLW51bT48L3Jl

Y29yZD48L0NpdGU+PC9FbmROb3RlPn==

ADDIN EN.CITE PEVuZE5vdGU+PENpdGU+PEF1dGhvcj5OYXlhPC9BdXRob3I+PFllYXI+MjAwNzwvWWVhcj48UmVj

TnVtPjE2Mjk4PC9SZWNOdW0+PERpc3BsYXlUZXh0PjxzdHlsZSBmYWNlPSJzdXBlcnNjcmlwdCI+

MzMsIDM0PC9zdHlsZT48L0Rpc3BsYXlUZXh0PjxyZWNvcmQ+PHJlYy1udW1iZXI+MTYyOTg8L3Jl

Yy1udW1iZXI+PGZvcmVpZ24ta2V5cz48a2V5IGFwcD0iRU4iIGRiLWlkPSJ6dHphc3hlNWNzMDB2

NGVmd3JwdmZ0cnd0YWZ6d2UyMnhlenQiIHRpbWVzdGFtcD0iMTQ3MjAzMjQxMSI+MTYyOTg8L2tl

eT48L2ZvcmVpZ24ta2V5cz48cmVmLXR5cGUgbmFtZT0iSm91cm5hbCBBcnRpY2xlIj4xNzwvcmVm

LXR5cGU+PGNvbnRyaWJ1dG9ycz48YXV0aG9ycz48YXV0aG9yPk5heWEsIE0uPC9hdXRob3I+PGF1

dGhvcj5Uc3VrYW1vdG8sIFQuPC9hdXRob3I+PGF1dGhvcj5Nb3JpdGEsIEsuPC9hdXRob3I+PGF1

dGhvcj5LYXRvaCwgQy48L2F1dGhvcj48YXV0aG9yPkZ1cnVtb3RvLCBULjwvYXV0aG9yPjxhdXRo

b3I+RnVqaWksIFMuPC9hdXRob3I+PGF1dGhvcj5UYW1ha2ksIE4uPC9hdXRob3I+PGF1dGhvcj5U

c3V0c3VpLCBILjwvYXV0aG9yPjwvYXV0aG9ycz48L2NvbnRyaWJ1dG9ycz48YXV0aC1hZGRyZXNz

PkRlcGFydG1lbnQgb2YgQ2FyZGlvdmFzY3VsYXIgTWVkaWNpbmUsIEhva2thaWRvIFVuaXZlcnNp

dHkgR3JhZHVhdGUgU2Nob29sIG9mIE1lZGljaW5lLCBTYXBwb3JvLCBKYXBhbi48L2F1dGgtYWRk

cmVzcz48dGl0bGVzPjx0aXRsZT5PbG1lc2FydGFuLCBidXQgbm90IGFtbG9kaXBpbmUsIGltcHJv

dmVzIGVuZG90aGVsaXVtLWRlcGVuZGVudCBjb3JvbmFyeSBkaWxhdGlvbiBpbiBoeXBlcnRlbnNp

dmUgcGF0aWVudHM8L3RpdGxlPjxzZWNvbmRhcnktdGl0bGU+SiBBbSBDb2xsIENhcmRpb2w8L3Nl

Y29uZGFyeS10aXRsZT48L3RpdGxlcz48cGVyaW9kaWNhbD48ZnVsbC10aXRsZT5KIEFtIENvbGwg

Q2FyZGlvbDwvZnVsbC10aXRsZT48L3BlcmlvZGljYWw+PHBhZ2VzPjExNDQtOTwvcGFnZXM+PHZv

bHVtZT41MDwvdm9sdW1lPjxudW1iZXI+MTI8L251bWJlcj48a2V5d29yZHM+PGtleXdvcmQ+QWR1

bHQ8L2tleXdvcmQ+PGtleXdvcmQ+QW1sb2RpcGluZS8qYWRtaW5pc3RyYXRpb24gJmFtcDsgZG9z

YWdlPC9rZXl3b3JkPjxrZXl3b3JkPkJsb29kIENoZW1pY2FsIEFuYWx5c2lzPC9rZXl3b3JkPjxr

ZXl3b3JkPkNvaG9ydCBTdHVkaWVzPC9rZXl3b3JkPjxrZXl3b3JkPkNvcm9uYXJ5IENpcmN1bGF0

aW9uLypkcnVnIGVmZmVjdHM8L2tleXdvcmQ+PGtleXdvcmQ+Q29yb25hcnkgU3Rlbm9zaXMvcHJl

dmVudGlvbiAmYW1wOyBjb250cm9sPC9rZXl3b3JkPjxrZXl3b3JkPkRvc2UtUmVzcG9uc2UgUmVs

YXRpb25zaGlwLCBEcnVnPC9rZXl3b3JkPjxrZXl3b3JkPkRydWcgQWRtaW5pc3RyYXRpb24gU2No

ZWR1bGU8L2tleXdvcmQ+PGtleXdvcmQ+RWNob2NhcmRpb2dyYXBoeTwva2V5d29yZD48a2V5d29y

ZD5FbmRvdGhlbGl1bSwgVmFzY3VsYXIvZHJ1ZyBlZmZlY3RzPC9rZXl3b3JkPjxrZXl3b3JkPkZl

bWFsZTwva2V5d29yZD48a2V5d29yZD5Gb2xsb3ctVXAgU3R1ZGllczwva2V5d29yZD48a2V5d29y

ZD5IdW1hbnM8L2tleXdvcmQ+PGtleXdvcmQ+SHlwZXJ0ZW5zaW9uL2RpYWdub3Npcy8qZHJ1ZyB0

aGVyYXB5PC9rZXl3b3JkPjxrZXl3b3JkPkltaWRhem9sZXMvKmFkbWluaXN0cmF0aW9uICZhbXA7

IGRvc2FnZTwva2V5d29yZD48a2V5d29yZD5NYWxlPC9rZXl3b3JkPjxrZXl3b3JkPk1pZGRsZSBB

Z2VkPC9rZXl3b3JkPjxrZXl3b3JkPlBvc2l0cm9uLUVtaXNzaW9uIFRvbW9ncmFwaHk8L2tleXdv

cmQ+PGtleXdvcmQ+UHJvYmFiaWxpdHk8L2tleXdvcmQ+PGtleXdvcmQ+UHJvc3BlY3RpdmUgU3R1

ZGllczwva2V5d29yZD48a2V5d29yZD5SaXNrIEFzc2Vzc21lbnQ8L2tleXdvcmQ+PGtleXdvcmQ+

VGV0cmF6b2xlcy8qYWRtaW5pc3RyYXRpb24gJmFtcDsgZG9zYWdlPC9rZXl3b3JkPjxrZXl3b3Jk

PlRyZWF0bWVudCBPdXRjb21lPC9rZXl3b3JkPjxrZXl3b3JkPlZhc29kaWxhdGlvbi9kcnVnIGVm

ZmVjdHM8L2tleXdvcmQ+PC9rZXl3b3Jkcz48ZGF0ZXM+PHllYXI+MjAwNzwveWVhcj48cHViLWRh

dGVzPjxkYXRlPlNlcCAxODwvZGF0ZT48L3B1Yi1kYXRlcz48L2RhdGVzPjxpc2JuPjE1NTgtMzU5

NyAoRWxlY3Ryb25pYykmI3hEOzA3MzUtMTA5NyAoTGlua2luZyk8L2lzYm4+PGFjY2Vzc2lvbi1u

dW0+MTc4Njg4MDU8L2FjY2Vzc2lvbi1udW0+PHVybHM+PHJlbGF0ZWQtdXJscz48dXJsPmh0dHA6

Ly93d3cubmNiaS5ubG0ubmloLmdvdi9wdWJtZWQvMTc4Njg4MDU8L3VybD48L3JlbGF0ZWQtdXJs

cz48L3VybHM+PGVsZWN0cm9uaWMtcmVzb3VyY2UtbnVtPjEwLjEwMTYvai5qYWNjLjIwMDcuMDYu

MDEzPC9lbGVjdHJvbmljLXJlc291cmNlLW51bT48L3JlY29yZD48L0NpdGU+PENpdGU+PEF1dGhv

cj5Ub3lhbWE8L0F1dGhvcj48WWVhcj4yMDEyPC9ZZWFyPjxSZWNOdW0+MTYyOTk8L1JlY051bT48

cmVjb3JkPjxyZWMtbnVtYmVyPjE2Mjk5PC9yZWMtbnVtYmVyPjxmb3JlaWduLWtleXM+PGtleSBh

cHA9IkVOIiBkYi1pZD0ienR6YXN4ZTVjczAwdjRlZndycHZmdHJ3dGFmendlMjJ4ZXp0IiB0aW1l

c3RhbXA9IjE0NzIwMzI1NTQiPjE2Mjk5PC9rZXk+PC9mb3JlaWduLWtleXM+PHJlZi10eXBlIG5h

bWU9IkpvdXJuYWwgQXJ0aWNsZSI+MTc8L3JlZi10eXBlPjxjb250cmlidXRvcnM+PGF1dGhvcnM+

PGF1dGhvcj5Ub3lhbWEsIFQuPC9hdXRob3I+PGF1dGhvcj5TYXRvLCBDLjwvYXV0aG9yPjxhdXRo

b3I+S295YW1hLCBLLjwvYXV0aG9yPjxhdXRob3I+S2FzYW1hLCBTLjwvYXV0aG9yPjxhdXRob3I+

TXVyYWthbWksIEouPC9hdXRob3I+PGF1dGhvcj5ZYW1hc2hpdGEsIEUuPC9hdXRob3I+PGF1dGhv

cj5LYXdhZ3VjaGksIFIuPC9hdXRob3I+PGF1dGhvcj5BZGFjaGksIEguPC9hdXRob3I+PGF1dGhv

cj5Ib3NoaXpha2ksIEguPC9hdXRob3I+PGF1dGhvcj5Pc2hpbWEsIFMuPC9hdXRob3I+PC9hdXRo

b3JzPjwvY29udHJpYnV0b3JzPjxhdXRoLWFkZHJlc3M+R3VubWEgUHJlZmVjdHVyYWwgQ2FyZGlv

dmFzY3VsYXIgQ2VudGVyLCBNYWViYXNoaSwgSmFwYW4uIHRveWFtYS10b3lhbWFAY3ZjLnByZWYu

Z3VubWEuanA8L2F1dGgtYWRkcmVzcz48dGl0bGVzPjx0aXRsZT5PbG1lc2FydGFuIGltcHJvdmVz

IGNvcm9uYXJ5IGZsb3cgcmVzZXJ2ZSBvZiBoeXBlcnRlbnNpdmUgcGF0aWVudHMgdXNpbmcgY29y

b25hcnkgbWFnbmV0aWMgcmVzb25hbmNlIGltYWdpbmcgY29tcGFyZWQgd2l0aCBhbWxvZGlwaW5l

PC90aXRsZT48c2Vjb25kYXJ5LXRpdGxlPkNhcmRpb2xvZ3k8L3NlY29uZGFyeS10aXRsZT48L3Rp

dGxlcz48cGVyaW9kaWNhbD48ZnVsbC10aXRsZT5DYXJkaW9sb2d5PC9mdWxsLXRpdGxlPjwvcGVy

aW9kaWNhbD48cGFnZXM+MjMwLTY8L3BhZ2VzPjx2b2x1bWU+MTIyPC92b2x1bWU+PG51bWJlcj40

PC9udW1iZXI+PGtleXdvcmRzPjxrZXl3b3JkPkFkZW5vc2luZS9waGFybWFjb2xvZ3k8L2tleXdv

cmQ+PGtleXdvcmQ+QWR1bHQ8L2tleXdvcmQ+PGtleXdvcmQ+QWdlZDwva2V5d29yZD48a2V5d29y

ZD5BbWxvZGlwaW5lLyp0aGVyYXBldXRpYyB1c2U8L2tleXdvcmQ+PGtleXdvcmQ+QW50aWh5cGVy

dGVuc2l2ZSBBZ2VudHMvKnRoZXJhcGV1dGljIHVzZTwva2V5d29yZD48a2V5d29yZD5Db3JvbmFy

eSBDaXJjdWxhdGlvbi8qZHJ1ZyBlZmZlY3RzPC9rZXl3b3JkPjxrZXl3b3JkPkVjaG9jYXJkaW9n

cmFwaHkvbWV0aG9kczwva2V5d29yZD48a2V5d29yZD5GZW1hbGU8L2tleXdvcmQ+PGtleXdvcmQ+

SHVtYW5zPC9rZXl3b3JkPjxrZXl3b3JkPkh5cGVydGVuc2lvbi8qZHJ1ZyB0aGVyYXB5L3BoeXNp

b3BhdGhvbG9neTwva2V5d29yZD48a2V5d29yZD5JbWlkYXpvbGVzLyp0aGVyYXBldXRpYyB1c2U8

L2tleXdvcmQ+PGtleXdvcmQ+TWFnbmV0aWMgUmVzb25hbmNlIEFuZ2lvZ3JhcGh5L21ldGhvZHM8

L2tleXdvcmQ+PGtleXdvcmQ+TWFsZTwva2V5d29yZD48a2V5d29yZD5NaWRkbGUgQWdlZDwva2V5

d29yZD48a2V5d29yZD5TdHJva2UgVm9sdW1lL2RydWcgZWZmZWN0czwva2V5d29yZD48a2V5d29y

ZD5UZXRyYXpvbGVzLyp0aGVyYXBldXRpYyB1c2U8L2tleXdvcmQ+PGtleXdvcmQ+VmFzb2RpbGF0

b3IgQWdlbnRzL3BoYXJtYWNvbG9neTwva2V5d29yZD48a2V5d29yZD5WZW50cmljdWxhciBGdW5j

dGlvbiwgTGVmdC9kcnVnIGVmZmVjdHM8L2tleXdvcmQ+PC9rZXl3b3Jkcz48ZGF0ZXM+PHllYXI+

MjAxMjwveWVhcj48L2RhdGVzPjxpc2JuPjE0MjEtOTc1MSAoRWxlY3Ryb25pYykmI3hEOzAwMDgt

NjMxMiAoTGlua2luZyk8L2lzYm4+PGFjY2Vzc2lvbi1udW0+MjI5MDY4NDc8L2FjY2Vzc2lvbi1u

dW0+PHVybHM+PHJlbGF0ZWQtdXJscz48dXJsPmh0dHA6Ly93d3cubmNiaS5ubG0ubmloLmdvdi9w

dWJtZWQvMjI5MDY4NDc8L3VybD48L3JlbGF0ZWQtdXJscz48L3VybHM+PGVsZWN0cm9uaWMtcmVz

b3VyY2UtbnVtPjEwLjExNTkvMDAwMzM5NzYyPC9lbGVjdHJvbmljLXJlc291cmNlLW51bT48L3Jl

Y29yZD48L0NpdGU+PC9FbmROb3RlPn==

ADDIN EN.CITE.DATA 33, 34 Similarly in the spontaneously hypertensive rat amlodipine and candesartan did not show any significant reverse arteriolar remodeling compared to placebo. ADDIN EN.CITE <EndNote><Cite><Author>Mancini</Author><Year>2016</Year><RecNum>16300</RecNum><DisplayText><style face="superscript">35</style></DisplayText><record><rec-number>16300</rec-number><foreign-keys><key app="EN" db-id="ztzasxe5cs00v4efwrpvftrwtafzwe22xezt" timestamp="1472033064">16300</key></foreign-keys><ref-type name="Journal Article">17</ref-type><contributors><authors><author>Mancini, M.</author><author>Scavone, A.</author><author>Sartorio, C. L.</author><author>Baccaro, R.</author><author>Kleinert, C.</author><author>Pernazza, A.</author><author>Buia, V.</author><author>Leopizzi, M.</author><author>D&apos;Amati, G.</author><author>Camici, P. G.</author></authors></contributors><auth-address>Istituto &quot;Marco Pasquali&quot; ICOT GIOMI, Latina, Italy.&#xD;Vita Salute University and Scientific Institute San Raffaele, Milan, Italy.&#xD;Department of Radiology, Oncology and Pathology, &quot;Sapienza&quot; University, Rome, Italy.</auth-address><titles><title>Effect of different drug classes on reverse remodeling of intramural coronary arterioles in the spontaneously hypertensive rat</title><secondary-title>Microcirculation</secondary-title></titles><periodical><full-title>Microcirculation</full-title></periodical><keywords><keyword>Shr</keyword><keyword>Antihypertensive drugs</keyword><keyword>Coronary blood flow</keyword><keyword>Coronary microcirculation</keyword><keyword>Hypertension</keyword><keyword>Vascular remodeling</keyword></keywords><dates><year>2016</year><pub-dates><date>Jul 21</date></pub-dates></dates><isbn>1549-8719 (Electronic)&#xD;1073-9688 (Linking)</isbn><accession-num>27441420</accession-num><urls><related-urls><url> In conclusion, this study has shown that 4 weeks and 8 weeks treatment with candesartan or amlodipine resulted in significant reductions of both systolic and diastolic brachial BP and central systolic BP but had no significant effect on basal (functional) or maximal (structural) capillary densities. These results indicate that normalization of BP with amlodipine or candesartan treatment does not necessarily results in reversal of capillary rarefaction in essential hypertension. The study also showed that both candesartan and amlodipine significantly reduced Aortic Augmentation Index but had no significant effect on pulse wave velocity.Conflicts of Interest and Source of Funding: Takeda, UK funded the study. The authors declare no conflict of interest.Details of ethics approval:The London-Surrey Borders Research Ethics committee approved this study. (REC: 08/H0806/72)Trial registration: (EudraCT: 2008-005432-32, ISRCTN 62554526)?References: ADDIN EN.REFLIST 1.Gavin JB, Maxwell L, Edgar SG. Microvascular involvement in cardiac pathology. J Mol Cell Cardiol. 1998;30:2531-2540.2.Levy BI, Schiffrin EL, Mourad JJ, Agostini D, Vicaut E, Safar ME, Struijker-Boudier HA. Impaired tissue perfusion: A pathology common to hypertension, obesity, and diabetes mellitus. Circulation. 2008;118:968-976.3.Struijker Boudier HA, le Noble JL, Messing MW, Huijberts MS, le Noble FA, van Essen H. The microcirculation and hypertension. J Hypertens Suppl. 1992;10:S147-S156.4.Antonios TFT, Singer DR, Markandu ND, Mortimer PS, MacGregor GA. Structural skin capillary rarefaction in essential hypertension. Hypertension. 1999;33:998-1001.5.Antonios TFT, Singer DR, Markandu ND, Mortimer PS, MacGregor GA. Rarefaction of skin capillaries in borderline essential hypertension suggests an early structural abnormality. Hypertension. 1999;34:655-658.6.Antonios TF, Rattray FM, Singer DR, Markandu ND, Mortimer PS, MacGregor GA. Rarefaction of skin capillaries in normotensive offspring of individuals with essential hypertension. Heart. 2003;89:175-178.7.Antonios TF, Raghuraman RP, D'Souza R, Nathan P, Wang D, Manyonda IT. Capillary remodeling in infants born to hypertensive pregnancy: Pilot study. Am J Hypertens. 2012;25:848-853.8.Antonios TF, Nama V, Wang D, Manyonda IT. Microvascular remodelling in preeclampsia: Quantifying capillary rarefaction accurately and independently predicts preeclampsia. Am J Hypertens. 2013;26:1162-1169.9.Nama V, Manyonda IT, Onwude J, Antonios TF. Structural capillary rarefaction and the onset of preeclampsia. Obstet Gynecol. 2012;119:967-974.10.De Ciuceis C, Salvetti M, Rossini C, Muiesan ML, Paini A, Duse S, La Boria E, Semeraro F, Cancarini A, Rosei CA, Sarkar A, Ruggeri G, Caimi L, Ricotta D, Rizzoni D, Rosei EA. Effect of antihypertensive treatment on microvascular structure, central blood pressure and oxidative stress in patients with mild essential hypertension. J Hypertens. 2014;32:565-574.11.Antonios TF, Kaski JC, Hasan KM, Brown SJ, Singer DR. Rarefaction of skin capillaries in patients with anginal chest pain and normal coronary arteriograms. Eur Heart J. 2001;22:1144-1148.12.Penna GL, Garbero Rde F, Neves MF, Oigman W, Bottino DA, Bouskela E. Treatment of essential hypertension does not normalize capillary rarefaction. Clinics (Sao Paulo). 2008;63:613-618.13.Debbabi H, Bonnin P, Levy BI. Effects of blood pressure control with perindopril/indapamide on the microcirculation in hypertensive patients. Am J Hypertens. 2010;23:1136-1143.14.Antonios TFT, Rattray FE, Singer DR, Markandu ND, Mortimer PS, MacGregor GA. Maximization of skin capillaries during intravital video-microscopy in essential hypertension: Comparison between venous congestion, reactive hyperaemia and core heat load tests. Clin Sci. 1999;97:523-528.15.Asmar R, Topouchian J, Pannier B, Benetos A, Safar M, Scientific QCC, Investigation Committees of the Complior S. Pulse wave velocity as endpoint in large-scale intervention trial. The complior study. Scientific, quality control, coordination and investigation committees of the complior study. J Hypertens. 2001;19:813-818.16.Kips JG, Schutte AE, Vermeersch SJ, Huisman HW, Van Rooyen JM, Glyn MC, Fourie CM, Malan L, Schutte R, Van Bortel LM, Segers P. Comparison of central pressure estimates obtained from sphygmocor, omron hem-9000ai and carotid applanation tonometry. J Hypertens. 2011;29:1115-1120.17.Rizzoni D, Pasini E, Flati V, Rodella LF, Paiardi S, Assanelli D, De Ciuceis C, Porteri E, Boari GE, Rezzani R, Speca S, Favero G, Martinotti S, Toniato E, Platto C, Agabiti-Rosei E. Angiotensin receptor blockers improve insulin signaling and prevent microvascular rarefaction in the skeletal muscle of spontaneously hypertensive rats. J Hypertens. 2008;26:1595-1601.18.Sabino B, Lessa MA, Nascimento AR, Rodrigues CA, Henriques M, Garzoni LR, Levy BI, Tibirica E. Effects of antihypertensive drugs on capillary rarefaction in spontaneously hypertensive rats: Intravital microscopy and histologic analysis. J Cardiovasc Pharmacol. 2008;51:402-409.19.Strauer BE. Significance of coronary circulation in hypertensive heart disease for development and prevention of heart failure. Am J Cardiol. 1990;65:34G-41G.20.Debbabi H, Uzan L, Mourad JJ, Safar M, Levy BI, Tibirica E. Increased skin capillary density in treated essential hypertensive patients. Am J Hypertens. 2006;19:477-483.21.Antonios TF. Microvascular rarefaction in hypertension-reversal or over-correction by treatment? Am J Hypertens. 2006;19:484-485.22.Agabiti-Rosei E, Heagerty AM, Rizzoni D. Effects of antihypertensive treatment on small artery remodelling. J Hypertens. 2009;27:1107-1114.23.Rattray FE, Coltart RA, Markandu ND, MacGregor GA, Antonios TFT. Effect of an angiotensin ii antagonist; irbesartan on blood pressure and skin capillary density in patients with essential hypertension. Journal of Hypertens. 2004;22:S25.24.Kaiser SE, Sanjuliani AF, Estato V, Gomes MB, Tibirica E. Antihypertensive treatment improves microvascular rarefaction and reactivity in low-risk hypertensive individuals. Microcirculation. 2013;20:703-716.25.Jumar A, Harazny JM, Ott C, Kistner I, Friedrich S, Schmieder RE. Improvement in retinal capillary rarefaction after valsartan treatment in hypertensive patients. J Clin Hypertens (Greenwich). 2016.26.van der Zijl NJ, Serne EH, Goossens GH, Moors CC, Ijzerman RG, Blaak EE, Diamant M. Valsartan-induced improvement in insulin sensitivity is not paralleled by changes in microvascular function in individuals with impaired glucose metabolism. J Hypertens. 2011;29:1955-1962.27.Olsen MH, Fossum E, Hoieggen A, Wachtell K, Hjerkinn E, Nesbitt SD, Andersen UB, Phillips RA, Gaboury CL, Ibsen H, Kjeldsen SE, Julius S. Long-term treatment with losartan versus atenolol improves insulin sensitivity in hypertension: Icarus, a life substudy. J Hypertens. 2005;23:891-898.28.De Ciuceis C, Savoia C, Arrabito E, Porteri E, Mazza M, Rossini C, Duse S, Semeraro F, Agabiti Rosei C, Alonzo A, Sada L, La Boria E, Sarkar A, Petroboni B, Mercantini P, Volpe M, Rizzoni D, Agabiti Rosei E. Effects of a long-term treatment with aliskiren or ramipril on structural alterations of subcutaneous small-resistance arteries of diabetic hypertensive patients. Hypertension. 2014;64:717-724.29.Schiffrin EL, Deng LY. Structure and function of resistance arteries of hypertensive patients treated with a beta-blocker or a calcium channel antagonist. J Hypertens. 1996;14:1247-1255.30.Rajzer M, Klocek M, Kawecka-Jaszcz K. Effect of amlodipine, quinapril, and losartan on pulse wave velocity and plasma collagen markers in patients with mild-to-moderate arterial hypertension. Am J Hypertens. 2003;16:439-444.31.Mackenzie IS, McEniery CM, Dhakam Z, Brown MJ, Cockcroft JR, Wilkinson IB. Comparison of the effects of antihypertensive agents on central blood pressure and arterial stiffness in isolated systolic hypertension. Hypertension. 2009;54:409-413.32.Agnoletti D, Zhang Y, Borghi C, Blacher J, Safar ME. Effects of antihypertensive drugs on central blood pressure in humans: A preliminary observation. Am J Hypertens. 2013;26:1045-1052.33.Naya M, Tsukamoto T, Morita K, Katoh C, Furumoto T, Fujii S, Tamaki N, Tsutsui H. Olmesartan, but not amlodipine, improves endothelium-dependent coronary dilation in hypertensive patients. J Am Coll Cardiol. 2007;50:1144-1149.34.Toyama T, Sato C, Koyama K, Kasama S, Murakami J, Yamashita E, Kawaguchi R, Adachi H, Hoshizaki H, Oshima S. Olmesartan improves coronary flow reserve of hypertensive patients using coronary magnetic resonance imaging compared with amlodipine. Cardiology. 2012;122:230-236.35.Mancini M, Scavone A, Sartorio CL, Baccaro R, Kleinert C, Pernazza A, Buia V, Leopizzi M, D'Amati G, Camici PG. Effect of different drug classes on reverse remodeling of intramural coronary arterioles in the spontaneously hypertensive rat. Microcirculation. 2016.Table 3. Changes in Variables from End of Placebo run-in period to 4 and 8 weeks Visit in randomised subjectsVariableAllCandesartanAmlodipineBetween Groupst testp-valuet-test Overallp-valueMean (SE) changeMean (SE) changeMean (SE) changeSitting Systolic BP (mmHg)4 weeks treatment-19.0(3.7)-19.4(5.6)-18.5(4.8)0.25<0.00018 weeks treatment-26.3(4.0)-29.4(5.6)-21.8(5.4)0.94<0.0001Sitting Diastolic BP (mmHg)4 weeks treatment-13.8(1.8)-11.8(2.5)-16.5(2.5)0.93<0.00018 weeks treatment-16.1(1.3)-15.9(1.8)-16.4(2.3)0.49<0.0001Sitting Mean BP (mmHg)4 weeks treatment-15.0(2.4)-14.5(3.3)-15.8(3.8)0.80<0.00018 weeks treatment-18.7(2.4)-20.6(2.7)-16.1(4.5)0.39<0.0001Standing Systolic BP (mmHg)4 weeks treatment-21.9(5.0)-24.8(5.3)-17.4(10.2)0.63<0.00018 weeks treatment-26.5(4.8)-30.1(4.0)-20.3(11.6)0.88<0.0001Standing Diastolic BP (mmHg)4 weeks treatment-11.8(2.5)-11.0(3.2)-13.2(4.4)0.99<0.00018 weeks treatment-16.1(2.1)-16.4(1.8)-15.5(5.4)0.24<0.0001Basal Capillary Density (capillaries per field)4 weeks treatment-0.4(1.4)0(1.5)-1.0(2.8)0.730.768 weeks treatment1.2(1.6)2.2(2.1)-0.2(2.7)0.480.48Maximal Capillary Density (capillaries per field)4 weeks treatment1.5(1.7)0.4(2.0)3.0(3.0)0.480.388 weeks treatment1.8(1.3)0.6(1.6)3.5(2.3)0.300.2Pulse Wave Velocity (meters per second)4 weeks treatment-0.1(0.3)-0.3(0.5)0.04(0.4)0.800.678 weeks treatment0.1(0.4)0.5(0.5)-0.5(0.7)0.250.79Central Systolic BP (mmHg)4 weeks treatment-18.4(4.8)-18.5(7.3)-18.2(5.3)0.980.0028 weeks treatment-22.6(4.0)-24.9(6.0)-18.8(4.2)0.50<0.0001Augmentation Index (%)4 weeks treatment-7.6(2.5-4.3(3.2)-13.0(2.7)0.090.018 weeks treatment-9.2(2.0)-8.4(3.1)-10.5(1.7)0.640.001 ................
................

In order to avoid copyright disputes, this page is only a partial summary.

Google Online Preview   Download